FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Braga, JU
   Ramos, AN
   Ferreira, AF
   Lacerda, VM
   Freire, RMC
   Bertoncini, BV
AF Braga, Jose Ueleres
   Ramos, Alberto Novaes
   Ferreira, Anderson Fuentes
   Lacerda, Victor Macedo
   Freire, Renan Monteiro Carioca
   Bertoncini, Bruno Vieira
TI Propensity for COVID-19 severe epidemic among the populations of the
   neighborhoods of Fortaleza, Brazil, in 2020
SO BMC PUBLIC HEALTH
LA English
DT Article
DE COVID-19; Public health surveillance; Disease outbreaks
AB Background: The state of Ceara (Northeast Brazil) has shown a high incidence of coronavirus disease (COVID-19), and most of the cases that were diagnosed during the epidemic originated from the capital Fortaleza. Monitoring the dynamics of the COVID-19 epidemic is of strategic importance and requires the use of sensitive tools for epidemiological surveillance, including consistent analyses that allow the recognition of areas with a greater propensity for increased severity throughout the cycle of the epidemic. This study aims to classify neighborhoods in the city of Fortaleza according to their propensity for a severe epidemic of COVID-19 in 2020.
   Methods: We conducted an ecological study within the geographical area of the 119 neighborhoods located in the city of Fortaleza. To define the main transmission networks (infection chains), we assumed that the spatial diffusion of the COVID-19 epidemic was influenced by population mobility. To measure the propensity for a severe epidemic, we calculated the infectivity burden (ItyB), infection burden (IonB), and population epidemic vulnerability index (PEVI). The propensity score for a severe epidemic in the neighborhoods of the city of Fortaleza was estimated by combining the IonB and PEVI.
   Results: The neighborhoods with the highest propensity for a severe COVID-19 epidemic were Aldeota, Cais do Porto, Centro, Edson Queiroz, Vicente Pinzon, Jose de Alencar, Presidente Kennedy, Papicu, Vila Velha, Antonio Bezerra, and Cambeba. Importantly, we found that the propensity for a COVID-19 epidemic was high in areas with differing socioeconomic profiles. These areas include a very poor neighborhood situated on the western border of the city (Vila Velha), neighborhoods characterized by a large number of subnormal agglomerates in the Cais do Porto region (Vicente Pinzon), and those located in the oldest central area of the city, where despite the wealth, low-income groups have remained (Aldeota and the adjacent Edson Queiroz).
   Conclusion: Although measures against COVID-19 should be applied to the entire municipality of Fortaleza, the classification of neighborhoods generated through this study can help improve the specificity and efficiency of these measures.
C1 [Braga, Jose Ueleres] Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, Rua Sao Francisco Xavier 524-7017D,7 Floor, BR-20550013 Rio De Janeiro, RJ, Brazil.
   [Braga, Jose Ueleres] Oswaldo Cruz Fdn FIOCRUZ, Sergio Arouca Natl Sch Publ Hlth ENSP, Dept Epidemiol & Quantitat Methods, Rio De Janeiro, RJ, Brazil.
   [Ramos, Alberto Novaes] Fed Univ Ceara UFC, Sch Med, Dept Community Hlth, Fortaleza, Ceara, Brazil.
   [Ramos, Alberto Novaes; Ferreira, Anderson Fuentes] Fed Univ Ceara UFC, Sch Med, Postgrad Program Publ Hlth, Fortaleza, Ceara, Brazil.
   [Lacerda, Victor Macedo; Freire, Renan Monteiro Carioca] Municipal Secretariat Conservat & Publ Serv SCSP, Fortaleza, Ceara, Brazil.
   [Bertoncini, Bruno Vieira] Fed Univ Ceara UFC, Technol Ctr, Dept Transport Engn, Fortaleza, Ceara, Brazil.
   [Bertoncini, Bruno Vieira] Fed Univ Ceara UFC, Technol Ctr, Postgrad Program Transport Engn, Fortaleza, Ceara, Brazil.
RP Braga, JU (corresponding author), Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, Rua Sao Francisco Xavier 524-7017D,7 Floor, BR-20550013 Rio De Janeiro, RJ, Brazil.; Braga, JU (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Sergio Arouca Natl Sch Publ Hlth ENSP, Dept Epidemiol & Quantitat Methods, Rio De Janeiro, RJ, Brazil.
EM ueleres@gmail.com
CR [Anonymous], 2020, B EP
   [Anonymous], 2020, NOV COR INF PREF FOR
   [Anonymous], 2020, COVID 19 PAIN COR
   [Anonymous], 2020, 51 WHO
   [Anonymous], 2020, VIG MUND COVID 19 CA, P1
   Fan JC, 2020, EMERG INFECT DIS, V26, P1257, DOI 10.3201/eid2606.200251
   Faria NR, 2020, 1 CASES CORONAVIRS D
   Feske ML, 2011, TUBERCULOSIS, V91, pS16, DOI 10.1016/j.tube.2011.10.005
   Giuliani D, 2020, SSRN ELECT J, DOI [10.2139/ssrn.3559569, DOI 10.2139/SSRN.3559569]
   Kang D, 2020, INT J INFECT DIS, V94, P96, DOI 10.1016/j.ijid.2020.03.076
   Pluchino A., 2020, ARXIV200402739
   Rocha Filho T. M., 2020, EXPECTED IMPACT COVI, DOI [10.1101/2020.03.14.20035873, DOI 10.1101/2020.03.14.20035873]
   Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101613
   Schumaker E, 2020, ABC NEWS, P1
   Troko J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-16
   WHO, URBAN HLTH INDEX HDB
NR 16
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD OCT 1
PY 2020
VL 20
IS 1
AR 1486
DI 10.1186/s12889-020-09558-9
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA NZ3EU
UT WOS:000576981200003
PM 32998719
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Silva, MDB
   de Oliveira, RDC
   Braga, JU
   de Almeida, JAG
   Melo, ECP
AF Bernardes Silva, Maira Domingues
   Carvalhaes de Oliveira, Raquel de Vasconcellos
   Braga, Jose Ueleres
   Guerra de Almeida, Joao Aprigio
   Prates Melo, Enirtes Caetano
TI Breastfeeding patterns in cohort infants at a high-risk fetal, neonatal
   and child referral center in Brazil: a correspondence analysis
SO BMC PEDIATRICS
LA English
DT Article
DE Longitudinal cohort; Cohort profile; Correspondence analysis;
   Breastfeeding; High risk
ID HUMAN-MILK; HOSPITAL DISCHARGE; INTENSIVE-CARE; NICU DISCHARGE; SUPPORT;
   IMPACT; UNITS
AB Background To investigate the prevalence and patterns of breastfeeding at discharge and in the first six months of life in a high-risk fetal, neonatal and child referral center. Methods Prospective, longitudinal study that included the following three steps: hospital admission, first visit after hospital discharge and monthly telephone interview until the sixth month of life. The total number of losses was 75 mothers (7.5%). Exposure variables were sorted into four groups: factors related to the newborn, the mother, the health service and breastfeeding. The dependent variable is breastfeeding as per categories established by the WHO. All 1200 children born or transferred to the high-risk fetal, neonatal and child referral center, within a seven-day postpartum period, from March 2017 to April 2018, were considered eligible for the study, and only 1003 were included. The follow-up period ended in October 2018. For this paper, we performed an exploratory analysis at hospital discharge in three stages, as follows: (i) frequencies of baseline characteristics, stratified by risk for newborn; (ii) a multiple correspondence analysis (MCA); and (iii) clusters for variables related to hospital practice and exclusive breastfeeding (EBF). Results The prevalence of EBF at hospital discharge was 65.2% (62.1-68.2) and 20.6% (16.5-25.0) in the six months of life. Out of all at-risk newborns, 45.7% were in EBF at discharge. The total inertia corresponding to the two dimensions in the MCA explained for 75.4% of the total data variability, with the identification of four groups, confirmed by the cluster analysis. Discussion Our results suggest that robust breastfeeding hospital policies and practices influence the establishment and maintenance of breastfeeding in both healthy and at-risk infants. It is advisable to plan and implement additional strategies to ensure that vulnerable and healthy newborns receive optimal feeding. It is necessary to devote extra effort particularly to at-risk infants who are more vulnerable to negative outcomes. Conclusion At-risk newborns did not exclusively breastfeed to the same extent as healthy newborns at hospital discharge. A different approach is required for at-risk neonates, who are more physically challenged and more vulnerable to problems associated with initiation and maintenance of breastfeeding.
C1 [Bernardes Silva, Maira Domingues] Fundacao Oswaldo Cruz, Human Milk Bank Fernandes Figueira Nacl Inst Wome, FIOCRUZ, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Carvalhaes de Oliveira, Raquel de Vasconcellos] Fiocruz MS, Natl Inst Infectol, Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres; Prates Melo, Enirtes Caetano] Fiocruz MS, Natl Sch Publ Hlth, Rio De Janeiro, Brazil.
   [Guerra de Almeida, Joao Aprigio] Fiocruz MS, Global Network Human Milk Banks, Rio De Janeiro, Brazil.
RP Silva, MDB (corresponding author), Fundacao Oswaldo Cruz, Human Milk Bank Fernandes Figueira Nacl Inst Wome, FIOCRUZ, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM enfpedmaira@gmail.com
OI Silva, Maira/0000-0002-6849-329X
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]; ENSP
FX This study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. This
   funding supports the PhD program at ENSP. There was no funding for the
   study design, data collection, analysis, data interpretation or in
   writing the manuscript.
CR Abdulghani N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205696
   Alonso-Diaz C, 2016, J HUM LACT, V32, P613, DOI 10.1177/0890334416658246
   Alyahya W, 2019, INT BREASTFEED J, V14, DOI 10.1186/s13006-019-0233-x
   [Anonymous], 2011, GUID OPT FEED LOW BI
   Arslanoglu S, 2013, J PERINAT MED, V41, P129, DOI 10.1515/jpm-2012-0196
   Meio MDBB, 2018, CIENC SAUDE COLETIVA, V23, P2403, DOI 10.1590/1413-81232018237.15742016
   Berti E, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00387
   Bicalho-Mancini Paula G, 2004, J Pediatr (Rio J), V80, P241, DOI 10.2223/JPED.1190
   Boccolini CS, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005971
   Brazil-Ministerio da Saude. Secretaria de Atencao a Saude. Departamento de Acoes Programaticas Estrategicas, 2017, BAS DISC POL NAC PRO
   Costa EA org, 2009, VIGILANCIA SANITARIA
   Davanzo R, 2013, J HUM LACT, V29, P374, DOI 10.1177/0890334412451055
   Declercq E, 2009, AM J PUBLIC HEALTH, V99, P929, DOI 10.2105/AJPH.2008.135236
   Dritsakou K, 2017, J MATERN-FETAL NEO M, V30, P1302, DOI 10.1080/14767058.2016.1212329
   Global Nutrition Report, 2018, GLOB NUTR REP SHIN L
   Kassambara A., 2019, EXTRACT VISUALIZE RE
   Maastrup R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089077
   Maastrup R, 2012, J HUM LACT, V28, P370, DOI 10.1177/0890334412440846
   Maayan-Metzger A, 2012, AM J PERINAT, V29, P121, DOI 10.1055/s-0031-1295652
   Mamemoto K, 2013, ASIA PAC J CLIN NUTR, V22, P270, DOI 10.6133/apjcn.2013.22.2.11
   Manzoni P, 2013, EARLY HUM DEV, V89, P37, DOI [10.1016/j.earlhumdev.2012.07.002, 10.1016/S0378-3782(13)70019-7]
   McCoy MB, 2020, PEDIATRICS, V146, DOI [10.1542/peds.2019-2946, 10.1542/peds.2020-1221]
   Mekonnen AG, 2019, INT BREASTFEED J, V14, DOI 10.1186/s13006-019-0206-0
   Ministerio da Saude. Secretaria de AtencAo a Saude. Departamento de Acoes Programaticas Estrategicas, 2009, 2 PESQ PREV AL MAT N
   Ministerio de Saude/SVS/DASIS-Sistema de Informacoes sobre Nascidos Vivos-SINASC/BRASIL, TABNET WIN32 3 0
   Nenadic O, 2007, J STAT SOFTW, V20
   O'Connor M, 2018, WOMEN BIRTH, V31, P319, DOI 10.1016/j.wombi.2017.10.013
   Perez-Escamilla R, 2016, MATERN CHILD NUTR, V12, P402, DOI 10.1111/mcn.12294
   Renfrew MJ, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13400
   Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2
   Salvatori G, 2014, BREASTFEED MED, V9, P491, DOI 10.1089/bfm.2014.0097
   Sankar MJ, 2015, ACTA PAEDIATR, V104, P3, DOI 10.1111/apa.13147
   Scime NV, 2018, JOGNN-J OBST GYN NEO, V47, P202, DOI 10.1016/j.jogn.2017.12.005
   Shah PS, 2012, COCHRANE DB SYST REV, P12
   Stark AR, 2008, PEDIATRICS, V122, P1119, DOI 10.1542/peds.2008-2174
   Underwood MA, 2013, PEDIATR CLIN N AM, V60, P189, DOI 10.1016/j.pcl.2012.09.008
   Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7
   Vieira TO, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-175
   WHO, 2018, IMPL GUID PROT PROM
   Wickham H, 2019, ELEGANT GRAPHICS DAT
   World Health Organization, 2017, INV CAS BREASTF NURT
   World Health Organization, 2009, BAB FRIENDL HOSP IN
   World Health Organization UNICEF, 2019, GLOB BREASTF SCOR
   Zhu XQ, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2323-6
NR 44
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2431
J9 BMC PEDIATR
JI BMC Pediatr.
PD AUG 7
PY 2020
VL 20
IS 1
AR 372
DI 10.1186/s12887-020-02272-w
PG 13
WC Pediatrics
SC Pediatrics
GA NC2KX
UT WOS:000561044900002
PM 32767990
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Proenca, R
   Souza, FM
   Bastos, ML
   Caetano, R
   Braga, JU
   Faerstein, E
   Trajman, A
AF Proenca, Raquel
   Souza, Fernanda Mattos
   Bastos, Mayara Lisboa
   Caetano, Rosangela
   Braga, Jose Ueleres
   Faerstein, Eduardo
   Trajman, Anete
TI Active and latent tuberculosis in refugees and asylum seekers: a
   systematic review and meta-analysis
SO BMC PUBLIC HEALTH
LA English
DT Review
DE Forced migration; Mycobacterium tuberculosis; Latent tuberculosis
   infection; Prevalence; Global health
ID SAN-DIEGO COUNTY; MULTIDRUG-RESISTANT TUBERCULOSIS; NEWLY RESETTLED
   REFUGEES; NEWLY ARRIVED REFUGEES; HIV-INFECTED REFUGEES; UNITED-STATES;
   IRAQI REFUGEES; HEALTH PROFILE; SEEKING ASYLUM; SKIN-TEST
AB BackgroundIn 2018, there were 70.8 million refugees, asylum seekers and persons displaced by wars and conflicts worldwide. Many of these individuals face a high risk for tuberculosis in their country of origin, which may be accentuated by adverse conditions endured during their journey. We summarised the prevalence of active and latent tuberculosis infection in refugees and asylum seekers through a systematic literature review and meta-analyses by country of origin and host continent.MethodsArticles published in Medline, EMBASE, Web of Science and LILACS from January 2000 to August 2017 were searched for, without language restriction. Two independent authors performed the study selection, data extraction and quality assessment. Random effect models were used to estimate average measures of active and latent tuberculosis prevalence. Sub-group meta-analyses were performed according to country of origin and host continent.ResultsSixty-seven out of 767 identified articles were included, of which 16 entered the meta-analyses. Average prevalence of active and latent tuberculosis was 1331 per 100 thousand inhabitants [95% confidence interval (CI)=542-2384] and 37% (95% CI=23-52%), respectively, both with high level of heterogeneity (variation in estimative attributable to heterogeneity [I-2]=98.2 and 99.8%). Prevalence varied more according to countries of origin than host continent. Ninety-one per cent of studies reported routine screening of recently arrived immigrants in the host country; two-thirds confirmed tuberculosis bacteriologically. Many studies failed to provide relevant information.ConclusionTuberculosis is a major health problem among refugees and asylum seekers and should be given special attention in any host continent. To protect this vulnerable population, ensuring access to healthcare for early detection for prevention and treatment of the disease is essential.
C1 [Proenca, Raquel; Souza, Fernanda Mattos; Bastos, Mayara Lisboa; Caetano, Rosangela; Braga, Jose Ueleres; Faerstein, Eduardo; Trajman, Anete] Univ Estado Rio De Janeiro, Rio De Janeiro, RJ, Brazil.
   [Braga, Jose Ueleres] Fundacao Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [Trajman, Anete] McGill Univ, Montreal, PQ, Canada.
   [Trajman, Anete] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
RP Trajman, A (corresponding author), Univ Estado Rio De Janeiro, Rio De Janeiro, RJ, Brazil.; Trajman, A (corresponding author), McGill Univ, Montreal, PQ, Canada.; Trajman, A (corresponding author), Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
EM atrajman@gmail.com
RI ; Trajman, Anete/C-7679-2016
OI Proenca, Raquel/0000-0002-3380-5089; Trajman, Anete/0000-0002-4000-4984
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]
FX This study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. CAPES had
   no role in the constructions, analysis or writing of this manuscript.
CR Abubakar I, 2018, LANCET, V392, P2606, DOI 10.1016/S0140-6736(18)32114-7
   [Anonymous], 2012, BAS TB FACTS
   [Anonymous], 2007, TUB CAR CONTR REF DI
   Arshad S, 2010, EUR RESPIR J, V35, P1336, DOI 10.1183/09031936.00054709
   Baker CA, 2009, AM J TROP MED HYG, V80, P628, DOI 10.4269/ajtmh.2009.80.628
   Banfield S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038556
   Beggs CB, 2003, INT J TUBERC LUNG D, V7, P1015
   Beijer U, 2012, LANCET INFECT DIS, V12, P859, DOI 10.1016/S1473-3099(12)70177-9
   Bennet R, 2017, INFECT DIS-NOR, V49, P501, DOI 10.1080/23744235.2017.1292540
   Bennett RJ, 2014, AM J PUBLIC HEALTH, V104, pE95, DOI 10.2105/AJPH.2013.301637
   Bertelsen NS, 2018, J IMMIGR MINOR HEALT, V20, P171, DOI 10.1007/s10903-016-0507-y
   Bloch-Infanger C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179537
   Board AR, 2016, INT HEALTH, V8, P67, DOI 10.1093/inthealth/ihv033
   Bozorgmehr K, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.12.30491
   Bua A, 2016, J PUBLIC HEALTH-UK, V38, P760, DOI 10.1093/pubmed/fdv215
   Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1614
   Chai SJ, 2013, CLIN INFECT DIS, V56, P652, DOI 10.1093/cid/cis927
   Chaves NJ, 2009, EMERG INFECT DIS, V15, P1769, DOI 10.3201/eid1511.090777
   Choi CM, 2007, J KOREAN MED SCI, V22, P963, DOI 10.3346/jkms.2007.22.6.963
   Clark RC, 2007, J PUBLIC HEALTH-UK, V29, P420, DOI 10.1093/pubmed/fdm063
   de Navarro PD, 2016, J BRAS PNEUMOL, V42, P348, DOI 10.1590/S1806-37562016000000001
   de Vries Sophia G, 2017, Lancet Infect Dis, V17, pe128, DOI 10.1016/S1473-3099(16)30531-X
   Dhavan P, 2017, INT J TUBERC LUNG D, V21, P610, DOI 10.5588/ijtld.16.0917
   Diel R, 2004, J CLIN MICROBIOL, V42, P2952, DOI 10.1128/JCM.42.7.2952-2960.2004
   Dierberg KL, 2016, EMERG INFECT DIS, V22, P463, DOI 10.3201/eid2203.140732
   Eiset AH, 2017, PUBLIC HEALTH REV, V38, DOI 10.1186/s40985-017-0065-4
   Entzel PP, 2003, AM J PUBLIC HEALTH, V93, P286, DOI 10.2105/AJPH.93.2.286
   Faerstein E, 2019, ROUTLEDGE HDB POLITI, P359
   Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7
   Gavagan T, 1998, AM FAM PHYSICIAN, V57, P1061
   Geisler SS, 2010, INT J TUBERC LUNG D, V14, P1388
   Gibson-Helm ME, 2015, BIRTH-ISS PERINAT C, V42, P116, DOI 10.1111/birt.12159
   Gilpin C, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00098-2018
   Goldberg SV, 2004, INT J TUBERC LUNG D, V8, P76
   Gray K, 2012, PEDIATR INFECT DIS J, V31, P521, DOI 10.1097/INF.0b013e3182456c55
   Harling R, 2007, PUBLIC HEALTH, V121, P822, DOI 10.1016/j.puhe.2007.02.019
   Harstad I, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-670
   Harstad I, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-141
   Hensel RL, 2016, INT J TUBERC LUNG D, V20, P71, DOI 10.5588/ijtld.15.0457
   Hobbs Mark, 2002, N Z Med J, V115, pU152
   Horton KC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002119
   Ismail MB, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007014
   Johnston V, 2012, AUST J PRIM HEALTH, V18, P242, DOI 10.1071/PY11065
   Kimbrough W, 2012, LANCET INFECT DIS, V12, P950, DOI 10.1016/S1473-3099(12)70225-6
   Klinkenberg E, 2009, EUR RESPIR J, V34, P1180, DOI 10.1183/09031936.00038009
   Kowatsch-Beyer K, 2013, INT J TUBERC LUNG D, V17, P320, DOI 10.5588/ijtld.12.0439
   Lalchandani S, 2001, Ir Med J, V94, P79
   Lee D, 2013, MMWR SURVEILL SUMM, V62, P1
   Lim R, 2016, CAN RESPIR J, V2016, DOI 10.1155/2016/8249843
   Liu YC, 2015, ANN INTERN MED, V162, P420, DOI 10.7326/M14-2082
   Liu YC, 2009, NEW ENGL J MED, V360, P2406, DOI 10.1056/NEJMoa0809497
   Lobato MN, 2008, INT J TUBERC LUNG D, V12, P506
   LoBue PA, 2004, CHEST, V126, P1777, DOI 10.1378/chest.126.6.1777
   Lonnroth K, 2017, INT J TUBERC LUNG D, V21, P624, DOI 10.5588/ijtld.16.0845
   Lowther SA, 2012, INT J ENV RES PUB HE, V9, P4197, DOI 10.3390/ijerph9114197
   Lucas M, 2010, THORAX, V65, P442, DOI 10.1136/thx.2009.127555
   Marras TK, 2003, CHEST, V124, P915, DOI 10.1378/chest.124.3.915
   Meier V, 2016, INT J HYG ENVIR HEAL, V219, P811, DOI 10.1016/j.ijheh.2016.07.018
   Mockenhaupt FP, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.10.30160
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097]
   Moreno Alejandro, 2006, J Immigr Minor Health, V8, P163, DOI 10.1007/s10903-006-8524-x
   Nisbet SM, 2007, INTERN MED J, V37, P290, DOI 10.1111/j.1445-5994.2007.01335.x
   Oeltmann JE, 2008, EMERG INFECT DIS, V14, P1715, DOI 10.3201/eid1411.071629
   Otoukesh S, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-82
   Ouimet MJ, 2008, CAN J PUBLIC HEALTH, V99, P499, DOI 10.1007/BF03403785
   Padovese V, 2014, J PUBLIC HEALTH-UK, V36, P22, DOI 10.1093/pubmed/fdt036
   Pareek M, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0595-5
   Pavlopoulou ID, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0888-7
   Paxton GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038194
   Pottie K, 2007, CAN FAM PHYSICIAN, V53, P1928
   Rajamanoharan S, 2004, INT J STD AIDS, V15, P509, DOI 10.1258/0956462041558140
   Ravensbergen SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154791
   Rennert-May E, 2016, CAN RESPIR J, V2016, DOI 10.1155/2016/7980869
   Russo G, 2016, J PUBLIC HEALTH-UK, V38, P212, DOI 10.1093/pubmed/fdv049
   Sarivalasis A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-285
   Schepisi MS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-872
   Seedat F, 2018, LANCET INFECT DIS, V18, pE259, DOI 10.1016/S1473-3099(18)30117-8
   Sheikh M, 2009, J PAEDIATR CHILD H, V45, P509, DOI 10.1111/j.1440-1754.2009.01550.x
   Shete PB, 2018, INT J TUBERC LUNG D, V22, P835, DOI 10.5588/ijtld.17.0503
   Soydan L, 2017, INT HEALTH, V9, P118, DOI 10.1093/inthealth/ihw057
   StataCorp, 2013, STATA STAT SOFTW REL
   Subedi P, 2015, INT J TUBERC LUNG D, V19, P565, DOI 10.5588/ijtld.14.0729
   Tafuri S, 2011, AM J INFECT CONTROL, V39, P495, DOI 10.1016/j.ajic.2010.10.013
   Taylor EM, 2016, J IMMIGR MINOR HEALT, V18, P966, DOI 10.1007/s10903-015-0273-2
   The United Nations High Commissioner for Refugees, 1951, CONV PROT REL STAT R
   Tiong ACD, 2006, MED J AUSTRALIA, V185, P602, DOI 10.5694/j.1326-5377.2006.tb00724.x
   TOOLE MJ, 1993, JAMA-J AM MED ASSOC, V270, P600, DOI 10.1001/jama.270.5.600
   Trauer JM, 2011, MED J AUSTRALIA, V194, P579, DOI 10.5694/j.1326-5377.2011.tb03108.x
   United Nations High Commissioner For Refugees, 2007, REF PROT INT MIGR
   United Nations High Commissioner for Refugees, 2019, GLOB TRENDS FORC DIS
   Varkey P, 2007, J TRAVEL MED, V14, P1, DOI 10.1111/j.1708-8305.2006.00083.x
   von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X
   Walker PF, 1999, MED CLIN N AM, V83, P1103
   Walters JK, 2016, J IMMIGR MINOR HEALT, V18, P292, DOI 10.1007/s10903-015-0187-z
   Watts NS, 2017, TRAVEL MED INFECT DI, V16, P35, DOI 10.1016/j.tmaid.2017.03.007
   Weinfurter P, 2011, INT J TUBERC LUNG D, V15, P1056, DOI 10.5588/ijtld.10.0650
   Weinrich JM, 2017, EUR RADIOL, V27, P3244, DOI 10.1007/s00330-016-4684-9
   Winje BA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-65
   World Health Organization, 2015, END TB STRAT
   World Health Organization, 2019, WHO GLOB TUB REP 201
   Yanni EA, 2013, J IMMIGR MINOR HEALT, V15, P1, DOI 10.1007/s10903-012-9578-6
   Zimmerman C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001034
NR 102
TC 0
Z9 0
U1 2
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JUN 3
PY 2020
VL 20
IS 1
DI 10.1186/s12889-020-08907-y
PG 17
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LY1CB
UT WOS:000540259000004
PM 32493327
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU da Silva, LAM
   Braga, JU
   da Silva, JP
   Cruz, MDPE
   de Oliveira, ALS
   Werneck, GL
AF Marques da Silva, Lilia Aparecida
   Braga, Jose Ueleres
   da Silva, Joao Pereira
   Pires e Cruz, Maria do Socorro
   de Oliveira, Andre Luiz Sa
   Werneck, Guilherme Loureiro
TI Spatial distribution of Leishmania seropositive dogs in the Angelim
   neighborhood, Teresina, Piaui, Brazil: appraisal of three spatial
   clustering methods
SO GEOJOURNAL
LA English
DT Article; Early Access
DE Canine leishmaniasis; Spatial analysis; Cluster techniques; Brazil
ID CANINE VISCERAL LEISHMANIASIS; STATE; SCAN; IDENTIFICATION; SPREAD;
   HEALTH; AREAS; RISK; CITY
AB The detection of spatial clusters has been suggested as a potential tool for guiding the delivery of interventions against visceral leishmaniasis; however, little attention has been given to the consistency of results by using different spatial clustering methods. The present study aimed to assess the performance of three different techniques for identifying patterns in the spatial distribution of canine leishmaniasis in the city of Teresina, Brazil. This cross-sectional study was based on a serological survey for canine leishmaniasis in which each dog domicile was georeferenced to the exact location of each animal in space. The spatial analysis was performed using three methods: the Cuzick-Edwards statistic, the Hierarchical Nearest Neighbour analysis, and the Kulldorff Scan statistic. All techniques were able to identify clusters of high prevalences of canine leishmaniasis, but results were not consistent among techniques. The feasibility of the identification and location of clusters of cases in a restricted number of villages in neighborhoods might contribute to the optimization of control measures against visceral leishmaniasis. However, given the relative inconsistency of the results provided by the different methods, protocols for assessing clusters of diseases should always include more than one method of evaluation.
C1 [Marques da Silva, Lilia Aparecida; Werneck, Guilherme Loureiro] Univ Fed Rio de Janeiro, Inst Estudos Sande Colet, Ave Horacio Macedo S-N, BR-21941598 Rio De Janeiro, RJ, Brazil.
   [Braga, Jose Ueleres; Werneck, Guilherme Loureiro] Univ Estado Rio De Janeiro, Inst Med Social, Dept Epidemiol, Rua Sao Francisco Xavier 524 Maracana,Bloco D, BR-20550013 Rio De Janeiro, RJ, Brazil.
   [da Silva, Joao Pereira] Fundacao Municipal Saude, Gerencia Controle Zoonoses, Rua Minas Gerais 909, BR-64003850 Teresina, PI, Brazil.
   [Pires e Cruz, Maria do Socorro] Univ Fed Piaui, Ctr Ciencias Agr, Programa Posgrad Tecnol Aplicadas Anim Interesse, Dept Morfofisiol Vet, Socopo S-N, BR-64049550 Teresina, PI, Brazil.
   [de Oliveira, Andre Luiz Sa] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Nucleo Estat & Geoproc, Av Prof Moraes Rego S-N,Cidade Univ, BR-740465 Recife, PE, Brazil.
   [Werneck, Guilherme Loureiro] Fiocruz Piaui, Rua Magalhaes Filho 519 Ctr Norte, BR-64000128 Teresina, PI, Brazil.
RP Werneck, GL (corresponding author), Univ Estado Rio De Janeiro, Inst Med Social, Dept Epidemiol, Rua Sao Francisco Xavier 524 Maracana,Bloco D, BR-20550013 Rio De Janeiro, RJ, Brazil.
EM gwerneck@iesc.ufrj.br
RI Werneck, Guilherme/A-2841-2013
OI Werneck, Guilherme/0000-0003-1169-1436
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPqBrazil)National Council for Scientific and Technological
   Development (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ)
FX The study was partially funded by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPqBrazil) and the Fundacao
   de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The study
   sponsors have no role in study design; collection, analysis, and
   interpretation of data; writing of the paper; and decision to submit it
   for publication.
CR Adeola AM, 2016, TROP MED INT HEALTH, V21, P675, DOI 10.1111/tmi.12680
   Albuquerque HG, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2844-2
   Barbosa DS, 2014, ACTA TROP, V131, P56, DOI 10.1016/j.actatropica.2013.12.002
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Benitez AD, 2018, PREV VET MED, V154, P47, DOI 10.1016/j.prevetmed.2018.02.011
   Lins TNB, 2018, REV SOC BRAS MED TRO, V51, P680, DOI 10.1590/0037-8682-0087-2018
   Boaz R, 2019, SPAT SPATIO-TEMPORAL, V29, P177, DOI 10.1016/j.sste.2018.09.001
   Costa MA, 2005, ENVIRON ECOL STAT, V12, P301, DOI 10.1007/s10651-005-1515-6
   de Almeida AS, 2011, AM J TROP MED HYG, V84, P681, DOI 10.4269/ajtmh.2011.10-0325
   de Carvalho AG, 2018, PATHOG GLOB HEALTH, V112, P29, DOI 10.1080/20477724.2018.1438229
   do Prado PF, 2011, REV SOC BRAS MED TRO, V44, P561, DOI 10.1590/S0037-86822011000500006
   Duncombe J, 2012, AM J TROP MED HYG, V86, P753, DOI 10.4269/ajtmh.2012.11-0650
   Emch M., 2017, HLTH MED GEOGRAPHY
   Figueiredo ABF, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311x00093516, 10.1590/0102-311X00093516]
   Fritz CE, 2013, GEOSPATIAL HEALTH, V7, P183, DOI 10.4081/gh.2013.79
   Glass GE, 2000, EPIDEMIOL REV, V22, P136, DOI 10.1093/oxfordjournals.epirev.a018010
   JACQUEZ GM, 1994, AM J EPIDEMIOL, V140, P58, DOI 10.1093/oxfordjournals.aje.a117159
   Krieger N, 2003, EPIDEMIOLOGY, V14, P384, DOI 10.1097/01.ede.0000071473.69307.8a
   Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995
   Kulldorff M, 2006, STAT MED, V25, P3929, DOI 10.1002/sim.2490
   Last JM, 2001, DICT EPIDEMIOLOGY
   Lawson AB, 2006, STAT METHODS SPATIAL, P13
   Levine N, 2013, CRIMESTAT 4 SPATIAL
   Louis VR, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-50
   Machado G, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-018-3564-0
   McLafferty S, 2015, ANN GIS, V21, P127, DOI DOI 10.1080/19475683.2015.1008572
   Ministerio da Saude, 2019, CAS CONF LEISHM VISC
   Ministerio da Saude, 2019, LET LEISHM VISC BRAS
   Ministerio da Saude Datasus: Informacoes de Saude Brasil, 2020, LEISHM VISC CAS CONF
   de Araujo VEM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002540
   Neill DB, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-20
   Bruhn FRP, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2877-6
   Peixoto HM, 2015, TROP MED INT HEALTH, V20, P334, DOI 10.1111/tmi.12429
   Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001
   Prestes-Carneiro LE, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3496-6
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Teixeira-Neto RG, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0485-7
   Vieira CP, 2014, REV SOC BRAS MED TRO, V47, P350, DOI 10.1590/0037-8682-0047-2014
   Werneck GL, 2007, EPIDEMIOL INFECT, V135, P195, DOI 10.1017/S0950268806006881
   Werneck GL, 2002, EPIDEMIOLOGY, V13, P364, DOI 10.1097/00001648-200205000-00020
   Werneck GL, 2008, CAD SAUDE PUBLICA, V24, P2937, DOI 10.1590/S0102-311X2008001200023
   Werneck GL, 2008, CIENC SAUDE COLETIVA, V13, P1753, DOI 10.1590/S1413-81232008000600010
   WHO, 2010, CONTR LEISHM REP M W
   Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338
   World Health Organization (WHO), 2019, LEISHMANIASIS
   Young RL, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-37
NR 46
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0343-2521
EI 1572-9893
J9 GEOJOURNAL
JI GeoJournal
DI 10.1007/s10708-020-10195-3
EA MAY 2020
PG 9
WC Geography
SC Geography
GA LK3LE
UT WOS:000530762900001
DA 2020-12-01
ER

PT J
AU Santana, LS
   Braga, JU
AF Santana, Lais Santos
   Braga, Jose Ueleres
TI Spatial diffusion of Zika fever epidemics in the Municipality of
   Salvador-Bahia, Brazil, in 2015-2016: does Zika fever have the same
   spread pattern as Dengue and Chikungunya fever epidemics?
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Zika; Chikungunya; Dengue; Arboviruses; Spatial diffusion
ID VIRUS OUTBREAK
AB Introduction: The recent emergence and rapid spread of Zika and Chikungunya fevers in Brazil, occurring simultaneously to a Dengue fever epidemic, together represent major challenges to public health authorities. This study aimed to identify and compare the 2015-2016 spatial diffusion pattern of Zika, Chikungunya, and Dengue epidemics in Salvador-Bahia. Methods: We used two study designs comprising a cross-sectional-to-point pattern and an ecological analysis of lattice data. Residential addresses involving notified cases were geocoded. We used four spatial diffusion analysis techniques: (i) visual inspection of the sequential kernel and choropleth map. (ii) spatial correlogram analysis, (iii) spatial local autocorrelation (LISA) changes analysis and, (iv) nearest neighbor index (NNI) modeling. Results: Kernel and choropleth maps indicated that arboviruses spread to neighboring areas near the first reported cases and occupied these new areas, suggesting a diffusion expansion pattern. A greater case density occurred in central and western areas. In 2015 and 2016, the NNI best-fit model had an S-curve compatible with an expansion pattern for Zika (R-2 = 0.94; 0.95), Chikungunya (R-2 = 0.99; 0.98) and Dengue (R-2 = 0.93; 0.99) epidemics, respectively. Spatial correlograms indicated a decline in spatial lag autocorrelations for the three diseases (expansion pattern). Significant LISA changes suggested different diffusion patterns, although a small number of changes were detected. Conclusions: These findings indicate diffusion expansion, a unique spatial diffusion pattern of Zika, Chikungunya, and Dengue epidemics in Salvador-Bahia, namely. Knowing how and where arboviruses spread in Salvador-Bahia can help improve subsequent specific epidemic control interventions.
C1 [Santana, Lais Santos] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Programa Posgrad Stricto Sensu Epidemiol Saude Pu, Rio De Janeiro, RJ, Brazil.
   [Braga, Jose Ueleres] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Epidemiol & Metodos Quantitativos, Rio De Janeiro, RJ, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, RJ, Brazil.
RP Braga, JU (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Epidemiol & Metodos Quantitativos, Rio De Janeiro, RJ, Brazil.; Braga, JU (corresponding author), Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, RJ, Brazil.
EM ueleres@gmail.com
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES
FX This study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brasil (CAPES).
CR Andrade Ana Lúcia Sampaio Sgambatti de, 2004, Cad. Saúde Pública, V20, P411, DOI 10.1590/S0102-311X2004000200008
   ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x
   Anselin L., 2017, GEODA USERS GUIDE
   Barreto FR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-51
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cliff A. D., 1981, SPATIAL DIFFUSION
   Cohen J, 1999, J QUANT CRIMINOL, V15
   Cromley EK, 2012, GIS PUBLIC HLTH, P234
   Gatrell AC, 1996, SOC SCI MED, V42, P843, DOI 10.1016/0277-9536(95)00183-2
   Gubler DJ, 2016, NOVART FDN SYMP, V277, P3
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   IBGE, 2016, POP MUN SALV 2016
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lam NS, 1996, SPATIAL TEMPORAL SPR, V28
   Lee J, 2014, INT J APPL GEOSPAT R, V5, P1, DOI 10.4018/ijagr.2014010101
   Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006245, 10.1590/s1518-8787.2016050006245]
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Ministerio da Saude ( MS), 2014, SIST NAC VIG SAUD RE, V45
   Ministerio da Saude ( MS), 2017, SIST NAC VIG SAUD VI, V48
   Ministerio da Saude ( MS), 2015, SIST NAC VIG SAUD PL
   Morato DG, 2015, MEM I OSWALDO CRUZ, V110, P528, DOI 10.1590/0074-0276140388
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1
   R Core Team, 2016, R FDN STAT COMP
   Rajapakse S, 2010, T ROY SOC TROP MED H, V104, P89, DOI 10.1016/j.trstmh.2009.07.031
   Sant-Julien T, 2010, MODEL SPAT ANAL, P127, DOI 10.1002/9780470612255
   SEDUR, 2016, PLAN DIR DES URB MUN
   Team Qgis Development, 2016, QGIS GEOGR INF SYST
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 32
TC 0
Z9 0
U1 0
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PY 2020
VL 53
AR e20190563
DI 10.1590/0037-8682-0563-2019
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LC6AV
UT WOS:000525414000001
PM 32267460
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Loureiro, RB
   Macie, ELN
   Caetano, R
   Peres, RL
   Fregona, G
   Golub, JE
   Braga, JU
AF Loureiro, Rafaela Borge
   Noia Macie, Ethel Leonor
   Caetano, Rosangela
   Peres, Renata Lyrio
   Fregona, Geisa
   Golub, Jonathan E.
   Braga, Jose Ueleres
TI Cost-effectiveness of QuantiFERON-TB Gold In-Tube versus tuberculin skin
   test for diagnosis and treatment of Latent Tuberculosis Infection in
   primary health care workers in Brazil
SO PLOS ONE
LA English
DT Article
ID GAMMA RELEASE ASSAYS; BLOOD INTERFERON-GAMMA; ISONIAZID PREVENTIVE
   THERAPY; MYCOBACTERIUM-TUBERCULOSIS; INCREASED RISK; UNITED-STATES;
   HEPATOTOXICITY; RECOMMENDATIONS; TRANSMISSION; PERFORMANCE
AB Objectives
   The goal of this study was to perform a cost-effectiveness analysis from the public health system perspective, comparing five strategies for Latent Tuberculosis Infection (LTBI) diagnosis in primary health care workers in Brazil.
   Design
   Analytical model for decision making, characterized by cost-effectiveness analysis.
   Setting
   Primary Care Level, considering primary health care workers in Brazil.
   Participants
   An analytical model for decision making, characterized by a tree of probabilities of events, was developed considering a hypothetical cohort of 10,000 primary health care workers, using the software TreeAge ProT 2013 to simulate the clinical and economic impacts of new diagnostic technology (QuantiFERON (R)-TB Gold in-Tube) versus the traditional tuberculin skin test.
   Methods
   This model simulated five diagnostic strategies for LTBI in primary health care workers (HCW) in Brazil: tuberculin skin testing using >= 5 mm cut-off, tuberculin skin testing >= 10 mm cut-off, QuantiFERON (R)-TB Gold in-Tube, tuberculin skin testing using >= 5 mm cut-off confirmed by QuantiFERON (R)-TB Gold In-Tube if TST positive, tuberculin skin testing using >= 10 mm cut-off confirmed by QuantiFERON (R)-TB Gold In-Tube if TST positive.
   Primary and secondary outcome measures
   The outcome measures are the number of individuals correctly classified by the test and the number of Tuberculosis cases avoided.
   Results
   The most cost-effective strategy was the tuberculin skin test considering >= 10mm cut-off. The isolated use of the QuantiFERON (R)-TB Gold In-Tube revealed the strategy of lower efficiency with incremental cost-effectiveness ratio (ICER) of US$ 146.05 for each HCW correctly classified by the test.
   Conclusions
   The tuberculin skin test using >= 10 mm cut-off was the most cost-effective strategy in the diagnosis of Latent Tuberculosis Infection in primary health care works in Brazil.
C1 [Loureiro, Rafaela Borge; Braga, Jose Ueleres] Univ Estado Rio de Janeiro UERJ, Inst Social Med IMS, Dept Epidemiol, Rio De Janeiro, RJ, Brazil.
   [Loureiro, Rafaela Borge; Noia Macie, Ethel Leonor; Peres, Renata Lyrio; Fregona, Geisa] Univ Fed Espirito Santo UFES, Lab Epidemiol Lab Epi, Vitoria, ES, Brazil.
   [Noia Macie, Ethel Leonor] Univ Fed Espirito Santo UFES, Grad Program Collect Hlth PPGSC, Vitoria, ES, Brazil.
   [Caetano, Rosangela] Univ Estado Rio de Janeiro UERJ, Inst Social Med IMS, Dept Hlth Policy Planning & Adm, Rio De Janeiro, RJ, Brazil.
   [Peres, Renata Lyrio] Univ Fed Espirito Santo UFES, Ctr Infect Dis NDI, Vitoria, ES, Brazil.
   [Golub, Jonathan E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Div Infect Dis, Baltimore, MD USA.
RP Braga, JU (corresponding author), Univ Estado Rio de Janeiro UERJ, Inst Social Med IMS, Dept Epidemiol, Rio De Janeiro, RJ, Brazil.
EM ueleres@gmail.com
OI Maciel, Ethel Leonor/0000-0003-4826-3355; Fregona,
   Geisa/0000-0001-5835-8222
FU CNPq (Conselho Nacional de Desenvolvimento Cienti'fico e Tecnologico)
   MCT/CNPq - UniversalNational Council for Scientific and Technological
   Development (CNPq) [14/2009]; International Clinical, Operational and
   Health Services Research Training Award grant ICOHRTA [AIDS/TB]
FX This study was supported by CNPq (Conselho Nacional de Desenvolvimento
   Cienti ' fico e Tecnologico) MCT/CNPq No. 14/2009 - Universal and by the
   International Clinical, Operational and Health Services Research
   Training Award grant ICOHRTA [AIDS/TB]. None of the funding agencies is
   responsible for the statements in this article. The funders had no role
   in study design, data analysis, decision to publish, or preparation of
   the manuscript.
CR Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2
   [Anonymous], 2010, Can Commun Dis Rep, V36, P1, DOI [10.14745/ccdr.v36i00as2, 10.14745/ccdr.v36i00a05, 10.14745/ccdr.v36i00as3]
   [Anonymous], 1972, Bull World Health Organ, V46, P371
   [Anonymous], 2000, MMWR Recomm Rep, V49, P1
   Arend SM, 2002, J INFECT DIS, V186, P1797, DOI 10.1086/345760
   Barnes PF, 2004, AM J RESP CRIT CARE, V170, P5, DOI 10.1164/rccm.2404004
   BRASIL Sau de Md Secretaria de TeIE Tecnologia DdCe, 2009, DIR MET EST EC TECN
   Canada C Health Mo Diseases CfC Control I of PHA, 2014, CANADIAN TUBERCULOSI
   Canadian Tuberculosis Committee (CTC), 2008, Can Commun Dis Rep, V34, P1
   Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab
   Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847
   Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011
   Control ECfDPa, 2011, US INT GAMM REL ASS
   de Leon DP, 2008, J RHEUMATOL, V35, P776
   de Perio MA, 2009, ARCH INTERN MED, V169, P179, DOI 10.1001/archinternmed.2008.524
   Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x
   Deuffic-Burban S, 2010, INT J TUBERC LUNG D, V14, P471
   Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110
   Diel R, 2007, CHEST, V131, P1424, DOI 10.1378/chest.06-2728
   Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350
   Diel R, 2009, CHEST, V135, P1010, DOI 10.1378/chest.08-2048
   Do AN, 1999, INT J TUBERC LUNG D, V3, P377
   Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767
   Esteban J, 2001, INT J TUBERC LUNG D, V5, P583
   Ferrara G, 2005, AM J RESP CRIT CARE, V172, P631, DOI 10.1164/rccm.200502-196OC
   Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6
   Fountain FF, 2005, CHEST, V128, P116, DOI 10.1378/chest.128.1.116
   Fox BD, 2009, LUNG, V187, P413, DOI 10.1007/s00408-009-9182-2
   Garcia-Garcia MD, 2001, INFECT CONT HOSP EP, V22, P88
   Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358
   Horsburgh CR, 2010, CHEST, V137, P401, DOI 10.1378/chest.09-0394
   Horton KC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002119
   HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968
   Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045
   Khan K, 2002, NEW ENGL J MED, V347, P1850, DOI 10.1056/NEJMsa021099
   Kowada A, 2015, J HOSP INFECT, V89, P99, DOI 10.1016/j.jhin.2014.10.002
   Lee JY, 2006, EUR RESPIR J, V28, P24, DOI 10.1183/09031936.06.00016906
   Leung CC, 2011, EUR RESPIR J, V37, P690, DOI 10.1183/09031936.00079310
   Linas BP, 2011, AM J RESP CRIT CARE, V184, P590, DOI 10.1164/rccm.201101-0181OC
   LoBue PA, 2003, AM J RESP CRIT CARE, V168, P443, DOI 10.1164/rccm.200303-390OC
   MALONEY SA, 1995, ANN INTERN MED, V122, P90, DOI 10.7326/0003-4819-122-2-199501150-00002
   Mancuso JD, 2011, INT J TUBERC LUNG D, V15, P1223, DOI 10.5588/ijtld.10.0542
   Marra F, 2008, INT J TUBERC LUNG D, V12, P1414
   Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1
   Mazurek Gerald H, 2003, MMWR Recomm Rep, V52, P15
   McKenna MT, 1996, AM J RESP CRIT CARE, V154, P587, DOI 10.1164/ajrccm.154.3.8810591
   Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006
   Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410
   Millard PS, 1996, WESTERN J MED, V164, P486
   Nienhaus A, 2008, INT ARCH OCC ENV HEA, V81, P295, DOI 10.1007/s00420-007-0212-1
   Nienhaus A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-247
   Nolan CM, 1999, JAMA-J AM MED ASSOC, V281, P1014, DOI 10.1001/jama.281.11.1014
   Nolan CM, 2003, AM J RESP CRIT CARE, V168, P412, DOI 10.1164/rccm.2306004
   Ozdemir D, 2007, JPN J INFECT DIS, V60, P102
   Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746
   Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241
   Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208
   Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC
   Player S, 1998, Healthc Financ Manage, V52, P66
   Pollock NR, 2008, INFECT CONT HOSP EP, V29, P878, DOI 10.1086/590262
   Pooran A, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-7
   Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2
   Roth VR, 2005, INT J TUBERC LUNG D, V9, P1335
   Salpeter SR, 1997, ANN INTERN MED, V127, P1051, DOI 10.7326/0003-4819-127-12-199712150-00001
   Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3
   Saude B Saude Md em SdV, 2014, B EPIDEMIOLOGICO, V44, P1
   Saude Md em SdV, 2019, B EPIDEMIOLOGICO, V50, P1
   Saude Md Saude SdVe Vigilancia Dd, 2011, VIG DD MAN REC BRAS
   Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST
   SEPKOWITZ KA, 1995, CLIN INFECT DIS, V21, P1098, DOI 10.1093/clinids/21.5.1098
   Shahidi N, 2012, INFLAMM BOWEL DIS, V18, P2034, DOI 10.1002/ibd.22901
   STEELE MA, 1991, CHEST, V99, P465, DOI 10.1378/chest.99.2.465
   Steffen RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059546
   Tan LH, 2002, INFECT CONT HOSP EP, V23, P584, DOI 10.1086/501975
   THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555
   Tissot F, 2005, CLIN INFECT DIS, V40, P211, DOI 10.1086/426434
   Trajman A, 2010, INT J TUBERC LUNG D, V14, P551
   Transmissiveis B, 2017, BRASIL LIVRE TUBERCU
   UK NCCfCC NICE CfCPa, 2011, TUB CLIN DIAGN MAN T
   Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917
   WHO, 2019, GLOB TUB REP 2018
   WHO Department ST Epidemic Alert P Department R Department HA, 2009, WHO POL TB INF CONTR
   Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180
NR 83
TC 1
Z9 1
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 14
PY 2019
VL 14
IS 11
AR e0225197
DI 10.1371/journal.pone.0225197
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LN2HK
UT WOS:000532764500066
PM 31725786
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Tapajos, R
   Castro, D
   Melo, G
   Balogun, S
   James, M
   Pessoa, R
   Almeida, A
   Costa, M
   Pinto, R
   Albuquerque, B
   Monteiro, W
   Braga, J
   Lacerda, M
   Mourao, MP
AF Tapajos, Raquel
   Castro, Daniel
   Melo, Gisely
   Balogun, Seyi
   James, Mark
   Pessoa, Rockson
   Almeida, Anne
   Costa, Monica
   Pinto, Rosemary
   Albuquerque, Bernardino
   Monteiro, Wuelton
   Braga, Jose
   Lacerda, Marcus
   Mourao, Maria Paula
TI Malaria impact on cognitive function of children in a peri-urban
   community in the Brazilian Amazon
SO MALARIA JOURNAL
LA English
DT Article
DE Malaria; Plasmodium vivax; Cognition; Children
ID FALCIPARUM-MALARIA; CEREBRAL MALARIA; PERFORMANCE; INFECTIONS; ANEMIA
AB BackgroundIn Latin America, where Plasmodium vivax malaria is more prevalent, it is known that this species plays an important role in the sustainability of transmission, and can have an impact on morbidity in terms of anaemia, nutritional status, and cognitive development in children.MethodsThe present study aimed to assess the impact of malaria infection on cognition of children in a peri-urban community in the Brazilian Amazon with moderate endemicity by applying Home Inventory and WPPSI-IV. A non-concurrent cohort study was designed and the cognitive, haematological, and nutritional profiles of the children were assessed. Children with documented malaria history were identified from official reported data.ResultsA total of 219 children aged between 2 and 7years were enrolled. Although 205 (95%) children had normal birth weight, 177 (81%) were malnourished, and 35 (16%) had anaemia. Among the 100 (46%) children who experienced at least one episode of malaria, 89 (89%) children demonstrated low level of cognitive development. The findings showed that Plasmodium vivax malaria was an independent risk factor for low cognitive development.ConclusionsIn addition to the known economic impact of malaria in the Amazon region, the study highlights the deleterious effects P. vivax malaria has on the socio-cultural development of the population.
C1 [Tapajos, Raquel; Castro, Daniel; Pinto, Rosemary; Albuquerque, Bernardino] Fundacao Vigilancia Saude Amazonas, Manaus, Amazonas, Brazil.
   [Tapajos, Raquel; Melo, Gisely; Almeida, Anne; Costa, Monica; Monteiro, Wuelton; Lacerda, Marcus; Mourao, Maria Paula] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Castro, Daniel; Braga, Jose] Fiocruz MS, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil.
   [Melo, Gisely; Pessoa, Rockson; Almeida, Anne; Monteiro, Wuelton; Mourao, Maria Paula] Univ Estado Amazonas, Escola Super Ciencias Saude, Manaus, Amazonas, Brazil.
   [Braga, Jose] Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, Brazil.
   [Lacerda, Marcus] Fiocruz MS, Inst Leonidas e Maria Deane, Manaus, Amazonas, Brazil.
   [Balogun, Seyi; James, Mark; Lacerda, Marcus] Kent Univ, Kent, OH USA.
RP Lacerda, M (corresponding author), Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
EM marcuslacerda.submissao@gmail.com
RI Pessoa, Rockson/AAV-5347-2020; Barros de Castro, Daniel/J-9358-2016
OI Barros de Castro, Daniel/0000-0001-5969-544X
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [486989/2012-7]
FX National Council for Scientific and Technological Development (CNPq)
   (Cogmal Study, Process Number 486989/2012-7). WM and ML are CNPq
   fellows.
CR Ali NS, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-274
   Almeida ACG, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2787-7
   [Anonymous], 2005, CHILD DEV, V76, P795
   [Anonymous], 2010, BAS MAL MICR 1
   Bangirana P, 2014, CLIN INFECT DIS, V59, P336, DOI 10.1093/cid/ciu293
   Benzecry SG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151019
   Blouin B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006688
   Boivin MJ, 2007, PEDIATRICS, V119, pE360, DOI 10.1542/peds.2006-2027
   Boivin MJ, 2002, J DEV BEHAV PEDIATR, V23, P353, DOI 10.1097/00004703-200210000-00010
   Brasil LMBF, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2026-2
   Carter JA, 2005, J NEUROL NEUROSUR PS, V76, P476, DOI 10.1136/jnnp.2004.043893
   da Saude Ministerio, 2009, MAN DIAGN LAB MAL
   dos Santos LM, 2008, CAD SAUDE PUBLICA, V24, P427, DOI 10.1590/S0102-311X2008000200022
   Fernando SD, 2003, AM J TROP MED HYG, V69, P582, DOI 10.4269/ajtmh.2003.69.582
   Fernando SD, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-366
   Gashu D, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0155-z
   Halpern R, 2000, J Pediatr (Rio J), V76, P421
   Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612
   Holding PA, 2001, AM J TROP MED HYG, V64, P68, DOI 10.4269/ajtmh.2001.64.68
   Idro Richard, 2010, BMC Res Notes, V3, P104, DOI 10.1186/1756-0500-3-104
   Instituto Brasileiro de Geografia e Estatistica. IBGE. Ministerio do Planejamento Orcamento e Gestao, 2011, CENS DEM 2010 CAR PO
   Jardim-Botelho A, 2008, TROP MED INT HEALTH, V13, P994, DOI 10.1111/j.1365-3156.2008.02103.x
   KVALSVIG JD, 1991, ANN TROP MED PARASIT, V85, P551, DOI 10.1080/00034983.1991.11812608
   Lampah DA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001032
   Malta, 1998, Cad Saude Publica, V14, P157, DOI 10.1590/S0102-311X1998000100023
   Marturano EM, 2005, PSYCHOL REP, V96, P307
   McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185
   Meio M D, 2001, Cad Saude Publica, V17, P99, DOI 10.1590/S0102-311X2001000100010
   Meremikwu M M, 1997, Cent Afr J Med, V43, P231
   Lapouble OMM, 2015, REV PANAM SALUD PUBL, V38, P300
   Nelson HD, 2006, PEDIATRICS, V117, pE298, DOI 10.1542/peds.2005-1467
   NOKES C, 1992, PARASITOLOGY, V104, P539, DOI 10.1017/S0031182000063800
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Olney DK, 2007, J NUTR, V137, P2756
   Schantz-Dunn Julianna, 2009, Rev Obstet Gynecol, V2, P186
   Serghides L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003980
   Tine Roger C K, 2012, BMC Res Notes, V5, P565, DOI 10.1186/1756-0500-5-565
   Vitor-Silva S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-230
   Vorasan N, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0917-7
   WECHSLER D, 1991, WECHSLER PRESCHOOL P
   Yang H, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-19
NR 41
TC 1
Z9 1
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD MAY 16
PY 2019
VL 18
AR 173
DI 10.1186/s12936-019-2802-2
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HY9LZ
UT WOS:000468463800001
PM 31096985
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Teixeira, LR
   Azevedo, TM
   Bortkiewicz, A
   da Silva, DTC
   de Abreu, W
   de Almeida, MS
   de Araujo, MAN
   Gadzicka, E
   Ivanov, ID
   Leppink, N
   Macedo, MRV
   Maciel, EMGD
   Pawlaczyk-Luszczynska, M
   Pega, F
   Pruss-Ustun, AM
   Siedlecka, J
   Stevens, GA
   Ujita, Y
   Braga, JU
AF Teixeira, Liliane R.
   Azevedo, Tatiana M.
   Bortkiewicz, Alicja
   Correa da Silva, Denise T.
   de Abreu, Wagner
   de Almeida, Marcia S.
   de Araujo, Marco A. N.
   Gadzicka, Elzbieta
   Ivanov, Ivan D.
   Leppink, Nancy
   Macedo, Marta R. V.
   Maciel, Elvira M. G. de S.
   Pawlaczyk-Luszczynska, Malgorzata
   Pega, Frank
   Pruss-Ustun, Annette M.
   Siedlecka, Jadwiga
   Stevens, Gretchen A.
   Ujita, Yuka
   Braga, Jose Ueleres
TI WHO/ILO work-related burden of disease and injury: Protocol for
   systematic reviews of exposure to occupational noise and of the effect
   of exposure to occupational noise on cardiovascular disease
SO ENVIRONMENT INTERNATIONAL
LA English
DT Review
ID EVIDENCE-BASED MEDICINE; ISCHEMIC-HEART-DISEASE; BLOOD-PRESSURE;
   ASSESSING RISK; METHODOLOGY; COMPLEXITY; SCIENCE; BIAS; TOOL
AB Background: The World Health Organization (WHO) and the International Labour Organization (ILO) are developing a joint methodology for estimating the national and global work-related burden of disease and injury (WHO/ILO joint methodology), with contributions from a large network of experts. In this paper, we present the protocol for two systematic reviews of parameters for estimating the number of deaths and disability-adjusted life years from cardiovascular disease attributable to exposure to occupational noise, to inform the development of the WHO/ILO joint methodology.
   Objectives: We aim to systematically review studies on exposure to occupational noise (Systematic Review 1) and systematically review and meta-analyse estimates of the effect of occupational noise on cardiovascular diseases (Systematic Review 2), applying the Navigation Guide systematic review methodology as an organizing framework, conducting both systematic reviews in tandem and in a harmonized way.
   Data sources: Separately for Systematic Reviews 1 and 2, we will search electronic academic databases for potentially relevant records from published and unpublished studies, including Medline, EMBASE, Web of Science and CISDOC. We will also search electronic grey literature databases, Internet search engines and organizational websites; hand search reference list of previous systematic reviews and included study records; and consult additional experts.
   Study eligibility and criteria: We will include working-age (>= 15 years) workers in the formal and informal economy in any WHO and/or ILO Member State, but exclude children (< 15 years) and unpaid domestic workers. The eligible risk factor will be occupational noise. Eligible outcomes will be hypertensive heart disease, ischaemic heart disease, stroke, cardiomyopathy, myocarditis, endocarditis and other circulatory diseases. For Systematic Review 1, we will include quantitative prevalence studies of exposure to occupational noise (i.e., low: < 85 dB(A) and high: >= 85 dB(A)) stratified by country, sex, age and industrial sector or occupation. For Systematic Review 2, we will include randomized controlled trials, cohort studies, case-control studies and other non-randomized intervention studies with an estimate of the relative effect of high exposure to occupational noise on the prevalence of, incidence of or mortality due to cardiovascular disease, compared with the theoretical minimum risk exposure level (i.e., low exposure).
   Study appraisal and synthesis methods: At least two review authors will independently screen titles and abstracts against the eligibility criteria at a first stage and full texts of potentially eligible records at a second stage, followed by extraction of data from qualifying studies. At least two review authors will assess risk of bias and the quality of evidence, using the most suited tools currently available. For Systematic Review 2, if feasible, we will combine relative risks using meta-analysis. We will report results using the guidelines for accurate and transparent health estimates reporting (GATHER) for Systematic Review 1 and the preferred reporting items for systematic reviews and meta-analyses guidelines (PRISMA) for Systematic Review 2.
C1 [Teixeira, Liliane R.; Correa da Silva, Denise T.; de Abreu, Wagner; de Almeida, Marcia S.; de Araujo, Marco A. N.] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth Sergio Arouca, Workers Hlth & Human Ecol Res Ctr, Rio De Janeiro, RJ, Brazil.
   [Azevedo, Tatiana M.] State Reference Ctr Workers Hlth, Workers State Secretariat Hlth, Rio De Janeiro, RJ, Brazil.
   [Bortkiewicz, Alicja; Gadzicka, Elzbieta; Siedlecka, Jadwiga] Nofer Inst Occupat Med, Dept Work Physiol & Ergon, Lodz, Poland.
   [Ivanov, Ivan D.; Pega, Frank; Pruss-Ustun, Annette M.] WHO, Dept Publ Hlth Environm & Social Determinants Hlt, Geneva, Switzerland.
   [Leppink, Nancy; Ujita, Yuka] Int Labor Org, Labour Inspect & Occupat Safety & Hlth Branch, Labour Adm, Geneva, Switzerland.
   [Macedo, Marta R. V.] Fundacao Oswaldo Cruz, Workers Hlth Coordinat, Rio De Janeiro, RJ, Brazil.
   [Maciel, Elvira M. G. de S.] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth Sergio Arouca, Dept Epidemiol & Quantitat Methods Hlth, Rio De Janeiro, RJ, Brazil.
   [Pawlaczyk-Luszczynska, Malgorzata] Nofer Inst Occupat Med, Dept Phys Hazards, Lodz, Poland.
   [Stevens, Gretchen A.] WHO, Dept Informat Evidence & Res, Geneva, Switzerland.
RP Teixeira, LR (corresponding author), Lab Sono & Eletrofisiol, Rua Leopoldo Bulhoes 1480, BR-21041210 Rio De Janeiro, RJ, Brazil.
EM lilianeteixeira@ensp.fiocruz.br; tamaze@gmail.com; alab@imp.lodz.pl;
   denisetorreao@gmail.com; abreu.wagner41@gmail.com;
   soalheir@ensp.fiocruz.br; nabuco@terra.com.br; elag@imp.lodz.pl;
   ivanovi@who.int; leppink@ilo.org; mribeiro@fiocruz.br;
   elviramaciel@ensp.fiocruz.br; Malgorzata.Pawlaczyk@imp.lodz.pl;
   pegaf@who.int; pruessa@who.int; jadzias@imp.lodz.pl; stevensg@who.int;
   ujita@ilo.org; ueleres@ensp.fiocruz.br
RI Teixeira, Liliane/AAG-9865-2020; Bortkiewicz, Alicja/G-5513-2010;
   Teixeira, Liliane/P-5992-2017; Teixeira, Liliane R/G-8837-2016
OI Teixeira, Liliane/0000-0003-2460-0767; Bortkiewicz,
   Alicja/0000-0002-0042-4597; Teixeira, Liliane R/0000-0003-2460-0767;
   Pawlaczyk-Luszczynska, Malgorzata/0000-0001-5950-8421
FU World Health OrganizationWorld Health Organization [1 E11 OH0010676-02];
   Centres for Disease Control and Prevention National Institute for
   Occupational Safety and Health of the United States of America [1 E11
   OH0010676-02]
FX AB, MSDA, JUB, EG, IDI, NL, MRVM, EMM, MPL, FP, AMPU, JS, LRT and YU are
   salaried staff members of their respective institutions. This
   publication was prepared with financial support from the World Health
   Organization cooperative agreement with the Centres for Disease Control
   and Prevention National Institute for Occupational Safety and Health of
   the United States of America on implementing Resolution WHA 60.26
   "Workers' Health: Global Plan of Action" (Grant 1 E11 OH0010676-02).
CR Anderson LM, 2011, RES SYNTH METHODS, V2, P33, DOI 10.1002/jrsm.32
   [Anonymous], 2015, 104 INT LAB C TRANS
   [Anonymous], 2017, WHO METH DAT SOURC G
   [Anonymous], 2014, REV MAN REVMAN, V3
   Arditi C, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1816-5
   Babineau J, 2014, J CAN HEALTH LIBRARI, V35, P68, DOI 10.5596/c14-016
   Babisch W, 2002, NOISE HEALTH, V4, P1
   Babisch W, 2014, NOISE HEALTH, V16, P1, DOI 10.4103/1463-1741.127847
   Barroga E.F., 2013, EUR SCI ED, P44
   Beller EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001419
   Branco N A A Castelo, 2004, Noise Health, V6, P3
   Brits J, 2012, OCCUP ENVIRON MED, V69, P243, DOI 10.1136/oemed-2011-100106
   Chandola T, 2010, NEUROSCI BIOBEHAV R, V35, P51, DOI 10.1016/j.neubiorev.2009.11.005
   Concha-Barrientos M, 2004, OCCUPATIONAL NOISE A, V9
   Descatha A, 2018, ENVIRON INT, V119, P366, DOI 10.1016/j.envint.2018.06.016
   Doi SAR, 2017, INT J EVID-BASED HEA, V15, P152, DOI 10.1097/XEB.0000000000000125
   Domingo-Pueyo A, 2016, NOISE HEALTH, V18, P229, DOI 10.4103/1463-1741.192479
   Drazen JM, 2010, JAMA-J AM MED ASSOC, V304, P212, DOI 10.1001/jama.2010.918
   Drazen JM, 2010, JAMA-J AM MED ASSOC, V303, P75, DOI 10.1001/jama.2009.1542
   Dzhambov AM, 2016, NOISE HEALTH, V18, P167, DOI [10.4103/1463-1741.181996, 10.4103/1463-1741.189241]
   EvidencePartner, 2017, DISTILLERSR
   Figueroa JL, 2014, SOC SCI MED, V113, P42, DOI 10.1016/j.socscimed.2014.04.044
   Forsyth SR, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-122
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8
   Godderis L, 2018, ENVIRON INT, V120, P22, DOI 10.1016/j.envint.2018.07.025
   Goodman JE, 2017, ENVIRON INT, V102, P74, DOI 10.1016/j.envint.2017.01.011
   Guida HL, 2010, BRAZ J OTORHINOLAR, V76, P423, DOI 10.1590/S1808-86942010000400003
   Gunasekara FI, 2014, INT J EPIDEMIOL, V43, P264, DOI 10.1093/ije/dyt221
   Han E, 2016, COCHRANE HDB SYSTEMA, V95, pe2786
   HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001
   Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014
   Hulshof CTJ, 2019, ENVIRON INT, V125, P554, DOI 10.1016/j.envint.2018.09.053
   Hwang WJ, 2012, EUR J CARDIOVASC NUR, V11, P114, DOI 10.1177/1474515111430890
   International Labour Organization, 2014, 20 WORLD C SAF HLTH
   International Labour Organization, 1987, ISCO88 INT LAB ORG
   International Labour Organization, 2012, ISCO08 INT LAB ORG
   Johnson PI, 2016, ENVIRON INT, V92-93, P716, DOI 10.1016/j.envint.2016.03.009
   Johnson PI, 2014, ENVIRON HEALTH PERSP, V122, P1028, DOI 10.1289/ehp.1307893
   Kelly SAM, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005051.pub3
   Kirkham TL, 2011, ANN OCCUP HYG, V55, P764, DOI 10.1093/annhyg/mer038
   Koustas E, 2014, ENVIRON HEALTH PERSP, V122, P1015, DOI 10.1289/ehp.1307177
   Krauth D, 2013, ENVIRON HEALTH PERSP, V121, P985, DOI 10.1289/ehp.1206389
   Lam J, 2016, APPL NAVIGATIO UNPUB
   Lam J., 2016, PLOS ONE, V21
   Lam J., 2016, APPL NAVIGATION GUID
   Lam J, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1632
   Lam J, 2014, ENVIRON HEALTH PERSP, V122, P1040, DOI 10.1289/ehp.1307923
   Li J, 2018, ENVIRON INT, V119, P558, DOI 10.1016/j.envint.2018.06.022
   Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136]
   Mandrioli D, 2018, ENVIRON INT, V119, P174, DOI 10.1016/j.envint.2018.06.005
   Mandrioli D, 2016, ENVIRON HEALTH PERSP, V124, P6, DOI 10.1289/ehp.1509880
   Melamed S, 2004, J OCCUP ENVIRON MED, V46, P1023, DOI 10.1097/01.jom.0000141661.66655.a5
   Moher D, 2015, SYST REV, V4, DOI 10.1186/s13643-015-0087-2
   Morata TC, 1998, SCAND AUDIOL, V27, P111
   Morgan RL, 2016, ENVIRON INT, V92-93, P611, DOI 10.1016/j.envint.2016.01.004
   Munzel T, 2018, J AM COLL CARDIOL, V71, P688, DOI 10.1016/j.jacc.2017.12.015
   Munn Z, 2014, INT J HEALTH POLICY, V3, P123, DOI 10.15171/ijhpm.2014.71
   Murray C.J.L., 2004, COMP QUANTIFICATION
   Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4
   Paulo M. S, 2018, ENVIRON INT, DOI [10.1016/j.envint.2018.10.001, DOI 10.1016/J.ENVINT.2018.10.001]
   PEGA F, 2015, COCHRANE DB SYST REV, V9
   Pega F., 2017, COCHRANE DB SYST REV, V11
   Pega F, 2016, AM J EPIDEMIOL, V183, P315, DOI 10.1093/aje/kwv211
   Pruss-Ustun A., 2017, PREVENTING DIS HLTH
   Rehfuess EA, 2018, RES SYNTH METHODS, V9, P13, DOI 10.1002/jrsm.1254
   Rooney AA, 2016, ENVIRON INT, V92-93, P617, DOI 10.1016/j.envint.2016.01.005
   Rowland M, 1980, VITAL HLTH STAT, V11, P1
   Rugulies R, 2019, ENVIRON INT, V125, P515, DOI 10.1016/j.envint.2018.11.011
   Ryder G., 2017, 21 WORLD C SAF HLTH
   Schunemann H., 2011, COCHRANE HDB SYSTEMA
   Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1136/bmj.i4086]
   Skogstad M, 2016, OCCUP MED-OXFORD, V66, P500, DOI 10.1093/occmed/kqw113
   Spreng M., 2000, NOISE HEALTH, V7, P49
   Stevens GA, 2016, LANCET, V388, pE19, DOI 10.1016/S0140-6736(16)30388-9
   Tenkate T. D, 2018, ENVIRON INT, DOI [10.1016/j.envint.2018.11.011, DOI 10.1016/J.ENVINT.2018.11.011]
   The GATHER Working Group, 2016, GATHER STAT EXPL EL
   United Nations, 2008, STAT PAP SER M, V4
   van Kempen EEMM, 2002, ENVIRON HEALTH PERSP, V110, P307, DOI 10.1289/ehp.02110307
   Vandenberg LN, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0156-6
   Vangelova Katia K., 2007, Reviews on Environmental Health, V22, P303
   Vesterinen H., 2014, J MATERN-FETAL NEO M, P1
   Viswanathan M, 2008, ASSESSING RISK BIAS
   Woodruff TJ, 2014, ENVIRON HEALTH PERSP, V122, P1007, DOI 10.1289/ehp.1307175
   World Health Organization, 2015, ICD 10
   Xu C, 2017, INT J EVID BASED HEA, V15
NR 85
TC 9
Z9 10
U1 1
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0160-4120
EI 1873-6750
J9 ENVIRON INT
JI Environ. Int.
PD APR
PY 2019
VL 125
BP 567
EP 578
DI 10.1016/j.envint.2018.09.040
PG 12
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA HL8PN
UT WOS:000459005200052
PM 30683322
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Leite, TH
   de Moraes, CL
   Marques, ES
   Caetano, R
   Braga, JU
   Reichenheim, ME
AF Leite, Tatiana Henriques
   de Moraes, Claudia Leite
   Marques, Emanuele Souza
   Caetano, Rosangela
   Braga, Jose Ueleres
   Reichenheim, Michael Eduardo
TI Women economic empowerment via cash transfer and microcredit programs is
   enough to decrease intimate partner violence? Evidence from a systematic
   review
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Review
DE Intimate Partner Violence; Government Programs; Empowerment; Women
ID RURAL SOUTH-AFRICA; DOMESTIC VIOLENCE; PHYSICAL VIOLENCE; MARITAL
   VIOLENCE; BANGLADESH; MICROFINANCE; PARTICIPATION; INTERVENTION;
   PREVALENCE; HEALTH
AB Intimate partner violence (IPV) is a worldwide public health problem. Many proposals aiming to eliminate its occurrence include the empowerment of women through their socio-economic development. In this context, some studies suggested that microcredit programs (MP) and cash transfer programs (CTP) are initiatives that can also reduce the risk of IPV. Others pointed to an opposite effect. The objective of this study was to investigate the influence of women's economic empowerment in MP and CTP on the risk of physical, psychological and sexual violence through a systematic review. Papers/documents selection was conducted by two researchers according to the following criteria: published in English, Portuguese or Spanish; primary data; assessing the effect of MP or CTP on IPV; in heterosexual couples; on women beneficiaries of the intervention; using a comparator group eligible for an MP or CTP: and focusing on risk IPV as the outcomes. Our results showed that the impact of MP are mixed when it comes to physical and physical/sexual violence. Even so, the review suggests that the effect of MP on sexual violence is trivial or nonexistent. Regarding the impact of CTPs, the present study showed that the effects on physical, physical/sexual, psychological, and sexual violence were also heterogeneous. Women more empowered and with some autonomy could he at risk. Despite that, participation in the empowerment program should be encouraged for poor women and families. However, parallel interventions to lead with IPV should be addressed to the main actions to reduce the risk of increasing IPV prevalence in certain scenarios.
C1 [Leite, Tatiana Henriques; de Moraes, Claudia Leite; Marques, Emanuele Souza; Caetano, Rosangela; Braga, Jose Ueleres; Reichenheim, Michael Eduardo] Univ Estado Rio de Janeiro, Rua Sao Francisco Xavier 524,7 Andar,Blocos D&E, BR-22775003 Rio De Janeiro, RJ, Brazil.
RP Leite, TH (corresponding author), Univ Estado Rio de Janeiro, Rua Sao Francisco Xavier 524,7 Andar,Blocos D&E, BR-22775003 Rio De Janeiro, RJ, Brazil.
EM henriques.tatiana@gmail.com
RI Moraes, claudia/AAK-9418-2020
OI Moraes, claudia/0000-0002-3223-1634; Marques,
   Emanuele/0000-0002-8633-7290; Caetano, Rosangela/0000-0003-1480-2453
FU Brazilian Graduate Studies Coordinating Board (Capes)CAPES
FX This article was an integral part of the doctoral dissertation of the
   first author, who obtained funding from the Brazilian Graduate Studies
   Coordinating Board (Capes) for 39 months.
CR Ahmed SM, 2005, J HEALTH POPUL NUTR, V23, P95
   Aisa M. G., 2014, THESIS
   Angelucci M, 2008, BE J ECON ANAL POLI, V8, DOI 10.2202/1935-1682.1766
   [Anonymous], 2014, JOANN BRIGGS I REV M
   Bajracharya A, 2013, DEMOGRAPHY, V50, P1819, DOI 10.1007/s13524-013-0226-0
   Bastagli F., 2016, CASH TRANSFERS WHAT
   Bates LM, 2004, INT FAM PLAN PERSPEC, V30, P190, DOI 10.1363/3019004
   Bhuiya A, 2003, J HEALTH POPUL NUTR, V21, P48
   Bloch F, 2002, AM ECON REV, V92, P1029, DOI 10.1257/00028280260344588
   Bobonis G, 2015, CONDITIONAL CASH TRA
   Bobonis GJ, 2013, AM ECON J-ECON POLIC, V5, P179, DOI 10.1257/pol.5.1.179
   Martins APB, 2013, REV SAUDE PUBL, V47, P1159, DOI 10.1590/S0034-8910.2013047004557
   Bourey C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2460-4
   Brody C, 2015, CAMPBELL SYSTEMATIC
   Carter DJ, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001029
   Cepeda I, 2017, J INTERPERS VIOLENCE
   Chin YM, 2012, WORLD DEV, V40, P1690, DOI 10.1016/j.worlddev.2012.04.003
   Dalal K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002941
   de Souza RA, 2018, INT J TUBERC LUNG D, V22, P1300, DOI 10.5588/ijtld.17.0907
   Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937
   Dutt A, 2016, ANAL SOC ISS PUB POL, V16, P363, DOI 10.1111/asap.12091
   Farmer A, 1997, REV SOC ECON, V55, P337, DOI 10.1080/00346769700000004
   Gibbs A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1290427
   Green EP, 2015, SOC SCI MED, V133, P177, DOI 10.1016/j.socscimed.2015.03.042
   Hadi A, 2005, J FAM VIOLENCE, V20, P181, DOI 10.1007/s10896-005-3654-9
   Hadi A, 2000, J INTERPERS VIOLENCE, V15, P787, DOI 10.1177/088626000015008001
   Hasan MT, 2014, J INTERPERS VIOLENCE, V29, P3105, DOI 10.1177/0886260514534525
   Hidrobo M, 2013, J HEALTH ECON, V32, P304, DOI 10.1016/j.jhealeco.2012.11.002
   Karim KMR, 2016, J FAM VIOLENCE, V31, P227, DOI 10.1007/s10896-015-9763-1
   Kim J, 2009, B WORLD HEALTH ORGAN, V87, P824, DOI 10.2471/BLT.08.056580
   Kim JC, 2007, AM J PUBLIC HEALTH, V97, P1794, DOI 10.2105/AJPH.2006.095521
   Koenig MA, 2003, DEMOGRAPHY, V40, P269, DOI 10.1353/dem.2003.0014
   MOHER D, 2009, PLOS MED, V339, DOI DOI 10.1136/BMJ.B2535
   Murshid NS, 2016, PUBLIC HEALTH, V141, P146, DOI 10.1016/j.puhe.2016.09.016
   Murshid NS, 2016, J INTERPERS VIOLENCE, V31, P1579, DOI 10.1177/0886260515569065
   Naved RT, 2005, STUD FAMILY PLANN, V36, P289, DOI 10.1111/j.1728-4465.2005.00071.x
   Naved RT, 2006, SOC SCI MED, V62, P2917, DOI 10.1016/j.socscimed.2005.12.001
   Orton L, 2016, B WORLD HEALTH ORGAN, V94, P694, DOI 10.2471/BLT.15.168252
   Perova E., 2010, THESIS
   Pettifor A, 2016, LANCET GLOB HEALTH, V4, pE978, DOI [10.1016/S2214-109X(16)30253-4, 10.1016/s2214-109x(16)30253-4]
   Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4
   Rasanathan K, 2011, DISCUSSION PAPER SER, V4
   Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1
   Rivera L, 2006, PROGRAMA OPORTUNIDAD, P69
   Rothman K.M., 2012, EPIDEMIOLOGY INTRO
   Sarker M, 2016, INNOVATIVE ISSUES AP, V9, P43
   Schuler SR, 1996, SOC SCI MED, V43, P1729, DOI 10.1016/S0277-9536(96)00068-8
   Stromquist N. P., 2002, RETHINKING EMPOWERME, P22
   TAUCHEN HV, 1991, INT ECON REV, V32, P491, DOI 10.2307/2526888
   Tolman RM, 2001, VIOLENCE AGAINST WOM, V7, P141, DOI 10.1177/1077801201007002003
   Tsai LC, 2016, BMC INT HEALTH HUM R, V16, DOI 10.1186/s12914-016-0101-3
   Vyas S, 2015, SOC SCI MED, V146, P307, DOI 10.1016/j.socscimed.2015.10.016
   Vyas S, 2009, J INT DEV, V21, P577, DOI 10.1002/jid.1500
   *WHO, 1997, VIOL WOM PRIOR HLTH
   World Health Organization, 2012, UND ADR VIOL WOM
   Yunus M, 2010, LONG RANGE PLANN, V43, P308, DOI 10.1016/j.lrp.2009.12.005
NR 56
TC 4
Z9 4
U1 2
U2 5
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2019
VL 35
IS 9
AR e00174818
DI 10.1590/0102-311X00174818
PG 28
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IX5DD
UT WOS:000485704000001
PM 31508698
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Dalvi, APR
   Braga, JU
AF Dalvi, A. P. R.
   Braga, J. U.
TI Spatial diffusion of the 2015-2016 Zika, dengue and chikungunya
   epidemics in Rio de Janeiro Municipality, Brazil
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Chikungunya virus; dengue virus; spatio temporal analysis; Zika virus
ID NEAREST-NEIGHBOR ANALYSIS; VIRUS; SPREAD; RISK
AB Different countries, especially Brazil, that have faced recurrent dengue epidemics for decades and chikungunya epidemics since 2014, have had to restructure their health services to combat a triple epidemic of arboviruses - Zika, dengue and Chikungunya - transmitted by the same vector, mainly Aedes aegypti, in 2015-2016. Several efforts have been made to better understand these three arboviruses. Spatial analysis plays an important role in the knowledge of disease dynamics. The knowledge of the patterns of spatial diffusion of these three arboviruses during an epidemic can contribute to the planning of surveillance actions and control of these diseases. This study aimed to identify the spatial diffusion processes of these viruses in the context of the triple epidemic in 2015-2016 in Rio de Janeiro, Brazil. Two study designs were used: cross-sectional and ecological. Sequential Kernel maps, nearest-neighbour ratios calculated cumulatively over time, Moran global autocorrelation correlograms, and local autocorrelation changes over time were used to identify spatial diffusion patterns. The results suggested an expansion diffusion pattern for the three arboviruses during 2015-2016 in Rio de Janeiro. These findings can be considered for more effective control measures and for new studies on the dynamics of these three arboviruses.
C1 [Dalvi, A. P. R.; Braga, J. U.] Esco Natl Saude PubE Sergio Arouca, Fundacao Oswa Cruz, Rio De Janeiro, Brazil.
   [Braga, J. U.] Univ Estado Rio de Janeiro, Lnstituto Med Social, Rio De Janeiro, Brazil.
RP Braga, JU (corresponding author), Esco Natl Saude PubE Sergio Arouca, Fundacao Oswa Cruz, Rio De Janeiro, Brazil.
EM ueleres@gmail.com
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]; Escola Nacional de Saude Publica Sergio Arouca of
   Fundacao Oswaldo Cruz
FX This study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. APRD was
   supported by a doctoral fellowship from the Escola Nacional de Saude
   Publica Sergio Arouca of Fundacao Oswaldo Cruz.
CR [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953
   ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x
   Anselin L, 2016, GEODA 1 8 14 USERS G
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   BAILEY TC, 1995, INTERACTIVE SPATIAL, P413
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barreto FR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-51
   Brasil. Instituto Brasileiro de Geografia e Estatistica, 2011, CENS DEM 2010 CAR PO
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CLIFF AD, 1989, PROG HUM GEOG, V13, P315, DOI 10.1177/030913258901300301
   Cliff AD, 1981, SPATIAL DIFFUSION HI, P248
   Cohen J, 1999, J QUANT CRIMINOL, V15, P451, DOI 10.1023/A:1007596225550
   Cromley EK, 2012, GIS PUBLIC HLTH, P503
   Farinelli EC, 2018, ACTA TROP, V180, P47, DOI 10.1016/j.actatropica.2018.01.005
   Fletcher-Lartey SM, 2016, PARASITOLOGY, V143, P401, DOI 10.1017/S0031182015001869
   Gardner LM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006194
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Lam NSN, 1996, GEOGR ANAL, V28, P93
   Passos SRL, 2017, EMERG INFECT DIS, V23, P2120, DOI 10.3201/eid2312.171375
   Lee J, 2014, INT J APPL GEOSPAT R, V5, P1, DOI 10.4018/ijagr.2014010101
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Ministerio da Saude do Brasil, 2017, B EP MON CAS DENG FE, V52, P2016
   Ministerio da Saude do Brasil, 2014, PREP RESP INTR VIR C, P100
   Morato DG, 2015, MEM I OSWALDO CRUZ, V110, P528, DOI 10.1590/0074-0276140388
   Murthy S, 2013, CRIT CARE CLIN, V29, P485, DOI 10.1016/j.ccc.2013.03.005
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Pan American Health Organization, 2015, EP UPD ZIK VIR INF
   Programa das Nacoes Unidas para o desenvolvimento Instituto de Pesquisa Economica Aplicada Fundacao Joao Pinheiro, 2014, ATL DES HUM NAS REG, P120
   QGIS Development Team, 2009, QGIS GEOGR INF SYST
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rossbacher L. A., 1986, Geografiska Annaler, A, V68, P101
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Saint-Julien T, 2007, MODELS SPATIAL ANAL, P127, DOI DOI 10.1002/9780470612255.CH5
   Melo MSS, 2010, REV SOC BRAS MED TRO, V43, P139, DOI 10.1590/S0037-86822010000200007
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7
   World Health Organization, 2017, ZIK VIR MICR GUILL B
NR 42
TC 1
Z9 1
U1 0
U2 1
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PY 2019
VL 147
AR e237
DI 10.1017/S0950268819001250
PG 13
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA IH5TG
UT WOS:000474555800001
PM 31364556
OA Green Published, Other Gold
DA 2020-12-01
ER

PT J
AU de Castro, DB
   Maciel, EMGD
   Sadahiro, M
   Pinto, RC
   de Albuquerque, BC
   Braga, JU
AF de Castro, Daniel Barros
   Godinho de Seixas Maciel, Elvira Maria
   Sadahiro, Megumi
   Pinto, Rosemary Costa
   de Albuquerque, Bernardino Claudio
   Braga, Jose Ueleres
TI Tuberculosis incidence inequalities and its social determinants in
   Manaus from 2007 to 2016
SO INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH
LA English
DT Article
DE Healthcare disparities; Socioeconomic level; Tuberculosis; Brazil
ID SOCIOECONOMIC INEQUALITIES; HEALTH; EPIDEMIOLOGY; GENDER; POPULATION;
   AMAZONIA; INDIANS; STATE; RISK
AB BackgroundBrazil is among the 30 countries with high-burden of tuberculosis worldwide, and Manaus is the capital with the highest tuberculosis incidence. The accelerated economic and population growth in Manaus in the last 30years has strengthened the process of social stratification that may result in population groups that are less favored in terms of healthcare and are vulnerable to infection and illness due to tuberculosis. This study aimed to characterize inequalities associated with tuberculosis incidence in relation to the socioeconomic and demographic characteristics of the resident population of Manaus and to identify their determinants from 2007 to 2016.MethodsAn ecological study was conducted using the data from the Diseases Notification Information System. Tuberculosis incidence rates by population characteristics (gender, ethnicity, and socioeconomic level) were calculated for each year, studied, and represented in equiplot charts. To measure the disparity of tuberculosis incidence in the resident population in Manaus, the Gini index of tuberculosis in each neighborhood was calculated based on the incidence rates of the census sectors. A thematic map was constructed to represent the spatial distribution of tuberculosis incidence inequality. Linear regression models were used to identify the relationship between the tuberculosis incidence inequality and its social determinants.ResultsFrom 2007 to 2016, there was an increase in the tuberculosis incidence in Manaus, together with an increase in incident inequality among genders, ethnic groups, and socioeconomic level. The incidence of tuberculosis inequality was associated with the inequalities of its possible determinants (Gini of the proportion of male population, Gini of the proportion of indigenous population, Gini of the proportion of illiteracy, Gini of income, Gini of the proportion of households connected to the water network, and Gini of the mean number of bathrooms per inhabitant), the per capita income, and the proportion of cases with laboratory confirmation.ConclusionsDisparities in tuberculosis incidence in the resident population in neighborhoods can be explained by the sociodemographic and economic heterogeneity. Our findings recommend that public policies and tuberculosis control strategies consider differences in the determinants of tuberculosis inequality for the development of specific actions for each population group.
C1 [de Castro, Daniel Barros; Sadahiro, Megumi; Pinto, Rosemary Costa; de Albuquerque, Bernardino Claudio] Fundacao Vigilancia Saude Amazonas, Manaus, Amazonas, Brazil.
   [de Castro, Daniel Barros; Godinho de Seixas Maciel, Elvira Maria; Braga, Jose Ueleres] Fiocruz MS, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio De Janeiro, Inst Med Social, Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Fundacao Amparo Pesquisa Estado Amazonas, PECTI SAUDE, Manaus, Amazonas, Brazil.
RP Braga, JU (corresponding author), Fiocruz MS, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), Univ Estado Rio De Janeiro, Inst Med Social, Rio De Janeiro, Brazil.
EM ueleres@gmail.com
FU Government of the State of Amazonas, through the Research Foundation of
   the State of Amazonas
FX This study was supported by Government of the State of Amazonas, through
   the Research Foundation of the State of Amazonas, by providing
   scholarships. DBC is a fellow of the RH-PhD program from the Research
   Foundation for the State of Amazonas.
CR Alvaredo F, 2018, WORLD INEQUALITY REP
   Amarante JM, 2000, B PNEUMOLOGIA SANITA, V8, P5
   Amoakwa K, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofu120
   Andrews JR, 2015, INT J TUBERC LUNG D, V19, P375, DOI 10.5588/ijtld.14.0423
   [Anonymous], 2015, BANC DAD CID INT
   [Anonymous], 2013, IND DES HUM MUN BRAS
   [Anonymous], 2018, B EP, V49
   Arcaya MC, 2015, REV PANAM SALUD PUBL, V38, P261, DOI 10.3402/gha.v8.27106
   Basta RC, 2006, INT J TUBERC LUNG D, V10, P1354
   Boia MN, 2009, REV SAUDE PUBL, V43, P176, DOI 10.1590/s0034-89102009000100023
   Bossio JC, 2012, SALUD COLECT, V8, P77, DOI 10.1590/s1851-82652012000300013
   Braga JU, 2007, REV SAUDE PUBL S1, V41, P77, DOI DOI 10.1590/S0034-89102007000800011
   Braveman P, 2014, PUBLIC HEALTH REP, V129, P5, DOI 10.1177/00333549141291S203
   Belo MTCT, 2010, J BRAS PNEUMOL, V36, P621, DOI 10.1590/S1806-37132010000500015
   Coimbra CEA, 2007, T ROY SOC TROP MED H, V101, P635, DOI 10.1016/j.trstmh.2007.03.013
   Ximenes RAD, 2009, INT J EPIDEMIOL, V38, P1285, DOI 10.1093/ije/dyp224
   de Castro DB, 2018, INT J TUBERC LUNG D, V22, P171, DOI 10.5588/ijtld.17.0369
   Escobar AL, 2004, INT J TUBERC LUNG D, V8, P45
   Fink G, 2017, AM J PUBLIC HEALTH, V107, P550, DOI 10.2105/AJPH.2017.303657
   GASTWIRT.JL, 1972, REV ECON STAT, V54, P306, DOI 10.2307/1937992
   Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026
   Harling G, 2014, HEALTH PLACE, V25, P56, DOI 10.1016/j.healthplace.2013.10.008
   Hudelson P, 1996, TUBERCLE LUNG DIS, V77, P391, DOI 10.1016/S0962-8479(96)90110-0
   Hurtado AM, 2003, AM J PHYS ANTHROPOL, V121, P134, DOI 10.1002/ajpa.10228
   Jenkins S. P., 1999, INEQDEC0 STATA MODUL
   Keppel Kenneth, 2005, Vital Health Stat 2, P1
   Kjellstrom T, 2007, OUR CITIES OUR HLTH
   Krieger N, 2001, INT J EPIDEMIOL, V30, P668, DOI 10.1093/ije/30.4.668
   LEGRAND J, 1987, EUR ECON REV, V31, P182, DOI 10.1016/0014-2921(87)90030-4
   Lin HH, 2009, AM J RESP CRIT CARE, V180, P475, DOI 10.1164/rccm.200904-0549OC
   Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041
   Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3
   Marreiro LD, 2009, EPIDEMIOL SERV SAUDE, V18, P237
   McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307
   Millet JP, 2013, EUR SPINE J, V22, P539, DOI 10.1007/s00586-012-2334-8
   Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2011, MAN REC CONTR TUB BR
   da Silva ICM, 2018, EPIDEMIOL SERV SAUDE, V27, DOI 10.5123/S1679-49742018000100017
   Munayco CV, 2015, REV PANAM SALUD PUBL, V38, P177
   Muniyandi M, 2008, EXPERT OPIN PHARMACO, V9, P1623, DOI 10.1517/14656566.9.10.1623 
   Nazareth T, 2011, REV PARANAENSE DESEN, V121, P201
   Nogueira ACF, 2007, AN 13 S BRAS SENS RE, P5427
   Orellana Jesem Douglas Yamall, 2012, Rev. bras. epidemiol., V15, P714, DOI 10.1590/S1415-790X2012000400004
   Pradhan M, 2003, J HEALTH ECON, V22, P271, DOI 10.1016/S0167-6296(02)00123-6
   Solar Orielle, 2010, 2 WHO
   Sousa AO, 1997, P NATL ACAD SCI USA, V94, P13227, DOI 10.1073/pnas.94.24.13227
   Thorson A, 2001, Curr Opin Pulm Med, V7, P165, DOI 10.1097/00063198-200105000-00009
   Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0
   WHO, 2017, GLOB TUB REP 2017
   Woodward A, 2000, J EPIDEMIOL COMMUN H, V54, P923, DOI 10.1136/jech.54.12.923
NR 49
TC 2
Z9 2
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-9276
J9 INT J EQUITY HEALTH
JI Int. J. Equity Health
PD DEC 29
PY 2018
VL 17
AR 187
DI 10.1186/s12939-018-0900-3
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HF9KQ
UT WOS:000454561300001
PM 30594205
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Albuquerque, BC
   Pinto, RC
   Sadahiro, M
   Sampaio, VS
   de Castro, DB
   Terrazas, WCM
   Mustafa, LM
   da Costa, CF
   dos Passos, RA
   Lima, JBP
   Braga, JU
AF de Albuquerque, Bernardino Claudio
   Pinto, Rosemary Costa
   Sadahiro, Megumi
   Sampaio, Vanderson Souza
   de Castro, Daniel Barros
   Morhy Terrazas, Wagner Cosme
   Mustafa, Luzia Melo
   da Costa, Cristiano Fernandes
   dos Passos, Ricardo Augusto
   Pereira Lima, Jose Bento
   Braga, Jose Ueleres
TI Relationship between local presence and density of Aedes aegypti eggs
   with dengue cases: a spatial analysis approach
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE epidemic; dengue; population surveillance; ovitrap; Aedes
ID VECTOR CONTROL; SURVEILLANCE; TRANSMISSION; ABUNDANCE; TRINIDAD; BRAZIL;
   TRAP; RISK
AB Objectives To analyze the relationship between the occurrence of dengue and ovitrap positivity and dengue egg density in two Amazonas municipalities (Brazil) in 2016. Methods Results We performed a case-control study using secondary data from the dengue fever surveillance system. Ovitraps distributed regularly in the urban area of two cities were used to monitor the presence of the vector. The relationship between egg positivity, egg density and the location of dengue cases was evaluated using two approaches as follows: (i) based on the result of the nearest neighbour ovitrap and (ii) based on the results of the set of ovitraps within the influence area of 300 m from the location of each case and control. During the study period, 229 confirmed cases of dengue fever were reported in Tabatinga and 89 cases in Itacoatiara. In this study, we found that the positivity of ovitraps was related to the occurrence of dengue in Tabatinga and Itacoatiara. An association between egg density of Ae. aegypti and dengue occurrence was also observed in Itacoatiara. The temporal lags for ovitrap positivity measurements were predominantly 15 or 30 days. A dengue association for egg density for a 15-day time lag was detected for one of the case-control approaches. Conclusions Objectifs The location of dengue cases is related to ovitrap egg positivity, while a less evident possible association may exist for egg density. This indicates that these traps could be used to improve vector control actions.
C1 [de Albuquerque, Bernardino Claudio; Pinto, Rosemary Costa; Sadahiro, Megumi; Sampaio, Vanderson Souza; de Castro, Daniel Barros; Morhy Terrazas, Wagner Cosme; Mustafa, Luzia Melo; da Costa, Cristiano Fernandes; dos Passos, Ricardo Augusto] Fundacao Vigilancia Saude Amazonas, Manaus, Amazonas, Brazil.
   [Sampaio, Vanderson Souza] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [de Castro, Daniel Barros; Braga, Jose Ueleres] Fiocruz MS, Escola Nacl Saude Publ Sergio Arouca, Rua Belisario Tavora 653-202, BR-22245070 Rio De Janeiro, Brazil.
   [dos Passos, Ricardo Augusto; Pereira Lima, Jose Bento] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Pereira Lima, Jose Bento; Braga, Jose Ueleres] Fundacao Amparo Pesquisa Estado Amazonas, PECTI SAUDE, Manaus, Amazonas, Brazil.
   [Braga, Jose Ueleres] Inst Med Social UERJ, Rio De Janeiro, Brazil.
RP Braga, JU (corresponding author), Fiocruz MS, Escola Nacl Saude Publ Sergio Arouca, Rua Belisario Tavora 653-202, BR-22245070 Rio De Janeiro, Brazil.
EM ueleres@gmail.com
RI Sampaio, Vanderson/M-4337-2015; Sampaio, Vanderson/AAQ-1418-2020
OI Sampaio, Vanderson/0000-0001-7307-8851; Sampaio,
   Vanderson/0000-0001-7307-8851; Dos Passos/0000-0002-2155-9351
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [440856/2016-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES [88881.130825/2016-01, 88887.130823/2016-00]
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (http://www.cnpq.br, grant 440856/2016-7) and
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (http://www.capes.gov.br, grants 88881.130825/2016-01 and
   88887.130823/2016-00) call MCTIC/FNDCT -CNPq/MEC-CAPES/MS-Decit 14/2016
   -Prevencao e Combate ao virus Zika.
CR Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Cecilio AB, 2009, BRAZ J BIOL, V69, P123, DOI 10.1590/S1519-69842009000100015
   Chadee DD, 2005, TROP MED INT HEALTH, V10, P748, DOI 10.1111/j.1365-3156.2005.01449.x
   Codeco CT, 2015, PLOS NEGLECT TROP D, V9, P1
   da Costa CF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2194-5
   Degener CM, 2014, MEM I OSWALDO CRUZ, V109, P1030, DOI 10.1590/0074-0276140234
   Departamento de Vigilancia Epidemiologica Secretaria de Vigilancia em Saude M da S, 2009, DIR NAC PREV CONTR D
   desMelo DPO, 2012, PLOS ONE, V7
   FAY R. W., 1965, MOSQUITO NEWS, V25, P276
   Focks D.A., 2003, REV ENTOMOLOGICAL SA
   Gomes AC, 1998, INF EPIDEMIOL SUS, V7, P49, DOI DOI 10.5123/S0104-16731998000300006
   Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Pessanha JEM, 2014, J HLTH BIOL SCI, V2, P51
   Pham HV, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-172
   Rawlins SC, 1998, J AM MOSQUITO CONTR, V14, P131
   Rubio-Palis Y, 2011, B MALARIOL SALUD AMB, V51, P145
   Sanchez L, 2006, EMERG INFECT DIS, V12, P800
   Scott TW, 2003, WAG UR FRON, V2, P187
   Sivagnaname N, 2012, INDIAN J MED RES, V136, P739
   Townson H, 2005, B WORLD HEALTH ORGAN, V83, P942
   Vargas WP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2097-3
NR 22
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD NOV
PY 2018
VL 23
IS 11
BP 1269
EP 1279
DI 10.1111/tmi.13150
PG 11
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GZ7UQ
UT WOS:000449690300012
PM 30282110
OA Bronze
DA 2020-12-01
ER

PT J
AU da Luz, EF
   Braga, JU
AF Furtado da Luz, E.
   Braga, J. U.
TI Under-reporting of tuberculosis in Praia, Cape Verde: study reports
   doubtful results Reply
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Letter
C1 [Furtado da Luz, E.] Univ Estado Rio De Janeiro, Rio De Janeiro, RJ, Brazil.
   [Braga, J. U.] Fundacao Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
RP da Luz, EF (corresponding author), Univ Estado Rio De Janeiro, Rio De Janeiro, RJ, Brazil.
EM furtadoermelinda@gmail.com
CR [Anonymous], 2005, GUIA VIG EP
   Braga JU, 2007, REV SAUDE PUBL S1, V41, P77, DOI DOI 10.1590/S0034-89102007000800011
   da Luz EF, 2018, INT J TUBERC LUNG D, V22, P258, DOI 10.5588/ijtld.17.0256
   Glaziou Pavli A, 2012, ASSESSING TUBERCULOS
NR 4
TC 0
Z9 0
U1 0
U2 0
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD SEP
PY 2018
VL 22
IS 9
BP 1107
EP 1107
DI 10.5588/ijtld.18.0284-2
PG 1
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA GQ0DU
UT WOS:000441287700023
PM 30092880
DA 2020-12-01
ER

PT J
AU Gayoso, R
   Dalcolmo, M
   Braga, JU
   Barreira, D
AF Gayoso, Regina
   Dalcolmo, Margareth
   Braga, Jose Ueleres
   Barreira, Draurio
TI Predictors of mortality in multidrug-resistant tuberculosis patients
   from Brazilian reference centers, 2005 to 2012
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Survival; Tuberculosis multidrug-resistant; Tuberculosis; Death
ID TREATMENT OUTCOMES; DRUG-RESISTANCE; RISK-FACTORS; SURVIVAL;
   EPIDEMIOLOGY
AB Objectives: To determine the main predictors of death in multidrug-resistant (MDRTB) patients from Brazil.
   Design: Retrospective cohort study, a survival analysis of patients treated between 2005 and 2012.
   Results: Of 3802 individuals included in study, 64.7% were men, mean age was 39 (1-93) years, and 70.3% had bilateral pulmonary disease. Prevalence of human immunodeficiency virus (HIV) was 8.3%. There were 479 (12.6%) deaths. Median survival time was 1452 days (4 years). Factors associated with increased risk of death were age greater than or equal to 60 years (hazard rate [HR] =1.6, confidence interval [CI] = 1.15-2.2), HIV co-infection (HR = 1.46; CI =1.05-1.96), XDR resistance pattern (HR= 1.74, CI =1.05-2.9), beginning of treatment after failure (HR =1.72, CI =1.27-2.32), drug abuse (HR =1.64, CI =1.22-2.2), resistance to ethambutol (HR= 1.30, CI =1.06-1.6) or streptomycin (HR= 1.24, CI =1.01-1.51). Mainly protective factors were presence of only pulmonary disease (HR = 0.57, CI =0.35-0.92), moxifloxacin use (HR= 0.44, CI = 0.25-0.80), and levofloxacin use (HR = 0.75; CI = 0.60-0.94).
   Conclusion: A more comprehensive approach is needed to manage MDRTB, addressing early diagnostic, improving adhesion, and comorbidities, mainly HIV infection and drug abuse. The latest generation quinolones have an important effect in improving survival in MDRTB. (C) 2018 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.
C1 [Gayoso, Regina; Dalcolmo, Margareth] Fundacao Oswaldo Cruz, Ctr Referencia Prof Helio Fraga, Rio De Janeiro, RJ, Brazil.
   [Braga, Jose Ueleres] Fundacao Oswaldo Cruz, Escola Nacl Scude Publ Sergio, Rio De Janeiro, RJ, Brazil.
   [Barreira, Draurio] UNITAID, Vernier, Switzerland.
RP Gayoso, R (corresponding author), Fundacao Oswaldo Cruz, Ctr Referencia Prof Helio Fraga, Rio De Janeiro, RJ, Brazil.
EM reginagayoso@ensp.fiocruz.br
CR Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300
   Anderson LF, 2013, EUROSURVEILLANCE, V18, P7, DOI 10.2807/1560-7917.ES2013.18.40.20601
   Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81
   Balabanova Y, 2011, BMJ OPEN, V1, DOI [10.1136/bmjopen-2011-000351, 10.1136/bmjopen-2011-0003511]
   Brasil-Ministerio da Sande, 2015, B EPIDEMIOL, V46
   Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382
   Cavanaugh JS, 2012, INT J TUBERC LUNG D, V16, P1069, DOI 10.5588/ijtld.11.0696
   Chung-Delgado K, 2014, INT J INFECT DIS, V23, P20, DOI 10.1016/j.ijid.2014.01.001
   Dalcolmo Margareth Pretti, 2007, Rev. Saúde Pública, V41, P34, DOI [10.1590/s0034-89102007000800006, 10.1590/S0034-89102007000800006]
   Micheletti VCD, 2014, J BRAS PNEUMOL, V40, P155, DOI 10.1590/S1806-37132014000200009
   Drobniewski F, 2002, THORAX, V57, P810, DOI 10.1136/thorax.57.9.810
   Glaziou P, 2013, SEMIN RESP CRIT CARE, V34, P3, DOI 10.1055/s-0032-1333467
   Jeon CY, 2008, CLIN INFECT DIS, V46, P42, DOI 10.1086/524017
   Jeon DS, 2011, J KOREAN MED SCI, V26, P33, DOI 10.3346/jkms.2011.26.1.33
   Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914
   Kim DH, 2010, AM J RESP CRIT CARE, V182, P113, DOI 10.1164/rccm.200911-1656OC
   Kurbatova EV, 2012, TUBERCULOSIS, V92, P397, DOI 10.1016/j.tube.2012.06.003
   Ministerio da Sande (BR). Secretaria de Vigilancia em Sande. Departamento de Vigilancia Epidemiologica, 2011, MAN REC CONTR TUB BR
   Mitnick CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058664
   Padayatchi N, 2014, INT J TUBERC LUNG D, V18, P147, DOI 10.5588/ijtld.13.0627
   Pefura-Yone EW, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-138
   Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273
   San Pedro A, 2013, REV PANAM SALUD PUBL, V33, P294, DOI 10.1590/S1020-49892013000400009
   Schaaf S, 2009, TUBERCULOSIS COMPREH
   Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601
   WHO, 2017, GLOB TUB REP 2017
   World Health Organization, 2013, DEF REP FRAM TUB 201
NR 27
TC 7
Z9 7
U1 0
U2 0
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD JUL-AUG
PY 2018
VL 22
IS 4
BP 305
EP 310
DI 10.1016/j.bjid.2018.07.002
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA HH6QA
UT WOS:000455854900006
PM 30086258
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Ferreira, MD
   de Moraes, CL
   Braga, JU
   Reichenheim, ME
   da Veiga, GV
AF de Freitas Ferreira, M.
   de Moraes, C. L.
   Braga, J. U.
   Reichenheim, M. E.
   da Veiga, G. V.
TI Abusive alcohol consumption among adolescents: a predictive model for
   maximizing early detection and responses
SO PUBLIC HEALTH
LA English
DT Article
DE Alcohol consumption; Alcohol abuse; Adolescent; Predictive model
ID INDIVIDUAL PROGNOSIS; DIAGNOSIS TRIPOD; SUBSTANCE USE; DRINKING; WOMEN
AB Objective: To present a predictive model of alcohol abuse among adolescents based on prevalence projections in various population subgroups.
   Study design: Cross-sectional study.
   Methods: The sample consisted of 785 adolescents enrolled in the second year of high school in Rio de Janeiro, Brazil. Alcohol consumption was assessed using the Alcohol Use Disorder Identification Test. Socio-economic, demographic, family, individuals, and school-related variables were examined as potential predictors. The logit model was used to estimate the prevalence projections. Model fitting was examined in relation to the observed data set, and in a subset, that was generated from 200 subsamples of individuals via a bootstrap process using general fit estimators, discrimination, and calibration measures.
   Results: About 25.5% of the adolescents were classified as positive for alcohol abuse. Being male, being 17-19 years old, not living with mothers, presenting symptoms suggestive of binge eating, having used a strategy of weight reduction in the last 3 months, and, especially, being a victim of family violence were important predictors of abusive consumption of alcohol. While the model's prevalence projection in the absence of these features was 8%, it reaches 68% in the presence of all predictors.
   Conclusions: Knowledge of predictive characteristics of alcohol abuse is essential for screening, early detection of positive cases, and establishing interventions to reduce consumption among adolescents. (C) 2018 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.
C1 [de Freitas Ferreira, M.; de Moraes, C. L.; Braga, J. U.; Reichenheim, M. E.] Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, Rua Sao Francisco Xavier 524,7 Andar, BR-20559900 Rio De Janeiro, RJ, Brazil.
   [de Moraes, C. L.] Univ Estacio Sa, Med Sch, Rua Riachuelo 27, BR-20230010 Rio De Janeiro, RJ, Brazil.
   [Braga, J. U.] Fiocruz MS, Natl Sch Publ Hlth, Prof Helio Fraga Reference Ctr, Rio De Janeiro, Brazil.
   [da Veiga, G. V.] Univ Fed Rio de Janeiro, Hlth Sci Ctr, Dept Nutr Josue de Castro, Ave Carlos Chagas Filho 373,Bloco J,2 Andar, BR-21941590 Rio De Janeiro, RJ, Brazil.
RP Ferreira, MD (corresponding author), Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, Rua Sao Francisco Xavier 524,7 Andar, BR-20559900 Rio De Janeiro, RJ, Brazil.
EM mdfferreira@gmail.com
RI Moraes, claudia/AAK-9418-2020
OI Moraes, claudia/0000-0002-3223-1634
FU National Council for Scientific and Technological DevelopmentNational
   Council for Scientific and Technological Development (CNPq)
   [47667/2011-9]; Research Support Foundation of the State of Rio de
   Janeiro [E26/110.847/2009, E26/110.626/2011, E-26/110.774/2013];
   Coordination for the Improvement of Higher Education PersonnelCAPES
   [23038.007702/2011-5]
FX This work was supported by the National Council for Scientific and
   Technological Development [grant 47667/2011-9]; the Research Support
   Foundation of the State of Rio de Janeiro [grants E26/110.847/2009,
   E26/110.626/2011, and E-26/110.774/2013]; and Coordination for the
   Improvement of Higher Education Personnel [grant 23038.007702/2011-5].
CR American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Caballero MA, 2010, CHILD ABUSE NEGLECT, V34, P576, DOI 10.1016/j.chiabu.2010.02.001
   [Anonymous], 2015, COMPUTING TRPFS R VE
   Bahr SJ, 2010, J STUD ALCOHOL DRUGS, V71, P539, DOI 10.15288/jsad.2010.71.539
   Barbor TF, 2001, DEPENDENCE DOMHAS, P40
   Barbor TF, 2010, ALCOHOL NO ORDINARY
   Barbosa VC, 2012, REV SAUDE PUBL, V46, P901, DOI 10.1590/s0034-89102012000500018
   Barry AE, 2012, J AM COLL HEALTH, V60, P236, DOI 10.1080/07448481.2011.587487
   Brazilian Association of Companies and Research, 2015, EC CLASS CRIT BRAZ
   Brazilian Istitute of Geography and Statistics, 2010, SYNTH SOC IND AN LIV
   Brazilian Istitute of Geography and Statistics, 2013, COORD POP SOC IND, P256
   Center for Disease Control Prevention, 2016, YOUTH RISK BEH SURV, P180
   Chung T, 2000, J STUD ALCOHOL, V61, P579, DOI 10.15288/jsa.2000.61.579
   Collins GS, 2015, EUR UROL, V67, P1142, DOI 10.1016/j.eururo.2014.11.025
   Collins GS, 2015, ANN INTERN MED, V162, P55, DOI 10.7326/M14-0697
   de Looze M, 2015, EUR J PUBLIC HEALTH, V25, P69, DOI 10.1093/eurpub/ckv031
   de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497
   Dube SR, 2002, ADDICT BEHAV, V27, P713, DOI 10.1016/S0306-4603(01)00204-0
   Emond JA, 2014, J PEDIATR-US, V165, P1194, DOI 10.1016/j.jpeds.2014.08.050
   Coutinho ESF, 2016, REV SAUDE PUBL, V50, DOI 10.1590/S01518-8787.2016050006684
   Gadalla T, 2007, ARCH WOMEN MENT HLTH, V10, P133, DOI 10.1007/s00737-007-0184-x
   Hasselmann Maria Helena, 2003, Cad. Saúde Pública, V19, P1083, DOI 10.1590/S0102-311X2003000400030
   Laranjeira R, 2007, 1 LEVANTAMENTO NACL, P76
   Laranjeira R, 2014, 2 NATL SURVEY ALCOHO
   Machado IE, 2013, CAD SAUDE PUBLICA, V29, P1449, DOI 10.1590/S0102-311X2013000700018
   Madruga CS, 2011, ADDICT BEHAV, V36, P251, DOI 10.1016/j.addbeh.2010.10.011
   Malta DC, 2014, REV SAUDE PUBL, V48, P52, DOI 10.1590/S0034-8910.2014048004563
   Malta Deborah Carvalho, 2011, Rev. bras. epidemiol., V14, P166, DOI 10.1590/S1415-790X2011000500017
   Mendez EB, 1999, BRAZILIAN VERSION AU
   Moran PB, 2004, CHILD ABUSE NEGLECT, V28, P565, DOI 10.1016/j.chiabu.2003.12.002
   National Commission for Research Ethics C, 2013, 0012013 NAT COMM RES
   Pilgrim CC, 2006, PREV SCI, V7, P75, DOI 10.1007/s11121-005-0019-9
   Sanchez AM, 2011, BMC PUBLIC HEALTH, V11, P2
   Santos Walberto Silva dos, 2012, J. bras. psiquiatr., V61, P117, DOI 10.1590/S0047-20852012000300001
   Shin SH, 2009, ADDICT BEHAV, V34, P277, DOI 10.1016/j.addbeh.2008.10.023
   StataCorp, 2013, STATA STAT SOFTW REL
   Steyerberg EW., 2009, CLIN PREDICTION MODE, P255, DOI DOI 10.1007/978-0-387-77244-8_15
   Straus M., 1979, J MARRIAGE FAM, V41
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
   Widom CS, 2007, J STUD ALCOHOL DRUGS, V68, P317, DOI 10.15288/jsad.2007.68.317
   World Health Organization, 2008, HLTH POLICY CHILDREN
NR 41
TC 2
Z9 2
U1 0
U2 33
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0033-3506
EI 1476-5616
J9 PUBLIC HEALTH
JI Public Health
PD JUN
PY 2018
VL 159
BP 99
EP 106
DI 10.1016/j.puhe.2018.02.008
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GH4CD
UT WOS:000433349700019
PM 29559184
DA 2020-12-01
ER

PT J
AU Maciel, EL
   Braga, JU
   Bertolde, AI
   Zandonade, E
AF Maciel, Ethel Leonor
   Braga, Jose Ueleres
   Bertolde, Adelmo Inacio
   Zandonade, Eliana
TI Reflections upon the article "Evaluation of the impact that the changes
   in tuberculosis treatment implemented in Brazil in 2009 have had on
   disease control in the country"
SO JORNAL BRASILEIRO DE PNEUMOLOGIA
LA English
DT Letter
ID TIME-SERIES ANALYSIS
C1 [Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [Braga, Jose Ueleres] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Dept Epidemiol & Metodos Quantitat, Rio De Janeiro, RJ, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, RJ, Brazil.
   [Bertolde, Adelmo Inacio; Zandonade, Eliana] Univ Fed Espirito Santo, Dept Estat, Vitoria, ES, Brazil.
RP Maciel, EL (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Zandonade,
   Eliana/0000-0001-5160-3280; Barreto Conte, Marcus/0000-0002-7249-4455
CR Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098
   Braga JU, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0820-4
   Durovni B, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001766
   Linden A, 2015, STATA J, V15, P480, DOI 10.1177/1536867X1501500208
   Maciel EL, 2015, REV PANAM SALUD PUBL, V38, P28
   Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002
   Rabahi MF, 2017, J BRAS PNEUMOL, V43, P437, DOI [10.1590/S1806-37562017000000004, 10.1590/s1806-37562017000000004]
NR 7
TC 2
Z9 2
U1 1
U2 1
PU SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA
PI BRASILIA DF
PA SEPS 714-719, BLOCO E ASA SUL, SALAS 220-223, BRASILIA DF, CEP70390-145,
   BRAZIL
SN 1806-3713
EI 1806-3756
J9 J BRAS PNEUMOL
JI J. Bras. Pneumol.
PD MAY-JUN
PY 2018
VL 44
IS 3
BP 249
EP 250
DI 10.1590/S1806-37562018000000096
PG 2
WC Respiratory System
SC Respiratory System
GA GJ7QC
UT WOS:000435582000021
PM 30043894
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Castanheira, M
   Chor, D
   Braga, JU
   Cardoso, LD
   Griep, RH
   Molina, MDB
   da Fonseca, MDM
AF Castanheira, Marcelo
   Chor, Dora
   Braga, Jose Ueleres
   Cardoso, Leticia de Oliveira
   Griep, Rosane Harter
   Bisi Molina, Maria Del Carmen
   Mendes da Fonseca, Maria de Jesus
TI Predicting cardiometabolic disturbances from waist-to-height ratio:
   findings from the Brazilian Longitudinal Study of Adult Health
   (ELSA-Brasil) baseline
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Abdominal obesity; Waist-to-height ratio; Anthropometric indices;
   Cardiometabolic outcomes; Cross-sectional studies
ID CARDIOVASCULAR RISK-FACTORS; ANTHROPOMETRIC INDEXES; SCREENING TOOL;
   OBESITY; INDICATORS; DISEASE; COULD; BMI
AB Objective: To evaluate the performance of waist-to-height ratio (WHtR) in predicting cardiometabolic outcomes and compare cut-off points for Brazilian adults.
   Design: Cross-sectional study. WHtR areas under the curve (AUC) were compared with those for BMI, waist circumference (WC) and waist-to-hip ratio (WHR). The outcomes of interest were hypertension, diabetes, hypertriacylglycerolaemia and presence of at least two components of metabolic syndrome (>= 2 MetS). Cut-offs for WHtR were compared and validity measures were estimated for each point.
   Setting: Teaching and research institutions in six Brazilian state capitals, 2008-2010.
   Subjects: Women (n 5026) and men (n 4238) aged 35-54 years who participated in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) at baseline.
   Results: WHtR age-adjusted AUC ranged from 0.68 to 0.72 in men and 0.69 to 0.75 in women, with smaller AUC for hypertriacylglycerolaemia and the largest for >= 2 MetS. WHtR performed better than BMI for practically all outcomes; better than WHR for hypertension in both sexes; and displayed larger AUC than WC in predicting diabetes mellitus. It also offered better discriminatory power for >= 2 MetS in men; and was better than WC, but not WHR, in women. Optimal cut-off points of WHtR were 0.55 (women) and 0.54 (men), but they presented high falsenegative rate compared with 0.50.
   Conclusions: We recommend using WHtR (which performed similarly to, or better than, other available indices of adiposity) as an anthropometric index with good discriminatory power for cardiometabolic outcomes in Brazilian adults, indicating the already referenced limit of WHtR >= 0.50.
C1 [Castanheira, Marcelo] Univ Fed Estado Rio de Janeiro, Escola Nutr, Dept Nutr Fundamental, Av Pasteur 296,3rd Floor Urca, Rio De Janeiro, RJ, Brazil.
   [Chor, Dora; Braga, Jose Ueleres; Cardoso, Leticia de Oliveira; Mendes da Fonseca, Maria de Jesus] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, RJ, Brazil.
   [Griep, Rosane Harter] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Educa Ambiente & Saude, Rio De Janeiro, RJ, Brazil.
   [Bisi Molina, Maria Del Carmen] Univ Fed Espirito Santo, Ctr Ciencias Saude, Vitoria, ES, Brazil.
RP Castanheira, M (corresponding author), Univ Fed Estado Rio de Janeiro, Escola Nutr, Dept Nutr Fundamental, Av Pasteur 296,3rd Floor Urca, Rio De Janeiro, RJ, Brazil.
EM celocast@yahoo.com.br
RI Griep, Rosane Harter/ABB-4509-2020
OI Molina, Maria del Carmen/0000-0002-8614-988X
FU Brazilian Ministry of Health (Science and Technology Department);
   Brazilian Ministry of Science and Technology (Financiadora de Estudos e
   Projetos); Brazilian Ministry of Science and Technology (CNPq National
   Research Council) [01 06 0010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES,
   01 06 0278.00 MG, 01 06 0115.00 SP, 01 06 0071.00 RJ]
FX The ELSA-Brasil baseline study was supported by the Brazilian Ministry
   of Health (Science and Technology Department) and the Brazilian Ministry
   of Science and Technology (Financiadora de Estudos e Projetos and CNPq
   National Research Council; grant numbers 01 06 0010.00 RS, 01 06 0212.00
   BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 06 0071.00
   RJ). The Brazilian Ministry of Health and the Brazilian Ministry of
   Science and Technology had no role in the design, analysis or writing of
   this article.
CR Almeida Rogério Tosta de, 2009, Arq. Bras. Cardiol., V92, P375, DOI 10.1590/S0066-782X2009000500007
   Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
   Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066
   Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x
   Ashwell M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010159
   Bohr AD, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2964-6
   Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144
   Caminha TCS, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005874
   Can AS, 2010, PUBLIC HEALTH NUTR, V13, P488, DOI 10.1017/S1368980009991637
   Can AS, 2009, PUBLIC HEALTH NUTR, V12, P538, DOI 10.1017/S1368980008002474
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Fedeli LG, 2013, REV SAUDE PUBL, V47, P63, DOI 10.1590/S0034-8910.2013047003807
   Fuchs FD, 2005, OBES RES, V13, P1515, DOI 10.1038/oby.2005.184
   Haun DR, 2009, REV ASSOC MED BRAS, V55, P705, DOI 10.1590/S0104-42302009000600015
   Janes H, 2008, AM J EPIDEMIOL, V168, P89, DOI 10.1093/aje/kwn099
   Vasques ACJ, 2009, ARQ BRAS ENDOCRINOL, V53, P72, DOI 10.1590/S0004-27302009000100011
   Kapur A, 2007, INDIAN J MED RES, V125, P473
   Langenberg C, 2005, AM J PUBLIC HEALTH, V95, P628, DOI 10.2105/2004.046219
   Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012
   Liu Y, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-35
   Lohman TG, 1988, ANTHROPOMETRIC STAND
   Martinez EZ, 2003, CADERNOS SAUDE COLET, V11, P7
   Mill JG, 2013, REV SAUDE PUBL, V47, P54, DOI 10.1590/S0034-8910.2013047003851
   Mirmiran P, 2004, EUR J CLIN NUTR, V58, P1110, DOI 10.1038/sj.ejcn.1601936
   Neamat-Allah J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091586
   Pereira R A, 1999, Cad Saude Publica, V15, P333, DOI 10.1590/S0102-311X1999000200018
   Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063
   Savva SC, 2013, DIABETES METAB SYNDR, V6, P403, DOI 10.2147/DMSO.S34220
   Sawaya AL, 2013, FISIOLOGIA NUTR SAUD, P323
   Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027
   Schmidt MI, 2013, REV SAUDE PUBL, V47, P105, DOI 10.1590/S0034-8910.2013047003889
   Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9
   Schneider Harald J, 2011, Diabetes Care, V34, pe7, DOI 10.2337/dc10-1794
   Steyerberg EW., 2008, CLIN PREDICTION MODE, P255
   Steyerberg EW, 2012, EUR J CLIN INVEST, V42, P216, DOI 10.1111/j.1365-2362.2011.02562.x
   Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011
   Vasques AC, 2010, ARQ BRAS CARDIOL, V95, pE14, DOI 10.1590/S0066-782X2010001100025
   World Health Organization, 1998, WHO TECHN REP SER, V899
   World Health Organization, 2008, WAIST CIRCUMFERENCE
NR 39
TC 9
Z9 9
U1 0
U2 1
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD APR
PY 2018
VL 21
IS 6
BP 1028
EP 1035
DI 10.1017/S136898001700338X
PG 8
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA FZ3PS
UT WOS:000427502500002
PM 29310740
OA Bronze
DA 2020-12-01
ER

PT J
AU de Castro, DB
   Sampaio, VS
   de Albuquerque, BC
   Pinto, RC
   Sadahiro, M
   dos Passos, RA
   da Costa, CF
   Braga, JU
AF de Castro, Daniel Barros
   Sampaio, Vanderson Souza
   de Albuquerque, Bernardino Claudio
   Pinto, Rosemary Costa
   Sadahiro, Megumi
   dos Passos, Ricardo Augusto
   da Costa, Cristiano Fernandes
   Braga, Jose Ueleres
TI Dengue epidemic typology and risk factors for extensive epidemic in
   Amazonas state, Brazil, 2010-2011
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Dengue epidemics classification; Socioeconomic; Environment; Climate;
   Amazon
ID HEMORRHAGIC-FEVER; CLIMATE; TRANSMISSION; URBANIZATION; THAILAND;
   HISTORY; AREAS; MODEL
AB Background: Dengue is the most prevalent arboviral disease affecting humans. The frequency and magnitude of dengue epidemic have significantly increased over recent decades. This study aimed to identify dengue epidemic types and risk factors for the extensive epidemics that occurred in 2010-2011, across the municipalities of Amazonas state, Brazil.
   Methods: Using an ecological approach, secondary data were obtained from the dengue fever surveillance system. Epidemic waves were classified according to three indices: duration, intensity, and coverage. A hierarchical model of multiple logistic regression was used for the identification of risk factors, with the occurrence of extensive dengue epidemic.
   Results: During the study period, dengue virus affected 49 of the 62 Amazonas municipalities. In 22 of these, the epidemics were of high intensity, wide range, and long time span, and therefore categorized as "extensive epidemics". The final multivariable model revealed a significant association between extensive dengue epidemics occurrence and the average number of days with precipitation (adjusted OR = 1.40, 95% CI: 1.01-1.94) and the number of years with infestation (adjusted OR = 1.53, 95% CI: 1.18-1.98).
   Conclusions: Our results indicate that it is crucial to integrate vector control, case management, epidemiological investigation, and health education, in order to respond to the growing threat of multiple mosquito-borne diseases, such as dengue, Zika and chikungunya, which are highly prevalent in the South America region.
C1 [de Castro, Daniel Barros; Sampaio, Vanderson Souza; de Albuquerque, Bernardino Claudio; Pinto, Rosemary Costa; Sadahiro, Megumi; dos Passos, Ricardo Augusto; da Costa, Cristiano Fernandes] Fundacao Vigilancia Saude Amazonas, Manaus, Amazonas, Brazil.
   [de Castro, Daniel Barros; Braga, Jose Ueleres] Fiocruz MS, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil.
   [Sampaio, Vanderson Souza] Fundacao Med Trop Dr Heitor Vieira Dourado FMT HV, Manaus, Amazonas, Brazil.
   [dos Passos, Ricardo Augusto] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio De Janeiro, Inst Med Social, Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Fundacao Amparo Pesquisa Estado Amazonas, PECTI SAUDE, Manaus, Amazonas, Brazil.
RP Braga, JU (corresponding author), Fiocruz MS, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), Univ Estado Rio De Janeiro, Inst Med Social, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), Fundacao Amparo Pesquisa Estado Amazonas, PECTI SAUDE, Manaus, Amazonas, Brazil.
EM ueleres@gmail.com
RI Sampaio, Vanderson/AAQ-1418-2020; Sampaio, Vanderson/M-4337-2015
OI Sampaio, Vanderson/0000-0001-7307-8851; Sampaio,
   Vanderson/0000-0001-7307-8851; Dos Passos/0000-0002-2155-9351
FU state of Amazonas, through the Fundacao de Amparo a Pesquisa do Estado
   do Amazonas, FAPEAM (Research Foundation of the State of Amazonas);
   National Council for Scientific and Technological DevelopmentNational
   Council for Scientific and Technological Development (CNPq) [440856 /
   2016-7]; Coordination for the Improvement of Higher Education
   PersonnelCAPES [88881.130825 / 2016-00, 88887.130823 / 2016-00]
FX This study was supported by government of the state of Amazonas, through
   the Fundacao de Amparo a Pesquisa do Estado do Amazonas, FAPEAM
   (Research Foundation of the State of Amazonas), for granting
   scholarships. DBC is a fellow of the RH-Doctoral Program at FAPEAM. This
   work was funded by the National Council for Scientific and Technological
   Development (http://www.cnpq.br, grant 440856 / 2016-7) and Coordination
   for the Improvement of Higher Education Personnel
   (http://www.capes.gov.br, grants 88881.130825 / 2016-00 and 88887.130823
   / 2016-00).
CR Adde A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004681
   Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507
   Barcellos C, 2014, TROP MED INT HEALTH, V19, P159, DOI 10.1111/tmi.12227
   Bastos MD, 2012, REV SOC BRAS MED TRO, V45, P393, DOI 10.1590/S0037-86822012000300022
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Brazilian Ministry of Health, 2009, DIR NAC PREV CONTR E, P160
   Camara FP, 2009, REV SOC BRAS MED TRO, V42, P137, DOI 10.1590/S0037-86822009000200008
   Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106
   COBRA C, 1995, AM J EPIDEMIOL, V142, P1204, DOI 10.1093/oxfordjournals.aje.a117579
   Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Fan J, 2014, EPIDEMIOL INFECT, V142, P634, DOI 10.1017/S0950268813001519
   Galli B, 2008, REV SAUDE PUBL, V42, P656, DOI [10.1590/S0034-89102008005000032, 10.1590/s0034-89102008000400011]
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   Hopp MJ, 2003, CLIM RES, V25, P85, DOI 10.3354/cr025085
   Instituto Brasileiro de Geografia e Estatistica. IBGE. Ministerio do Planejamento Orcamento e Gestao, 2011, CENS DEM 2010 CAR PO
   Instituto Brasileiro de Geografiae Estatistica. (IBGE), 2013, PROJ POP BRAS UN FED
   Jetten TH, 1997, AM J TROP MED HYG, V57, P285, DOI 10.4269/ajtmh.1997.57.285
   Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168
   Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047
   KOOPMAN JS, 1991, AM J EPIDEMIOL, V133, P1168, DOI 10.1093/oxfordjournals.aje.a115829
   Lowe R, 2013, STAT MED, V32, P864, DOI 10.1002/sim.5549
   Pan American Health Organization, 1994, DENG DENG HEM FEV AM, P548
   Parker D, 2012, INT J INFECT DIS, V16, pE793, DOI 10.1016/j.ijid.2012.07.002
   PINHEIRO Valéria Cristina Soares, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P245, DOI 10.1590/S0036-46652002000500002
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Rios-Velasquez CM, 2007, MEM I OSWALDO CRUZ, V102, P617, DOI 10.1590/S0074-02762007005000076
   Ritchie SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068137
   Vargas WP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2097-3
   Wen TH, 2006, SCI TOTAL ENVIRON, V367, P631, DOI 10.1016/j.scitotenv.2006.02.009
   World Health Organization, 2012, GLOB STRAT DENG PREV
NR 32
TC 6
Z9 6
U1 0
U2 8
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAR 15
PY 2018
VL 18
AR 356
DI 10.1186/s12889-018-5251-x
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FZ6ZI
UT WOS:000427748700003
PM 29544456
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU da Luz, EF
   Braga, JU
AF Furtado da Luz, E.
   Braga, J. U.
TI Under-reporting of tuberculosis in Praia, Cape Verde, from 2006 to 2012
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE tuberculosis; surveillance; record linkage; report
ID RESOURCE-LIMITED COUNTRIES; CAPTURE-RECAPTURE; BURDEN
AB SETTING: According to World Health Organization (WHO) estimates, the under-reporting rate for tuberculosis (TB) in Cape Verde between 2006 and 2012 was 49%. However, the WHO recognises the challenges associated with this estimation process and recommends implementing other methods, such as record linkage, to combat TB under-reporting.
   OBJECTIVES : To estimate and analyse under-reporting of cases by TB surveillance health units and to evaluate TB cases retrieved from other TB diagnostic sources in Praia, Cape Verde, from 2006 to 2012.
   DESIGN: This cross-sectional study evaluated under-reporting using the following data: 1) the under-reporting index from TB reporting health units (RHUs), where the number of validated TB cases from RHUs was compared with data from the National Programme for the Fight against Tuberculosis and Leprosy (NPFTL); and 2) the under-reporting index among overall data sources, or a comparison of the number of all validated TB cases from all sources with NPFTL data.
   RESULTS : The TB under-reporting rate was 40% in Praia during the study period, and results were influenced by laboratory findings.
   CONCLUSION: The TB under-reporting rate was very similar to the rate estimated by the WHO. TB surveillance must be improved to reduce under-reporting.
C1 [Furtado da Luz, E.; Braga, J. U.] Univ Estado Rio De Janeiro, Rio De Janeiro, RJ, Brazil.
   [Braga, J. U.] Fundacao Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
RP da Luz, EF (corresponding author), Univ Estado Rio de Janeiro, 7 Andar,Bloco E,Rua San Francisco Xavier 524, BR-20550900 Rio De Janeiro, RJ, Brazil.
EM furtadoermelinda@gmail.com
CR Anderson L, 2010, TUBERCULOSIS UK REPO
   Andrade S M, 2001, DATA HLTH INFORM WHA
   Bassili A, 2013, INT J TUBERC LUNG D, V17, P456, DOI 10.5588/ijtld.11.0483
   Bassili A, 2010, INT J TUBERC LUNG D, V14, P727
   Braga J U, 2007, REV SAUDE PUBL, V41, pS1
   Gibbons CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-147
   Glaziou P, 2016, METHODS USED WHO EST
   Glaziou P, 2012, WHOHTMTB201212
   Huseynova S, 2013, INT J TUBERC LUNG D, V17, P462, DOI 10.5588/ijtld.12.0209
   Melosini L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-472
   Ministerio da Saude da Cabo Verde, 2013, REL EST 2012
   Ministerio da Saude da Cabo Verde, 2011, REL EST 2010
   Ministerio da Saude de Cabo Verde, 2007, PLAN ESTR NAC LUT TI
   Ministerio da Saude de Cabo Verde, 2017, PRIM SEC HLTH CAR
   Ministerio da Saude do Brasil, 2005, GUIA VIG EP
   Rothman K.J., MODERN EPIDEMIOLOGY
   Seligi L, 2010, REV SAUDE PUBL, V44, P1
   Theme M M, 2012, ANAL TUBERCULOSIS UN
   van Hest NAH, 2007, EPIDEMIOL INFECT, V135, P1021, DOI 10.1017/S0950268806007540
   W. H. Organization, 2016, WHOHTMTB201613
   WHO AHO, 2014, HLTH INF RES EV KNOW
   World Health Organization, 2010, WHOHTMTB2009420
   World Health Organization, 2017, GLOB HLTH OBS DAT RE
   YIP PSF, 1995, AM J EPIDEMIOL, V142, P1047
NR 24
TC 2
Z9 2
U1 0
U2 2
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD MAR
PY 2018
VL 22
IS 3
BP 258
EP +
DI 10.5588/ijtld.17.0256
PG 7
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA GC4XY
UT WOS:000429790700006
PM 29471902
DA 2020-12-01
ER

PT J
AU de Castro, DB
   Sadahiro, M
   Pinto, RC
   de Albuquerque, BC
   Braga, JU
AF de Castro, D. B.
   Sadahiro, M.
   Pinto, R. C.
   de Albuquerque, B. C.
   Braga, J. U.
TI Spatial distribution of tuberculosis in Manaus and its social
   determinants, 2008-2013
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE TB; social determinants of health; Amazon; spatial analysis
ID PULMONARY TUBERCULOSIS; RISK-FACTORS; ASSOCIATION; STATE
AB SETTING: Brazil ranks eighteenth worldwide in annual numbers of new tuberculosis (TB) cases. The municipality of Manaus, Amazonas State, has the highest incidence of TB in Brazil.
   OBJECTIVE : To evaluate the quality of TB epidemiological surveillance, and to describe the spatial distribution pattern of TB incidence in Manaus and its social determinants.
   DESIGN: An ecological study was performed based on secondary data from TB epidemiological surveillance reports.
   RESULTS : An index was developed to classify neighborhoods in terms of the quality of surveillance and suspected underreporting. Based on data from neighborhoods with better surveillance performance, we observed that the average number of residents per room, the unemployment rate and the proportion of households connected to a sewage system were significant predictors of TB incidence. Seven neighborhoods in the south and west of the city had clusters of high TB transmission.
   CONCLUSION: Our results suggest that the association between TB and social vulnerability is obscured by the poor quality of TB surveillance data. We identified priority areas that require immediate TB control interventions and those where local surveillance efforts should be improved, and generated information useful for formulating more effective actions.
C1 [de Castro, D. B.; Sadahiro, M.; Pinto, R. C.; de Albuquerque, B. C.] Fundacao Vigilancia Saude Amazonas, Manaus, Amazonas, Brazil.
   [de Castro, D. B.; Braga, J. U.] Fiocruz MS, Escola Nacl Saud Publ Sergio Arouca, Rio De Janeiro, RJ, Brazil.
   [Braga, J. U.] Univ Estado Rio de Janeiro, Inst Med Social, Rua Belisario Tavora 653-202, BR-22245070 Rio De Janeiro, RJ, Brazil.
   [Braga, J. U.] Fundacao Amparo Pesquisa Estado Amazonas, Programa Estrateg Ciencia Tecnol & Inovacao Saude, Manaus, Amazonas, Brazil.
RP Braga, JU (corresponding author), Univ Estado Rio de Janeiro, Inst Med Social, Rua Belisario Tavora 653-202, BR-22245070 Rio De Janeiro, RJ, Brazil.
EM ueleres@gmail.com
FU Research Foundation of the State of Amazonas, Government of the State of
   Amazonas, Manaus
FX The authors thank the Research Foundation of the State of Amazonas,
   Government of the State of Amazonas, Manaus, for scholarships. DBC is a
   fellow of the RH-PhD program from the Research Foundation for the State
   of Amazonas (Fundacao de Amparo a Pesquisa do Estado do Amazonas),
   Manaus, AM, Brazil.
CR ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x
   Braga JU, 2012, CAD SAUDE COLET RIO, V20, P225
   Braga JU, 2007, REV SAUDE PUBL S1, V41, P77, DOI DOI 10.1590/S0034-89102007000800011
   Brasil. Instituto Brasileiro de Geografia e Estatistica, 2011, CENS DEM 2010 CAR PO
   Couceiro L, 2011, INT J TUBERC LUNG D, V15, P1445, DOI 10.5588/ijtld.10.0302
   Erazo C, 2014, REV PANAM SALUD PUBL, V36, P24
   FAO, 2006, STAT FOOD INS WORLD
   Gilson L, 2007, KNOWLEDGE NETWORK HL
   Gomes MGM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1464-8
   Ferreira Gonçalves Maria Jacirema, 2009, Rev. salud pública, V11, P918
   Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026
   Harling G, 2014, HEALTH PLACE, V25, P56, DOI 10.1016/j.healthplace.2013.10.008
   Hassarangsee S, 2015, INT J ENV RES PUB HE, V12, P16005, DOI 10.3390/ijerph121215040
   Kjellstrom T, 2007, OUR CITIES OUR HLTH
   Pereira AGL, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005470
   Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041
   MANGTANI P, 1995, BRIT MED J, V310, P963, DOI 10.1136/bmj.310.6985.963
   Marreiro LD, 2009, EPIDEMIOL SERV SAUDE, V18, P237
   Menezes A, 1998, REV BRAS EPIDEMIOL, V1, P50, DOI [10.1590/S1415-790X1998000100006, DOI 10.1590/S1415-790X1998000100006]
   Ministerio da Saude do Brasil, 2016, 13 MIN SAUD BRAS
   MORAN PAP, 1948, J ROY STAT SOC B, V10, P243
   Orellana Jesem Douglas Yamall, 2012, Rev. bras. epidemiol., V15, P714, DOI 10.1590/S1415-790X2012000400004
   Parra-Amaya Mayra Elizabeth, 2016, Diseases, V4, DOI 10.3390/diseases4020016
   Pinheiro J S., 2008, MONOGRAFIA
   Queiroga Rodrigo Pinheiro Fernandes de, 2012, Rev. bras. epidemiol., V15, P222
   Randremanana RV, 2009, TROP MED INT HEALTH, V14, P429, DOI 10.1111/j.1365-3156.2009.02239.x
   RIEDER HL, 1995, INFECTION, V23, P1, DOI 10.1007/BF01710048
   Visser S, 2011, CIENC SAUDE COLETIVA, V16, P3481, DOI 10.1590/S1413-81232011000900016
   World Health Organization, 2015, WHOHTMTB201522
   Yamamura M, 2014, REV PANAM SALUD PUBL, V35, P270
NR 30
TC 4
Z9 4
U1 1
U2 10
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD FEB
PY 2018
VL 22
IS 2
BP 171
EP +
DI 10.5588/ijtld.17.0369
PG 9
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA GC4WU
UT WOS:000429786700010
PM 29506613
DA 2020-12-01
ER

PT J
AU Maciel, EMGD
   Amancio, JD
   de Castro, DB
   Braga, JU
AF Godinho de Seixas Maciel, Elvira Maria
   Amancio, Juliana de Souza
   de Castro, Daniel Barros
   Braga, Jose Ueleres
TI Social determinants of pulmonary tuberculosis treatment non-adherence in
   Rio de Janeiro, Brazil
SO PLOS ONE
LA English
DT Article
ID SOUTH-AFRICA; HEALTH; ADHERENCE; DIAGNOSIS; EDUCATION; PATIENT; CARE;
   HIV
AB Success in tuberculosis control depends on the implementation of steps that reduce social inequities, allowing the diagnosis and effective treatment of the disease. Little is known about the conditions affecting antituberculosis treatment non-adherence in areas of great social and economic heterogeneity, such as the municipality of Rio de Janeiro. This study aimed to describe and identify the social determinants of antituberculosis treatment non-adherence in the municipality of Rio de Janeiro between 2008 and 2012. An ecological study was conducted with the districts of Rio de Janeiro as the units of analysis. Analyzes using Poisson regression models allowed us to identify the association between dropout from antituberculosis treatment and the human development index and social development index. The final model showed that economic conditions, infrastructure, and the tuberculosis control quality of surveillance were associated with treatment non-adherence. This study demonstrated that the scenarios of socio-environmental precariousness found in the districts of Rio de Janeiro were able to identify populations with an increased risk of default treatment from antituberculosis.
C1 [Godinho de Seixas Maciel, Elvira Maria; Amancio, Juliana de Souza; de Castro, Daniel Barros; Braga, Jose Ueleres] Fiocruz MS, Sergio Arouca Natl Sch Publ Hlth, Rio De Janeiro, Brazil.
   [de Castro, Daniel Barros] Hlth Surveillance Fdn, Manaus, Amazonas, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil.
RP Braga, JU (corresponding author), Fiocruz MS, Sergio Arouca Natl Sch Publ Hlth, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil.
EM ueleres@gmail.com
RI Barros de Castro, Daniel/J-9358-2016
OI Barros de Castro, Daniel/0000-0001-5969-544X
CR Abekah-Nkrumah G, 2016, HEALTH ECON REV, V6, DOI 10.1186/s13561-016-0085-7
   Silva APB, 2016, INT J TUBERC LUNG D, V20, P479, DOI 10.5588/ijtld.15.0609
   Barros RP, 2002, PELO FIM DECADAS PER
   Birch S, 2016, HEALTH POLICY PLANN, V31, P454, DOI 10.1093/heapol/czv084
   Bortz M, 2015, CAD SAUDE PUBLICA, V31, pS107, DOI 10.1590/0102-311X00081214
   Brasil, 2015, B EP DET TRAT CUR DE, V46
   Brasil, 2014, CONTR TUB BRAS AV IN, V44
   Brasil, 2016, B EP PERSP BRAS FIM
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia das Doencas Transmissiveis, 2014, PAN TUB BRAS IND EP
   Brasil Pedro Emmanuel Alvarenga Americano do, 2008, Cad. Saúde Pública, V24, ps485, DOI 10.1590/S0102-311X2008001600003
   Brasil. Portal da Saude. Departamento de Atenc Basica, 2016, HIST COB SAUD FAM
   Mendonca AMC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154843
   Comolet TM, 1998, INT J TUBERC LUNG D, V2, P891
   de Paula HC, 2013, REV BAIANA SAUDE PUB, V37, P192
   Dick J, 1997, INT J TUBERC LUNG D, V1, P181
   Greene JA, 2004, CULT MED PSYCHIAT, V28, P401, DOI 10.1023/B:MEDI.0000046429.55801.c8
   Instituto Brasileiro de Geografia e Estatistica. IBGE. Ministerio do Planejamento Orcamento e Gestao, 2011, CENS DEM 2010 CAR PO
   Kehr J, 2016, MED ANTHROPOL, V35, P377, DOI 10.1080/01459740.2015.1091819
   Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041
   Mason PH, 2016, J BIOSOC SCI, V48, P206, DOI 10.1017/S0021932015000115
   Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2011, MAN REC CONTR TUB BR
   Otwombe KN, 2013, INT J TUBERC LUNG D, V17, P1199, DOI 10.5588/ijtld.12.0891
   Poggensee G, 2014, PAN AFR MED J, V18, DOI [10.11694/pamj.supp.2014.18.1.4189, 10.11604/pamj.2014.18.262.4804]
   Raviglione MC, 2009, 40 UN WORLD C LUNG H
   Sabates R, 2006, SOC SCI MED, V62, P2998, DOI 10.1016/j.socscimed.2005.11.032
   Sobral F, 2008, EDUCAC COMPETITIVADE
   Tola HH, 2015, IRAN J PUBLIC HEALTH, V44, P1
   Tulloch O, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1523-x
   Vijay S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010043
   WHO, 2013, DEF REP FRAM WORK TU
   World Health Organization, 2015, GLOB TUB REP 2015
   World Health Organization, 2003, ADHERENCE LONG TERM
NR 32
TC 5
Z9 5
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 5
PY 2018
VL 13
IS 1
AR e0190578
DI 10.1371/journal.pone.0190578
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FR9OU
UT WOS:000419403800071
PM 29304100
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Rodrigues, NCP
   Andrade, MKD
   O'Dwyer, G
   Flynn, M
   Braga, JU
   de Almeida, AS
   Bastos, LS
   Lino, VTS
AF Pinheiro Rodrigues, Nadia Cristina
   de Noronha Andrade, Monica Kramer
   O'Dwyer, Gisele
   Flynn, Matthew
   Braga, Jose Ueleres
   de Almeida, Andrea Sobral
   Bastos, Leonardo Soares
   Saraiva Lino, Valeria Teresa
TI Distribution of pulmonary tuberculosis in Rio de Janeiro (Brazil): a
   spatial analysis
SO CIENCIA & SAUDE COLETIVA
LA English
DT Article
DE Tuberculosis; Spatial analysis; Incidence; Epidemiology; Multilevel
   analysis
ID RISK-FACTORS; TRANSMISSION; STATE; PATTERNS
AB The aim of this study was to analyze the spatial distribution of the tuberculosis endemic in Rio de Janeiro State from 2002 to 2011. A retrospective study was conducted in the state of Rio de Janeiro from 2002 to 2011. Spatial analysis techniques were used to describe the distribution of tuberculosis incidence in the state. Multilevel Poisson regression model was used to access the relationship of tuberculosis and the following factors: "sex", "age-group" and "diagnostic year" (individual-level factors). Demographic density and municipality were also included in the model as contextual-level factors. A reduction in endemic tuberculosis was observed over the years. The highest incidence rates were concentrated on the south coast of the state, covering Rio de Janeiro City (capital) and neighboring cities. We detected a significant clustering of high TB incidence rates on the south coast of the state and a cluster of low incidence in the northeastern region of state. The risk of tuberculosis was higher in early 2000s, in males and in 40-59 age group. Metropolitan regions are important risk areas for the spread of tuberculosis. These findings could be used to plan control measures according to the characteristics of each region.
C1 [Pinheiro Rodrigues, Nadia Cristina; de Noronha Andrade, Monica Kramer; O'Dwyer, Gisele; Braga, Jose Ueleres; de Almeida, Andrea Sobral; Saraiva Lino, Valeria Teresa] Escola Nacl Saude Publ Sergio Arouca, Fiocruz R Leopoldo Bulhoes 1480, BR-21041210 Rio De Janeiro, RJ, Brazil.
   [Flynn, Matthew] Georgia Southern Coll, Sociol & Anthropol Fac, Statesboro, GA 30460 USA.
   [Bastos, Leonardo Soares] Fiocruz MS, Programa Comp Cient, Rio De Janeiro, RJ, Brazil.
RP Rodrigues, NCP (corresponding author), Escola Nacl Saude Publ Sergio Arouca, Fiocruz R Leopoldo Bulhoes 1480, BR-21041210 Rio De Janeiro, RJ, Brazil.
EM nadiacristinapr@gmail.com
RI Sobral, Andrea/K-2319-2016; Bastos, Leonardo Soares/AAD-5335-2019
OI Sobral, Andrea/0000-0003-0552-771X; Bastos, Leonardo
   Soares/0000-0002-1406-0122
CR Anselin L., 1996, SPATIAL ANAL PERSPEC, V4, P111, DOI DOI 10.1201/9780203739051-8
   Bai GH, 2001, INT J TUBERC LUNG D, V5, P346
   Barbosa IR, 2013, EPIDEMIOL SERV SAUDE, V22, P687, DOI 10.5123/S1679-49742013000400015
   Barcellos, 1996, Cad Saude Publica, V12, P389
   Belo EN, 2013, REV PANAM SALUD PUBL, V34, P321
   Bessa Ferreira V M, 1999, Cad Saude Publica, V15, P317, DOI 10.1590/S0102-311X1999000200016
   Bierrenbach Ana Luiza, 2007, Rev. Saúde Pública, V41, P24, DOI 10.1590/S0034-89102007000800005
   Bishai WR, 1998, JAMA-J AM MED ASSOC, V280, P1679, DOI 10.1001/jama.280.19.1679
   Brasil. Ministerio da Saude (MS), 2012, EP B SPEC TUB
   Brasil. Ministerio da Saude (MS) HM, 2014, SIST INF AGR NOT SIN
   Brazilian Health Ministry, 2007, MULT RES TUB GUID EP
   Brazilian Health Ministry, 2014, PRIM CAR PORT HIST F
   Belo MTCT, 2010, J BRAS PNEUMOL, V36, P621, DOI 10.1590/S1806-37132010000500015
   Chan-Yeung M, 2005, INT J TUBERC LUNG D, V9, P1320
   Coimbra CEA, 2007, T ROY SOC TROP MED H, V101, P635, DOI 10.1016/j.trstmh.2007.03.013
   Ribeiro FKC, 2015, CLIN INFECT DIS, V61, P758, DOI 10.1093/cid/civ365
   Couceiro L, 2011, INT J TUBERC LUNG D, V15, P1445, DOI 10.5588/ijtld.10.0302
   Druck S, 2004, SPATIAL ANAL GEOGRAP
   Fasca SF, 2008, TUBERCULOSIS LIVING
   Ferreira SMB, 2004, EPIDEMIOLOGIA SERVIC, V13, P175
   Gelman A., 2007, DATA ANAL USING REGR
   Haase I, 2007, INT J TUBERC LUNG D, V11, P632
   Harling G, 2014, HEALTH PLACE, V25, P56, DOI 10.1016/j.healthplace.2013.10.008
   Hernandez M, 2014, REV CHIL INFECTOL, V31, P254, DOI 10.4067/S0716-10182014000300002
   IBGE-Brazilian Institute of Geography and Statistics, 2014, EST RES POP BRAZ FED
   Ismail Noriszura, 2007, CASUALTY ACTUARIAL S, V2007, P103
   Jia ZW, 2008, EMERG INFECT DIS, V14, P1413, DOI [10.3201/1409.071543, 10.3201/eid1409.071543]
   Korzeniewska-Kosela Maria, 2014, Przegl Epidemiol, V68, P295
   Lindoso JAL, 2009, REV INST MED TROP SP, V51, P247, DOI 10.1590/S0036-46652009000500003
   Liu Y, 2012, INT J TUBERC LUNG D, V16, P486, DOI 10.5588/ijtld.11.0255
   Melo TEMD, 2012, CAD SAUDE PUBLICA, V28, P267, DOI 10.1590/S0102-311X2012000200006
   Sales CMM, 2010, REV SOC BRAS MED TRO, V43, P435, DOI 10.1590/S0037-86822010000400020
   MORAN PAP, 1948, J ROY STAT SOC B, V10, P243
   Munch Z, 2003, INT J TUBERC LUNG D, V7, P271
   Ng IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050740
   Okanurak K, 2007, INT J TUBERC LUNG D, V11, P762
   Paixão Lúcia Miana M., 2007, Rev. Saúde Pública, V41, P205, DOI 10.1590/s0034-89102007000200006
   Pereira AGL, 2010, SPATIAL DISTRIBUTION
   Public Health England, 2014, TUB UK 2013 REP
   Sanchez AR, 2007, CAD SAUDE PUBLICA, V23, P545, DOI 10.1590/S0102-311X2007000300013
   Tadesse T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065022
   Touray K, 2010, TROP MED INT HEALTH, V15, P664, DOI 10.1111/j.1365-3156.2010.02533.x
   Universidade Federal do Estado do Rio de Janeiro (Unirio), 2012, SIT CIT STAT RIO DE
   Wong MK, 2013, WEST PAC SURVEILL RE, V4, P25, DOI [10.5365/wpsar.2013.4.1.002, 10.5365/WPSAR.2013.4.1.002]
   2012, GLOB TUB REP 2013, P1
NR 45
TC 2
Z9 2
U1 0
U2 1
PU ABRASCO
PI RIO DE JANEIRO
PA RUA HESPERIA, 16-PARTE MANGUINHOS, RIO DE JANEIRO, 21050-040, BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD DEC
PY 2017
VL 22
IS 12
BP 4125
EP 4134
DI 10.1590/1413-812320172212.0143016
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FQ8ZI
UT WOS:000418651400030
PM 29267729
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Paravidino, VB
   Curioni, C
   Mediano, MFF
   Braga, JU
   Sichieri, R
AF Paravidino, Vitor Barreto
   Curioni, Cintia
   Felix Mediano, Mauro Felippe
   Braga, Jose Ueleres
   Sichieri, Rosely
TI "Effect of Exercise Training on Non-exercise Physical Activity: A
   Systematic Review and Meta-Analysis of Randomized Controlled Trials''
SO SPORTS MEDICINE
LA English
DT Letter
ID OBESITY
C1 [Paravidino, Vitor Barreto; Braga, Jose Ueleres; Sichieri, Rosely] Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, Rua Sao Francisco Xavier 524, BR-20550013 Rio De Janeiro, Brazil.
   [Paravidino, Vitor Barreto] Naval Acad Brazilian Navy, Dept Phys Educ & Sports, Ave Almirante Silvio de Noronha S-N, BR-20021010 Rio De Janeiro, Brazil.
   [Curioni, Cintia] Univ Estado Rio De Janeiro, Inst Nutr, Dept Social Nutr, Rua Sao Francisco Xavier 524, BR-20550013 Rio De Janeiro, Brazil.
   [Felix Mediano, Mauro Felippe] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Ave Brasil 4365-18, BR-21040360 Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rua Leopoldo Bulhoes 1480, BR-21041210 Rio De Janeiro, Brazil.
RP Paravidino, VB (corresponding author), Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, Rua Sao Francisco Xavier 524, BR-20550013 Rio De Janeiro, Brazil.; Paravidino, VB (corresponding author), Naval Acad Brazilian Navy, Dept Phys Educ & Sports, Ave Almirante Silvio de Noronha S-N, BR-20021010 Rio De Janeiro, Brazil.
EM vparavidino@gmail.com
RI Paravidino, Vitor/AAV-1711-2020; Curioni, Cintia/X-9075-2019;
   Paravidino, Vitor B/A-6957-2018
OI Paravidino, Vitor/0000-0002-4972-1269; Paravidino, Vitor
   B/0000-0002-4972-1269
CR Borenstein M, 2009, INTRO METAANALYSIS
   Ebersole KE, 2008, OBESITY, V16, P2148, DOI 10.1038/oby.2008.330
   Fedewa MV, 2017, SPORTS MED, V47, P1171, DOI 10.1007/s40279-016-0649-z
   Gleser L. J., 2007, STOCHASTICALLY DEPEN
   Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049
   Hox J.J., 2010, MULTILEVEL ANAL TECH
   Luke A, 2013, INT J EPIDEMIOL, V42, P1831, DOI 10.1093/ije/dyt159
   Slentz CA, 2004, ARCH INTERN MED, V164, P31, DOI 10.1001/archinte.164.1.31
NR 8
TC 1
Z9 1
U1 2
U2 3
PU ADIS INT LTD
PI NORTHCOTE
PA 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND
SN 0112-1642
EI 1179-2035
J9 SPORTS MED
JI Sports Med.
PD OCT
PY 2017
VL 47
IS 10
BP 2129
EP 2130
DI 10.1007/s40279-017-0757-4
PG 2
WC Sport Sciences
SC Sport Sciences
GA FH1FQ
UT WOS:000410885700015
PM 28653206
DA 2020-12-01
ER

PT J
AU Ramalho, DMP
   Miranda, PFC
   Andrade, MK
   Brigido, T
   Dalcolmo, MP
   Mesquita, E
   Dias, CF
   Gambirasio, AN
   Braga, JU
   Detjen, A
   Phillips, PPJ
   Langley, I
   Fujiwara, PI
   Squire, SB
   Oliveira, MM
   Kritski, AL
AF Ramalho, D. M. P.
   Miranda, P. F. C.
   Andrade, M. K.
   Brigido, T.
   Dalcolmo, M. P.
   Mesquita, E.
   Dias, C. F.
   Gambirasio, A. N.
   Ueleres Braga, J.
   Detjen, A.
   Phillips, P. P. J.
   Langley, I.
   Fujiwara, P. I.
   Squire, S. B.
   Oliveira, M. M.
   Kritski, A. L.
CA Rede-TB Study Grp
TI Outcomes from patients with presumed drug resistant tuberculosis in five
   reference centers in Brazil
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Multi-drug resistant tuberculosis; Diagnosis; Treatment outcome
ID MULTIDRUG-RESISTANCE; CULTURE CONVERSION; DIAGNOSTIC-TESTS;
   SOUTH-AFRICA; IMPLEMENTATION; METAANALYSIS; FEASIBILITY; MULTICENTER;
   PREDICTORS; INITIATION
AB Background: The implementation of rapid drug susceptibility testing (DST) is a current global priority for TB control. However, data are scarce on patient-relevant outcomes for presumptive diagnosis of drug-resistant tuberculosis (pDR-TB) evaluated under field conditions in high burden countries.
   Methods: Observational study of pDR-TB patients referred by primary and secondary health units. TB reference centers addressing DR-TB in five cities in Brazil. Patients age 18 years and older were eligible if pDR-TB, culture positive results for Mycobacterium tuberculosis and, if no prior DST results from another laboratory were used by a physician to start anti-TB treatment. The outcome measures were median time from triage to initiating appropriate anti-TB treatment, empirical treatment and, the treatment outcomes.
   Results: Between February, 16th, 2011 and February, 15th, 2012, among 175 pDR TB cases, 110 (63.0%) confirmed TB cases with DST results were enrolled. Among study participants, 72 (65.5%) were male and 62 (56.4%) aged 26 to 45 years. At triage, empirical treatment was given to 106 (96.0%) subjects. Among those, 85 were treated with first line drugs and 21 with second line. Median time for DST results was 69.5 [interquartile -IQR: 35.7-111.0] days and, for initiating appropriate anti-TB treatment, the median time was 1.0 (IQR: 0-41.2) days. Among 95 patients that were followed-up during the first 6 month period, 24 (25.3%; IC: 17.5%-34.9%) changed or initiated the treatment after DST results: 16/29 MDRTB, 5/21 DR-TB and 3/45 DS-TB cases. Comparing the treatment outcome to DS-TB cases, MDRTB had higher proportions changing or initiating treatment after DST results (p = 0.01) and favorable outcomes (p = 0.07).
   Conclusions: This study shows a high rate of empirical treatment and long delay for DST results. Strategies to speed up the detection and early treatment of drug resistant TB should be prioritized.
C1 [Ramalho, D. M. P.; Miranda, P. F. C.; Andrade, M. K.; Oliveira, M. M.; Kritski, A. L.] Univ Fed Rio de Janeiro, Med Sch & Hosp Complex HUCFF IDT, TB Acad Program, Rio De Janeiro, Brazil.
   [Andrade, M. K.; Dalcolmo, M. P.; Ueleres Braga, J.] Fiocruz MS, ENSP, Helio Fraga Reference Ctr, Rio De Janeiro, Brazil.
   [Brigido, T.] Messejana Hosp State Secretary Hlth, Fortaleza, Ceara, Brazil.
   [Mesquita, E.] Ary Parreiras Inst State Secretary Hlth, Rio De Janeiro, Brazil.
   [Dias, C. F.] Sanatario Partenon Hosp State Secretary Hlth, Porto Alegre, RS, Brazil.
   [Gambirasio, A. N.] Clemente Ferreira Inst State Secretary Hlth, Sao Paulo, Brazil.
   [Detjen, A.; Fujiwara, P. I.] Int Union TB & Lung Dis, Paris, France.
   [Langley, I.; Squire, S. B.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.
   [Phillips, P. P. J.] MRC Clin Trials Unit, London, England.
RP Kritski, AL (corresponding author), Univ Fed Rio de Janeiro, Med Sch & Hosp Complex HUCFF IDT, TB Acad Program, Rio De Janeiro, Brazil.
EM kritskia@gmail.com
RI Kritski, Afranio/I-6760-2016; Phillips, Patrick/B-6347-2008
OI kritski, afranio/0000-0002-5900-6007; Langley, Ivor/0000-0002-9275-6731;
   Squire, Stephen/0000-0001-7173-9038; Phillips,
   Patrick/0000-0002-6336-7024
FU United States Agency for International Development (USAID)United States
   Agency for International Development (USAID) [GHN-A-00-08-00004-00];
   CNPq/INCTNational Council for Scientific and Technological Development
   (CNPq) [573548/2008-0]; CNPq (produtividade em pesquisa); FAPERJ
   (Cientistas do Nosso Estado)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX This research was supported by the United States Agency for
   International Development (USAID) Cooperative Agreement (TREAT TB
   Agreement No. GHN-A-00-08-00004-00) and CNPq/INCT 573548/2008-0. ALK is
   recipient of a career award from CNPq (produtividade em pesquisa) and
   FAPERJ (Cientistas do Nosso Estado). The funders had no role in study
   design, data collection and analysis, the decision to publish, or the
   preparation of the manuscript.
CR Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300
   Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC
   Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8
   Casal M, 2005, MICROB DRUG RESIST, V11, P62, DOI 10.1089/mdr.2005.11.62
   Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2
   de Oliveira GP, 2013, BRAZ J INFECT DIS, V17, P218, DOI 10.1016/j.bjid.2013.01.005
   Dheda K, 2014, LANCET RESP MED, V2, P321, DOI 10.1016/S2213-2600(14)70031-1
   Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030
   Gler MT, 2012, INT J TUBERC LUNG D, V16, P1326, DOI 10.5588/ijtld.12.0038
   Granich RM, 2005, JAMA-J AM MED ASSOC, V293, P2732, DOI 10.1001/jama.293.22.2732
   Hanrahan CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049898
   Jacobson KR, 2013, CLIN INFECT DIS, V56, P503, DOI 10.1093/cid/cis920
   Joh JS, 2007, J KOREAN MED SCI, V22, P26, DOI 10.3346/jkms.2007.22.1.26
   Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914
   Kent PT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012082
   Kurbatova EV, 2012, INT J TUBERC LUNG D, V16, P1335, DOI 10.5588/ijtld.11.0811
   Magee MJ, 2015, INT J TUBERC LUNG D, V19, P685, DOI 10.5588/ijtld.14.0811
   Martinez D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012082
   MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121
   Ministerio da Saude do Brasil, 2011, MAN REC CONTR TUB BR, P284
   Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6
   Qazi F, 2011, INT J TUBERC LUNG D, V15, P1556, DOI 10.5588/ijtld.10.0679
   Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922
   Shin SS, 2012, INT J TUBERC LUNG D, V16, P1538, DOI 10.5588/ijtld.12.0071
   Smith SE, 2012, INT J TUBERC LUNG D, V16, P203, DOI 10.5588/ijtld.11.0445
   Theron G, 2014, LANCET INFECT DIS, V14, P527, DOI 10.1016/S1473-3099(13)70360-8
   Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5
   Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537
   Tukvadze N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031563
   WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance, 2008, ANT DRUG RES WORLD 4, P142
   World Health Organization, 2016, GLOB TUB REP
   World Health Organization, 2013, WHO MON XPERT MTB RI
   World Health Organization, 2014, DRUG RES TB SURV RES
   Yadav RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072036
NR 34
TC 5
Z9 5
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD AUG 15
PY 2017
VL 17
AR 571
DI 10.1186/s12879-017-2669-1
PG 13
WC Infectious Diseases
SC Infectious Diseases
GA FD5TB
UT WOS:000407591600007
PM 28810911
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-12-01
ER

PT J
AU Aguirre, S
   Cuellar, CM
   Herrero, MB
   Cortesi, GC
   de Romero, NG
   Alvarez, M
   Braga, JU
AF Aguirre, Sarita
   Martinez Cuellar, Celia
   Belen Herrero, Maria
   Chamorro Cortesi, Gustavo
   Gimenez de Romero, Nilda
   Alvarez, Mirian
   Ueleres Braga, Jose
TI Prevalence of tuberculosis respiratory symptoms and associated factors
   in the indigenous populations of Paraguay (2012)
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE pulmonary tuberculosis; population groups; cross-sectional studies; risk
   factors
ID HEALTH
AB BACKGROUND The prevalence of respiratory symptoms and confirmed tuberculosis ( TB) among indigenous groups in Paraguay is unknown.
   METHODS This study assessed the prevalence of respiratory symptoms, confirmed pulmonary TB, and associated socio-economic factors among indigenous Paraguayan populations. Indigenous persons residing in selected communities were included in the study. A total of 24,352 participants were interviewed at home between October and December 2012. Respiratory symptomatic individuals were defined as those with respiratory symptoms of TB. A hierarchical Poisson regression analysis was performed with four levels: individual characteristics, living conditions and environmental characteristics, source of food, and type of nutrition.
   FINDINGS In this study, 1,383 participants had respiratory symptoms (5.7%), but only 10 had culture-confirmed TB (41/100,000 inhabitants). The small number of cases did not allow evaluation of the risk factors for TB. Age older than 37 years was associated with a two-fold increased risk of symptoms. Female sex; family history of TB; type of housing; home heating; a lack of hunting, fishing, or purchasing food; and a lack of vegetable consumption were also associated with the presence of symptoms. A lack of cereal consumption had a protective effect. Members of the Ayoreo or Manjui ethnic groups had a three-fold increased risk of symptoms.
   MAIN CONCLUSION Individual characteristics, dietary habits, and belonging to specific ethnic groups were associated with respiratory symptoms.
C1 [Aguirre, Sarita] Minist Publ Hlth & Social Welf Paraguay, TB Control Program, Asuncion, Paraguay.
   [Martinez Cuellar, Celia] Univ Nacl Asuncion, Fac Ciencias Med, Asuncion, Paraguay.
   [Belen Herrero, Maria] Fac Latinoamer Ciencias Sociales, Dept Int Relat, Buenos Aires, DF, Argentina.
   [Chamorro Cortesi, Gustavo; Gimenez de Romero, Nilda] Minist Publ Hlth & Social Welf Paraguay, Cent Publ Hlth Lab, Asuncion, Paraguay.
   [Alvarez, Mirian] Minist Publ Hlth & Social Welf Paraguay, Dept Stat TB Control Program, Asuncion, Paraguay.
   [Ueleres Braga, Jose] Fundacao Oswaldo Cruz Fiocruz, Escola Nacl Saude Publ, Dept Epidemiol & Metodos Quantitat, Rio De Janeiro, RJ, Brazil.
   [Ueleres Braga, Jose] Univ Estado Rio de Janeiro, Inst Med Social, Dept Epidemiol, Rio De Janeiro, RJ, Brazil.
RP Braga, JU (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Escola Nacl Saude Publ, Dept Epidemiol & Metodos Quantitat, Rio De Janeiro, RJ, Brazil.; Braga, JU (corresponding author), Univ Estado Rio de Janeiro, Inst Med Social, Dept Epidemiol, Rio De Janeiro, RJ, Brazil.
EM ueleres@gmail.com
CR [Anonymous], 2009, GLOB IND PEOPL IN ST
   Arana JE Daza, 2013, THESIS U VALLE
   Barry C, 2009, COMMUN DIS INTELL, V33, P304
   Collazos C, 2010, BIOMEDICA, V30, P519
   Culqui DR, 2010, REV PERU MED EXP SAL, V27, P278
   Das Dilip, 2006, N Z Med J, V119, pU2249
   Freitas FTD, 2011, REV PANAM SALUD PUBL, V29, P451
   DGEEC-Direccion General de Estadistica Encuestas y Censos, 2012, CENS NAC IND 2002
   Fanning A, 1999, CAN MED ASSOC J, V160, P837
   Fitzgerald JM, 2000, CAN MED ASSOC J, V162, P351
   García Ingrid, 2004, Biomédica, V24, P124
   Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505
   Henao G, 1999, INFORME QUINCENAL EP, V4, P85
   Hoeppner V H, 2000, Can Respir J, V7, P141
   Krieger J, 2002, AM J PUBLIC HEALTH, V92, P758, DOI 10.2105/AJPH.92.5.758
   Lopez PA, 2013, PREVALENCIA TUBERCUL
   Moreno LL, 2010, MEDUNAB, V13, P75
   Muniyandi M, 2007, INT J TUBERC LUNG D, V11, P1042
   Nobrega RG, 2010, REV LAT-AM ENFERM, V18, P1169, DOI 10.1590/S0104-11692010000600018
   Thorson A, 2004, J CLIN EPIDEMIOL, V57, P398, DOI 10.1016/j.jclinepi.2002.11.001
   Tollefson D, 2013, INT J TUBERC LUNG D, V17, P1139, DOI 10.5588/ijtld.12.0385
   UN-United Nations, 2012, STAT WORLDS IND PEOP
   WHO-World Health Organization, 2004, TUB GEND TUB RES
   Winston C., 2010, Morbidity and Mortality Weekly Report, V59, P289
NR 24
TC 2
Z9 2
U1 0
U2 7
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUL
PY 2017
VL 112
IS 7
BP 474
EP 484
DI 10.1590/0074-02760160443
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EX5HL
UT WOS:000403270100002
PM 28591308
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Braga, JU
   Bressan, C
   Dalvi, APR
   Calvet, GA
   Daumas, RP
   Rodrigues, N
   Wakimoto, M
   Nogueira, RMR
   Nielsen-Saines, K
   Brito, C
   de Filippis, AMB
   Brasil, P
AF Braga, Jose Ueleres
   Bressan, Clarisse
   Razal Dalvi, Ana Paula
   Amaral Calvet, Guilherme
   Daumas, Regina Paiva
   Rodrigues, Nadia
   Wakimoto, Mayumi
   Ribeiro Nogueira, Rita Maria
   Nielsen-Saines, Karin
   Brito, Carlos
   Bispo de Filippis, Ana Maria
   Brasil, Patricia
TI Accuracy of Zika virus disease case definition during simultaneous
   Dengue and Chikungunya epidemics
SO PLOS ONE
LA English
DT Article
ID OUTBREAK; ILLNESS; BRAZIL
AB Background
   Zika is a new disease in the American continent and its surveillance is of utmost importance, especially because of its ability to cause neurological manifestations as Guillain-Barre A syndrome and serious congenital malformations through vertical transmission. The detection of suspected cases by the surveillance system depends on the case definition adopted. As the laboratory diagnosis of Zika infection still relies on the use of expensive and complex molecular techniques with low sensitivity due to a narrow window of detection, most suspected cases are not confirmed by laboratory tests, mainly reserved for pregnant women and new-borns. In this context, an accurate definition of a suspected Zika case is crucial in order for the surveillance system to gauge the magnitude of an epidemic.
   Methodology
   We evaluated the accuracy of various Zika case definitions in a scenario where Dengue and Chikungunya viruses co-circulate. Signs and symptoms that best discriminated PCR confirmed Zika from other laboratory confirmed febrile or exanthematic diseases were identified to propose and test predictive models for Zika infection based on these clinical features.
   Results and discussion
   Our derived score prediction model had the best performance because it demonstrated the highest sensitivity and specificity, 86.6% and 78.3%, respectively. This Zika case definition also had the highest values for auROC (0.903) and R-2 (0.417), and the lowest Brier score 0.096.
   Conclusions
   In areas where multiple arboviruses circulate, the presence of rash with pruritus or conjunctival hyperemia, without any other general clinical manifestations such as fever, petechia or anorexia is the best Zika case definition.
C1 [Braga, Jose Ueleres; Razal Dalvi, Ana Paula; Daumas, Regina Paiva; Rodrigues, Nadia] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, Brazil.
   [Bressan, Clarisse; Amaral Calvet, Guilherme; Wakimoto, Mayumi; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Referencia Flavivirus, Rio De Janeiro, Brazil.
   [Nielsen-Saines, Karin] David Geffen UCLA Sch Med, Los Angeles, CA USA.
   [Brito, Carlos] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
RP Braga, JU (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, Brazil.
EM ueleres@gmail.com
RI Calvet, GA/G-6959-2013; DAUMAS, REGINA/M-9387-2013; amsalu,
   ribka/G-8780-2019; Barros de Castro, Daniel/J-9358-2016
OI Calvet, GA/0000-0002-3545-5238; DAUMAS, REGINA/0000-0002-8923-7711;
   Barros de Castro, Daniel/0000-0001-5969-544X
FU Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da Saude do
   Brasil; Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [CAPES/88887.116627/2016-01]; NATIONAL EYE INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Eye Institute (NEI) [R21EY028318] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R21AI129534, R21AI129534] Funding Source: NIH RePORTER
FX Funding Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da
   Saude do Brasil and Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES/88887.116627/2016-01).
CR de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Brasil. Ministerio da Saude Secretaria de Vigilancia em Sande Departamento de Vigilancia das Doencas Transmissiveis, 2016, SECR VIG SANDE DEP V
   Brasil. Secretaria de Vigilancia em Saude - Ministerio da Saude, 2016, SECRETARIA VIGILANCI
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lorenzi OD, 2013, AM J TROP MED HYG, V88, P472, DOI 10.4269/ajtmh.12-0373
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Pan American Health Organization / World Health Organization, 2015, EP UPD ZIK VIR  1016
   Pan American Health Organization / World Health Organization (PAHO / WHO), 2014, EP AL CHIK DENG FEV
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Rezza G, 2014, EMERG INFECT DIS, V20, P1351, DOI 10.3201/eid2008.131615
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P58, DOI 10.1016/j.tmaid.2015.09.001
   Solet J. L., 2007, PLOS BIOL, V77, P727
   WHO, 2017, SIT REP
   World Health Organization, 2016, ZIKA VIRUS DIS  0212
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 17
TC 30
Z9 30
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 26
PY 2017
VL 12
IS 6
AR e0179725
DI 10.1371/journal.pone.0179725
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EZ2KD
UT WOS:000404537300015
PM 28650987
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Dalcolmo, M
   Gayoso, R
   Sotgiu, G
   D'Ambrosio, L
   Rocha, JL
   Borga, L
   Fandinho, F
   Braga, JU
   Sanchez, DA
   Dockhorn, F
   Centis, R
   Migliori, GB
AF Dalcolmo, Margareth
   Gayoso, Regina
   Sotgiu, Giovanni
   D'Ambrosio, Lia
   Rocha, Jorge Luiz
   Borga, Liamar
   Fandinho, Fatima
   Braga, Jose Ueleres
   Sanchez, Denise Arakaki
   Dockhorn, Fernanda
   Centis, Rosella
   Migliori, Giovanni Battista
TI Resistance profile of drugs composing the "shorter" regimen for
   multidrug-resistant tuberculosis in Brazil, 2000-2015
SO EUROPEAN RESPIRATORY JOURNAL
LA English
DT Letter
C1 [Dalcolmo, Margareth; Gayoso, Regina; Rocha, Jorge Luiz; Borga, Liamar] Fiocruz MS, Helio Fraga Reference Ctr, MoH, Rio De Janeiro, Brazil.
   [Sotgiu, Giovanni] Univ Sassari, AOU Sassari, Dept Biomed Sci, Res Med Educ & Profess Dev Unit,Clin Epidemiol &, Sassari, Italy.
   [D'Ambrosio, Lia; Centis, Rosella; Migliori, Giovanni Battista] WHO, Collaborating Ctr TB & Lung Dis, IRCCS Tradate, Maugeri Inst, Via Roncaccio 16, I-21049 Tradate, Italy.
   [D'Ambrosio, Lia] Publ Hlth Consulting Grp, Lugano, Switzerland.
   [Fandinho, Fatima] Fiocruz MS, Natl TB Reference Ctr, CRPHF, Natl Mycobacteriol Lab,MoH, Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Fiocruz MS, MoH, Natl Publ Hlth Sch, Dept Epidemiol, Rio De Janeiro, Brazil.
   [Sanchez, Denise Arakaki; Dockhorn, Fernanda] SVS, Natl TB Control Programme, Minist Hlth, Rio De Janeiro, Brazil.
RP Migliori, GB (corresponding author), WHO, Collaborating Ctr TB & Lung Dis, IRCCS Tradate, Maugeri Inst, Via Roncaccio 16, I-21049 Tradate, Italy.
EM giovannibattista.migliori@icsmaugeri.it
RI Sotgiu, Giovanni/N-1032-2017; Centis, Rosella/E-8882-2018; Migliori,
   Giovanni Battista/AAB-8589-2020
OI Sotgiu, Giovanni/0000-0002-1600-4474; Centis,
   Rosella/0000-0002-8551-3598; Migliori, Giovanni
   Battista/0000-0002-2597-574X
CR Aung KJM, 2014, INT J TUBERC LUNG D, V18, P1180, DOI 10.5588/ijtld.14.0100
   Dalcolmo MP, 1999, J PNEUMOL, V25, P70
   Diel R, 2014, EUR RESPIR J, V43, P554, DOI 10.1183/09031936.00079413
   Falzon D, 2013, EUR RESPIR J, V42, P156, DOI 10.1183/09031936.00134712
   Javaid A, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01967-2016
   Kendall EA, 2017, LANCET RESP MED, V5, P191, DOI 10.1016/S2213-2600(16)30423-4
   Kuaban C, 2015, INT J TUBERC LUNG D, V19, P517, DOI 10.5588/ijtld.14.0535
   Migliori GB, 2013, EUR RESPIR J, V42, P169, DOI 10.1183/09031936.00136312
   Piubello A, 2014, INT J TUBERC LUNG D, V18, P1188, DOI 10.5588/ijtld.13.0075
   Sotgiu G, 2017, LANCET RESP MED, V5, P159, DOI 10.1016/S2213-2600(16)30432-5
   Sotgiu G, 2016, EUR RESPIR J, V48, P1503, DOI 10.1183/13993003.01249-2016
   Sotgiu G, 2016, LANCET, V387, P2486, DOI 10.1016/S0140-6736(16)30729-2
   van der Werf MJ, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01992-2016
   Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC
   World Health Organization, 2016, WHOHTMTB201604
NR 15
TC 19
Z9 19
U1 0
U2 1
PU EUROPEAN RESPIRATORY SOC JOURNALS LTD
PI SHEFFIELD
PA 442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND
SN 0903-1936
EI 1399-3003
J9 EUR RESPIR J
JI Eur. Resp. J.
PD APR
PY 2017
VL 49
IS 4
AR 1602309
DI 10.1183/13993003.02309-2016
PG 4
WC Respiratory System
SC Respiratory System
GA ET5RL
UT WOS:000400342500026
PM 28404651
OA Bronze
DA 2020-12-01
ER

PT J
AU Dalcolmo, M
   Gayoso, R
   Sotgiu, G
   D'Ambrosio, L
   Rocha, JL
   Borga, L
   Fandinho, F
   Braga, JU
   Galesi, VMN
   Barreira, D
   Sanchez, DA
   Dockhorn, F
   Centis, R
   Caminero, JA
   Migliori, GB
AF Dalcolmo, Margareth
   Gayoso, Regina
   Sotgiu, Giovanni
   D'Ambrosio, Lia
   Rocha, Jorge L.
   Borga, Liamar
   Fandinho, Fatima
   Braga, Jose U.
   Galesi, Vera M. N.
   Barreira, Draurio
   Sanchez, Denise A.
   Dockhorn, Fernanda
   Centis, Rosella
   Caminero, Jose A.
   Migliori, Giovanni B.
TI Effectiveness and safety of clofazimine in multidrug-resistant
   tuberculosis: a nationwide report from Brazil
SO EUROPEAN RESPIRATORY JOURNAL
LA English
DT Article
ID MEROPENEM/CLAVULANATE-CONTAINING REGIMENS; MDR-TB; DRUGS; BEDAQUILINE;
   1ST
AB Although clofazimine is used to treat multidrug-resistant tuberculosis (MDR-TB), there is scant information on its effectiveness and safety. The aim of this retrospective, observational study was to evaluate these factors as well as the tolerability of clofazimine in populations in Brazil, where it was administered at a daily dose of 100 mg center dot day(-1) (body weight. 45 kg) as part of a standardised MDR-TB treatment regimen until 2006 (thereafter pyrazinamide was used).
   All MDR-TB patients included in the Sistema de Informacao de Tratamentos Especiais da Tuberculose (SITETB) individual electronic register were analysed. The effectiveness of clofazimine was assessed by comparing the treatment outcomes of patients undergoing clofazimine-containing regimens against those undergoing clofazimine-free regimens and its safety by describing clofazimine-attributed adverse events. A total of 1446 patients were treated with clofazimine-containing regimens and 1096 with pyrazinamide-containing regimens.
   Although success rates were similar in patients treated with clofazimine versus those treated with pyrazinamide (880 out of 1446, 60.9%, versus 708 out of 1096, 64.6%; p=0.054), clofazimine-treated cases exhibited higher death rates due to tuberculosis than pyrazinamide-treated ones (314 out of 1446, 21.7%, versus 120 out of 1096, 10.9%) but fewer failures (78 out of 1446, 5.4%, versus 95 out of 1096, 8.7%) and less loss to follow-up (144 out of 1446, 10.0%, versus 151 out of 1096, 13.8%). No relevant differences were detected when comparing adverse events in patients treated with clofazimine-containing regimens to those treated with clofazimine-free regimens. However, the incidence of side-effects was less than previously reported (gastro-intestinal complaints: 10.5%; hyper-pigmentation: 50.2%; neurological disturbances: 9-13%).
C1 [Dalcolmo, Margareth; Gayoso, Regina; Rocha, Jorge L.; Borga, Liamar] Fundacao Oswaldo Cruz Fiocruz, Reference Ctr Helio Fraga, Minist Hlth, Rio De Janeiro, Brazil.
   [Sotgiu, Giovanni] Univ Sassari, Dept Biomed Sci, Clin Epidemiol & Med Stat Unit, Sassari, Italy.
   [D'Ambrosio, Lia; Centis, Rosella; Migliori, Giovanni B.] Fdn S Maugeri, IRCCS, WHO, Collaborating Ctr TB & Lung Dis, Via Roncaccio 16, I-21049 Tradate, Varese, Italy.
   [D'Ambrosio, Lia] Publ Hlth Consulting Grp, Lugano, Switzerland.
   [Fandinho, Fatima] Fundacao Oswaldo Cruz Fiocruz, Minist Hlth, Reference Ctr Helio Fraga, Natl Mycobacteriol Lab, Rio De Janeiro, Brazil.
   [Braga, Jose U.] Fundacao Oswaldo Cruz Fiocruz, ENSP, Minist Hlth, Dept Epidemiol, Rio De Janeiro, Brazil.
   [Galesi, Vera M. N.] State Secretariat Hlth, Div TB, Sao Paulo, Brazil.
   [Barreira, Draurio] UNITAID, TB Unit, Geneva, Switzerland.
   [Sanchez, Denise A.; Dockhorn, Fernanda] Minist Hlth, SVS, Natl TB Control Programme, Brasilia, DF, Brazil.
   [Caminero, Jose A.] Gen Hosp Gran Canaria Dr Negrin, Dept Pneumol, Las Palmas Gran Canaria, Spain.
   [Caminero, Jose A.] Union Int Union TB & Lung Dis, Dept TB, Paris, France.
RP Migliori, GB (corresponding author), Fdn S Maugeri, IRCCS, WHO, Collaborating Ctr TB & Lung Dis, Via Roncaccio 16, I-21049 Tradate, Varese, Italy.
EM giovannibattista.migliori@icsmaugeri.it
RI Centis, Rosella/E-8882-2018; Migliori, Giovanni Battista/AAB-8589-2020;
   Sotgiu, Giovanni/N-1032-2017
OI Centis, Rosella/0000-0002-8551-3598; Migliori, Giovanni
   Battista/0000-0002-2597-574X; Sotgiu, Giovanni/0000-0002-1600-4474
CR Ammerman NC, 2017, J ANTIMICROB CHEMOTH, V72, P455, DOI 10.1093/jac/dkw417
   Andries K, 2015, INT J TUBERC LUNG S2, V19, pS127
   Aung KJM, 2014, INT J TUBERC LUNG D, V18, P1180, DOI 10.5588/ijtld.14.0100
   Caminero JA, 2015, EUR RESPIR J, V46, P887, DOI 10.1183/13993003.00432-2015
   Dalcolmo M, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02309-2016
   Dalcolmo MP, 1999, J PNEUMOL, V25, P70
   Diacon AH, 2016, NEW ENGL J MED, V375, P393, DOI 10.1056/NEJMc1513236
   Diel R, 2014, EUR RESPIR J, V43, P554, DOI 10.1183/09031936.00079413
   Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611
   Falzon D, 2016, EUR RESPIR J, V48, DOI 10.1183/13993003.congress-2016.PA2712
   Falzon D, 2013, EUR RESPIR J, V42, P156, DOI 10.1183/09031936.00134712
   Gopal M, 2013, INT J TUBERC LUNG D, V17, P1001, DOI 10.5588/ijtld.12.0144
   Hartkoorn RC, 2014, ANTIMICROB AGENTS CH, V58, P2979, DOI 10.1128/AAC.00037-14
   Javaid A, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01967-2016
   Kuaban C, 2015, INT J TUBERC LUNG D, V19, P517, DOI 10.5588/ijtld.14.0535
   Migliori GB, 2013, EUR RESPIR J, V42, P169, DOI 10.1183/09031936.00136312
   Piubello A, 2014, INT J TUBERC LUNG D, V18, P1188, DOI 10.5588/ijtld.13.0075
   Pontali E, 2016, EUR RESPIR J, V47, P394, DOI 10.1183/13993003.01891-2015
   Sotgiu G, 2016, EUR RESPIR J, V48, P1503, DOI 10.1183/13993003.01249-2016
   Sotgiu G, 2015, EXPERT REV ANTI-INFE, V13, P305, DOI 10.1586/14787210.2015.1011127
   Sotgiu G, 2015, EUR RESPIR J, V45, P25, DOI 10.1183/09031936.00145014
   Sotgiu G, 2012, EUR RESPIR J, V40, P1430, DOI 10.1183/09031936.00022912
   Tang SJ, 2015, CLIN INFECT DIS, V60, P1361, DOI 10.1093/cid/civ027
   Tiberi S, 2016, CLIN INFECT DIS, V62, P1188, DOI 10.1093/cid/ciw088
   Tiberi S, 2016, EUR RESPIR J, V47, P1235, DOI 10.1183/13993003.02146-2015
   Tiberi S, 2016, EUR RESPIR J, V47, P333, DOI 10.1183/13993003.01278-2015
   Van der Paardt AFL, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01612-2016
   van der Werf MJ, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01992-2016
   Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC
   W. H. Organization, 2016, WHOHTMTB201613
   Williams K, 2012, ANTIMICROB AGENTS CH, V56, P3114, DOI 10.1128/AAC.00384-12
   World Health Organization, 2016, WHOHTMTB201604
   Zhang S, 2015, J ANTIMICROB CHEMOTH, V70, P2507, DOI 10.1093/jac/dkv150
NR 33
TC 37
Z9 38
U1 0
U2 11
PU EUROPEAN RESPIRATORY SOC JOURNALS LTD
PI SHEFFIELD
PA 442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND
SN 0903-1936
EI 1399-3003
J9 EUR RESPIR J
JI Eur. Resp. J.
PD MAR
PY 2017
VL 49
IS 3
AR 1602445
DI 10.1183/13993003.02445-2016
PG 10
WC Respiratory System
SC Respiratory System
GA EQ2WI
UT WOS:000397931500043
PM 28331044
OA Bronze
DA 2020-12-01
ER

PT J
AU Nascimento, RDD
   Costa, MDN
   Braga, JU
   da Natividade, MS
AF de Sousa Nascimento, Rita de Cassia
   Nascimento Costa, Maria da Conceicao
   Braga, Jose Ueleres
   da Natividade, Marcio Santos
TI Spatial patterns of preventable perinatal mortality in Salvador, Bahia,
   Brazil
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Perinatal Death prevention & control; Perinatal Mortality; Risk Factors;
   Spatial Analysis
AB OBJECTIVE: To identify the spatial distribution patterns and areas of higher risk of preventable perinatal mortality in the city of Salvador, State of Bahia, Brazil.
   METHODS: We carried out a spatial aggregated study in 2007, considering the weighting areas (census tracts contiguous sets) of Salvador, of which the center and north present low life conditions. Data were obtained from national vital statistics systems and the 2010 Census. Addresses of live births and stillbirths were geocoded by weighting area. The spatial distribution of the perinatal mortality rate was analyzed from thematic maps. Spatial dependence was evaluated by the Global and Local Geary's and Moran's Indexes.
   RESULTS: Crude and smoothed perinatal mortality rates were high in areas situated to the north, west, and in center of Salvador. The smoothed rates in weighting areas ranged from 4.9/1,000 to 22.3/1,000 births. Of all perinatal deaths, 92.1% could have been prevented. We identified spatial dependence for preventable perinatal mortality for care in pregnancy, with neighboring areas with high risk in the north of the city.
   CONCLUSIONS: The preventability potential of perinatal mortality was high in Salvador, in 2007. The spatial distribution pattern with higher rates in disadvantaged areas of the city suggests the existence of social inequalities in health. The characteristics of the process of urban development of Salvador, which has inadequate prenatal care, possibly influenced the magnitude and spatial distribution pattern of this mortality.
C1 [de Sousa Nascimento, Rita de Cassia; Nascimento Costa, Maria da Conceicao; da Natividade, Marcio Santos] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio De Janeiro, Rio De Janeiro, RJ, Brazil.
RP Nascimento, RDD (corresponding author), Rua Altino Serbeto Barros,119-103 Itaigara, BR-41830492 Salvador, BA, Brazil.
EM nascimento.rita@gmail.com
RI de Cassia de Sousa Nascimento, Rita/AAM-8228-2020; Natividade,
   Marcio/Q-5662-2019
OI Natividade, Marcio/0000-0002-3986-5656
CR Almeida Marcia Furquim de, 2006, Rev. bras. epidemiol., V9, P56
   Andrade Carla Lourenço Tavares de, 2004, Cad. Saúde Pública, V20, pS44, DOI 10.1590/S0102-311X2004000700005
   Aquino R, 2009, AM J PUBLIC HEALTH, V99, P87, DOI 10.2105/AJPH.2007.127480
   CARVALHO I. M. M., 2001, TEMPO SOC, V13, P89
   Centro Colaborador da OMS para Doencas em Portugues, 2008, CLASS EST INT DOENC
   Fonseca Sandra Costa, 2004, Cad. Saúde Pública, V20, pS7, DOI 10.1590/S0102-311X2004000700002
   Goncalves AC, 2011, CAD SAUDE PUBLICA, V27, P1581, DOI 10.1590/S0102-311X2011000800013
   Lansky S, 2002, REV SAUDE PUBL, V36, P759, DOI 10.1590/s0034-89102002000700017
   Lansky S, 2007, AM J PUBLIC HEALTH, V97, P867, DOI 10.2105/AJPH.2005.075986
   Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8
   Malta DC, 2010, EPIDEMIOL SERV SAUDE, V19, P173
   Pisati M, 2012, GERM STAT US GROUP M
   SANTOS M., 2007, O ESPACO DO CIDADAO
   World Health Organization, 2006, NEON PER MORT COUNTR
NR 14
TC 1
Z9 2
U1 0
U2 1
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PY 2017
VL 51
AR 73
DI 10.11606/S1518-8787.2017051007076
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FG7OK
UT WOS:000410607400001
PM 28832759
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Pinto, RC
   de Castro, DB
   de Albuquerque, BC
   Sampaio, VD
   dos Passos, RA
   da Costa, CF
   Sadahiro, M
   Braga, JU
AF Pinto, Rosemary Costa
   de Castro, Daniel Barros
   de Albuquerque, Bernardino Claudio
   Sampaio, Vanderson de Souza
   dos Passos, Ricardo Augusto
   da Costa, Cristiano Fernandes
   Sadahiro, Megumi
   Braga, Jose Ueleres
TI Mortality Predictors in Patients with Severe Dengue in the State of
   Amazonas, Brazil
SO PLOS ONE
LA English
DT Article
ID HEMORRHAGIC-FEVER
AB Dengue is a major public health problem in tropical and subtropical areas worldwide. There is a lack of information on the risk factors for death due to severe dengue fever in developing countries, including Brazil where the state of Amazonas is located. This knowledge is important for decision making and the implementation of effective measures for patient care. This study aimed to identify factors associated with death among patients with severe dengue, in Amazonas from 2001 to 2013. We conducted a retrospective cohort study based on secondary data from the epidemiological surveillance of dengue provided by the Fundacao de Vigilancia em Saude do Amazonas, FVS (Health Surveillance Foundation) of the Secretaria de Saude do Amazonas, SUSAM (Health Secretariat of the State of Amazonas). Data on dengue cases were obtained from the SINAN (Notifiable Diseases Information System) and SIM (Mortality Information System) databases. We selected cases of severe dengue with laboratory confirmation, including dengue-related deaths of residents in the state of Amazonas from January 1, 2001, to December 31, 2013. The explanatory variables analyzed were sex, age, level of education, spontaneous hemorrhagic manifestations, plasma extravasation and platelet count. Patients who died due to severe dengue had more hematuria, gastrointestinal bleeding, and thrombocytopenia than the survivors. Considering the simultaneous effects of demographic and clinical characteristics with a multiple logistic regression model, it was observed that the factors associated with death were age >55 years (odds ratio [OR] 4.98), gastrointestinal bleeding (OR 10.26), hematuria (OR 5.07), and thrombocytopenia (OR 2.55). Gastrointestinal bleeding was the clinical sign most strongly associated with death, followed by hematuria and age >55 years. The study results showed that the best predictor of death from severe dengue is based on the characteristic of age >55 years, together with the clinical signs of gastrointestinal bleeding, hematuria, and low platelet count.
C1 [Pinto, Rosemary Costa; de Castro, Daniel Barros; de Albuquerque, Bernardino Claudio; Sampaio, Vanderson de Souza; dos Passos, Ricardo Augusto; da Costa, Cristiano Fernandes; Sadahiro, Megumi] Fundacao Vigilancia Saude Amazonas FVS, Hlth Surveillance Fdn Amazonas State, Manaus, Amazonas, Brazil.
   [de Castro, Daniel Barros; Braga, Jose Ueleres] Fiocruz MS, Sergio Arouca Natl Sch Publ Hlth, Rio De Janeiro, Brazil.
   [dos Passos, Ricardo Augusto] Fiocruz MS, Inst Oswaldo Cruz, Lab Physiol & Control Arthropod Vectors, Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Res Fdn State Amazonas, PECTI SAUDE, Manaus, Amazonas, Brazil.
RP Braga, JU (corresponding author), Fiocruz MS, Sergio Arouca Natl Sch Publ Hlth, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), Res Fdn State Amazonas, PECTI SAUDE, Manaus, Amazonas, Brazil.
EM ueleres@gmail.com
RI Sampaio, Vanderson/M-4337-2015; Sampaio, Vanderson/AAQ-1418-2020
OI Sampaio, Vanderson/0000-0001-7307-8851; Sampaio,
   Vanderson/0000-0001-7307-8851; Dos Passos/0000-0002-2155-9351
FU government of the state of Amazonas, through the Fundacao de Amparo a
   Pesquisa do Estado do Amazonas, FAPEAM (Research Foundation of the State
   of Amazonas); Journal Articles Publishing Support Program (PAPAC); 
   [015/2014]
FX This work was supported by the government of the state of Amazonas,
   through the Fundacao de Amparo a Pesquisa do Estado do Amazonas, FAPEAM
   (Research Foundation of the State of Amazonas), for granting
   scholarships by the RH-Doctoral Program (DBC has a fellowship) and
   publishing support by Journal Articles Publishing Support Program (PAPAC
   number 015/2014). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.; We would like to thank the Nucleo de Sistemas de Informacao
   em Saude da Fundacao de Vigilancia em Sause do Amazonas (Center for
   Health Information Systems of the Health Surveillance Foundation of
   Amazonas) for allowing us to access the SINAN and SIM database, and to
   the government of the state of Amazonas, through the Fundacao de Amparo
   a Pesquisa do Estado do Amazonas, FAPEAM (Research Foundation of the
   State of Amazonas), for granting scholarships. DBC is a fellow of the
   RH-Doctoral Program at FAPEAM. The authors declare that there is no
   conflict of interest.
CR Martins VDA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100535
   Bethell DB, 2001, CLIN INFECT DIS, V32, P243, DOI 10.1086/318453
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Brazilian Ministry of Health, 2009, DIR NAC PREV CONTR E
   Brazilian Ministry of Health, 2011, DENG DIAGN MAN CLIN
   Brazilian Ministry of Health, 2014, B EP, V53
   Costa MDCN, 2011, J EPIDEMIOL COMMUN H, V65, pA361, DOI 10.1136/jech.2011.142976m.35
   De Figueiredo RMP, REV SOC BRAS MED TRO, V37, P476
   Diaz-Quijano FA, 2012, AM J TROP MED HYG, V86, P328, DOI 10.4269/ajtmh.2012.11-0074
   dos Passos RA, 2012, MONITORAMENTO CASOS
   Figueiro AC, 2011, CAD SAUDE PUBLICA, V27, P2373, DOI 10.1590/S0102-311X2011001200009
   Fundacao de Vigilancia em Saude do Amazonas, 2014, B VIG SAUD, V15
   Fundagao de Vigilancia em Saude do Amazonas, 2012, B VIG SAUD
   Fundagao Nacional de Saude, 2002, DENG DIAGN MAN CLIN
   García-Rivera Enid J., 2003, Rev Panam Salud Publica, V13, P362, DOI 10.1590/S1020-49892003000500004
   Gubler DJ, 1999, ADV VIRUS RES, V53, P35, DOI 10.1016/S0065-3527(08)60342-5
   Hosmer D., 2004, APPL LOGISTIC REGRES
   Hung N, 2003, DENGUE B
   Instituto Brasileiro de Geografia e Estatistica. IBGE. Ministerio do Planejamento Orcamento e Gestao, 2011, CENS DEM 2010 CAR PO
   Lye DC, 2008, SINGAP MED J, V49, P476
   Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774
   Paixao ES, 2015, REV SOC BRAS MED TRO, V48, P399, DOI 10.1590/0037-8682-0145-2015
   Pongpan S, 2013, INT J
   Vicente CR, 2013, REV SOC BRAS MED TRO, V46, P629, DOI 10.1590/0037-8682-1579-2013
   Rocha L, 2009, REV SOC BRAS MED TRO
   WHO T, 2009, DENG GUID DIAGN TREA
NR 27
TC 15
Z9 16
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 26
PY 2016
VL 11
IS 8
AR e0161884
DI 10.1371/journal.pone.0161884
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DU8WL
UT WOS:000382496300031
PM 27564084
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Micheletti, VCD
   Kritski, AL
   Braga, JU
AF Dezoti Micheletti, Vania Celina
   Kritski, Afranio Lineu
   Braga, Jose Ueleres
TI Clinical Features and Treatment Outcomes of Patients with Drug-Resistant
   and Drug-Sensitive Tuberculosis: A Historical Cohort Study in Porto
   Alegre, Brazil
SO PLOS ONE
LA English
DT Article
ID CULTURE CONVERSION; HIV-INFECTION; METAANALYSIS; PREDICTORS
AB Purpose
   To evaluate the clinical features and treatment outcomes of patients with pulmonary tuberculosis, stratified by level of drug resistance.
   Methods
   This was a historical cohort study based on data from the II National Anti-Tuberculosis Drug Resistance Survey (2006-2007) collected at eight participating health care facilities in Porto Alegre, southern Brazil. The cohort was followed for 3 years after the start of treatment.
   Results
   Of 299 cases of smear-positive pulmonary tuberculosis included in the study, 216 (72.2%) were diagnosed at five public primary health care units and 83 (27.8%) at three public hospitals. Among these cases, the prevalence of drug-resistant tuberculosis was 14.4%, and that of multidrug-resistant tuberculosis was 4.7%. Overall, 32.0% of drug-resistant and 2.0% of multidrug-resistant cases occurred in previously treated patients. The most common comorbidity in the sample was HIV infection (26.2%). There was no association between drug-resistant or multidrug-resistant tuberculosis and sociodemographic variables. Cure was achieved in 66.7% of patients, and the default rate was 21.2%. The 2-month sputum conversion rate was 34.2%, and the relapse rate was 16.9%. Patients with drug-resistant tuberculosis had lower rates of cure (45.2%) and 2-month sputum conversion (25%), as well as a higher relapse rate (30.7%).
   Conclusion
   These results highlight the urgent need for a more effective TB control program in this geographical setting, with a major emphasis on treatment of drug-resistant and multidrug-resistant tuberculosis.
C1 [Dezoti Micheletti, Vania Celina] Univ Fed Rio Grande do Sul, Postgrad Sch Pulmonol, Porto Alegre, RS, Brazil.
   [Kritski, Afranio Lineu] Univ Fed Rio de Janeiro, Sch Med, Rio De Janeiro, RJ, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio De Janeiro, Dept Collect Hlth, Rio De Janeiro, RJ, Brazil.
   [Braga, Jose Ueleres] Fundacao Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
RP Micheletti, VCD (corresponding author), Univ Fed Rio Grande do Sul, Postgrad Sch Pulmonol, Porto Alegre, RS, Brazil.
EM vaniadezoti@uol.com.br
RI Kritski, Afranio/I-6760-2016
OI kritski, afranio/0000-0002-5900-6007
CR Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300
   Drummond AMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145553
   Brazil. Ministry of Health, 2012, TUB BRAS MUND
   Brazil. Ministry of Health, 1994, MAN BACT TUB
   Brazil. Ministry of Health, 2005, 2 INQ NAC RES DROG T
   Brito RC, 2010, INT J TUBERC LUNG D, V14, P24
   Brust JCM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073975
   Calixto M, 2010, UMA ANALISE HISTORIC
   Castelo Filho Adauto, 2004, J. bras. pneumol., V30, pS57, DOI 10.1590/S1806-37132004000700002
   Cortezi MD, 2006, B PNEUMOL SANIT, V14, P145
   de Oliveira H B, 2000, Rev Panam Salud Publica, V7, P232
   Micheletti VCD, 2014, J BRAS PNEUMOL, V40, P155, DOI 10.1590/S1806-37132014000200009
   Ferreira MMC, 1996, J ACQ IMMUN DEF SYND, V13, P177, DOI 10.1097/00042560-199610010-00009
   Haar CH, 2007, EMERG INFECT DIS, V13, P776, DOI 10.3201/eid1305.060334
   Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2
   Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152
   Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914
   Kurbatova EV, 2012, INT J TUBERC LUNG D, V16, P1335, DOI 10.5588/ijtld.11.0811
   Mesfin YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082235
   [Ministry of Health Health Surveillance Department Department of Epidemiological Surveillance Brazil], 2011, PROGR NAC CONTR TUB
   [Municipal Administration of Porto Alegre Brazil. National Cancer Institute], 2011, REL GEST 2010
   [National Secretariat for Drug Policy Brazil. Presidency of the Republic], 2009, RELATORIO BRASILEIRO
   Qazi F, 2011, INT J TUBERC LUNG D, V15, P1556, DOI 10.5588/ijtld.10.0679
   Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450
   Ruffino-Netto Antonio, 2007, J. bras. pneumol., V33, pxxvii, DOI 10.1590/S1806-37132007000500001
   Suhadev M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019485
   Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537
   Vieira R, 2007, REV BRAS EPIDEMIOL, V10, P10
   *WHO, 2003, GLOB TUB CONTR SURV
   *WHO, 2006, STOP TB STRAT BUILD
   World Health Organization, 1998, LAB SERV TUB CONTR 2
   World Health Organization, 1997, ANT DRUG RES WORLD
   World Health Organization, 2009, WHOHTMTB2008402
NR 33
TC 6
Z9 6
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 9
PY 2016
VL 11
IS 8
AR e0160109
DI 10.1371/journal.pone.0160109
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT3IK
UT WOS:000381374200022
PM 27505633
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Malacarne, J
   Rios, DPG
   da Silva, CMFP
   Braga, JU
   Camacho, LAB
   Basta, PC
AF Malacarne, Jocieli
   Giraldo Rios, Diana Patricia
   Furtado Passos da Silva, Cosme Marcelo
   Braga, Jose Ueleres
   Bastos Camacho, Luiz Antonio
   Basta, Paulo Cesar
TI Prevalence and factors associated with latent tuberculosis infection in
   an indigenous population in the Brazilian Amazon
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Epidemiology; Health services indigenous; Mycobacterium tuberculosis;
   Public health surveillance; South American Indians
ID RONDONIA; INDIANS; PEOPLES; SURUI; RISK; SITUATION
AB Introduction: Recent studies have shown a high incidence and prevalence of latent tuberculosis infection (LTBI) in indigenous populations around the World. We aimed to estimate the prevalence and annual risk of infection (ARI) as well as to identify factors associated with LTBI in an indigenous population from the Brazilian Amazon. Methods: We conducted a cross-sectional study in 2011. We performed tuberculin skin tests (TSTs), smears and cultures of sputum samples, and chest radiographs for individuals who reported cough for two or more weeks. Associations between LTBI (TST >= 5mm) and socio-demographic, clinical, and epidemiological characteristics were investigated using Poisson regression with robust variance. Prevalence ratio (PR) was used as the measure of association. Results: We examined 263 individuals. The prevalence of LTBI was 40.3%, and the ARI was 2.4%. Age >= 15 years [PR=5.5; 95% confi dence interval (CI): 3.5-8.6], contact with tuberculosis (TB) patients (PR=3.8; 95% CI: 1.2-11.9), previous TB history (PR=1.4; 95% CI: 1.2-1.7), and presence of Bacillus Calmette-Guerin (BCG) scar (PR=1.9, 95% CI: 1.2-2.9) were associated with LTBI. Conclusions: Although some adults may have been infected years prior, the high prevalence of infection and its strong association with age >= 15 years, history of TB, and recent contact with TB patients suggest that the TB transmission risk is high in the study area.
C1 [Malacarne, Jocieli; Giraldo Rios, Diana Patricia] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Programa Posgrad Stricto Sensu Epidemiol Saude Pu, Rio De Janeiro, RJ, Brazil.
   [Furtado Passos da Silva, Cosme Marcelo; Braga, Jose Ueleres; Bastos Camacho, Luiz Antonio] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Epidemiol & Metodos Quantitat Saude, Rio De Janeiro, RJ, Brazil.
   [Basta, Paulo Cesar] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Endemias Samuel Pessoa, Rio De Janeiro, RJ, Brazil.
RP Basta, PC (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Endemias Samuel Pessoa, Rio De Janeiro, RJ, Brazil.
EM pcbasta@ensp.fiocruz.br
FU Brazilian National Council for Technological Development [Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)]
   [402505/2008-5]
FX We received support from the Brazilian National Council for
   Technological Development [Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)], process number 402505/2008-5.
CR American Thoracic Society, 2000, RESP CRIT CARE MED, V161, P1376
   Committee to Advise on Tropical Medicine and Travel (CATMAT), 2007, Can Commun Dis Rep, V33, P1
   Arnadottir T, 1996, TUBERCLE LUNG DIS, V77, P1, DOI 10.1016/S0962-8479(96)90127-6
   Barbosa T, 2008, ENF EMERG, V10, P138
   Barros A.J., 2003, BMC MED RES METHODOL, V3
   Basta PC, 2006, MEM I OSWALDO CRUZ, V101, P581, DOI 10.1590/S0074-02762006000600001
   Basta Paulo Cesar, 2006, Cad. Saúde Pública, V22, P245, DOI 10.1590/S0102-311X2006000200002
   Basta PC, 2010, ANN HUM BIOL, V37, P643, DOI 10.3109/03014460903524451
   Basta PC, 2006, T ROY SOC TROP MED H, V100, P579, DOI 10.1016/j.trstmh.2005.07.014
   Basta RC, 2006, INT J TUBERC LUNG D, V10, P1354
   Belo EN, 2013, REV PANAM SALUD PUBL, V34, P321
   Board AR, 2016, INT HEALTH, V8, P67, DOI 10.1093/inthealth/ihv033
   Cauthen GM, 2002, B WORLD HEALTH ORGAN, V80, P503
   Coimbra CEA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-52
   Sacchi FPC, 2013, T ROY SOC TROP MED H, V107, P152, DOI 10.1093/trstmh/trs089
   Culqui DR, 2010, REV PERU MED EXP SAL, V27, P8
   Cunha EA, 2014, MEM I OSWALDO CRUZ, V109, P108, DOI 10.1590/0074-0276130082
   de Assis EM, 2013, CAD SAUDE PUBLICA, V29, P681, DOI 10.1590/S0102-311X2013000800006
   Den Boon S, 2005, INT J TUBERC LUNG D, V9, P1088
   Escobar A L, 2001, Cad Saude Publica, V17, P285, DOI 10.1590/S0102-311X2001000200004
   Escobar AL, 2004, INT J TUBERC LUNG D, V8, P45
   Rios DPG, 2013, REV PANAM SALUD PUBL, V33, P22, DOI 10.1590/S1020-49892013000100004
   GRZYBOWSKI S, 1976, TUBERCLE, V57, pS1, DOI 10.1016/0041-3879(76)90059-3
   Melo TEMD, 2012, CAD SAUDE PUBLICA, V28, P267, DOI 10.1590/S0102-311X2012000200006
   Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2011, MAN REC CONTR TUB BR
   Nava-Aguilera E, 2009, INT J TUBERC LUNG D, V13, P17
   Orellana Jesem Douglas Yamall, 2012, Rev. bras. epidemiol., V15, P714, DOI 10.1590/S1415-790X2012000400004
   Palhano-Silva CS, 2009, INTERCIENCIA, V34, P259
   Longhi RMP, 2013, BRAZ J INFECT DIS, V17, P363, DOI 10.1016/j.bjid.2012.11.001
   Robertus LM, 2011, AUST NZ J PUBL HEAL, V35, P6, DOI 10.1111/j.1753-6405.2010.00663.x
   Villa TCS, 2009, J BRAS PNEUMOL, V35, P610, DOI 10.1590/S1806-37132009000600014
   Tollefson D, 2013, INT J TUBERC LUNG D, V17, P1139, DOI 10.5588/ijtld.12.0385
   Villalba JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085638
   YOUNG TK, 1992, TUBERCLE LUNG DIS, V73, P94, DOI 10.1016/0962-8479(92)90062-O
   Yuhara LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071201
   Zembrzuski VM, 2010, TUBERCULOSIS, V90, P44, DOI 10.1016/j.tube.2009.11.002
NR 36
TC 8
Z9 9
U1 0
U2 3
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JUL-AUG
PY 2016
VL 49
IS 4
BP 456
EP 464
DI 10.1590/0037-8682-0220-2016
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DU8IT
UT WOS:000382457200010
PM 27598632
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU de Castro, DB
   Pinto, RC
   de Albuquerque, BC
   Sadahiro, M
   Braga, JU
AF de Castro, Daniel Barros
   Pinto, Rosemary Costa
   de Albuquerque, Bernardino Claudio
   Sadahiro, Megumi
   Braga, Jose Ueleres
TI The Socioeconomic Factors and the Indigenous Component of Tuberculosis
   in Amazonas
SO PLOS ONE
LA English
DT Article
ID SOCIAL DETERMINANTS; BRAZILIAN AMAZON; RISK-FACTORS
AB Despite the availability of tuberculosis prevention and control services throughout Amazonas, high rates of morbidity and mortality from tuberculosis remain in the region. Knowledge of the social determinants of tuberculosis in Amazonas is important for the establishment of public policies and the planning of effective preventive and control measures for the disease. To analyze the relationship of the spatial distribution of the incidence of tuberculosis in municipalities and regions of Amazonas to the socioeconomic factors and indigenous tuberculosis component, from 2007 to 2013. An ecological study was conducted based on secondary data from the epidemiological surveillance of tuberculosis. A linear regression model was used to analyze the relationship of the annual incidence of tuberculosis to the socioeconomic factors, performance indicators of health services, and indigenous tuberculosis component. The distribution of the incidence of tuberculosis in the municipalities of Amazonas was positively associated with the Gini index and the population attributable fraction of tuberculosis in the indigenous peoples, but negatively associated with the proportion of the poor and the unemployment rate. The spatial distribution of tuberculosis in the different regions of Amazonas was heterogeneous and closely related with the socioeconomic factors and indigenous component of tuberculosis.
C1 [de Castro, Daniel Barros; Pinto, Rosemary Costa; de Albuquerque, Bernardino Claudio; Sadahiro, Megumi] Hlth Surveillance Fdn Amazonas State, Manaus, Amazonas, Brazil.
   [de Castro, Daniel Barros; Braga, Jose Ueleres] Fiocruz MS, Sergio Arouca Natl Sch Publ Hlth, Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] PVS PECTI SAUDE Res Fdn State Amazonas, Manaus, Amazonas, Brazil.
RP Braga, JU (corresponding author), Fiocruz MS, Sergio Arouca Natl Sch Publ Hlth, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), PVS PECTI SAUDE Res Fdn State Amazonas, Manaus, Amazonas, Brazil.
EM ueleres@gmail.com
RI Barros de Castro, Daniel/J-9358-2016
OI Barros de Castro, Daniel/0000-0001-5969-544X
FU Government of the State of Amazonas, through the Research Foundation of
   the State of Amazonas
FX This work was supported by the Government of the State of Amazonas,
   through the Research Foundation of the State of Amazonas, by providing
   scholarships. DBC is a fellow of the RH-PhD program from the Research
   Foundation for the State of Amazonas-FAPEAM. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Amarante JM, 2000, B PNEUMOLOGIA SANITA, V8, P5
   Baruzzi R G, 2001, Cad Saude Publica, V17, P407, DOI 10.1590/S0102-311X2001000200015
   Basta RC, 2006, INT J TUBERC LUNG D, V10, P1354
   Bhargava A, 2014, NATL MED J INDIA, V27, P128
   Braga JU, 2007, REV SAUDE PUBL, V41
   Brasil, 2011, MAN REC CONTR TUB BR
   Brasil, 2015, IND DES SIST UN SAUD
   Brasil, 2014, 44 MIN SAUD
   Buchillet, 1998, Cad Saude Publica, V14, P181, DOI 10.1590/S0102-311X1998000100026
   Costa DC, 1987, CAD SAUDE PUBLICA, V3, P388
   Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453
   Rios DPG, 2013, REV PANAM SALUD PUBL, V33, P22, DOI 10.1590/S1020-49892013000100004
   Harling G, 2014, HEALTH PLACE, V25, P56, DOI 10.1016/j.healthplace.2013.10.008
   Holtgrave DR, 2004, AM J PREV MED, V26, P159, DOI 10.1016/j.amepre.2003.10.014
   IBGE, 2012, CENS DEM 2010 CAR GE
   Instituto Brasileiro de Geografiae Estatistica. (IBGE), 2013, PROJ POP BRAS UN FED
   Kawatsu Lisa, 2015, Kekkaku, V90, P395
   Leung CC, 2004, INT J TUBERC LUNG D, V8, P958
   Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041
   Marreiro LS, 2003, TUBERCULOSE MANAUS E, V237
   Nazareth T, 2011, REV PARANA DESENVOLV, P201
   Programa das Nacoes Unidas para o Desenvolvimento (PNUD), 2013, ATL DES HUM BRAS
   Programa das Nacoes Unidas para o Desenvolvimento-PNUD, 2013, IND DES HUM MUN BRAS
   Santos RV, 2011, CAD SAUDE PUBLICA, V27, P1049, DOI 10.1590/S0102-311X2011000600001
   Sousa AO, 1997, P NATL ACAD SCI USA, V94, P13227, DOI 10.1073/pnas.94.24.13227
   Suk JE, 2009, EMERG INFECT DIS, V15, P1812, DOI 10.3201/eid1511.090916
   Tanrikulu AC, 2008, PUBLIC HEALTH, V122, P613, DOI 10.1016/j.puhe.2007.09.005
   World Health Organization, 2014, GLOB TUB REP 2014
NR 28
TC 10
Z9 10
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 30
PY 2016
VL 11
IS 6
AR e0158574
DI 10.1371/journal.pone.0158574
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ0CH
UT WOS:000378865200095
PM 27362428
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU do Brasil, PEAA
   Xavier, SS
   Holanda, MT
   Hasslocher-Moreno, AM
   Braga, JU
AF Alvarenga Americano do Brasil, Pedro Emmanuel
   Xavier, Sergio Salles
   Holanda, Marcelo Teixeira
   Hasslocher-Moreno, Alejandro Marcel
   Braga, Jose Ueleres
TI Does my patient have chronic Chagas disease? Development and temporal
   validation of a diagnostic risk score
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Chagas disease; Signs and symptoms; Diagnosis; Sensitivity and
   specificity; Nomograms
ID TRYPANOSOMA-CRUZI INFECTION; PREGNANT-WOMEN; UNITED-STATES;
   BLOOD-DONORS; PREVALENCE
AB Introduction: With the globalization of Chagas disease, unexperienced health care providers may have difficulties in identifying which patients should be examined for this condition. This study aimed to develop and validate a diagnostic clinical prediction model for chronic Chagas disease. Methods: This diagnostic cohort study included consecutive volunteers suspected to have chronic Chagas disease. The clinical information was blindly compared to serological tests results, and a logistic regression model was fit and validated. Results: The development cohort included 602 patients, and the validation cohort included 138 patients. The Chagas disease prevalence was 19.9%. Sex, age, referral from blood bank, history of living in a rural area, recognizing the kissing bug, systemic hypertension, number of siblings with Chagas disease, number of relatives with a history of stroke, ECG with low voltage, anterosuperior divisional block, pathologic Q wave, right bundle branch block, and any kind of extrasystole were included in the final model. Calibration and discrimination in the development and validation cohorts (ROC AUC 0.904 and 0.912, respectively) were good. Sensitivity and specificity analyses showed that specificity reaches at least 95% above the predicted 43% risk, while sensitivity is at least 95% below the predicted 7% risk. Net benefit decision curves favor the model across all thresholds. Conclusions: A nomogram and an online calculator (available at http://shiny.ipec.fiocruz.br:3838/pedrobrasil/chronic_chagas_disease_prediction/) were developed to aid in individual risk estimation.
C1 [Alvarenga Americano do Brasil, Pedro Emmanuel; Xavier, Sergio Salles; Holanda, Marcelo Teixeira; Hasslocher-Moreno, Alejandro Marcel] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doenca Chagas, Rio De Janeiro, RJ, Brazil.
   [Braga, Jose Ueleres] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Dept Epidemiol & Metodos Quantitativos Saude, Rio De Janeiro, RJ, Brazil.
RP do Brasil, PEAA (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doenca Chagas, Rio De Janeiro, RJ, Brazil.
EM pedro.brasil@ini.fiocruz.br
RI Brasil, Pedro Emmanuel/AAG-2280-2019; Hasslocher-Moreno, Alejandro
   Marcel/F-3414-2011
OI Brasil, Pedro Emmanuel/0000-0002-6700-2268; 
CR [Anonymous], 2005, Rev. Soc. Bras. Med. Trop., V38, P538, DOI 10.1590/S0037-86822005000600021
   [Anonymous], 2008, REV CHIL INFECTOL, V25, P379
   Arzanegui OA, 2013, ENFERM INFEC MICR CL, V31, P210, DOI 10.1016/j.eimc.2012.01.029
   Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171
   Boggio, 1997, Cad Saude Publica, V13, P389, DOI 10.1590/S0102-311X1997000300014
   Cucunuba ZM, 2012, AM J TROP MED HYG, V87, P837, DOI 10.4269/ajtmh.2012.12-0086
   Custer B, 2012, TRANSFUSION, V52, P1901, DOI 10.1111/j.1537-2995.2012.03569.x
   D'Elia C, 2005, REV SOC BRAS MED TRO, V38, P7, DOI 10.1590/S0037-86822005000100002
   Furucho CR, 2008, TROP MED INT HEALTH, V13, P1527, DOI 10.1111/j.1365-3156.2008.02172.x
   Gascon J, 2005, MED CLIN-BARCELONA, V125, P230, DOI 10.1157/13077386
   GREINER M, 1995, J IMMUNOL METHODS, V185, P123, DOI 10.1016/0022-1759(95)00121-P
   Guyatt G, 2008, USERS GUIDES MED LIT
   Hamerschlak N, 1997, Rev Soc Bras Med Trop, V30, P205, DOI 10.1590/S0037-86821997000300006
   Haynes RB, 2009, EVIDENCE BASED CLIN, V2
   Lee BY, 2013, LANCET INFECT DIS, V13, P342, DOI 10.1016/S1473-3099(13)70002-1
   Leiby DA, 1997, J INFECT DIS, V176, P1047, DOI 10.1086/516534
   MARTELLI CMT, 1992, MEM I OSWALDO CRUZ, V87, P339, DOI 10.1590/S0074-02761992000300002
   Ministerio de la Salud Publica y Assitencia Social, 2007, NORM TECN PREV CONTR
   Ministerio del Poder Popular para la Salud, 2014, GUIA DIAGN AT MAN CL
   Moncayo A, 2009, MEM I OSWALDO CRUZ, V104, P17, DOI 10.1590/S0074-02762009000900005
   Nattino G, 2014, STAT MED, V33, P2390, DOI 10.1002/sim.6100
   Pereira Gilberto de Araujo, 2012, Rev. Bras. Hematol. Hemoter., V34, P292, DOI 10.5581/1516-8484.20120074
   Perez-Molina JA, 2011, HIV CLIN TRIALS, V12, P287, DOI 10.1310/hct1206-287
   Pirard M, 2005, TRANSFUSION, V45, P554, DOI 10.1111/j.0041-1132.2005.04214.x
   Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2
   R Development Core Team, 2011, R LANG ENV STAT COMP
   Ribeiro A L, 1998, Rev Soc Bras Med Trop, V31, P301, DOI 10.1590/S0037-86821998000300008
   Salles NA, 1996, TRANSFUSION, V36, P969, DOI 10.1046/j.1537-2995.1996.36111297091740.x
   Savioli L, 2008, 1 WHO
   Steyerberg E. W., 2008, CLIN PREDICTION MODE
   Tanowitz HB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001136
   Andrade J.P., 2011, Arq. Bras. Cardiol., V97, P01, DOI 10.1590/S0066-782X2011001600001
   van Buuren S, 2011, J STAT SOFTW, V45, P1
   Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53
   Vinelli E, 1995, REV MED HONDUR, V63, P96
NR 35
TC 2
Z9 2
U1 0
U2 5
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAY-JUN
PY 2016
VL 49
IS 3
BP 329
EP 340
DI 10.1590/0037-8682-0196-2016
PG 12
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DQ6YW
UT WOS:000379354400011
PM 27384830
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Caetano, R
   Bastos, CRG
   de Oliveira, IAG
   da Silva, RM
   Fortes, CPDD
   Pepe, VLE
   Reis, LG
   Braga, JU
AF Caetano, Rosangela
   Garcia Bastos, Claudia Regina
   Gualandi de Oliveira, Ione Ayala
   da Silva, Rondineli Mendes
   Dias Drumond Fortes, Clarisse Pereira
   Edais Pepe, Vera Lucia
   Reis, Lenice Gnocchi
   Braga, Jose Ueleres
TI Accuracy of positron emission tomography and positron emission
   tomography-CT in the detection of differentiated thyroid cancer
   recurrence with negative I-131 whole-body scan results: A meta-analysis
SO HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND
   NECK
LA English
DT Review
DE thyroid cancer; differentiated thyroid carcinoma; negative radioiodine
   whole-body scan; F-18-fluorodeoxyglucose (FDG)-positron emission
   tomography (PET); meta-analysis
ID ELEVATED THYROGLOBULIN LEVELS; FOLLOW-UP; SERUM THYROGLOBULIN; FDG-PET;
   DIAGNOSTIC-VALUE; SUSPECTED RECURRENT; F-18-FDG PET/CT; CARCINOMA;
   PAPILLARY; IMPACT
AB BackgroundThe purpose of this review was to present a meta-analysis aimed to evaluate the accuracy of positron emission tomography (PET) and PET-CT for detecting recurrence of differentiated thyroid carcinoma (DTC) not identified by I-131 whole-body scintigraphy.
   MethodsMEDLINE, EMBASE, LILACS, and Cochrane databases were searched for studies published between January 1985 and March 2012. Systematic methods were used to select and evaluate the quality of studies. Pooled sensitivity and specificity for conventional PET and PET-CT was estimated using random effects model.
   ResultsTwenty studies were included in the systematic review; the data of 18 studies were used in the meta-analysis. The combined sensitivity and specificity for conventional PET were both found to be 84%; for PET-CT, they were 93% and 81%, respectively. The overall accuracies were 91% and 93%, respectively.
   Conclusion(18)Fluorodeoxyglucose (FDG)-PET and PET-CT are highly accurate diagnostics tools for DTC recurrence in patients who present a negative whole-body scintigraphy and could impact the clinical and therapeutic management of DTC. (c) 2015 Wiley Periodicals, Inc. Head Neck 38: 316-327, 2016
C1 [Caetano, Rosangela; Garcia Bastos, Claudia Regina; Gualandi de Oliveira, Ione Ayala; da Silva, Rondineli Mendes; Dias Drumond Fortes, Clarisse Pereira; Braga, Jose Ueleres] State Univ Rio Janeiro, Inst Social Med, Rio De Janeiro, Brazil.
   [Garcia Bastos, Claudia Regina] Reg Council Pharm State Rio Janeiro, Rio De Janeiro, Brazil.
   [Gualandi de Oliveira, Ione Ayala] Univ Severino Sombra, Rio De Janeiro, Brazil.
   [da Silva, Rondineli Mendes; Edais Pepe, Vera Lucia; Reis, Lenice Gnocchi; Braga, Jose Ueleres] Fundacao Oswaldo Cruz, Sergio Arouca Natl Sch Publ Hlth, Rio De Janeiro, Brazil.
   Rua Sao Francisco Xavier 524,7 Andar, BR-20550011 Rio De Janeiro, Brazil.
RP Caetano, R (corresponding author), State Univ Rio Janeiro, Inst Social Med, Rio De Janeiro, Brazil.
EM caetano.r@gmail.com
FU Ministry of Health/DECITMinistry of Health-Singapore; Ministry of
   Science and Technology/CNPq of Brazil as part of CNPq [564797/2010-3]
FX Contract grant sponsor: This study is part of a research program funded
   by the Ministry of Health/DECIT and the Ministry of Science and
   Technology/CNPq of Brazil as part of CNPq project 564797/2010-3.
CR Altenvoerde G, 1998, LANGENBECK ARCH SURG, V383, P160, DOI 10.1007/s004230050109
   Alzahrani Ali S, 2006, Endocr Pract, V12, P152
   Alzahrani Ali S, 2005, Endocr Pract, V11, P165
   Bannas P, 2012, ANN NUCL MED, V26, P77, DOI 10.1007/s12149-011-0545-4
   Bogsrud TV, 2011, NUCL MED COMMUN, V32, P245, DOI 10.1097/MNM.0b013e328343a742
   Chen YK, 2003, ACAD RADIOL, V10, P835, DOI 10.1016/S1076-6332(03)00014-X
   Choi MY, 2006, ANN NUCL MED, V20, P547, DOI 10.1007/BF03026819
   Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110
   Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016
   DEVILLE WL, 2002, EVIDENCE CLIN DIAGNO, P148
   Dietlein M, 1997, EUR J NUCL MED, V24, P1342, DOI 10.1007/s002590050158
   Dong MJ, 2009, NUCL MED COMMUN, V30, P639, DOI 10.1097/MNM.0b013e32832dcfa7
   Durante C, 2013, ENDOCR-RELAT CANCER, V20, pR141, DOI 10.1530/ERC-13-0066
   Dwamena BA, 2010, MIDAS METAANALYSIS D
   Dwamena BA, 2007, MIDAS PROGRAM METAAN
   Esteva D, 2009, ANN SURG ONCOL, V16, P2006, DOI 10.1245/s10434-009-0483-8
   Eustatia-Rutten CFA, 2004, CLIN ENDOCRINOL, V61, P61, DOI 10.1111/j.1365-2265.2004.02060.x
   Finkelstein SE, 2008, ANN SURG ONCOL, V15, P286, DOI 10.1245/s10434-007-9611-5
   Freudenberg LS, 2007, EUR RADIOL, V17, P3139, DOI 10.1007/s00330-007-0682-2
   Frilling A, 2001, ANN SURG, V234, P804, DOI 10.1097/00000658-200112000-00012
   Frilling A, 2000, SURGERY, V128, P1067, DOI 10.1067/msy.2000.110771
   Gabriel M, 2004, EUR J NUCL MED MOL I, V31, P330, DOI 10.1007/s00259-003-1376-x
   Galloway RJ, 1996, ENDOCRIN METAB CLIN, V25, P93, DOI 10.1016/S0889-8529(05)70314-5
   Giovanella L, 2012, HEAD NECK-J SCI SPEC, V34, P626, DOI 10.1002/hed.21791
   Grunwald F, 1999, EUR J NUCL MED, V26, P1547, DOI 10.1007/s002590050493
   Higgins JP, 2008, COCHRANE HDB SYSTEMA, P187, DOI DOI 10.1002/9780470712184
   Hooft L, 2001, J CLIN ENDOCR METAB, V86, P3779, DOI 10.1210/jc.86.8.3779
   Hung MC, 2003, ENDOCR RES, V29, P169, DOI 10.1081/ERC-120022297
   Iagaru A, 2006, MOL IMAGING BIOL, V8, P309, DOI 10.1007/s11307-006-0046-3
   Jadvar H, 1998, NUCL MED COMMUN, V19, P547, DOI 10.1097/00006231-199806000-00006
   JOENSUU H, 1987, J NUCL MED, V28, P910
   Kilfoy BA, 2009, CANCER CAUSE CONTROL, V20, P525, DOI 10.1007/s10552-008-9260-4
   Kim SJ, 2009, EUR J RADIOL, V70, P17, DOI 10.1016/j.ejrad.2007.12.004
   Kingpetch Kanaungnit, 2011, Journal of the Medical Association of Thailand, V94, P1238
   Larson SM, 2002, SEMIN ROENTGENOL, V37, P169, DOI 10.1016/S0037-198X(02)80035-9
   Ma C, 2005, J NUCL MED, V46, P1473
   Ma C, 2010, EUR J ENDOCRINOL, V163, P177, DOI 10.1530/EJE-10-0256
   Mijnhout GS, 2004, NUCL MED COMMUN, V25, P1187, DOI 10.1097/00006231-200412000-00006
   Miller ME, 2011, HEAD NECK-J SCI SPEC, V33, P562, DOI 10.1002/hed.21492
   Mirallie E, 2007, SURGERY, V142, P952, DOI 10.1016/j.surg.2007.09.015
   Nahas Z, 2005, LARYNGOSCOPE, V115, P237, DOI 10.1097/01.mlg.0000154725.00787.00
   Ong S. C., 2005, SMJ Singapore Medical Journal, V46, P297
   Pacini F, 2012, ANN ONCOL, V23, P110, DOI 10.1093/annonc/mds230
   Palmedo H, 2006, J NUCL MED, V47, P616
   Robbins RJ, 2006, J CLIN ENDOCR METAB, V91, P498, DOI 10.1210/jc.2005-1534
   Schlumberger MJ, 1998, NEW ENGL J MED, V338, P297, DOI 10.1056/NEJM199801293380506
   Schluter B, 2001, J NUCL MED, V42, P71
   Seo JH, 2010, CLIN ENDOCRINOL, V72, P558, DOI 10.1111/j.1365-2265.2009.03693.x
   Shammas A, 2007, J NUCL MED, V48, P221
   Sibille L, 2010, MED NUCL, V34, P78, DOI 10.1016/j.mednuc.2009.12.001
   Stokkel MPM, 2006, Q J NUCL MED MOL IM, V50, P78
   SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615
   Torlontano M, 2006, J CLIN ENDOCR METAB, V91, P60, DOI 10.1210/jc.2005-1185
   Utiger RD, 1997, NEW ENGL J MED, V337, P928, DOI 10.1056/NEJM199709253371311
   Wang WP, 1999, J CLIN ENDOCR METAB, V84, P2291, DOI 10.1210/jc.84.7.2291
   Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25
   Wilczynski NL, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-7
   Yamaga LYI, 2007, ARQ BRAS ENDOCRINOL, V51, P581, DOI 10.1590/S0004-27302007000400012
   Zimmer LA, 2003, OTOLARYNG HEAD NECK, V128, P178, DOI 10.1067/mhn.2003.74
NR 59
TC 17
Z9 19
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1043-3074
EI 1097-0347
J9 HEAD NECK-J SCI SPEC
JI Head Neck-J. Sci. Spec. Head Neck
PD FEB
PY 2016
VL 38
IS 2
BP 316
EP 327
DI 10.1002/hed.23881
PG 12
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA DB7ZB
UT WOS:000368735100031
PM 25251544
DA 2020-12-01
ER

PT J
AU Gouvea, MV
   Mendonca, IL
   Cruz, MDPE
   Costa, CHN
   Braga, JU
   Werneck, GL
AF Gouvea, Marcus Vinicius
   Mendonca, Ivete Lopes
   Pires e Cruz, Maria do Socorro
   Nery Costa, Carlos Henrique
   Braga, Jose Ueleres
   Werneck, Guilherme Loureiro
TI Predictive factors for Leishmania infantum infection in dogs examined at
   a veterinary teaching hospital in Teresina, State of Piaui, Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Canine; Control measures; Visceral leishmaniasis
ID CANINE VISCERAL LEISHMANIASIS; ANTIBODY-TEST; TRANSMISSION
AB Introduction: In Brazil, culling of seropositive dogs is one of the recommended strategies to control visceral leishmaniasis. Since infectiousness is correlated with clinical signs, control measures targeting symptomatic dogs could be more effective. Methods: A cross-sectional study was carried out among 1,410 dogs, predictive models were developed based on clinical signs and an indirect immunofluorescence antibody test. Results: The validated predictive model showed sensitivity and specificity of 86.5% and 70.0%, respectively. Conclusions: Predictive models could be used as tools to aid control programs in focusing on a smaller fraction of dogs contributing more to infection dissemination.
C1 [Gouvea, Marcus Vinicius; Braga, Jose Ueleres; Werneck, Guilherme Loureiro] Univ Estado Rio de Janeiro, Inst Med Social, Dept Epidemiol, BR-20550011 Rio De Janeiro, RJ, Brazil.
   [Mendonca, Ivete Lopes] Univ Fed Piaui, Lab Sanidade Anim, Teresina, Piaui, Brazil.
   [Pires e Cruz, Maria do Socorro] Univ Fed Piaui, Ctr Ciencias Agr, Programa Posgrad Ciencia Anim, Teresina, Piaui, Brazil.
   [Nery Costa, Carlos Henrique] Inst Doencas Tropicais Nathan Portella, Teresina, Piaui, Brazil.
   [Nery Costa, Carlos Henrique] Univ Fed Piaui, Dept Med Comunitaria, Teresina, Piaui, Brazil.
RP Gouvea, MV (corresponding author), Univ Estado Rio de Janeiro, Inst Med Social, Dept Epidemiol, BR-20550011 Rio De Janeiro, RJ, Brazil.
EM marcus.gouvea@agricultura.gov.br
RI Werneck, Guilherme/A-2841-2013; CRUZ, MARIA S/AAD-9243-2020
OI Werneck, Guilherme/0000-0003-1169-1436; Mendonca,
   Ivete/0000-0002-4000-4781
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [306267/2010-1, 483378/2010-0, 311507/2014-0]
FX Partially funded by CNPq (#306267/2010-1; # 483378/2010-0;
   #311507/2014-0).
CR Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Barquet N, 1997, JAMA-J AM MED ASSOC, V278, P491, DOI 10.1001/jama.278.6.491
   Boarino A, 2005, CLIN DIAGN LAB IMMUN, V12, P647, DOI 10.1128/CDLI.12.5.647-653.2005
   Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221
   Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312
   Oliveira TMFD, 2008, REV BRAS PARASITOL V, V17, P7, DOI 10.1590/S1984-29612008000100002
   do Rosario EY, 2005, MEM I OSWALDO CRUZ, V100, P197, DOI 10.1590/S0074-02762005000200015
   Hosmer DW, 2000, APPL LOGISTIC REGRES
   Koopman JS, 2005, EPIDEMIOLOGY, V16, P621, DOI 10.1097/01.ede.0000172133.46385.18
   Llera JLG, 2002, VET PARASITOL, V109, P185
   Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156
   Reis AB, 2006, RES VET SCI, V81, P68, DOI 10.1016/j.rvsc.2005.09.011
   Saridomichelakis MN, 2005, AM J TROP MED HYG, V73, P82, DOI 10.4269/ajtmh.2005.73.82
   Travi BL, 2001, AM J TROP MED HYG, V64, P119, DOI 10.4269/ajtmh.2001.64.119
   Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338
NR 15
TC 2
Z9 2
U1 0
U2 3
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JAN-FEB
PY 2016
VL 49
IS 1
BP 107
EP 111
DI 10.1590/0037-8682-0187-2015
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DH5RA
UT WOS:000372848300017
PM 27163573
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Biz, AN
   Schluckebier, LF
   Bastos, CR
   Silva, RM
   Braga, JU
   Caetano, R
AF Biz, A. N.
   Schluckebier, L. F.
   Bastos, C. R.
   Silva, R. M.
   Braga, J. U.
   Caetano, R.
TI COST-EFFECTIVENESS OF THE USE OF 18FDG-PET/CT IN THE DETECTION OF
   RECURRENT DIFFERENTIATED THYROID CANCER
SO VALUE IN HEALTH
LA English
DT Meeting Abstract
CT 18th ISPOR Annual European Congress
CY NOV 07-11, 2015
CL Milan, ITALY
C1 [Biz, A. N.; Bastos, C. R.; Braga, J. U.; Caetano, R.] Univ Estado Rio de Janeiro, Inst Social Med, Rio De Janeiro, Brazil.
   [Schluckebier, L. F.] Inst Nacl Canc, Rio De Janeiro, Brazil.
   [Silva, R. M.] Fiocruz MS, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1098-3015
EI 1524-4733
J9 VALUE HEALTH
JI Value Health
PD NOV
PY 2015
VL 18
IS 7
MA PMD11
BP A859
EP A859
DI 10.1016/j.jval.2015.09.480
PG 1
WC Economics; Health Care Sciences & Services; Health Policy & Services
SC Business & Economics; Health Care Sciences & Services
GA V46CD
UT WOS:000209861400792
PM 26534595
OA Bronze
DA 2020-12-01
ER

PT J
AU Terrazas, WCM
   Sampaio, VD
   de Castro, DB
   Pinto, RC
   de Albuquerque, BC
   Sadahiro, M
   dos Passos, RA
   Braga, JU
AF Morhy Terrazas, Wagner Cosme
   Sampaio, Vanderson de Souza
   de Castro, Daniel Barros
   Pinto, Rosemary Costa
   de Albuquerque, Bernardino Claudio
   Sadahiro, Megumi
   dos Passos, Ricardo Augusto
   Braga, Jose Ueleres
TI Deforestation, drainage network, indigenous status, and geographical
   differences of malaria in the State of Amazonas
SO MALARIA JOURNAL
LA English
DT Article
DE Malaria; Deforestation; Drainage network; Indigenous status; Brazilian
   Amazon
ID ANOPHELES-DARLINGI; BRAZILIAN AMAZON; POPULATION; FOREST; VECTOR;
   MOVEMENT
AB Background: Malaria is a major public health problem worldwide. In Brazil, an average of 420,000 cases of malaria have been reported annually in the last 12 years, of which 99.7 % occurred in the Amazon region. This study aimed to analyse the distribution of malaria in the State of Amazonas and the influence of indigenous malaria in this scenario, to evaluate the correlation between incidence rates and socio-economic and environmental factors, and to evaluate the performance of health surveillance services.
   Methods: This ecological study used secondary data obtained from the SIVEP-MALARIA malaria surveillance programme. The relationship between demographic, socio-economic and environmental factors, the performance of health surveillance services and the incidence of malaria in Amazonas, a multiple linear regression model was used.
   Results: The crude rate of malaria in Amazonas was 4142.72 cases per 100,000 inhabitants between 2003 and 2012. The incidence rates for the indigenous and non-indigenous populations were 12,976.02 and 3749.82, respectively, with an indigenous population attributable fraction of only 8 %. The results of the linear regression analysis indicated a negative correlation between the two socio-economic indicators (municipal human development index (MHDI) and poverty rate) and the incidence of malaria in the period. With regard to the environmental indicators (average annual deforestation rate and percentage of areas under the influence of watercourses), the correlation with the incidence rate was positive.
   Conclusions: The findings underscore the importance of implementing economic and social development policies articulated with strategic actions of environmental protection and health care for the population.
C1 [Morhy Terrazas, Wagner Cosme; Sampaio, Vanderson de Souza; de Castro, Daniel Barros; Pinto, Rosemary Costa; de Albuquerque, Bernardino Claudio; Sadahiro, Megumi; dos Passos, Ricardo Augusto] Fundacao Vigilancia Saude Amazonas, Manaus, Amazonas, Brazil.
   [Morhy Terrazas, Wagner Cosme; Braga, Jose Ueleres] Fiocruz MS, Escola Nacl Saude Publ Sergio Arouca, BR-21045900 Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Inst Social Med, BR-20550011 Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] FAPEAM, PVS PECTI SAUDE, Manaus, Amazonas, Brazil.
RP Braga, JU (corresponding author), FAPEAM, PVS PECTI SAUDE, Manaus, Amazonas, Brazil.
EM ueleres@gmail.com
RI Sampaio, Vanderson/M-4337-2015; Castro, Daniel/J-9358-2016; Sampaio,
   Vanderson/AAQ-1418-2020
OI Sampaio, Vanderson/0000-0001-7307-8851; Castro,
   Daniel/0000-0001-5969-544X; Sampaio, Vanderson/0000-0001-7307-8851; Dos
   Passos/0000-0002-2155-9351
FU Amazonas State Government through the Fundacao de Amparo a Pesquisa do
   Estado do Amazonas [23264-PECTI/AM/SAUDE]
FX We are grateful to the Health Surveillance Foundation of Amazonas for
   providing the data on malaria surveillance. We acknowledge and are
   grateful for support from Amazonas State Government through the Fundacao
   de Amparo a Pesquisa do Estado do Amazonas Grant 23264-PECTI/AM/SAUDE.
   We are also grateful to Ana Alzira Cabrinha, Maria Eunice Pereira,
   Osminda Loblein, Renato Ferreira Souza and Cristiano Fernandes. DBC is a
   fellow of the RH-PhD programme from the Fundacao de Amparo a Pesquisa do
   Estado do Amazonas.
CR Achcar JA, 2011, REV SOC BRAS MED TRO, V44, P749, DOI 10.1590/S0037-86822011000600019
   Araujo JJCN, 2010, NEW STRATEGIES DEV A
   Barros FSM, 2011, B ENTOMOL RES, V101, P643, DOI 10.1017/S0007485311000265
   Bauch SC, 2015, P NATL ACAD SCI USA, V112, P7414, DOI 10.1073/pnas.1406495111
   Bevilacqua M, 2009, B MALARIOL SALUD AMB, V49, P53
   Braz RM, 2013, CAD SAUDE PUBLICA, V29, P935, DOI 10.1590/S0102-311X2013000500011
   CNDSS-Comissao Nacional sobre Determinantes Sociais da Saude, 2008, CAUS SOC IN SAUD BRA, P1
   Dantas FLL, 2010, MORBIDITY PROFILE IN
   de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103
   ESRI, 2011, ARCGIS DESKT
   Ferreira ACS, 2011, REV LAT-AM ENFERM, V19, P1
   FVS, 2013, MAL IND AR 2003 2013, P12
   Garnelo L, 2005, REV SAUDE PUBL, V39, P634, DOI [10.1590/S0034-89102005000400018, 10.1590/s0034-89102005000400018]
   Hahn MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085725
   IBGE, 2013, ATL 2010 POP CENS PO
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2012, CENS DEM 2010 CAR GE, P1
   Kamdem C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039453
   Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202
   Medici A., 2012, INDICE DESEMPENHO SU
   Ministerio da Saude, 2003, PROGR NAC PREV CONTR
   Ministry of Water Resources China, 2013, B EP AIDS DST, P1
   Moutinho PR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-174
   Olson SH, 2010, EMERG INFECT DIS, V16, P1108, DOI 10.3201/eid1607.091785
   Pindolia DK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-205
   Pruss-Ustun A, 2006, PREVENTING DIS HLTH
   Sampaio VS, 2015, REV SOC BRAS MED TRO, V48, P4, DOI 10.1590/0037-8682-0275-2014
   Santos RV, 2005, EPIDEMIOLOGIA SAUDE, V260
   Saude MD, 2014, GUIA VIGILANCIA SAUD, P584
   SAWYER D R, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P342
   Singhasivanon P, 2013, SE ASIAN J TROP MED, V44, P166
   Sojo-Milano M, 2009, B MALARIOL SALUD AMB, V49, P209
   Tompkins AM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-65
   Tusting LS, 2013, LANCET, V382, P963, DOI 10.1016/S0140-6736(13)60851-X
   Valle D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057519
   Vasconcelos Cíntia Honório, 2006, Cad. Saúde Pública, V22, P517, DOI 10.1590/S0102-311X2006000300006
   Vittor AY, 2009, AM J TROP MED HYG, V81, P5
   Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3
   WALSH JF, 1993, PARASITOLOGY, V106, pS55, DOI 10.1017/S0031182000086121
   Wayant NM, 2010, GEOSPATIAL HEALTH, V4, P179, DOI 10.4081/gh.2010.199
   WHO, 2014, WORLD MALARIA REPORT, P284
   Yasuoka J, 2007, AM J TROP MED HYG, V76, P450, DOI 10.4269/ajtmh.2007.76.450
NR 41
TC 13
Z9 13
U1 0
U2 34
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2875
J9 MALARIA J
JI Malar. J.
PD SEP 30
PY 2015
VL 14
AR 379
DI 10.1186/s12936-015-0859-0
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CS2ZH
UT WOS:000361940100001
PM 26419523
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Herrero, MB
   Arrossi, S
   Ramos, S
   Braga, JU
AF Belen Herrero, Maria
   Arrossi, Silvina
   Ramos, Silvina
   Braga, Jose Ueleres
TI Social determinants of nonadherence to tuberculosis treatment in Buenos
   Aires, Argentina
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Tuberculosis; Medication Adherence; Epidemiologic Factors;
   Cross-sectional Studies
ID MULTILEVEL ANALYSIS; HEALTH; INDIA; AREA
AB This study aimed to identify the individual and environmental determinants of nonadherence to tuberculosis (TB) treatment in selected districts in the Buenos Aires Metropolitan Area, in Argentina. We conducted a cross-sectional study using a hierarchical model. Using primary and secondary data, logistic regression was performed to analyze two types of determinants. The likelihood of nonadherence to treatment was greatest among male patients. The following factors led to a greater likelihood of nonadherence to treatment: patients living in a home without running water; head of household without medical insurance; need to use more than one means of transport to reach the health center; place of residence in an area with a high proportion of households connected to the natural gas network; place of residence in an area where a large proportion of families fall below the minimum threshold of subsistence capacity; place of residence in an area where a high proportion of households do not have flushing toilets and basic sanitation. Our results show that social and economic factors - related to both individual and environmental characteristics - influence adherence to TB treatment.
C1 [Belen Herrero, Maria; Arrossi, Silvina; Ramos, Silvina] Ctr Estudios Estado & Soc, RA-1173 Buenos Aires, DF, Argentina.
   [Belen Herrero, Maria] Fac Latinoamer Ciencias Sociales, Area Relac Int, Buenos Aires, DF, Argentina.
   [Ramos, Silvina] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Inst Med Social, BR-20550011 Rio De Janeiro, Brazil.
RP Herrero, MB (corresponding author), Ctr Estudios Estado & Soc, Sanchez de Bustamante 27, RA-1173 Buenos Aires, DF, Argentina.
EM mbelen.herrero@gmail.com
RI Kuang, Jinyi/L-8488-2017
FU Comision Nacional Salud Investiga of the Ministry of Health of Argentina
FX The authors gratefully acknowledge: the support and resources provided
   by the Comision Nacional Salud Investiga of the Ministry of Health of
   Argentina; the support of the Regional Director of the Tuberculosis
   Control Program in the Sixth Health Region; and all the patients who
   kindly participated in this study and shared their stories and made this
   study possible.
CR Arrossi S, 2012, SALUD COLECT, V8, P65, DOI 10.1590/s1851-82652012000300012
   Balasubramanian VN, 2000, INT J TUBERC LUNG D, V4, P409
   Beccaria L, 1999, INFORM EXCLUSION SOC, P139
   Berkman LF, 2000, SOCIAL EPIDEMIOLOGY, P3
   Braga JU, 2011, CAD SAUDE PUBLICA, V27, P1271, DOI 10.1590/S0102-311X2011000700003
   Braga JU, 2008, CAD SAUDE PUBLICA S4, V24, P485, DOI DOI 10.1590/S0102-311X2008001600003
   Braga JU, 2012, CAD SAUDE COLET RIO, V20, P225
   Centers for Disease Control and Prevention (CDC), 2000, COR CURR TUB WHAT CL
   Ximenes RAD, 2009, INT J EPIDEMIOL, V38, P1285, DOI 10.1093/ije/dyp224
   Farmer P, 1997, SOC SCI MED, V44, P347, DOI 10.1016/S0277-9536(96)00143-8
   Feres J. C., 2001, ENFOQUES MED POBREZA
   Galiano MA, 2005, ENFERM CLIN, V15, P192
   Ferreira Gonçalves Maria Jacirema, 2009, Rev. salud pública, V11, P918
   Gopi P G, 2007, Indian J Tuberc, V54, P66
   Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026
   Herrero MB, 2011, REV ARGENT SALUD PUB, V2, P36
   Institute National de Enfermedades Respiratorias, 2012, RES TRAT TUB PULM ED
   Institute National de Enfermedades Respiratorias, 2012, PER 1980 2011
   Kawachi I, 2000, SOCIAL EPIDEMIOLOGY, P174, DOI DOI 10.1590/S0042-96862011001000003
   Mishra R, 2005, INT J TUBERC LUNG D, V9, P1134
   [National Institute for Health and Clinical Excellence Universidad del Desarrollo], 2007, SOC DET HLTH DEV EV
   Nene B, 2007, B WORLD HEALTH ORGAN, V85, P264, DOI 10.2471/BLT.06.031195
   O'Boyle SJ, 2002, INT J TUBERC LUNG D, V6, P307
   Pineda NIS, 2005, REV PANAM SALUD PUBL, V17, P271, DOI 10.1590/S1020-49892005000400008
   Programa National de Control de la Tuberculosis, 2008, NORM TECHN 2008
   Robirosa M, 1996, ASPECTOS TEORICOS ME, P630
   Roux AVD, 2002, J EPIDEMIOL COMMUN H, V56, P588, DOI 10.1136/jech.56.8.588
   Sabate E, 2004, ADHERENCIA TRATAMIEN
   Sabates R, 2006, SOC SCI MED, V62, P2998, DOI 10.1016/j.socscimed.2005.11.032
   Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003
   Sumartojo E, 2003, AM REV RESPIR DIS, V147, P1311
   Tanguis HG, 2000, INT J TUBERC LUNG D, V4, P55
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   Vijay S., 2002, Indian Journal of Tuberculosis, V49, P195
   World Health Organisation, 2003, TREATM TUB GUID NAT
NR 35
TC 4
Z9 5
U1 0
U2 8
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD SEP
PY 2015
VL 31
IS 9
BP 1983
EP 1994
DI 10.1590/0102-311X00024314
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CW9AC
UT WOS:000365289700019
PM 26578022
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Teixeira, MG
   Morato, V
   Barreto, FR
   Natividade, MS
   Braga, JU
   Costa, MCN
   Morato, D
AF Teixeira, M. G.
   Morato, V.
   Barreto, F. R.
   Natividade, M. S.
   Braga, J. U.
   Costa, M. C. N.
   Morato, D.
TI The spatiotemporal trajectory of a dengue epidemic
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Teixeira, M. G.; Barreto, F. R.; Natividade, M. S.; Costa, M. C. N.; Morato, D.] Univ Fed Bahia, Saude Colet, Salvador, BA, Brazil.
   [Morato, V.] Secretaria Seguranca Estado Bahia, Tecn, Salvador, BA, Brazil.
   [Braga, J. U.] Fundacao Oswaldo Cruz, Saude Publ, Rio De Janeiro, Brazil.
RI Natividade, Marcio/Q-5662-2019; Teixeira, Maria Gloria/G-4808-2012
OI Natividade, Marcio/0000-0002-3986-5656; Teixeira, Maria
   Gloria/0000-0003-3318-3408
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD SEP
PY 2015
VL 20
SU 1
SI SI
MA PS2.275
BP 406
EP 406
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CQ7BW
UT WOS:000360758802255
DA 2020-12-01
ER

PT J
AU Rodrigues, NCP
   de Almeida, AS
   Braga, JU
   O'Dwyer, G
   Apratto, PC
   Daumas, RP
   Lino, VTS
   Andrade, MKD
   Monteiro, DLM
   Barros, MBD
AF Pinheiro Rodrigues, Nadia Cristina
   de Almeida, Andrea Sobral
   Braga, Jose Ueleres
   O'Dwyer, Gisele
   Apratto Junior, Paulo Cavalcante
   Daumas, Regina Paiva
   Saraiva Lino, Valeria Teresa
   de Noronha Andrade, Monica Kramer
   Maia Monteiro, Denise Leite
   de Lima Barros, MNica Bastos
TI Spatial dynamics of AIDS incidence in the elderly in Rio de Janeiro,
   Brazil, 1997-2011
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Acquired Immunodeficiency Syndrome; HIV; Aged; Spatial Analysis
ID GEOGRAPHIC-MOBILITY; HIV; DIAGNOSIS; MORTALITY; EPIDEMIC; RATES
AB The dynamics of the spread of the AIDS epidemic ranges according to the characteristics of each geographical region in different population groups. The aim of this study was to evaluate spatial and temporal trends of the AIDS epidemic among the elderly in the State of Rio de Janeiro, Brazil. A retrospective study using spatial analysis techniques was conducted among AIDS cases (>= 60 years) diagnosed from 1997-2011. The Poisson regression model was used to assess the relationship between year of diagnosis and incidence of AIDS, adjusted by sex. The AIDS epidemic began in the south coast of the state and gradually reached neighboring cities. The highest rates were found in regions around Rio de Janeiro and Niteroi cities. The highest smoothed rates of the period were observed in Niteroi in 2002-2006: 11.87/100,000 (men) and 8,5/100,000 (women). AIDS incidence rates among the elderly have stabilized in recent decades. To prevent HIV from spreading further among the general population, greater attention should be given to the older population.
C1 [Pinheiro Rodrigues, Nadia Cristina; de Almeida, Andrea Sobral; Braga, Jose Ueleres; O'Dwyer, Gisele; Daumas, Regina Paiva; Saraiva Lino, Valeria Teresa; de Noronha Andrade, Monica Kramer; de Lima Barros, MNica Bastos] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, BR-21041210 Rio De Janeiro, RJ, Brazil.
   [Pinheiro Rodrigues, Nadia Cristina; Apratto Junior, Paulo Cavalcante; Maia Monteiro, Denise Leite] Univ Estado Rio de Janeiro, Fac Ciencias Med, BR-20550011 Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Inst Med Social, BR-20550011 Rio De Janeiro, Brazil.
RP Rodrigues, NCP (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rua Leopoldo Bulhoes 1480, BR-21041210 Rio De Janeiro, RJ, Brazil.
EM nadiacristinapr@gmail.com
RI DAUMAS, REGINA/M-9387-2013; Sobral, Andrea/K-2319-2016
OI DAUMAS, REGINA/0000-0002-8923-7711; Sobral, Andrea/0000-0003-0552-771X
CR Anselin L., 2002, VISUALIZING MULTIVAR
   Apratto PC, 2014, INT J ENV RES PUB HE, V11, P7608, DOI 10.3390/ijerph110807608
   Barcellos Christovam, 1996, Boletin de la Oficina Sanitaria Panamericana, V121, P11
   BASTOS FI, 1995, REV SAUDE PUBL, V29, P52, DOI 10.1590/S0034-89101995000100009
   Cardoso SW, 2013, BRAZ J INFECT DIS, V17, P464, DOI 10.1016/j.bjid.2012.11.007
   Carrel M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088512
   Carvalho MS, 1996, STAT MED, V15, P1885, DOI 10.1002/(SICI)1097-0258(19960915)15:17<1885::AID-SIM400>3.0.CO;2-#
   Centers for Disease Control and Prevention, 2011, MORBIDITY MORTALITY
   Centers for Disease Control and Prevention, 2010, MORBIDITY MORTALITY
   Chiao EY, 1999, CLIN INFECT DIS, V28, P740, DOI 10.1086/515219
   Chiu YW, 2008, J NATL MED ASSOC, V100, P788, DOI 10.1016/S0027-9684(15)31372-9
   CLAYTON D, 1987, BIOMETRICS, V43, P671, DOI 10.2307/2532003
   Departamento de Vigilancia Epidemiologica Secretaria de Vigilancia em Saude Ministerio da Saude, 2006, NORM MAN TECN A
   Dias P R, 2001, Cad Saude Publica, V17, P1173
   Driemeier M, 2012, CLINICS, V67, P19, DOI 10.6061/clinics/2012(01)04
   Druck S, 2004, ANALISE ESPACIAL ARE
   de Carvalho LMF, 2012, BRAZ J INFECT DIS, V16, P34, DOI 10.1590/S1413-86702012000100006
   FERREIRA VMB, 1999, CAD SAUDE PUBLICA, V15, P317
   Grangeiro A, 2010, CAD SAUDE PUBLICA, V26, P2354, DOI 10.1590/S0102-311X2010001200014
   Grangeiro A, 2010, REV SAUDE PUBL, V44, P430, DOI 10.1590/s0034-89102010005000013
   Hogg RS, 1995, AIDS PATIENT CARE, V9, P297, DOI 10.1089/apc.1995.9.297
   Hogg RS, 1997, CLIN INVEST MED, V20, P77
   Ismail N, HANDLING OVERDISPERS
   Jongsthapongpanth A, 2010, HEALTH PLACE, V16, P1084, DOI 10.1016/j.healthplace.2010.06.014
   Lazarus JV, 2010, HIV MED, V11, P479, DOI 10.1111/j.1468-1293.2009.00810.x
   Lopez-De Fede A, 2011, PUBLIC HEALTH REP, V126, P115
   MARSHALL RJ, 1991, J R STAT SOC C-APPL, V40, P283
   Ministerio da Saude, 2001, MAN PROC SIST INF MO
   Ministerio da Saude; Organizacao Pan-Americana da Saude; Fundacao Oswaldo Cruz, 2009, TEXT BAS SAUD B, V1
   MORAN PAP, 1948, J ROY STAT SOC B, V10, P243
   National Institute of Aging, 2009, HIV AIDS OLD PEOPL U
   Nguyen N, 2008, CLIN INTERV AGING, V3, P453
   Oliveira Maria Liz Cunha de, 2013, Rev. bras. epidemiol., V16, P30, DOI 10.1590/S1415-790X2013000100003
   Rodrigues NCP, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-22
   Programa Nacional de DST e AIDS Secretaria de Vigilancia em Saude Ministerio da Saude, 2003, MIN SAUD SER MAN, V60
   Reis CT, 2008, CAD SAUDE PUBLICA, V24, P1219, DOI 10.1590/S0102-311X2008000600003
   Santos Alessandra Fátima de Mattos, 2011, Rev. bras. geriatr. gerontol., V14, P147, DOI 10.1590/S1809-98232011000100015
   Steinberg S, 2000, J RURAL HEALTH, V16, P11, DOI 10.1111/j.1748-0361.2000.tb00432.x
   Szwarcwald C L, 2001, Cad Saude Publica, V17, P1123, DOI 10.1590/S0102-311X2001000500014
   Tomazelli Jeane, 2003, Cad. Saúde Pública, V19, P1049, DOI 10.1590/S0102-311X2003000400027
   Wood E, 2000, HEALTH PLACE, V6, P33, DOI 10.1016/S1353-8292(99)00028-3
NR 41
TC 1
Z9 2
U1 0
U2 3
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD AUG
PY 2015
VL 31
IS 8
BP 1721
EP 1731
DI 10.1590/0102-311X00152914
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CR7SR
UT WOS:000361551600014
PM 26375650
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Morato, DG
   Barreto, FR
   Braga, JU
   Natividade, MS
   Costa, MDN
   Morato, V
   Teixeira, MDLC
AF Morato, Daniela G.
   Barreto, Florisneide R.
   Braga, Jose U.
   Natividade, Marcio S.
   Costa, Maria da Conceicao N.
   Morato, Vanessa
   Lima Cruz Teixeira, Maria da Gloria
TI The spatiotemporal trajectory of a dengue epidemic in a medium-sized
   city
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue; epidemiology; epidemic; diffusion; spatiotemporal; trajectory
ID VIRUS CIRCULATION; PATTERNS; BRAZIL; FEVER; RISK
AB Understanding the transmission dynamics of infectious diseases is important to allow for improvements of control measures. To investigate the spatiotemporal pattern of an epidemic dengue occurred at a medium-sized city in the Northeast Region of Brazil in 2009, we conducted an ecological study of the notified dengue cases georeferenced according to epidemiological week (EW) and home address. Kernel density estimation and space-time interaction were analysed using the Knox method. The evolution of the epidemic was analysed using an animated projection technique. The dengue incidence was 6.918.7/100,000 inhabitants; the peak of the epidemic occurred from 8 February-1 March, EWs 6-9 (828.7/100,000 inhabitants). There were cases throughout the city and was identified space-time interaction. Three epicenters were responsible for spreading the disease in an expansion and relocation diffusion pattern. If the health services could detect in real time the epicenters and apply nimbly control measures, may possibly reduce the magnitude of dengue epidemics.
C1 [Morato, Daniela G.; Barreto, Florisneide R.; Natividade, Marcio S.; Costa, Maria da Conceicao N.; Morato, Vanessa; Lima Cruz Teixeira, Maria da Gloria] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Braga, Jose U.] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil.
   [Braga, Jose U.] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, RJ, Brazil.
RP Teixeira, MDLC (corresponding author), Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
EM magloria@ufba.br
RI Natividade, Marcio/Q-5662-2019
OI Natividade, Marcio/0000-0002-3986-5656
CR Ali M, 2003, AM J TROP MED HYG, V69, P634, DOI 10.4269/ajtmh.2003.69.634
   Barreto FR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-51
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   CLIFF AD, 1981, SPATIAL DIFFUSION HI
   da Rosa APAT, 2000, EMERG INFECT DIS, V6, P298
   Toan DTT, 2013, GLOBAL HEALTH ACTION, V6, P7, DOI 10.3402/gha.v6i0.18632
   Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975
   Gatrell AC, 1996, SOC SCI MED, V42, P843, DOI 10.1016/0277-9536(95)00183-2
   Guha-Sapir D, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-1
   Haggett P., 2000, GEOGRAPHICAL STRUCTU
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Jeefoo P, 2011, INT J ENV RES PUB HE, V8, P51, DOI 10.3390/ijerph8010051
   KNOX EG, 1964, ROY STAT SOC C-APP, V13, P25
   Kulldorff M, 1999, BIOMETRICS, V55, P544, DOI 10.1111/j.0006-341X.1999.00544.x
   Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196
   Levine N., 2013, CRIMESTAT SPATIAL ST
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Massad E, 2011, LANCET, V377, P1630, DOI 10.1016/S0140-6736(11)60470-4
   Medronho Roberto de Andrade, 2006, Rev. bras. epidemiol., V9, P159
   Mondini A, 2008, SCI TOTAL ENVIRON, V393, P241, DOI 10.1016/j.scitotenv.2008.01.010
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   MS - Ministerio da Saude, 2014, CAS DENG BRAS GRAND
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   SESAB/DIVEP - Secretaria de Saude do Estado da Bahia/Diretoria de Vigilancia Epidemiologica, 2012, B EPIDEMIOLOGICO DEN, V3, P2
   Melo MSS, 2010, REV SOC BRAS MED TRO, V43, P139, DOI 10.1590/S0037-86822010000200007
   Siqueira Jr JB, 2010, DENGUE BRASIL TENDEN
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Teixeira MG, 1999, INF EPIDEMIOL SUS, V8, P5, DOI DOI 10.5123/S0104-16731999000400002
   Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201
   WHO, 2013, GLOB HLTH ATL
   WHO, 2014, DENG SEV DENG
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 33
TC 5
Z9 6
U1 0
U2 9
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUN
PY 2015
VL 110
IS 4
BP 528
EP 533
DI 10.1590/0074-0276140388
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA CL0DT
UT WOS:000356610000011
PM 26061236
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Braga, JU
   Trajman, A
AF Braga, Jose Ueleres
   Trajman, Anete
TI Effectiveness of RHZE-FDC (fixed-dose combination) compared to RH-FDC
   plus Z for tuberculosis treatment in Brazil: a cohort study
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Effectiveness; Fixed-dose combination; Treatment; Tuberculosis
ID PULMONARY TUBERCULOSIS; PRIMARY-CARE; DRUGS; THERAPY
AB Background: In 2009, Brazil was the sole high-burden country to use three drugs [rifampin (R), isoniazid (H) and pyrazinamide (Z)] as the standard treatment for sensitive tuberculosis, with RH in fixed-dose combination (FDC). In December 2009, the country has adopted the FDC four-drug regimen including ethambutol (E). The rationale was the expectation to reduce default and resistance rates, by increasing adherence to treatment and avoiding monotherapy. However, there is no consensus on the superior effectiveness of the RHZE-FDC regimen over RH-FDC + Z. In particular, few studies evaluated its influence on default and smear negativation rates.
   Methods: We conducted a historic cohort study to assess the effectiveness of RHZE-FDC for the treatment of tuberculosis in Brazil, measured by the rates of treatment default and smear negativation in the second month of treatment, using secondary data from the national information system known as SINAN-TB.
   Results: The RHZE-FDC had a protective effect against treatment default compared to RH-FDC + Z, reducing it by 14%. However, it was not possible to show an effect of the RHZE-FDC on the rate of second month smear negativation. In addition to the regimen, other well-studied individual characteristics, such as older age (over 38 years) and higher education occupation were also protective against default. Conversely, alcoholism increased the probability of defaulting. These programmatic findings suggests the benefits of RHZE-FDC over RH-FDC + Z.
   Conclusion: Our analysis of a cohort database in a high burden country shows that compared to RH-FDC + Z, RHZE-FDC reduces the default rates, independently of other influencing individual or health service factors.
C1 [Braga, Jose Ueleres] Fiocruz MS, Natl Sch Publ Hlth, BR-21045900 Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio De Janeiro, Social Med Inst, Rio De Janeiro, Brazil.
   [Trajman, Anete] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Trajman, Anete] McGill Univ, Montreal Chest Inst, Montreal, PQ, Canada.
RP Braga, JU (corresponding author), Fiocruz MS, Natl Sch Publ Hlth, BR-21045900 Rio De Janeiro, Brazil.
EM ueleres@gmail.com
RI Trajman, Anete/C-7679-2016
OI Trajman, Anete/0000-0002-4000-4984
FU Ataulpho de Paiva Foundation [OPGH 5254]; Bill and Melinda Gates
   FoundationBill & Melinda Gates Foundation; CNPqNational Council for
   Scientific and Technological Development (CNPq)
FX Supported by the Ataulpho de Paiva Foundation, through a grant (OPGH
   5254) by the Bill and Melinda Gates Foundation. AT has a research grant
   by CNPq. We acknowledge Draurio Barreira, coordinator of the Brazilian
   NTP for allowing access to the tuberculosis database. None of the
   mentioned funding agencies are responsible for the statements in this
   article.
CR Agrawal S, 2004, INT J PHARMACEUT, V276, P41, DOI 10.1016/j.ijpharm.2004.02.019
   Albanna AS, 2013, EUR RESPIR J, V42, P721, DOI 10.1183/09031936.00180612
   Braga J, 2011, RELATORIO TECNICO ES
   BRASIL, 2009, NOT TECN MUD TRAT TU
   BRASIL Ministerio da Saude, 2013, TUB AL COM SOC AF CO
   Brasil. Ministerio da Saude, 1995, MAN NORM CONTR TUB, V50
   Brasil. Ministerio da Saude, 2002, MAN TEC CONTR TUB, P64
   Brasil Pedro Emmanuel Alvarenga Americano do, 2008, Cad. Saúde Pública, V24, ps485, DOI 10.1590/S0102-311X2008001600003
   de Oliveira HM, 2011, CAD SAUDE PUBLICA, V27, P35, DOI 10.1590/S0102-311X2011000100004
   de Sa LD, 2011, CIENC SAUDE COLETIVA, V16, P3917, DOI 10.1590/S1413-81232011001000028
   Escorel S, 2007, REV PANAM SALUD PUBL, V21, P164
   Ferreira V, 2011, REV SAUDE PUBL, V45, P40, DOI 10.1590/S0034-89102010005000055
   Geiter L J, 1987, Tubercle, V68, P41, DOI 10.1016/0041-3879(87)90021-3
   Glaziou P, 2011, B WORLD HEALTH ORGAN, V89, P573, DOI 10.2471/BLT.11.087510
   Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2
   Lienhardt C, 2011, JAMA-J AM MED ASSOC, V305, P1415, DOI 10.1001/jama.2011.436
   Ministerio da Saude do Brasil, 2011, MAN REC CONTR TUB BR, P284
   Monedero I, 2011, INT J TUBERC LUNG D, V15, P433, DOI 10.5588/ijtld.09.0439
   Su WJ, 2002, INT J TUBERC LUNG D, V6, P1029
   Suryanto AA, 2008, INT J TUBERC LUNG D, V12, P174
   United Nations Department of Economic and Social Affairs, 2008, MILL DEV GOALS REP 2, P52
   URQUHART J, 1994, CLIN PHARMACOKINET, V27, P202, DOI 10.2165/00003088-199427030-00004
   Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2
   World Health Organization, 2012, WHOHTMTB201116
   World Health Organization (WHO), 2013, GLOB TUB CONTR WHO R
   Zaka-Ur-Rehman Z, 2008, PAK J PHARM SCI, V21, P185
NR 26
TC 5
Z9 5
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD FEB 21
PY 2015
VL 15
AR 81
DI 10.1186/s12879-015-0820-4
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA CC8CS
UT WOS:000350596300001
PM 25879615
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Herrero, MB
   Arrossi, S
   Ramos, S
   Braga, JU
AF Herrero, Maria Belen
   Arrossi, Silvina
   Ramos, Silvina
   Braga, Jose Ueleres
TI Spatial analysis of the tuberculosis treatment dropout, Buenos Aires,
   Argentina
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Tuberculosis, drug therapy; Medication Adherence; Socioeconomic Factors;
   Health Inequalities; Ecological Studies
ID PREDICTIVE FACTORS; DETERMINANTS; INDIA; AREA
AB OBJECTIVE: Identify spatial distribution patterns of the proportion of nonadherence to tuberculosis treatment and its associated factors.
   METHODS: We conducted an ecological study based on secondary and primary data from municipalities of the metropolitan area of Buenos Aires, Argentina. An exploratory analysis of the characteristics of the area and the distributions of the cases included in the sample (proportion of nonadherence) was also carried out along with a multifactor analysis by linear regression. The variables related to the characteristics of the population, residences and families were analyzed.
   RESULTS: Areas with higher proportion of the population without social security benefits (p = 0.007) and of households with unsatisfied basic needs had a higher risk of nonadherence (p = 0.032). In addition, the proportion of nonadherence was higher in areas with the highest proportion of households with no public transportation within 300 meters (p = 0.070).
   CONCLUSIONS: We found a risk area for the nonadherence to treatment characterized by a population living in poverty, with precarious jobs and difficult access to public transportation.
C1 [Herrero, Maria Belen] Fac Latinoamer Ciencias Sociales, Area Relac Int, Buenos Aires, DF, Argentina.
   [Arrossi, Silvina; Ramos, Silvina] Ctr Estudios Estado & Soc, Area Salud Econ & Soc, Buenos Aires, DF, Argentina.
   [Herrero, Maria Belen] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.
   [Braga, Jose Ueleres] Fundacao Oswaldo Cruz, Dept Epidemiol & Metodos Quantitat, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Inst Social Med, Rio De Janeiro, RJ, Brazil.
RP Braga, JU (corresponding author), Fiocruz MS, Dept Epidemiol & Metodos Quantitat, Pavilhao Joao Lyra Filho Rua Sao Francisco Xavier, BR-20550013 Rio De Janeiro, RJ, Brazil.
EM ueleres@gmail.com
RI Oliveira, Claudia DL/G-8618-2011
FU Comision Nacional Salud Investiga of the Ministry of Health of Argentina
FX Research supported by the Comision Nacional Salud Investiga of the
   Ministry of Health of Argentina, 2008.
CR Arrossi S, 2012, SALUD COLECT, V8, P65, DOI 10.1590/s1851-82652012000300012
   Balasubramanian VN, 2000, INT J TUBERC LUNG D, V4, P409
   Barata Rita Barradas, 2005, Rev. bras. epidemiol., V8, P7
   Braga JU, 2008, CAD SAUDE PUBLICA S4, V24, P485, DOI DOI 10.1590/S0102-311X2008001600003
   Braga JU, 2012, CAD SAUDE COLET RIO, V20, P225
   Caceres FD, 2007, BIOMEDICA, V27, P498, DOI 10.7705/biomedica.v27i4.170
   Center for Diseases Control, 2000, COR CURR TUB WHAT CL
   Culqui DR, 2005, REV PANAM SALUD PUBL, V18, P14, DOI 10.1590/S1020-49892005000600003
   Ximenes RAD, 2009, INT J EPIDEMIOL, V38, P1285, DOI 10.1093/ije/dyp224
   de Lima MLC, 2005, REV SAUDE PUBL, V39, P176, DOI 10.1590/s0034-89102005000200006
   Galiano MA, 2005, ENFERM CLIN, V15, P192
   Ferreira Gonçalves Maria Jacirema, 2009, Rev. salud pública, V11, P918
   Herrero MB, 2011, REV ARGENT SALUD PUB, V2, P36
   Krieger Nancy, 2002, Rev Panam Salud Publica, V11, P480
   Mishra R, 2005, INT J TUBERC LUNG D, V9, P1134
   Nene B, 2007, B WORLD HEALTH ORGAN, V85, P264, DOI 10.2471/BLT.06.031195
   O'Boyle SJ, 2002, INT J TUBERC LUNG D, V6, P307
   Pineda NIS, 2005, REV PANAM SALUD PUBL, V17, P271, DOI 10.1590/S1020-49892005000400008
   Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427
   Roux AVD, 2002, J EPIDEMIOL COMMUN H, V56, P588, DOI 10.1136/jech.56.8.588
   Sabate E, 2004, ADHERENCIA TRATAMIEN
   Sabates R, 2006, SOC SCI MED, V62, P2998, DOI 10.1016/j.socscimed.2005.11.032
   Souza WV, 2005, REV SAUDE PUBL, V39, P82, DOI [10.1590/S0034-89102005000100011, 10.1590/s0034-89102005000100011]
   Tanguis HG, 2000, INT J TUBERC LUNG D, V4, P55
   World Health Organisation, 2003, TREATM TUB GUID NAT
NR 25
TC 4
Z9 5
U1 0
U2 12
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PY 2015
VL 49
AR 49
DI 10.1590/S0034-8910.2015049005391
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DB2ZJ
UT WOS:000368378900051
PM 26270011
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Souza, MSPL
   Aquino, R
   Pereira, SM
   Costa, MDN
   Barreto, ML
   Natividade, M
   Ximenes, R
   Souza, W
   Dantas, OM
   Braga, JU
AF Pedro Leal Souza, Marcia Sao
   Aquino, Rosana
   Pereira, Susan M.
   Nascimento Costa, Maria da Conceicao
   Barreto, Mauricio Lima
   Natividade, Marcio
   Ximenes, Ricardo
   Souza, Wayner
   Dantas, Odimariles Maria
   Braga, Jose Ueleres
TI Factors associated with geographic access to health services by TB
   patients in three State capitals in Northeast Brazil
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Tuberculosis; Health Services Accessibility; Health Centers
ID TUBERCULOSIS; CARE; CITY
AB The aim of this study was to identify factors associated with geographic access to health services by tuberculosis patients in three State capitals in Northeast Brazil. The sample consisted of new tuberculosis cases reported in 2007. The study used data from the Information System on Notifiable Diseases and the National Registry of Healthcare Organizations. Addresses of households and health services were geocoded, and difficult access was defined as a distance greater than 800 meters from the household to the health service. Crude prevalence ratios were estimated, as well as adjusted prevalence ratios using Poisson regression. After adjusting the study variables, the only variable that remained associated with difficult access was primary healthcare units in Salvador, Bahia State (PR = 0.75; 95%CI: 0.720-0.794) and in Recife, Pernambuco State (PR = 0.402; 95%CI: 0.318-0.508). The study concluded that decentralization of primary care can help improve access to health services.
C1 [Pedro Leal Souza, Marcia Sao; Aquino, Rosana; Pereira, Susan M.; Nascimento Costa, Maria da Conceicao; Barreto, Mauricio Lima; Natividade, Marcio] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Ximenes, Ricardo; Dantas, Odimariles Maria] Univ Fed Pernambuco, Ctr Ciencias Saude, Recife, PE, Brazil.
   [Souza, Wayner] Fundacao Oswald Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Ctr Biomed, BR-20550011 Rio De Janeiro, Brazil.
RP Souza, MSPL (corresponding author), Rua Basilio Gama S-N,Campus Univ Canela, BR-40110040 Salvador, BA, Brazil.
EM marciasaopedrosouza@gmail.com
RI Souza, Wayner V/H-3798-2013; Natividade, Marcio/Q-5662-2019; Barreto,
   Mauricio L/B-1752-2008
OI Natividade, Marcio/0000-0002-3986-5656; Barreto, Mauricio
   L/0000-0002-0215-4930
CR CAMPOS FILHO C. M, 2003, REINVENTE SEU BAIRRO
   Gonzales RIC, 2008, REV ESC ENFERM USP, V42, P627, DOI 10.1590/S0080-62342008000400003
   Castro MSM, 2005, REV SAUDE PUBL, V39, P277, DOI 10.1590/S0034-89102005000200020
   Chern JPS, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-236
   Coordenacao Geral de Doencas Endemicas Departamento de Vigilancia Epidemiologica Secretaria de Vigilancia em Saude Ministerio da Saude, 2007, PLAN ESTR CONTR TUB
   Departamento de Vigilancia Epidemiologica Secretaria de Vigilancia em Saude Ministerio da Saude, 2011, TRAT DIR OBS TDO F
   Departamento de Vigilancia Epidemiologica Secretaria de Vigilancia em Saude Ministerio da Saude, 2011, MAN REC CONTR TUB BR
   Dias-Da-Costa JS, 2008, CAD SAUDE PUBLICA, V24, P2843, DOI 10.1590/S0102-311X2008001200013
   do Amaral AS, 2010, SAUDE SOC, V19, P794, DOI 10.1590/S0104-12902010000400007
   Figueiredo Tânia Maria Ribeiro Monteiro de, 2009, Rev. Saúde Pública, V43, P825, DOI 10.1590/s0034-89102009005000054
   KLUGMAN J., 2011, RELATORIO DESENVOLVI
   Marmot M, 2006, LANCET, V368, P2081, DOI 10.1016/S0140-6736(06)69746-8
   McCullagh P, 1989, GEN LINEAR MODELS
   Ministerio da Saude, CONTR TUB BRAS AV IN
   Motta CPG, 2008, 16 C ASS BRAS EST PO, P1
   Cunha ABO, 2010, CAD SAUDE PUBLICA, V26, P725, DOI 10.1590/S0102-311X2010000400015
   Paim J, 2011, LANCET
   Ramos Donatela Dourado, 2003, Cad. Saúde Pública, V19, P27, DOI 10.1590/S0102-311X2003000100004
   Sawyer Diana Oya, 2002, Ciênc. saúde coletiva, V7, P757, DOI 10.1590/S1413-81232002000400012
   Scatena Lúcia Marina, 2009, Rev. Saúde Pública, V43, P389, DOI [10.1590/S0034-89102009005000022, 10.1590/S0034-89102009000300001]
   Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x
   Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15
   Perrechi MCT, 2009, J BRAS PNEUMOL, V35, P1100, DOI 10.1590/S1806-37132009001100007
   Travassos Claudia, 2004, Cad. Saúde Pública, V20, pS190
   Travassos Cláudia, 2002, Rev Panam Salud Publica, V11, P365, DOI 10.1590/S1020-49892002000500011
   Travassos Claudia, 2006, Ciênc. saúde coletiva, V11, P975, DOI 10.1590/S1413-81232006000400019
NR 26
TC 10
Z9 19
U1 0
U2 5
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD JAN
PY 2015
VL 31
IS 1
BP 111
EP 120
DI 10.1590/0102-311X00000414
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CE0GI
UT WOS:000351482100011
PM 25715296
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Erazo, C
   Pereira, SM
   Costa, MDN
   Evangelista, D
   Braga, JU
   Barreto, ML
AF Erazo, Carlos
   Pereira, Susan M.
   Costa, Maria da Conceicao N.
   Evangelista-Filho, Delsuc
   Braga, Jose Ueleres
   Barreto, Mauricio L.
TI Tuberculosis and living conditions in Salvador, Brazil: a spatial
   analysis
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Tuberculosis; tuberculosis, prevention & control; spatial analysis;
   social inequity; risk groups; Brazil
ID RISK-FACTORS; TRANSMISSION; PATTERNS; SYSTEM; CITY
AB Objective. To investigate spatial tuberculosis (TB) distribution patterns and the association between living conditions and incidence of the disease in Salvador, Bahia, Brazil.
   Methods. An ecological study with neighborhood as the unit of analysis. Data was collected from the Notifiable Diseases Information System (Sistema de Informacao de Agravos de Notificacao, SINAN) and the Brazilian Institute of Geography and Statistics (Instituto Brasileiro de Geografia e Estatistica, IBGE). Rates of TB incidence were transformed and smoothed. Spatial analysis was applied to identify spatial auto-correlation and "hotspot" areas of high and low risk. The relationship between TB and living conditions was confirmed by spatial linear regression.
   Results. The incidence of TB in Salvador displayed heterogeneous patterns, with higher rates occurring in neighborhoods with poor living conditions in 1995-1996. Over the study period, disease occurrence declined, particularly in less-privileged strata. In 2004-2005, the association between living conditions and TB was no longer observed.
   Conclusions. The heterogeneous spatial distribution of TB in Salvador previously reflected inequalities related to living conditions. Improvements in such conditions and health care for the less privileged may have contributed to observed changes.
C1 [Erazo, Carlos; Pereira, Susan M.; Costa, Maria da Conceicao N.; Evangelista-Filho, Delsuc; Barreto, Mauricio L.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Braga, Jose Ueleres] Fundacao Oswaldo Cruz FIOCRUZ, Escola Nacl Saude Publ, Dept Epidemiol & Metodos Quantitat Saude, BR-21045900 Rio De Janeiro, Brazil.
RP Pereira, SM (corresponding author), Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
EM susanmp@ufba.br
RI Oliveira, Claudia DL/G-8618-2011; Barreto, Mauricio L/B-1752-2008
OI Barreto, Mauricio L/0000-0002-0215-4930
CR Alvarez-Hernandez G, 2010, INT J TUBERC LUNG D, V14, P708
   Anselin L., 2005, EXPLORING SPATIAL DA
   Vieira RDA, 2008, REV SOC BRAS MED TRO, V41, P82, DOI 10.1590/S0037-86822008000100017
   Brasil. Minist rio da Saude. Secretaria de Vigilancia em Saude, 2006, PLAN ESTR IMPL PLAN
   Brasil. Ministerio da Saude, 2001, PLAN NAC MOB INT AC
   Brasil. Ministerio da Saude. Fundacao Nacional de Saude, 2001, PLAN NAC CONTR TUB
   Carneiro NMB, 1986, REV BAIA SAUDE PUBL, V13, P68
   Castelo Filho Adauto, 2004, J. bras. pneumol., V30, pS57, DOI 10.1590/S1806-37132004000700002
   Chan-Yeung M, 2005, INT J TUBERC LUNG D, V9, P1320
   Costa MCN, 2003, REV CIENCIAS MED BIO, V2, P30
   de Souza SF, 2012, REV SOC BRAS MED TRO, V45, P323, DOI 10.1590/S0037-86822012000300009
   Gonçalves Annelise C., 2013, Rev. bras. epidemiol., V16, P682, DOI 10.1590/S1415-790X2013000300012
   Gustafson P, 2004, INT J EPIDEMIOL, V33, P163, DOI 10.1093/ije/dyh026
   IDB, 2008, IDB 2008 BRAS IND DA
   Kaulagekar Aarti, 2007, Indian J Tuberc, V54, P17
   Kistemann T, 2002, SOC SCI MED, V55, P7, DOI 10.1016/S0277-9536(01)00216-7
   LAWSON AB, 1999, DIS MAPPING RISK ASS
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Mota Fábio Frias, 2003, Cad. Saúde Pública, V19, P915, DOI 10.1590/S0102-311X2003000400014
   Xavier MIM, 2007, CAD SAUDE PUBLICA, V23, P445, DOI 10.1590/S0102-311X2007000200021
   Munch Z, 2003, INT J TUBERC LUNG D, V7, P271
   Nava-Aguilera E, 2009, INT J TUBERC LUNG D, V13, P17
   Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
   Programa das Nacoes Unidas para o Desenvolvimento (PNUD), 2004, ATL DES HUM BRAS PER
   Programa das Nacoes Unidas para o Desenvolvimento (PNUD), 2008, IDH IND DES HUM REL
   Randremanana RV, 2009, TROP MED INT HEALTH, V14, P429, DOI 10.1111/j.1365-3156.2009.02239.x
   Ruffino-Netto A, 2001, Rev Panam Salud Publica, V9, P306, DOI 10.1590/S1020-49892001000500004
   Souza W V, 2000, Rev Panam Salud Publica, V8, P403, DOI 10.1590/S1020-49892000001100005
   Souza WV, 2005, REV SAUDE PUBL, V39, P82, DOI [10.1590/S0034-89102005000100011, 10.1590/s0034-89102005000100011]
   Teixeira Maria da Gloria, 2002, Rev. Soc. Bras. Med. Trop., V35, P491, DOI 10.1590/S0037-86822002000500012
   Uthman Olalekan A, 2008, World Health Popul, V10, P5
   Vendramini SHF, 2006, INT J TUBERC LUNG D, V10, P1231
   World Health Organization, 2010, WHO REP 2010 GLOB TU
   Ximenes R A, 1999, Cad Saude Publica, V15, P53
   dos Santos RMZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014140
NR 35
TC 6
Z9 11
U1 0
U2 10
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PD JUL
PY 2014
VL 36
IS 1
BP 24
EP 30
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AP6GO
UT WOS:000342175800004
PM 25211674
DA 2020-12-01
ER

PT J
AU Loureiro, RB
   Villa, TCS
   Ruffino-Netto, A
   Peres, RL
   Braga, JU
   Zandonade, E
   Maciel, ELN
AF Loureiro, Rafaela Borges
   Scatena Villa, Tereza Cristina
   Ruffino-Netto, Antonio
   Peres, Renata Lyrio
   Braga, Jose Ueleres
   Zandonade, Eliana
   Noia Maciel, Ethel Leonor
TI Access to the diagnosis of tuberculosis in health services in the
   municipality of Vitoria, state of Espirito Santo, Brazil
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Article
DE Tuberculosis; Access; Accessibility; Health Services; Diagnosis; Primary
   health care
ID PULMONARY TUBERCULOSIS; TREATMENT DELAY; CARE; BARRIERS; CLINICS
AB This study sought to assess the accessibility to the diagnosis of tuberculosis in health services in Victoria, state of Espirito Santo. It featured a cross-sectional study conducted in 2009 of patients with tuberculosis using the Primary Care Assessment Tool and statistical analysis with the Chi-square test (p < 0,05). In relation to initial access to care, it was seen that the health service of first access most sought was Primary Care (37.6%), with most diagnoses occurring in the Tuberculosis Control Program Reference Units (61.3%). There was evidence of association between first health service accessed and the factors of time delay in: obtaining consultation at the first health service sought (p = 0.0182); diagnosis made by the first health service sought (p = 0.0001); request for sputum exam (p = 0,0003); request for X-ray exams (p = 0.0159); referral for X-rays at another institution (p = 0.0001); diagnosis by the same health service (p = 0.0001); exams conducted by the same health service that initially diagnosed tuberculosis (p = 0.0018); and proximity to the home (p = 0.0001). Therefore, the identification of important gaps in accessibility to diagnosis of tuberculosis seems to be related to the operational difficulties of organization of health care.
C1 [Loureiro, Rafaela Borges; Peres, Renata Lyrio; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, BR-29040091 Vitoria, ES, Brazil.
   [Scatena Villa, Tereza Cristina] Univ Sao Paulo, Dept Enfermagem Saude Publ, Escola Enfermagem Ribeirao Preto, BR-05508 Sao Paulo, Brazil.
   [Ruffino-Netto, Antonio] Univ Sao Paulo, Dept Med Social, Fac Med Ribeirao Preto, BR-05508 Sao Paulo, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Dept Epidemiol, Inst Med Social, Rio De Janeiro, Brazil.
   [Zandonade, Eliana] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Vitoria, Spain.
RP Loureiro, RB (corresponding author), Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Av Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM rafaelabloureiro@gmail.com
RI Villa, Tereza Cristina Scatena/K-7891-2013; Maciel, Ethel Leonor
   LN/G-1027-2012
OI Villa, Tereza Cristina Scatena/0000-0001-8927-2624; Maciel, Ethel Leonor
   LN/0000-0003-4826-3355
CR de Jesus WLA, 2010, CIENC SAUDE COLETIVA, V15, P161, DOI 10.1590/S1413-81232010000100022
   Almeida C, 2006, VALIDACAO METODOLOGI
   Amendola F, 2011, REV ESC ENFERM USP, V45, P880, DOI 10.1590/S0080-62342011000400013
   Carr-Hill R, 1994, FORMULA DISTRIBUTING
   Cerqueira MB, 2009, REV BAIANA SAUDE PUB, V33
   Diez M, 2005, EUR J PUBLIC HEALTH, V15, P343, DOI 10.1093/eurpub/cki010
   Dimitrova B, 2006, HEALTH POLICY PLANN, V21, P265, DOI 10.1093/heapol/czl014
   Donabedian A., 1973, ASPECTS MED CARE ADM
   dos Santos MAPS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-25
   Fekete MC, 1997, ESTUDO ACESSIBILIDAD, VI
   Fekete MC, 1992, ESTUDO ACESSIBILIDAD
   Figueiredo Tânia Maria Ribeiro Monteiro de, 2009, Rev. Saúde Pública, V43, P825, DOI 10.1590/s0034-89102009005000054
   Fishbein M., 1975, BELIEF ATTITUDE INTE
   Frenk J, 1985, Salud Publica Mex, V27, P438
   Goddard M, 2001, SOC SCI MED, V53, P1149, DOI 10.1016/S0277-9536(00)00415-9
   Harter J, 2010, UTILIZACAO BACILOSCO
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2009, EST POP RES EM 1 JUL
   Jaiswal A, 2003, TROP MED INT HEALTH, V8, P625, DOI 10.1046/j.1365-3156.2003.01061.x
   Leung Eric C. C., 2007, Hong Kong Medical Journal, V13, P221
   Marcolino Alinne Beserra Lucena, 2009, Rev. bras. epidemiol., V12, P144, DOI 10.1590/S1415-790X2009000200005
   Moreira CMM, 2010, CAD SAUDE PUBLICA, V26, P1619, DOI 10.1590/S0102-311X2010000800015
   Maciel ELN, 2008, CAD SAUDE PUBLICA, V24, P1377, DOI 10.1590/S0102-311X2008000600018
   Oliveira MF, 2009, THESIS U SAO PAULO R
   Paixão Lúcia Miana M., 2007, Rev. Saúde Pública, V41, P205, DOI 10.1590/s0034-89102007000200006
   Palermo PU., 2005, THESIS U FEDERAL RIO
   Ribeiro Manoel Carlos Sampaio de Almeida, 2006, Ciênc. saúde coletiva, V11, P1011, DOI 10.1590/S1413-81232006000400022
   Villa TCS, 2009, J BRAS PNEUMOL, V35, P610, DOI 10.1590/S1806-37132009000600014
   Starfield B, 2002, ATENCAO PRIMARIA EQU
   Travassos C, 2008, POLITICAS SISTEMA SA, P215
   Travassos Claudia, 2004, Cad. Saúde Pública, V20, pS190
   Unglert C V, 1990, Rev Saude Publica, V24, P445, DOI 10.1590/S0034-89101990000600002
   Viacava Francisco, 2004, Ciênc. saúde coletiva, V9, P711, DOI 10.1590/S1413-81232004000300021
   Vieira E. M., 2005, FUNDAMENTOS EPIDEMIO, P337
   Wang WB, 2007, EUR J PUBLIC HEALTH, V17, P419, DOI 10.1093/eurpub/ckm029
   Yimer S, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-112
NR 35
TC 6
Z9 11
U1 0
U2 4
PU ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA
PI RIO DE JANEIRO
PA AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36,
   BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD APR
PY 2014
VL 19
IS 4
BP 1233
EP 1244
DI 10.1590/1413-81232014194.01002013
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AH3TY
UT WOS:000336049700024
PM 24820606
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Micheletti, VCD
   Vloreira, JD
   Ribeiro, MO
   Kritski, AL
   Braga, JU
AF Dezoti Micheletti, Vania Celina
   Vloreira, Jose da Silva
   Ribeiro, Marta Osorio
   Kritski, Afranio Lineu
   Braga, Jose Ueleres
TI Drug-resistant tuberculosis in subjects included in the Second National
   Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil
SO JORNAL BRASILEIRO DE PNEUMOLOGIA
LA English
DT Article
DE Tuberculosis/diagnosis; Drug resistance; HIV
ID PULMONARY TUBERCULOSIS; DIAGNOSIS; DELAY; STATE
AB Objective: To describe the prevalence of multidrug-resistant tuberculosis (MDR-TB) among tuberculosis patients in a major Brazilian city, evaluated via the Second National Survey on Antituberculosis Drug Resistance, as well as the social, demographic, and clinical characteristics of those patients. Methods: Clinical samples were collected from tuberculosis patients seen between 2006 to 2007 at three hospitals and five primary health care clinics participating in the survey in the city of Porto Alegre, Brazil. The samples were subjected to drug susceptibility testing. The species of mycobacteria was confirmed using biochemical methods. Results: Of the 299 patients included, 221 (73.9%) were men and 77 (27.3%) had a history of tuberculosis. The mean age was 36 years. Of the 252 patients who underwent HIV testing, 66 (26.2%) tested positive. The prevalence of MDR-TB in the sample as a whole was 4.7% (95% CI: 2.3-7.1), whereas it was 2.2% (950/0 CI: 0.3-4.2) among the new cases of tuberculosis and 12.0% (95% CI: 4.5-19.5) among the patients with a history of tuberculosis treatment. The multivariate analysis showed that a history of tuberculosis and a longer time to diagnosis were both associated with MDR-TB. Conclusions: lf our results are corroborated by other studies conducted in Brazil, a history of tuberculosis treatment and a longer time to diagnosis could be used as predictors of MDR-TB.
C1 [Dezoti Micheletti, Vania Celina] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Vloreira, Jose da Silva] Univ Fed Rio Grande do Sul, Dept Pulmonol, Porto Alegre, RS, Brazil.
   [Ribeiro, Marta Osorio] Univ Fed Rio Grande do Sul, Inst Microbiol, Porto Alegre, RS, Brazil.
   [Kritski, Afranio Lineu] Univ Fed Rio Grande do Sul, Sch Med, Dept Pulmonol, Porto Alegre, RS, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio De Janeiro, Dept Collect Hlth, Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Micheletti, VCD (corresponding author), Rua Coronel Feijo 473,Apto 201, BR-90520060 Porto Alegre, RS, Brazil.
EM vaniadezoti@uol.com.br
RI Kritski, Afranio/I-6760-2016
OI Moreira, Jose da Silva/0000-0003-1345-0476; kritski,
   afranio/0000-0002-5900-6007
FU Brazilian Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES, Office for the Advancement of Higher Education)
FX This study received financial support from the Brazilian Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Office for the
   Advancement of Higher Education).
CR Braga JU, 2003, B PNEUMOL SANIT, V11, P76
   Brasil. Ministerio da Saude, 2002, TUB GUIA VIG EP
   Brasil. Ministerio da Saude, 2005, INQ NAC RES DROG TUB
   Brasil. Ministerio da Saude, 2011, MAN REC CONTR TUB BR
   Brasil. Ministerio da Saude, 1994, MAN BACT TUB
   Brasil Ministerio da Saude, 2007, REV BRAS PNEUMOL SAN, V15, P39
   Brasil. Ministerio da Saude.Programa Nacional de Controle da Tuberculose Departamento de Vigilancia Epidemiologica, 2010, SIT TUB BRAS MUND SE
   Calixto M, 2010, B EPIDEMIOLOGICO, V42
   *CTR PAN ZOON, 1988, MAN NORM PROC TECN B
   Machado ACDT, 2011, J BRAS PNEUMOL, V37, P512, DOI 10.1590/S1806-37132011000400014
   dos Santos MAPS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-25
   Gomes C, 2000, J PNEUMOL, V26, P25
   Kritski AL, 2010, J BRAS PNEUMOL, V36, P157, DOI 10.1590/S1806-37132010000200001
   Lambert ML, 2005, TROP MED INT HEALTH, V10, P945, DOI 10.1111/j.1365-3156.2005.01485.x
   Maciel ELN, 2010, INT J TUBERC LUNG D, V14, P1403
   Marques M, 2010, J BRAS PNEUMOL, V36, P224, DOI 10.1590/S1806-37132010000200011
   Martinez D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012082
   Secretaria Municipal de Saude de Porto Alegre, 2004, B EPIDEMIOLOGICO, V23
   Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91
   Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15
   Union Internacional Contra la Tuberculosis y Enfermedades Respiratorias, 1978, B UNO INT TUBERC S2
   Uys PW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000757
   *WHO, 2001, GUID SURV DRUG RES T
   *WHO, 2008, ANT DRUG RES WORLD 4
   World Health Organization, 2000, 2 WHOIUATLD DIV COMM
   World Health Organization, 2003, COMM DIS GLOB TUB CO
   World Health Organization, 2011, GLOB TUB CONTR WHO R
   World Health Organization (WHO), 2010, MULT EXT DRUG RES TB
NR 28
TC 17
Z9 18
U1 0
U2 4
PU SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA
PI BRASILIA DF
PA SEPS 714-719, BLOCO E ASA SUL, SALAS 220-223, BRASILIA DF, CEP70390-145,
   BRAZIL
SN 1806-3713
EI 1806-3756
J9 J BRAS PNEUMOL
JI J. Bras. Pneumol.
PD MAR-APR
PY 2014
VL 40
IS 2
BP 155
EP 163
DI 10.1590/S1806-37132014000200009
PG 9
WC Respiratory System
SC Respiratory System
GA AF2UX
UT WOS:000334569100009
PM 24831400
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Almeida, RLF
   Bezerra, JG
   Braga, JU
   Magalhaes, FB
   Macedo, MCM
   Silva, KA
AF Freitas de Almeida, Rosa Livia
   Bezerra Filho, Jose Gomes
   Braga, Jose Ueleres
   Magalhaes, Francismeire Brasileiro
   Munguba Macedo, Marinila Calderaro
   Silva, Kellyanne Abreu
TI Man, road and vehicle: risk factors associated with the severity of
   traffic accidents
SO REVISTA DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Accidents, Traffic, mortality; Risk Factors; Hospital Information
   Systems; Mortality Registries; Urban Population
ID PROBABILISTIC RECORD LINKAGE; INJURY
AB OBJECTIVE: To describe the main characteristics of victims, roads and vehicles involved in traffic accidents and the risk factors involved in accidents resulting in death.
   METHODS: A non-concurrent cohort study of traffic accidents in Fortaleza, CE, Northeastern Brazil, in the period from January 2004 to December 2008. Data from the Fortaleza Traffic Accidents Information System, the Mortality Information System, the Hospital Information System and the State Traffic Department Driving Licenses and Vehicle database. Deterministic and probabilistic relationship techniques were used to integrate the databases. First, descriptive analysis of data relating to people, roads, vehicles and weather was carried out. In the investigation of risk factors for death by traffic accident, generalized linear models were used. The fit of the model was verified by likelihood ratio and ROC analysis.
   RESULTS: There were 118,830 accidents recorded in the period. The most common types of accidents were crashes/collisions (78.1%), running over pedestrians (11.9%), colliding with a fixed obstacle (3.9%), and with motorcycles (18.1%). Deaths occurred in 1.4% of accidents. The factors that were independently associated with death by traffic accident in the final model were bicycles (OR = 21.2, 95% CI 16.1; 27.8), running over pedestrians OR = 5.9 (95% CI 3.7; 9.2), collision with a fixed obstacle (OR = 5.7, 95% CI 3.1; 10.5) and accidents involving motorcyclists (OR = 3.5, 95% CI 2.6; 4.6). The main contributing factors were a single person being involved (OR = 6.6, 95% CI 4.1; 10.73), presence of unskilled drivers (OR = 4.1, 95% CI 2.9; 5.5) a single vehicle (OR = 3.9, 95% CI 2,3; 6,4), male (OR = 2.5, 95% CI 1.9; 3.3), traffic on roads under federal jurisdiction (OR = 2.4, 95% CI 1.8; 3.7), early morning hours (OR = 2.4, 95% CI 1.8; 3.0), and Sundays (OR = 1.7, 95% CI 1.3; 2.2), adjusted according to the log-binomial model.
   CONCLUSIONS: Activities promoting the prevention of traffic accidents should primarily focus on accidents involving two-wheeled vehicles that most often involves a single person, unskilled, male, at nighttime, on weekends and on roads where they travel at higher speeds.
C1 [Freitas de Almeida, Rosa Livia; Bezerra Filho, Jose Gomes] Univ Fed Ceara, Fac Med, Dept Saude Comunitaria, Fortaleza, CE, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Dept Med Interna, BR-20550011 Rio De Janeiro, RJ, Brazil.
   [Magalhaes, Francismeire Brasileiro] Univ Fortaleza, Univ Fed Ceara, Univ Estadual Ceara, Programa Posgrad Assoc Ampla, Fortaleza, CE, Brazil.
   [Munguba Macedo, Marinila Calderaro] Univ Fed Ceara, Fac Med Cariri, Fortaleza, CE, Brazil.
   [Silva, Kellyanne Abreu] Univ Fed Ceara, Fac Med, Programa Posgrad Saude Publ, Fortaleza, CE, Brazil.
RP de Almeida, RLF (corresponding author), Fac Med UFC, Dept Saude Comunitaria, Rua Prof Costa Mendes,1608 5 Andar Rodolfo Teofil, BR-60430140 Fortaleza, CE, Brazil.
EM rliviafa@gmail.com
RI de Almeida, Rosa Livia Freitas/M-7962-2018
OI de Almeida, Rosa Livia Freitas/0000-0001-6423-543X
CR Abreu Ângela Maria Mendes, 2009, Esc. Anna Nery, V13, P44, DOI 10.1590/S1414-81452009000100007
   Alves EF, 2010, SAUD PESQ, V3, P25
   Bacchieri G, 2011, REV SAUDE PUBL, V45, P949, DOI [10.1590/S0034-89102011005000069, 10.1590/s0034-89102011005000069]
   BARSS P, 1998, INJURY PREVENTION IN
   Bastos Yara Gerber Lima, 2005, Cad. Saúde Pública, V21, P815, DOI 10.1590/S0102-311X2005000300015
   Blakely T, 2002, INT J EPIDEMIOL, V31, P1246, DOI 10.1093/ije/31.6.1246
   Branco AG, 2003, REV ABRAMET, V11, P33
   Crundall D, 2001, ROAD SAFETY GOOD PRA
   Deslandes SF, 2000, REV SAUDE PUBL, V34, P367, DOI 10.1590/S0034-89102000000400009
   Gawryszewski Vilma Pinheiro, 2004, Cad. Saúde Pública, V20, P995, DOI 10.1590/S0102-311X2004000400014
   Hosmer DW, 2000, APPL LOGISTIC REGRES
   Jorge MHPD, 1997, REV SAUDE PUBL, V31, P5, DOI 10.1590/S0034-89101997000500002
   Kmet L, 2003, ACCIDENT ANAL PREV, V35, P177, DOI 10.1016/S0001-4575(01)00101-4
   Kweon YJ, 2003, ACCIDENT ANAL PREV, V35, P441, DOI 10.1016/S0001-4575(02)00021-0
   Machado Carla Jorge, 2004, Cad. Saúde Pública, V20, P915, DOI 10.1590/S0102-311X2004000400005
   Meray N, 2007, J CLIN EPIDEMIOL, V60, P883, DOI 10.1016/j.jclinepi.2006.11.021
   Organizacao Mundial de Saude, 2007, CLASS INT DOENC PROB, V1
   OTT EA, 1993, REV SAUDE PUBL, V27, P350, DOI 10.1590/S0034-89101993000500005
   Silva Daniela Wosiack da, 2008, Cad. Saúde Pública, V24, P2643, DOI 10.1590/S0102-311X2008001100019
   Montenegro MDS, 2011, REV SAUDE PUBL, V45, P529
   Soares Dorotéia Fátima Pelissari de Paula, 2006, Rev. bras. epidemiol., V9, P193, DOI 10.1590/S1415-790X2006000200006
   Whitlock G, 2004, INJURY PREV, V10, P33, DOI 10.1136/ip.2003.003020
NR 22
TC 14
Z9 19
U1 0
U2 21
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD AUG
PY 2013
VL 47
IS 4
BP 718
EP 731
DI 10.1590/S0034-8910.2013047003657
PG 14
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 279EW
UT WOS:000328944200009
PM 24346663
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Muraro, AP
   dos Santos, DF
   Rodrigues, PRM
   Braga, JU
AF Muraro, Ana Paula
   dos Santos, Debora Franca
   Melo Rodrigues, Paulo Rogerio
   Braga, Jose Ueleres
TI Factors associated with self-reported systemic arterial hypertension
   according to VIGITEL in 26 Brazilian capitals and the Federal District
   in 2008
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Article
DE Hypertension; Risk factors; Ecological studies; Telephone surveys
ID BODY-MASS INDEX; BLOOD-PRESSURE; RISK-FACTORS; CARDIOVASCULAR-DISEASE;
   VALIDATION; FREQUENCY; MORTALITY; FRUIT
AB The scope of this article is to study the association between lifestyle, nutritional status and the prevalence of self-reported systemic arterial hypertension, weighted by the system of risk and protective factors for Chronic Non-Communicable Diseases (CNCD) by telephone surveys and standardized by age and sex, in adults from 26 Brazilian state capitals and the Federal District in 2008. For each city the prevalence of hypertension was standardized by the direct method. Multiple linear regression analysis was performed between the factors of interest and the prevalence of hypertension, weighted and standardized by gender and age. After standardization, the prevalence of hypertension tended to increase in capitals with a younger population and decrease in those with a higher proportion of elderly individuals. In regression models, the prevalence of weighted and standardized hypertension remained associated with the prevalence of excess weight and the consumption of fruit and vegetables (FV). However, physical activity was only negatively associated with the weighted prevalence of hypertension. A positive association with weighted and standardized prevalence of hypertension was observed with excess weight and regular consumption of FV.
C1 [Muraro, Ana Paula; dos Santos, Debora Franca; Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Inst Med Social, Dept Epidemiol, BR-20550012 Rio De Janeiro, Brazil.
   [Melo Rodrigues, Paulo Rogerio] Univ Fed Rio de Janeiro, Inst Nutr Josue Castro, Dept Nutr Social & Aplicada, BR-21941 Rio De Janeiro, Brazil.
RP Muraro, AP (corresponding author), Univ Estado Rio de Janeiro, Inst Med Social, Dept Epidemiol, R Sao Francisco Xavier 524-7 Bloco E, BR-20550012 Rio De Janeiro, Brazil.
EM muraroap@gmail.com
RI Rodrigues, Paulo R Rogerio Pinto/R-1441-2018; Muraro, Ana
   Paula/X-8028-2019; Rodrigues, Paulo Rogerio Melo/P-4456-2017
OI Rodrigues, Paulo R Rogerio Pinto/0000-0001-8383-7225; Muraro, Ana
   Paula/0000-0001-6237-1673; Rodrigues, Paulo Rogerio
   Melo/0000-0002-4213-0685; dos Santos, Debora/0000-0003-3917-2291
CR Borges HP, 2008, ARQ BRAS CARDIOL, V91, P110, DOI 10.1590/S0066-782X2008001400007
   Brasil, 2010, VIG FAT RISC PROT DO
   Brummett BH, 2011, HYPERTENSION, V58, P161, DOI 10.1161/HYPERTENSIONAHA.111.171272
   COITINHO DC, 1991, CONDICOES NUTRICIONA
   DOREA EL, 2001, REV BRAS HIPERTENS, V8, P195
   Chrestani MAD, 2009, CAD SAUDE PUBLICA, V25, P2395, DOI 10.1590/S0102-311X2009001100010
   Ferreira Aline Dayrell, 2011, Rev. bras. epidemiol., V14, P16, DOI 10.1590/S1415-790X2011000500003
   Fung TT, 2001, AM J CLIN NUTR, V73, P61
   Ferreira SRG, 2009, REV SAUDE PUBL, V43, P98, DOI 10.1590/s0034-89102009000900013
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2010, PESQ NAC AM DOM PNAD
   Ishitani LH, 2006, REV SAUDE PUBL, V40, P684, DOI 10.1590/S0034-89102006000500019
   Ix JH, 2011, AM J EPIDEMIOL, V174, P1036, DOI 10.1093/aje/kwr228
   Juhola J, 2011, J PEDIATR-US, V159, P584, DOI 10.1016/j.jpeds.2011.03.021
   Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3
   LamonFava S, 1996, ARTERIOSCL THROM VAS, V16, P1509, DOI 10.1161/01.ATV.16.12.1509
   Lewington S, 2002, LANCET, V360, P1903
   Lima-Costa MF, 2004, REV SAUDE PUBL, V38, P637, DOI 10.1590/S0034-89102004000500004
   Liu S, 2000, AM J CLIN NUTR, V72, P922
   Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a
   Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f
   Martinez Maria Carmen, 2006, Arq. Bras. Cardiol., V87, P471, DOI 10.1590/S0066-782X2006001700012
   Millen BE, 2001, J AM DIET ASSOC, V101, P187, DOI 10.1016/S0002-8223(01)00051-7
   Monteiro CA, 2005, REV SAUDE PUBL, V39, P47, DOI 10.1590/s0034-89102005000100007
   Moura Erly Catarina, 2008, Rev. bras. epidemiol., V11, P20
   Ostchega Yechiam, 2008, NCHS Data Brief, P1
   Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9
   [Anonymous], 2010, Arq. Bras. Cardiol., V95, pI, DOI 10.1590/S0066-782X2010001700001
   Van Duyn MS, 2000, J AM DIET ASSOC, V100, P1511, DOI 10.1016/S0002-8223(00)00420-X
   Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1
   Jardim PCBV, 2007, ARQ BRAS CARDIOL, V88, P452, DOI 10.1590/S0066-782X2007000400015
   Velasquez-Melendez G, 2007, EPIDEMIOLOGIA NUTR
NR 31
TC 14
Z9 18
U1 0
U2 4
PU ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA
PI RIO DE JANEIRO
PA AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36,
   BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD MAY
PY 2013
VL 18
IS 5
BP 1387
EP 1398
DI 10.1590/S1413-81232013000500024
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 158WL
UT WOS:000320004600024
PM 23670467
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Braga, JU
   da Conceicao, DA
   Trajman, A
AF Braga, Jose Ueleres
   da Conceicao, Deborah Araujo
   Trajman, Anete
TI Factors associated with the rapid implementation process of the
   fixed-dose combination RHZE tuberculosis regimen in brazil: an
   ecological study
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Tuberculosis; Drug combinations; Health plan implementation;
   Epidemiology; Public health
ID FAMILY HEALTH-PROGRAM; DOTS STRATEGY
AB Background: The Brazilian National Tuberculosis Control Program (NTCP) recommended the fixed-dose four-drug combination (FDC-RHZE) regimen to treat new tuberculosis cases in December 2009, expecting to increase adherence and avoid resistance. We evaluated factors associated with the speed of the new regimen implementation process in this continent-sized country.
   Methods: We conducted an ecological study based on the Brazilian Case Notification Database (SINAN) having the Brazilian municipalities as the analytical unit. Municipalities with at least one case reported from December 2009 to March 2011 were considered eligible. The association of rapid (<= 3 months) implementation of the new regimen with demographic, epidemiological and operational health service characteristics, such as compliance with NTCP recommendations (supervised treatment, bacteriological confirmation of the diagnosis and monthly bacteriological monitoring), was analyzed. We used the adjusted odds ratios (OR) and their 95% confidence interval (CI) to assess the association of independent variables with the outcome in a multiple logistic regression model.
   Results: Rapid implementation of the new regimen in municipalities was associated with small populations (OR=25.5, 95% CI= 19.1-34.1), low population density (OR=2.3, 95% CI= 1.9-2.9), low tuberculosis incidence rates (OR=8.8, 95% CI= 6.7-11.4) and good compliance with other NTCP recommendations.
   Conclusions: We showed that SINAN secondary data analysis is feasible and useful to learn lessons from. Municipalities with high tuberculosis burden and large populations need special attention for implementing new recommendations. This is particularly important considering the Global Alliance pipeline for new tuberculosis treatment regimens.
C1 [Braga, Jose Ueleres] Fiocruz MS, Natl Sch Publ Hlth, Helio Fraga Reference Ctr, BR-21045900 Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres; da Conceicao, Deborah Araujo] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil.
   [Trajman, Anete] Univ Gama Filho, Hlth Educ Postgrad Program, Rio De Janeiro, Brazil.
   [Trajman, Anete] McGill Univ, Montreal Chest Inst, Montreal, PQ, Canada.
RP Braga, JU (corresponding author), Fiocruz MS, Natl Sch Publ Hlth, Helio Fraga Reference Ctr, BR-21045900 Rio De Janeiro, Brazil.
EM ueleres@gmail.com
RI Trajman, Anete/C-7679-2016
OI Trajman, Anete/0000-0002-4000-4984
FU Ataulpho de Paiva Foundation [OPGH 5254]; Bill and Melinda Gates
   FoundationBill & Melinda Gates Foundation; CNPqNational Council for
   Scientific and Technological Development (CNPq)
FX Supported by the Ataulpho de Paiva Foundation, through a grant (OPGH
   5254) by the Bill and Melinda Gates Foundation. AT has a research grant
   by CNPq. We acknowledge Draurio Barreira, coordinator of the Brazilian
   NTP for allowing access to the tuberculosis database and Alexandre
   Menezes for his review comments. None of the mentioned funding agencies
   are responsible for the statements in this article.
CR Bezerra LCA, 2009, CAD SAUDE PUBLICA, V25, P827, DOI 10.1590/S0102-311X2009000400014
   Braga J, 2011, RELATORIO TECNICO ES
   Brasil. Ministerio da Saude, 2009, NOT TECN MUD TRAT TU
   BRASIL Saude Md, 2011, APR PNCT
   Cobelens F, 2012, J INFECT DIS, V205, pS191, DOI 10.1093/infdis/jis188
   Quinino LRD, 2009, EPIDEMIOL SERV SAUDE, V18, P335
   de Sa LD, 2011, CIENC SAUDE COLETIVA, V16, P3917, DOI 10.1590/S1413-81232011001000028
   Elmahalli A. A., 2007, Eastern Mediterranean Health Journal, V13, P1085
   Felisberto Eronildo, 2009, Rev. Bras. Saude Mater. Infant., V9, P339, DOI 10.1590/S1519-38292009000300013
   Felisberto Eronildo, 2002, Cad. Saúde Pública, V18, P1737, DOI 10.1590/S0102-311X2002000600028
   Furin J, 2011, INT J TUBERC LUNG D, V15, P1294, DOI 10.5588/ijtld.10.0591
   Gardner CA, 2005, CLIN CHEST MED, V26, P341, DOI 10.1016/j.ccm.2005.02.008
   Gazetta Cláudia Eli, 2007, J. bras. pneumol., V33, P192, DOI 10.1590/S1806-37132007000200014
   Gerald LB, 2003, INT J TUBERC LUNG D, V7, pS369
   Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10
   Henrique F, 2009, CIENC SAUDE COLETIVA, V14, P1359, DOI 10.1590/S1413-81232009000800008
   Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5
   Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2011, MAN REC CONTR TUB BR
   Nagahama EEI, 2009, BRASIL CAD SAUDE S2, V25, pS279
   Nogueira JA, 2006, B PNEUMOL SANIT, V14, P141
   StataCorp LP, 2007, STAT GRAPH REF MAN R
   World Health Organization, 2012, WHOHTMTB201116
NR 22
TC 0
Z9 0
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD APR 9
PY 2013
VL 13
AR 321
DI 10.1186/1471-2458-13-321
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 140CL
UT WOS:000318631800001
PM 23570579
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Araujo, SCF
   Caetano, R
   Braga, JU
   Silva, FVCE
AF Fonseca de Araujo, Silvia Cristina
   Caetano, Rosangela
   Braga, Jose Ueleres
   Costa e Silva, Frances Valeria
TI Efficacy of commercially available vaccines against HPV infection in
   women: a systematic review and meta-analysis
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Review
DE Papillomavirus Vaccines; Uterine Cervical Neoplasms; Efficacy; Health
   Technology Evaluation
ID HUMAN-PAPILLOMAVIRUS TYPE-16; SUSTAINED EFFICACY; PARTICLE VACCINE;
   CONTROLLED TRIAL; NATURAL-HISTORY; CERVICAL-CANCER; IMMUNOGENICITY;
   PREVENTION; DISEASES; IMPACT
AB Persistent HPV infection is a necessary condition for the occurrence of cervical cancer. Prophylactic HPV vaccines have been developed to reduce the incidence of cervical cancer. Two vaccines are commercially available: bivalent (types 16, 18) and quadrivalent (6, 11, 16 and 18). This study aimed to perform a systematic review and meta-analysis of the HPV vaccines' efficacy in women, focusing its performance stratified by clinical outcomes. Randomized controlled trials (RCT) published between 2000 and 2009 were identified from searches of MEDLINE, LILACS and Cochrane Library, and evaluated by two independent reviewers. Six RCT were selected. The vaccines reduced the risk of precursor lesions of cervical cancer, presenting efficacy of 97% (95% CI: 90-99) for CIN 2 and 96% (95% CI: 89-99) for CIN 3, in the per protocol analysis. The efficacies in the analysis by intention to treat were smaller: 63% (95% CI: 52-71) and 42% (95% CI: 26-55), respectively. In order to evaluate its effectiveness on the incidence and mortality rates for cervical cancer, longer-term studies will be needed.
C1 [Fonseca de Araujo, Silvia Cristina] Secretaria Municipal Saude & Def Civil Rio de Jan, BR-23046830 Rio De Janeiro, RJ, Brazil.
   [Caetano, Rosangela; Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Inst Social Med, BR-20550011 Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil.
   [Costa e Silva, Frances Valeria] Univ Estado Rio de Janeiro, Fac Enfermagem, BR-20550011 Rio De Janeiro, RJ, Brazil.
RP de Araujo, SCF (corresponding author), Secretaria Municipal Saude & Def Civil Rio de Jan, Estr Monteiro 323,Bloco 2,Apto 210, BR-23046830 Rio De Janeiro, RJ, Brazil.
EM silvia.araujo@smsdc.rio.rj.gov.br
CR Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012
   Angell M., 2007, VERDADE LAB FARMACEU
   BOSCH FX, 1995, J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796
   Caetano Rosângela, 2006, Physis, V16, P99, DOI 10.1590/S0103-73312006000100007
   Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779
   Ciapponi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025493
   Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026
   Coordenacao de Prevencao e Vigilancia Coordenacao Geral de Acoes Estrategicas Instituto Nacional de Cancer Jose Alencar Gomes da Silva, 2011, EST 2012 INC CANC BR
   Dillner J, 2010, BMJ-BRIT MED J, V341, pc3493
   Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516
   Garland SM, 2003, MED J AUSTRALIA, V178, P647, DOI 10.5694/j.1326-5377.2003.tb05396.x
   Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760
   Giuliano AR, 2007, J INFECT DIS, V196, P1153, DOI 10.1086/521679
   Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0
   HAYNES RB, 1994, J AM MED INFORM ASSN, V1, P447, DOI 10.1136/jamia.1994.95153434
   Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703
   Kang S, 2008, INT J GYNECOL CANCER, V18, P1013, DOI 10.1111/j.1525-1438.2007.01123.x
   Kjaer SK, 2009, CANCER PREV RES, V2, P868, DOI 10.1158/1940-6207.CAPR-09-0031
   Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586
   Kulasingam Shalini L, 2008, Cost Eff Resour Alloc, V6, P4, DOI 10.1186/1478-7547-6-4
   La Torre G, 2007, VACCINE, V25, P8352, DOI 10.1016/j.vaccine.2007.09.027
   Lu BB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-13
   McCormack PL, 2010, DRUGS, V70, P2449, DOI 10.2165/11204920-000000000-00000
   Medeiros LR, 2009, INT J GYNECOL CANCER, V19, P1166, DOI 10.1111/IGC.0b013e3181a3d100
   Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641
   Munoz N, 2008, VACCINE, V26, pL96, DOI 10.1016/j.vaccine.2008.05.062
   Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534
   Munoz N, 2009, LANCET, V373, P1949, DOI 10.1016/S0140-6736(09)60691-7
   OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186
   Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   Rambout L, 2007, CAN MED ASSOC J, V177, P469, DOI 10.1503/cmaj.070948
   Rey-Ares L, 2012, ARCH ARGENT PEDIATR, V110, P483, DOI [10.5546/aap.2012.483, 10.1590/S0325-00752012000600005]
   Sawaya GF, 2007, NEW ENGL J MED, V356, P1991, DOI 10.1056/NEJMe078060
   Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1383, DOI 10.1067/mob.2003.457
   Stamatakis E, 2013, EUR J CLIN INVEST, V43, P469, DOI 10.1111/eci.12074
   Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469
   Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741
   Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F
   WHO/ICO Information Centre on HPV and Cervical Cancer, 2007, Vaccine, V25 Suppl 3, pC1
   Winer RL, 2005, J INFECT DIS, V191, P1787, DOI 10.1086/430275
   Wright TC, 2002, JAMA-J AM MED ASSOC, V287, P2120, DOI 10.1001/jama.287.16.2120
NR 42
TC 1
Z9 2
U1 0
U2 6
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2013
VL 29
SU S
BP S32
EP S44
DI 10.1590/0102-311X00163512
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 268YZ
UT WOS:000328208100004
PM 25402248
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Costa, FF
   Gondim, APS
   de Lima, MB
   Braga, JU
   Vieira, LJED
   Araujo, MAL
AF Costa, Fabianne Ferreira
   Soares Gondim, Ana Paula
   de Lima, Mary Braga
   Braga, Jose Ueleres
   Eyre de Souza Vieira, Luiza Jane
   Leite Araujo, Maria Alix
TI Preventive behavior for toxoplasmosis in pregnant adolescents in the
   state of Ceara, Brazil
SO BMC PUBLIC HEALTH
LA English
DT Article
ID GONDII INFECTION; CONGENITAL TOXOPLASMOSIS; NORTHEASTERN BRAZIL;
   RISK-FACTORS; WOMEN; PREVALENCE; SEROEPIDEMIOLOGY; ANTIBODIES;
   DIAGNOSIS; PARANA
AB Background: When toxoplasmosis is acquired during pregnancy, it can be transmitted to the fetus causing severe lesions in the first two gestational trimesters. This study analyzed the main factors associated with the preventive behavior for toxoplasmosis among pregnant adolescents in the city of Fortaleza in northeast Brazil.
   Methods: It is a cross-sectional study conducted from March 2009 to November 2010, with a sample of 320 pregnant adolescents, ages ranging from 12 to 19 years old, receiving prenatal care in the Public Health Care System. Bivariate and multivariate logistic regression model analyses were used to identify the association between preventive behavior for toxoplasmosis, and the independent variables and 95% confidence interval.
   Results: We observed that 16.3% of the pregnant adolescents showed preventive behavior for toxoplasmosis. The factors positively associated to the preventive behavior for toxoplasmosis were: age group between 12 and 14 years old (OR = 2.75; 95% CI 1.23-6.12) and more than two prenatal consultations (OR = 2.19; 95% CI 1.17-4.09).
   Conclusions: Noteworthy is the importance of a serologic follow-up for pregnant adolescents with clearer and more precise information about risk factors and the importance of adopting preventive behaviors. Thus, it is necessary to establish educational measures for handling food and raising kittens during prenatal care.
C1 [Costa, Fabianne Ferreira; Soares Gondim, Ana Paula; de Lima, Mary Braga; Eyre de Souza Vieira, Luiza Jane; Leite Araujo, Maria Alix] Univ Fortaleza, BR-60811905 Fortaleza, Ceara, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio De Janeiro, Dept Internal Med, BR-20551030 Rio De Janeiro, RJ, Brazil.
RP Costa, FF (corresponding author), Univ Fortaleza, Av Washington Soares 1321, BR-60811905 Fortaleza, Ceara, Brazil.
EM fabianneicapui@bol.com.br
FU National Counsel of Technological and Scientific Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX The source of funding for the study was the National Counsel of
   Technological and Scientific Development (CNPq).
CR Acosta-Bas C., 2001, REV BIOMEDICA MEXICO, V12, P250
   Alvarado-Esquivel C, 2009, J PARASITOL, V95, P271, DOI 10.1645/GE-1829.1
   [Anonymous], 2009, STRAT HLTH FAM
   Barbosa IR, 2009, T ROY SOC TROP MED H, V103, P377, DOI 10.1016/j.trstmh.2008.11.025
   Belarmino GO, 2009, ACTA PAUL ENFERM, V22, P169, DOI 10.1590/S0103-21002009000200009
   Brazil. Minister of Health, 2004, BAS TEXTS HLTH B, P332
   Brazil. Minister of Health, 2005, SEX REPR RIGHT NOT, V5, P163
   Brazilian Institute of Geography and Statistics, 2010, SYNTH SOC IND AN CON
   CADEMARTORI BG, 2008, REV PANAMERICANA INF, V10, P30
   Canales M, 2010, REV CHIL INFECTOL, V27, P499, DOI [10.4067/S0716-10182010000700002, /S0716-10182010000700002]
   Carniel Emília de Faria, 2006, Rev. Bras. Saude Mater. Infant., V6, P419, DOI 10.1590/S1519-38292006000400009
   Carral L, 2008, MEDICINA-BUENOS AIRE, V68, P417
   Castilho-Pelloso MP, 2007, REV SAUDE PUBL, V41, P27, DOI 10.1590/S0034-89102007000100005
   Costa TL, 2008, REV PATOL TROP, V37, P191
   Coutinho SG, 2005, COURA JR DINAMICA DO, P815
   Diaz-Suarez O, 2003, REV MED CHILE, V131, P1003, DOI 10.4067/S0034-98872003000900006
   Durlach R, 2008, MEDICINA-BUENOS AIRE, V68, P75
   Fallah M., 2008, Eastern Mediterranean Health Journal, V14, P163
   Ferguson W, 2008, Ir Med J, V101, P220
   Garry David J, 2005, Infect Dis Obstet Gynecol, V13, P151, DOI 10.1080/10647440500148024
   Gilot-Fromont E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-76
   Heukelbach J, 2007, EMERG INFECT DIS, V13, P287, DOI 10.3201/eid1302.060686
   Hung CC, 2007, T ROY SOC TROP MED H, V101, P134, DOI 10.1016/j.trstmh.2006.04.012
   Isabel TF, 2007, SCI MED, V17, P57
   Issa D, 2006, COL MED ESTADO TACHI, V15, P20
   Jones Jeffrey L, 2003, Infect Dis Obstet Gynecol, V11, P139, DOI 10.1080/10647440300025512
   Jones JL, 2009, CLIN INFECT DIS, V49, P878, DOI 10.1086/605433
   Liesenfeld O, 2005, TRATADO MED INTERNA, P2441
   Liu Q, 2009, T ROY SOC TROP MED H, V103, P162, DOI 10.1016/j.trstmh.2008.07.008
   Lopes FMR, 2009, MEM I OSWALDO CRUZ, V104, P378, DOI 10.1590/S0074-02762009000200036
   Lopez Adriana, 2000, Morbidity and Mortality Weekly Report, V49, P59
   López-Castillo Christian A., 2005, Rev. salud pública, V7, P180
   Carellos EV, 2008, CAD SAUDE PUBLICA, V24, P391, DOI 10.1590/S0102-311X2008000200018
   Maggi P, 2009, NEW MICROBIOL, V32, P89
   Mioranza SD, 2008, REV SOC BRAS MED TRO, V41, P628, DOI 10.1590/S0037-86822008000600014
   Ocampo Lina M, 2010, Rev. salud pública, V12, P317
   Ogunmodede Folashade, 2005, Minn Med, V88, P32
   Pan American Health Organization World Health Organization, 2008, ED MAT HLTH PERS, P44
   Peyron F, 2009, MEM I OSWALDO CRUZ, V104, P316, DOI 10.1590/S0074-02762009000200028
   Prusa AR, 2010, DIAGN MICR INFEC DIS, V68, P352, DOI 10.1016/j.diagmicrobio.2010.07.011
   Amorim MMR, 2009, REV BRAS GINECOL OBS, V31, P148, DOI 10.1590/S0100-72032009000300008
   Rasmussen SA, 2005, AM J PUBLIC HEALTH, V95, P3
   Sensini A, 2006, CLIN MICROBIOL INFEC, V12, P504, DOI 10.1111/j.1469-0691.2006.01444.x
   Sroka S, 2010, AM J TROP MED HYG, V83, P528, DOI 10.4269/ajtmh.2010.10-0082
   Stagni L, 2009, MEM I OSWALDO CRUZ, V104, P374, DOI 10.1590/S0074-02762009000200035
   Suzuki LA, 2001, J MED MICROBIOL, V50, P62, DOI 10.1099/0022-1317-50-1-62
   Varella IS, 2009, MEM I OSWALDO CRUZ, V104, P383, DOI 10.1590/S0074-02762009000200037
NR 47
TC 9
Z9 10
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JAN 24
PY 2012
VL 12
AR 73
DI 10.1186/1471-2458-12-73
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 908XK
UT WOS:000301526200002
PM 22272659
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Santos, MD
   Tura, BR
   Rouge, A
   Braga, JU
AF Santos, Marisa da Silva
   Tura, Bernardo Rangel
   Rouge, Alexandre
   Braga, Jose Ueleres
TI External Validation of Models for Predicting Pneumonia after Cardiac
   Surgery
SO SURGICAL INFECTIONS
LA English
DT Article
ID VENTILATOR-ASSOCIATED PNEUMONIA; LOGISTIC-REGRESSION MODELS; SURGICAL
   SITE INFECTION; NOSOCOMIAL INFECTIONS; SAMPLE-SIZES; RISK-FACTORS;
   IMPACT; RULES; BENCHMARKING; OUTCOMES
AB Background: Approximately 20% of patients become infected after cardiac surgery. Pneumonia is one of the most serious infections, increasing the chance of death 14-fold. The higher frequency of pneumonia after cardiac surgery may be explained by surgical conditions. Focusing on high-risk groups may make several strategies more effective, and external validation is an essential phase of building prediction models to identify such groups.
   Purpose: To compare the performance of two previously validated prediction models for pneumonia after cardiac surgery (classification and regression tree [CART] and a logistic regression model [LRM]) on an external validation set.
   Methods: A series of 527 adult cardiac surgery patients at a small private hospital were analyzed prospectively to identify prognostic factors for pneumonia. Pneumonia occurred in 7.6% of patients in this derivation set. The probability of pneumonia onset was estimated by means of CART and LRM using a cut-off point that maximized both sensitivity and specificity without decreasing accuracy greatly. The results were confirmed with a validation set obtained by enrollment of consecutive 333 adult patients undergoing major cardiac surgery. There were significant differences in the fraction of emergency cases in the derivation and validation sets.
   Results: The LRM selected emergency surgery (odds ratio [OR] 5.28), chronic obstructive pulmonary disease (COPD)(OR 4.29), ventricular dysfunction (OR 2.68), and age (OR 1.04) as independent predictors of pneumonia. The CART model selected emergency surgery, age, unstable angina, body mass index, COPD, weight, and ventricular dysfunction as predictors. The CART model also selected low body mass index, weight, and unstable angina as predictors. Emergency surgery was the strongest predictor in both models. The LRM performed better than the CART model for the global, discrimination, and calibration measures.
   Conclusion: The LRM model displayed superior performance. A possible advantage of the CART prediction model is that it may be easier to interpret via its graphical presentation than prediction models based on logistic regression. However, there are a number of disadvantages of the CART approach. The LRM model can be used by infection control practitioners for risk adjustment across different periods or units and for evaluation of the efficacy of new technologies.
C1 [Santos, Marisa da Silva; Tura, Bernardo Rangel; Rouge, Alexandre] Inst Nacl Cardiol, Rio De Janeiro, Brazil.
   [Santos, Marisa da Silva; Braga, Jose Ueleres] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil.
RP Santos, MD (corresponding author), R Pompeu Loureiro 44-501 Copacabana, BR-2206100 Rio De Janeiro, Brazil.
EM marisaccih@gmail.com
RI da Silva Santos, Marisa/ABA-3418-2020
OI da Silva Santos, Marisa/0000-0002-2174-6800
CR Arozullah AM, 2001, ANN INTERN MED, V135, P847, DOI 10.7326/0003-4819-135-10-200111200-00005
   Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5
   Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529
   De Oliveira AC, 2006, AM J INFECT CONTROL, V34, P201, DOI 10.1016/j.ajic.2005.12.011
   Escolano S, 2000, STAT MED, V19, P3465, DOI 10.1002/1097-0258(20001230)19:24&lt;3465::AID-SIM658&gt;3.0.CO;2-6
   Fowler VG, 2005, CIRCULATION, V112, pI358, DOI 10.1161/CIRCULATIONAHA.104.525790
   Friedman ND, 2007, INFECT CONT HOSP EP, V28, P812, DOI 10.1086/518455
   HARRELL FE, 1985, CANCER TREAT REP, V69, P1071
   HORAN TC, 1993, INFECT CONT HOSP EP, V14, P73, DOI 10.2307/30147164
   Hortal J, 2009, INTENS CARE MED, V35, P1518, DOI 10.1007/s00134-009-1523-3
   HOSMER DW, 1991, AM J PUBLIC HEALTH, V81, P1630, DOI 10.2105/AJPH.81.12.1630
   Janssen KJM, 2008, J CLIN EPIDEMIOL, V61, P76, DOI 10.1016/j.jclinepi.2007.04.018
   Klompas M, 2007, ANN INTERN MED, V147, P803, DOI 10.7326/0003-4819-147-11-200712040-00013
   Kollef MH, 1997, CHEST, V112, P666, DOI 10.1378/chest.112.3.666
   Moros CL, 2007, MED CLIN-BARCELONA, V128, P761
   LEWIS R, 2000, ACAD EMERG MED, V7, P419
   McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79
   Morise AP, 1996, MED DECIS MAKING, V16, P133, DOI 10.1177/0272989X9601600205
   Peek N, 2007, J CLIN EPIDEMIOL, V60, P491, DOI 10.1016/j.jclinepi.2006.08.011
   Rebollo MH, 1996, J THORAC CARDIOV SUR, V112, P908, DOI 10.1016/S0022-5223(96)70090-9
   Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009
   Santos M, 2007, INFECT CONT HOSP EP, V28, P382, DOI 10.1086/513119
   Shorr AF, 2008, ARCH INTERN MED, V168, P2205, DOI 10.1001/archinte.168.20.2205
   Staat P, 1999, EUR HEART J, V20, P960, DOI 10.1053/euhj.1998.1333
   Steyerberg E.W., 2009, CLIN PREDICTION MODE
   Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008
   Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017
   Wolfe R, 2006, J CLIN EPIDEMIOL, V59, P26, DOI 10.1016/j.jclinepi.2005.05.007
   Zahar JR, 2009, CRIT CARE MED, V37, P2545, DOI 10.1097/CCM.0b013e3181a38109
NR 29
TC 1
Z9 1
U1 0
U2 1
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-2964
J9 SURG INFECT
JI Surg. Infect.
PD OCT
PY 2011
VL 12
IS 5
BP 365
EP 372
DI 10.1089/sur.2010.014
PG 8
WC Infectious Diseases; Surgery
SC Infectious Diseases; Surgery
GA 846MB
UT WOS:000296905900007
PM 21943302
DA 2020-12-01
ER

PT J
AU Moraes, CL
   da Silva, TDT
   Reichenheim, ME
   Azevedo, GL
   Oliveira, ASD
   Braga, JU
AF Moraes, Claudia L.
   Tavares da Silva, Tatiana de S.
   Reichenheim, Michael E.
   Azevedo, Gustavo L.
   Dias Oliveira, Alessandra S.
   Braga, Jose U.
TI Physical violence between intimate partners during pregnancy and
   postpartum: a prediction model for use in primary health care facilities
SO PAEDIATRIC AND PERINATAL EPIDEMIOLOGY
LA English
DT Article
DE domestic violence; maternal age; maternal education; smoking; alcohol
   abuse; drug abuse
ID CONFLICT-TACTICS-SCALES; DOMESTIC VIOLENCE; CAGE QUESTIONNAIRE; ACUTE
   MALNUTRITION; WOMENS HEALTH; PUBLIC-HEALTH; PREVALENCE; VALIDATION;
   ALCOHOLISM; MULTICOUNTRY
AB This article offers a simple predictive model of physical intimate partner violence (PIPV) to be used by primary health care (PHC) professionals. The sample comprised 811 mothers of children <5 months old attending PHC facilities in Rio de Janeiro, Brazil. A multinomial logit model was used. Measured by the Revised Conflict Tactics Scales, PIPV was classified in three levels (absence, at least one episode during pregnancy or postpartum, and presence in both periods). Socio-economic, demographic and life style variables were considered as potential predictors. Maternal age <20 years, an education of <8 years of schooling, raising >2 children under 5, tobacco smoking, alcohol misuse and illicit drug use by the mother and/or partner, and perception of baby's ill-health were identified as predictors of PIPV. The model-projected prevalence of PIPV for pregnancy and/or postpartum was just 10.1% in the absence of these characteristics, whereas this increased to 96.4% when all the seven characteristics were present. Child, maternal and family characteristics greatly increase the likelihood of PIPV and could be used together as screening indicators.
C1 [Moraes, Claudia L.; Tavares da Silva, Tatiana de S.; Reichenheim, Michael E.; Azevedo, Gustavo L.; Dias Oliveira, Alessandra S.; Braga, Jose U.] Rio de Janeiro State Univ UERJ, Inst Social Med IMS, Dept Epidemiol, Rio De Janeiro, Brazil.
   [Moraes, Claudia L.] Estacio Sa Univ UNESA, Sch Med, Rio De Janeiro, Brazil.
   [Azevedo, Gustavo L.] Fiocruz MS, Oswaldo Cruz Fdn, Fernandes Figueira Inst, BR-21045900 Rio De Janeiro, Brazil.
   [Braga, Jose U.] Natl Hlth Fdn, Prof Helio Fraga Reference Ctr, Rio De Janeiro, Brazil.
RP Moraes, CL (corresponding author), Rua Sao Francisco Xavier 524,7 Andar, BR-20559900 Rio De Janeiro, Brazil.
EM clmoraes@ims.uerj.br
RI Moraes, claudia/AAK-9418-2020
OI Moraes, claudia/0000-0002-3223-1634; OLIVEIRA,
   ALESSANDRA/0000-0002-3232-5868
CR ABEP, 2003, BRAZ CRIT EC CLASS
   Castro Inês Rugani Ribeiro de, 2009, Rev. Saúde Pública, V43, P1021, DOI 10.1590/S0034-89102009005000079
   Chambliss LR, 2008, CLIN OBSTET GYNECOL, V51, P385, DOI 10.1097/GRF.0b013e31816f29ce
   Coker AL, 2004, PAEDIATR PERINAT EP, V18, P260, DOI 10.1111/j.1365-3016.2004.00569.x
   De Bruin A, 1996, WHO REG PUBL EUR SER, V58, P1
   Durand Julia Garcia, 2007, Rev. bras. epidemiol., V10, P310, DOI 10.1590/S1415-790X2007000300003
   Efron B., 1993, INTRO BOOTSTRAP
   Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X
   Erickson MJ, 2001, PEDIATRICS, V108, P98, DOI 10.1542/peds.108.1.98
   EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905
   Garcia-Moreno C, 2005, SCIENCE, V310, P1282, DOI 10.1126/science.1121400
   Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8
   Harrykissoon SD, 2002, ARCH PEDIAT ADOL MED, V156, P325, DOI 10.1001/archpedi.156.4.325
   Hartley Carolyn Copps, 2002, Child Maltreat, V7, P349, DOI 10.1177/107755902237264
   Hasselmann MH, 2006, PAEDIATR PERINAT EP, V20, P299, DOI 10.1111/j.1365-3016.2006.00735.x
   Hasselmann MH, 1998, REV SAUDE PUBL, V32, P437, DOI 10.1590/S0034-89101998000500006
   Hedin LW, 2000, ACTA OBSTET GYN SCAN, V79, P625, DOI 10.1034/j.1600-0412.2000.079008625.x
   Jasinski Jana L, 2004, Trauma Violence Abuse, V5, P47, DOI 10.1177/1524838003259322
   Kendall-Tackett KA, 2007, TRAUMA VIOLENCE ABUS, V8, P344, DOI 10.1177/1524838007304406
   Krug EG, 2002, WORLD REPORT VIOLENC
   Lau Ying, 2007, J Midwifery Womens Health, V52, pe15, DOI 10.1016/j.jmwh.2006.09.001
   LONG SJ, 2003, REGRESSION MODELS CA
   Martin SL, 2001, JAMA-J AM MED ASSOC, V285, P1581, DOI 10.1001/jama.285.12.1581
   MASUR J, 1983, BRAZ J MED BIOL RES, V16, P215
   MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121
   Menezes Telma Cursino, 2003, Rev. Bras. Ginecol. Obstet., V25, P309, DOI 10.1590/S0100-72032003000500002
   Moraes CL, 2002, INT J GYNECOL OBSTET, V79, P269, DOI 10.1016/S0020-7292(02)00250-3
   Moraes CL, 2005, J STUD ALCOHOL, V66, P165, DOI 10.15288/jsa.2005.66.165
   Moraes Claudia Leite, 2002, Cad. Saúde Pública, V18, P163, DOI 10.1590/S0102-311X2002000100017
   Moraes Claudia Leite, 2002, Cad. Saúde Pública, V18, P783, DOI 10.1590/S0102-311X2002000300022
   Moura Anna Tereza M Soares de, 2005, Cad Saude Publica, V21, P1124
   O'Donnell L, 2009, AM J PUBLIC HEALTH, V99, P2255, DOI 10.2105/AJPH.2008.156513
   O'Reilly R, 2007, CONTEMP NURSE, V25, P13, DOI 10.5172/conu.2007.25.1-2.13
   Reichenheim ME, 2006, CAD SAUDE PUBLICA, V22, P109
   Reichenheim ME, 2007, CAD SAUDE PUBLICA, V23, P53, DOI 10.1590/S0102-311X2007000100007
   Reichenheim ME, 2008, PUBLIC HEALTH, V122, P716, DOI 10.1016/j.puhe.2007.09.016
   RUSSELL M, 1994, ALCOHOL CLIN EXP RES, V18, P1156, DOI 10.1111/j.1530-0277.1994.tb00097.x
   Rutherford A, 2007, J EPIDEMIOL COMMUN H, V61, P764, DOI 10.1136/jech.2006.049072
   SaurelCubizolles MJ, 1997, CONTRACEPT FERTIL S, V25, P159
   Schraiber LB, 2007, REV SAUDE PUBL, V41, P797, DOI 10.1590/S0034-89102007000500014
   Sharps PW, 2007, TRAUMA VIOLENCE ABUS, V8, P105, DOI 10.1177/1524838007302594
   Shoffner DH, 2008, J PERINAT NEONAT NUR, V22, P39, DOI 10.1097/01.JPN.0000311874.30828.4e
   Silverman JG, 2007, BJOG-INT J OBSTET GY, V114, P1246, DOI 10.1111/j.1471-0528.2007.01481.x
   Silverman JG, 2010, AM J PUBLIC HEALTH, V100, P1415, DOI 10.2105/AJPH.2009.173393
   Smart R. G., 1981, DRUGS USE NONSTUDENT
   StataCorp, 2007, STAT STAT SOFTW REL
   Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9
   Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001
   Yalcin SS, 2010, PAEDIATR PERINAT EP, V24, P584, DOI 10.1111/j.1365-3016.2010.01150.x
   Zolotor AJ, 2009, PRIMARY CARE, V36, P167, DOI 10.1016/j.pop.2008.10.010
NR 50
TC 9
Z9 10
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-5022
EI 1365-3016
J9 PAEDIATR PERINAT EP
JI Paediatr. Perinat. Epidemiol.
PD SEP
PY 2011
VL 25
IS 5
BP 478
EP 486
DI 10.1111/j.1365-3016.2011.01208.x
PG 9
WC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
SC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
GA 804MV
UT WOS:000293658800008
PM 21819429
DA 2020-12-01
ER

PT J
AU Goncalves, AC
   Costa, MDN
   Braga, JU
AF Goncalves, Annelise C.
   Nascimento Costa, Maria da Conceicao
   Braga, Jose Ueleres
TI Spatial analysis of neonatal mortality and associated factors in
   Salvador, Bahia State, Brazil, 2000-2006
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Spatial Analysis; Neonatal Mortality (Public Health); Risk Zone; Risk
   Factors
ID LOW-BIRTH-WEIGHT; INFANT-MORTALITY; RATES; DIFFERENTIALS; COUNTRIES;
   INCOME; CITY
AB An ecological study was performed to identify patterns in the spatial distribution of neonatal mortality and risk areas as well as associated factors in Salvador, Bahia State, Brazil, 2000-2006. A thematic map was constructed, and techniques were used for formal assessment of spatial dependence. No spatial and spatial regression models were used to assess possible relationships between selected factors and spatial distribution of neonatal mortality. Spatial autocorrelation was observed in neonatal mortality (I = 0.17; p = 0.0100), so its distribution was non-random. The analysis showed a spatial pattern in which the highest risk (> 9.0/1,000 live births) was concentrated in the downtown areas and peripheral neighborhoods with the highest concentration of low-income families, and this was associated with the target risk factors. The proportion of low birth weight newborns was the only variable that was significantly associated with neonatal mortality. Living conditions may have contributed to the uneven spatial distribution of neonatal mortality in this city.
C1 [Nascimento Costa, Maria da Conceicao] Univ Fed Bahia, Inst Saude Colet, BR-40110040 Salvador, BA, Brazil.
   [Goncalves, Annelise C.] Univ Fed Rio Grande do Sul, Escola Enfermagem, Porto Alegre, RS, Brazil.
   [Braga, Jose Ueleres] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Ctr Biomed, BR-20550011 Rio De Janeiro, Brazil.
RP Costa, MDN (corresponding author), Univ Fed Bahia, Inst Saude Colet, Rua Basilio da Gama S-N, BR-40110040 Salvador, BA, Brazil.
EM mcncosta@ufba.br
CR Althabe F, 2006, BIRTH-ISS PERINAT C, V33, P270, DOI 10.1111/j.1523-536X.2006.00118.x
   Alvarez G, 2009, REV PANAM SALUD PUBL, V26, P31, DOI 10.1590/S1020-49892009000700005
   ANDRADE Adriano B, 2006, GEOGRAFIA SALVADOR
   Andrade C L, 2001, Cad Saude Publica, V17, P1199
   ANDRADE CL, 2004, CAD SAUDE PUBLICA S1, pS44
   Andrade Selma Maffei de, 2006, Cad. Saúde Pública, V22, P181, DOI 10.1590/S0102-311X2006000100019
   Barros FC, 2008, CAD SAUDE PUBLICA, V24, pS390, DOI 10.1590/S0102-311X2008001500004
   Bezerra JG, 2007, CAD SAUDE PUBLICA, V23, P1173, DOI 10.1590/S0102-311X2007000500019
   Campos Deise, 2007, Rev. bras. epidemiol., V10, P223, DOI 10.1590/S1415-790X2007000200010
   Carvalho I.M.M., 2006, COMO ANDA SALVADOR S
   Cliff A. D., 1981, SPATIAL PROCESS MODE
   Costa  M C, 2001, Cad Saude Publica, V17, P555
   COSTA MCN, 1999, CAD SAUDE PUBLICA, V15, P271
   Costa MCN, 2003, REV CIENCIAS MED BIO, V2, P30
   CRESSIE N, 1989, BIOMETRICAL J, V31, P699, DOI 10.1002/bimj.4710310607
   d'Orsi, 1998, Cad Saude Publica, V14, P367, DOI 10.1590/S0102-311X1998000200021
   d'Orsi Eleonora, 2005, Cad. Saúde Pública, V21, P786, DOI 10.1590/S0102-311X2005000300012
   Fundo das Nacoes Unidas para a Infancia, 2007, SIT MUND INF 2008 SO
   Grady SC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-10
   Gurgel Ricardo Queiroz, 2005, Cad. Saúde Pública, V21, P1329, DOI 10.1590/S0102-311X2005000500004
   Leal MD, 1997, REV SAUDE PUBL, V31, P457
   Loyola Enrique, 2002, Rev Panam Salud Publica, V12, P415, DOI 10.1590/S1020-49892002001200007
   Luo ZC, 2004, EPIDEMIOLOGY, V15, P679, DOI 10.1097/01.ede.0000142149.34095.88
   Martins Eunice Francisca, 2004, Rev. Bras. Saude Mater. Infant., V4, P405, DOI 10.1590/S1519-38292004000400010
   Ministerio da Saude (MS), 2006, PREN PUERP AT QUAL H
   Minuci EG, 2009, REV SAUDE PUBL, V43, P256, DOI 10.1590/s0034-89102009005000011
   Nascimento LFC, 2007, REV SAUDE PUBL, V41, P94, DOI [10.1590/S0034-89102007000100013, 10.1590/s0034-89102007000100013]
   Neto O L, 2001, Cad Saude Publica, V17, P1241
   *ORG PAN AM SAUD, 2009, RED INT INF SAUD INF
   Organizacao das Nacoes Unidas, 1990, DECL MUND SOBR PROT
   Paim J S, 1987, Bull Pan Am Health Organ, V21, P225
   Paulucci Ruth Sampaio, 2007, Rev. paul. pediatr., V25, P358, DOI 10.1590/S0103-05822007000400011
   Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6
   SANTOS M., 1992, ESPACO METODO
   *SECR MUN SAUD SAL, 2007, DAD SIM SINASC CD RO
   Shimakura S E, 2001, Cad Saude Publica, V17, P1251, DOI 10.1590/S0102-311X2001000500025
   Silva AAM, 2005, PAEDIATR PERINAT EP, V19, P43, DOI 10.1111/j.1365-3016.2004.00624.x
   *WHO, 2007, NEON PER EST COUNTR
NR 38
TC 9
Z9 12
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD AUG
PY 2011
VL 27
IS 8
BP 1581
EP 1592
DI 10.1590/S0102-311X2011000800013
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 814HK
UT WOS:000294439000013
PM 21877006
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Braga, JU
   Herrero, MB
   de Cuellar, CM
AF Braga, Jose Ueleres
   Belen Herrero, Maria
   Martinez de Cuellar, Celia
TI Tuberculosis transmission in the triple border region: Brazil, Paraguay,
   and Argentina
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Tuberculosis; Sanitary Control of Borders; Border Areas
ID POPULATION MOBILITY; MEXICO; HEALTH; DISEASE
AB Tuberculosis is a public health problem in South America, but numerous control strategies have proven ineffective in settings with intense transmission. This study aimed to determine whether the triple border region between Brazil, Argentina, and Paraguay is an area of high tuberculosis transmission. An ecological study was conducted with incidence data and population estimates for the three countries. Mean incidence rates were calculated for 2001 to 2007. Spatial analysis techniques identified high-incidence areas in the region using maps with Bayesian smoothing of rates and spatial averages. During the target period, Foz do Iguacu, Brazil, had the highest incidence, followed by Ciudad del Este in Paraguay, and Puerto Iguazu in Argentina. The analysis showed a spatial cluster of municipalities with high tuberculosis risk in the triple border region. Tuberculosis in the tri-border area shows increasing or stable incidence rates and municipalities with incidence rates above the State average. The area has high tuberculosis incidence and therefore heavy transmission of the disease.
C1 [Braga, Jose Ueleres] Fundacao Oswaldo Cruz, Ctr Referencia Prof Helio Fraga, Escola Nacl Saude Publ Sergio Arouca, BR-22245070 Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Ctr Biomed, BR-20550011 Rio De Janeiro, Brazil.
   [Belen Herrero, Maria] Ctr Estudios Estado & Soc, Area Salud Econ & Soc, Buenos Aires, DF, Argentina.
   [Martinez de Cuellar, Celia] Minist Salud Publ, Programa Nacl Control TB, Asuncion, Paraguay.
RP Braga, JU (corresponding author), Fundacao Oswaldo Cruz, Ctr Referencia Prof Helio Fraga, Escola Nacl Saude Publ Sergio Arouca, Rua Belisario Tavora 653,Apto 202, BR-22245070 Rio De Janeiro, Brazil.
EM ueleres@gmail.com
RI Mitchell, Ellen/H-5475-2013
CR Anselin L., 2003, GEODA 0 9 USERS GUID
   Bailey T.C., 1995, INTERACTIVE SPATIAL
   Burman WJ, 2001, INT J TUBERC LUNG D, V5, P299
   Deiss R, 2009, AM J PUBLIC HEALTH, V99, P1491, DOI 10.2105/AJPH.2008.142166
   *DEP DES TUR DIV P, 2009, INV OF TUR FOZ DO IG
   FARMER P, 2002, PAPELES POBLAC, P181
   Giovanella L, 2007, CAD SAUDE PUBLICA, V23, pS251, DOI 10.1590/S0102-311X2007001400014
   Gushulak BD, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-3
   Human D, 2001, BMJ-BRIT MED J, V323, P283
   Kamel WW, 1997, WORLD HEALTH FORUM, V18, P9
   MacPherson DW, 2006, PUBLIC HEALTH, V120, P712, DOI 10.1016/j.puhe.2006.05.002
   MARSHALL RJ, 1991, J R STAT SOC C-APPL, V40, P283
   PEITER PC, 2005, THESIS U FEDERAL RIO
   PORTER J, 2005, T R SOC TROP MED HYG, V89, P241
   RODRIGUEZ A, 2007, THESIS U SAO PAULO R
   ROSEIRA AM, 2006, THESIS U SAO PAULO S
   Salaniponi FM, 2004, T ROY SOC TROP MED H, V98, P251, DOI 10.1016/S0035-9203(03)00066-X
   Sanchez-Perez HJ, 1998, INT J TUBERC LUNG D, V2, P37
   Schneider E, 2004, REV PANAM SALUD PUBL, V16, P23, DOI 10.1590/S1020-49892004000700004
   Taylor JP, 2000, AM J PUBLIC HEALTH, V90, P271, DOI 10.2105/AJPH.90.2.271
   [Anonymous], 2001, MMWR Recomm Rep, V50, P1
   *US MEX BORD HLTH, 2002, 2001 ANN REP US MEX
   Weis SE, 2002, INFECT DIS CLIN N AM, V16, P59, DOI 10.1016/S0891-5520(03)00046-1
   10 TUBERCULOSIS
NR 24
TC 15
Z9 17
U1 0
U2 5
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD JUL
PY 2011
VL 27
IS 7
BP 1271
EP 1280
DI 10.1590/S0102-311X2011000700003
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 801LZ
UT WOS:000293441700003
PM 21808812
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Selig, L
   Kritski, AL
   Cascao, AM
   Braga, JU
   Trajman, A
   de Carvalho, RMG
AF Selig, Lia
   Kritski, Afranio Lineu
   Cascao, Angela Maria
   Braga, Jose Ueleres
   Trajman, Anete
   Guedes de Carvalho, Regina Maria
TI Proposal for tuberculosis death surveillance in information systems
SO REVISTA DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Tuberculosis, mortality; Disease Notification; Hospital Mortality;
   Mortality Registries; Information Systems; Epidemiologic Surveillance
AB OBJECTIVE: To propose a tuberculosis-related death surveillance strategy based on the Brazilian Mortality Information System.
   METHODS: Data on 55 tuberculosis-related deaths, which occurred in two large hospitals in Rio de Janeiro, Southeastern Brazil, between September 2005 and August 2006, were obtained from the SIM. These cases were searched and compared with cases in the National Notification System (Sinan). The increment in the number of notifications and completeness of data were evaluated, as well as entry type and outcome in Sinan.
   RESULTS: Of the 55 deaths, 28 were registered in Sinan. Comparison between systems allowed for the following corrections: 27 new cases were notified, 14 new notifications performed by the hospitals where death occurred and ten outcomes corrected. This represented an increment of 41/144 (28%) notifications by these two hospitals in 2006. Nine cases, previously classified as unconfirmed tuberculosis were reclassified as bacteriologically confirmed, and another five cases were reclassified from tuberculosis to AIDS as the primary cause of death.
   CONCLUSIONS: The proposed surveillance system for tuberculosis-related death was useful to increase data completeness, decrease under-notification and cases with unknown outcome, to evaluate epidemiological surveillance and death certificate quality and to trace previously unidentified contacts.
C1 [Selig, Lia] Secretaria Estado Saude & Defesa Civil Rio Janeri, Rio De Janeiro, RJ, Brazil.
   [Selig, Lia] Fdn Educ Serra Orgaos, Curso Grad & Med, Ctr Univ Serra Orgos, Teresopolis, RJ, Brazil.
   [Kritski, Afranio Lineu] Univ Fed Rio de Janeiro, Programa Acad Tuberculose, Fac Med, BR-21941 Rio De Janeiro, Brazil.
   [Cascao, Angela Maria] Ctr Apoio Gestao Vigilancia Saude Sesdec RJ, Rio De Janeiro, RJ, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Dept Epidemiol, Inst Social Med, BR-20550011 Rio De Janeiro, RJ, Brazil.
   [Braga, Jose Ueleres] Fundacao Oswaldo Cruz, Ctr Referenda Prof Helio Fraga, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil.
   [Trajman, Anete] Univ Gama Filho, Dept Clin Med, Fac Med, Rio De Janeiro, RJ, Brazil.
   [Guedes de Carvalho, Regina Maria] Sesdec RJ, Gerencia Pneumol Sanit, Superintendencia Vigilancia Epidemiol & Ambiental, Rio De Janeiro, RJ, Brazil.
RP Selig, L (corresponding author), R Alberto Torres 111 Alto, BR-25964004 Teresopolis, RJ, Brazil.
EM lia.selig@gmail.com
RI Kritski, Afranio/I-6760-2016; Trajman, Anete/C-7679-2016
OI Trajman, Anete/0000-0002-4000-4984; kritski, afranio/0000-0002-5900-6007
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883] Funding
   Source: NIH RePORTER; FIC NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [5U2 R TW006883-03] Funding Source: Medline
CR *2 CONS BRAS TUB, 2004, J BRAS PNEUMOL S1, V30, pS1, DOI DOI 10.1590/S1806-37132004000700002
   Braga JU, 2007, REV SAUDE PUBL S1, V41, P77, DOI DOI 10.1590/S0034-89102007000800011
   Lindoso AABP, 2008, REV SAUDE PUBL, V42
   Cailleaux-Cezar M, 2009, INT J TUBERC LUNG D, V13, P190
   Dye C, 2008, LANCET INFECT DIS, V8, P233, DOI 10.1016/S1473-3099(07)70291-8
   Façanha Mônica Cardoso, 2005, Rev. bras. epidemiol., V8, P25
   Franca E, 2008, INT J EPIDEMIOL, V37, P891, DOI 10.1093/ije/dyn121
   Galesi Vera Maria Neder, 2007, Rev. bras. epidemiol., V10, P48, DOI 10.1590/S1415-790X2007000100006
   Gonçalves Maria Jacirema Ferreira, 2007, Rev. Saúde Pública, V41, P95, DOI 10.1590/s0034-89102007000800013
   Korenromp EL, 2009, INT J TUBERC LUNG D, V13, P283
   Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171
   Pelaquin Monica Hid Haddad, 2007, J. bras. pneumol., V33, P311, DOI 10.1590/S1806-37132007000300013
   Picon Pedro Dornelles, 2007, J Bras Pneumol, V33, P572, DOI 10.1590/S1806-37132007000500013
   Santo Augusto Hasiak, 2006, J. bras. pneumol., V32, P544, DOI 10.1590/S1806-37132006000600012
   Selig L, 2009, INT J TUBERC LUNG D, V13, P982
   Selig L, 2004, J BRAS PNEUMOL, V30, P335, DOI DOI 10.1590/S1806-37132004000400006
   Maia-Elkhoury ANS, 2007, REV SAUDE PUBL, V41, P929
NR 17
TC 15
Z9 17
U1 0
U2 1
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD DEC
PY 2010
VL 44
IS 6
BP 1072
EP 1078
DI 10.1590/S0034-89102010000600012
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 710AD
UT WOS:000286481800012
PM 21107505
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Brasil, PEAA
   De Castro, L
   Hasslocher-Moreno, AM
   Sangenis, LHC
   Braga, JU
AF Brasil, Pedro E. A. A.
   De Castro, Liane
   Hasslocher-Moreno, Alejandro M.
   Sangenis, Luiz H. C.
   Braga, Jose U.
TI ELISA versus PCR for diagnosis of chronic Chagas disease: systematic
   review and meta-analysis
SO BMC INFECTIOUS DISEASES
LA English
DT Review
ID LINKED-IMMUNOSORBENT-ASSAY; POLYMERASE-CHAIN-REACTION; TRYPANOSOMA-CRUZI
   INFECTION; KINETOPLAST MINICIRCLE DNA; EXCRETED-SECRETED ANTIGENS;
   SEROLOGICAL TESTS; REACTION AMPLIFICATION; RECOMBINANT ANTIGENS;
   RADIOIMMUNOPRECIPITATION ASSAY; AMERICAN TRYPANOSOMIASIS
AB Background: Most current guidelines recommend two serological tests to diagnose chronic Chagas disease. When serological tests are persistently inconclusive, some guidelines recommend molecular tests. The aim of this investigation was to review chronic Chagas disease diagnosis literature and to summarize results of ELISA and PCR performance.
   Methods: A systematic review was conducted searching remote databases (MEDLINE, LILACS, EMBASE, SCOPUS and ISIWeb) and full texts bibliography for relevant abstracts. In addition, manufacturers of commercial tests were contacted. Original investigations were eligible if they estimated sensitivity and specificity, or reliability -or if their calculation was possible - of ELISA or PCR tests, for chronic Chagas disease.
   Results: Heterogeneity was high within each test (ELISA and PCR) and threshold effect was detected only in a particular subgroup. Reference standard blinding partially explained heterogeneity in ELISA studies, and pooled sensitivity and specificity were 97.7% [96.7%-98.5%] and 96.3% [94.6%-97.6%] respectively. Commercial ELISA with recombinant antigens studied in phase three investigations partially explained heterogeneity, and pooled sensitivity and specificity were 99.3% [97.9%-99.9%] and 97.5% [88.5%-99.5%] respectively. ELISA's reliability was seldom studied but was considered acceptable. PCR heterogeneity was not explained, but a threshold effect was detected in three groups created by using guanidine and boiling the sample before DNA extraction. PCR sensitivity is likely to be between 50% and 90%, while its specificity is close to 100%. PCR reliability was never studied.
   Conclusions: Both conventional and recombinant based ELISA give useful information, however there are commercial tests without technical reports and therefore were not included in this review. Physicians need to have access to technical reports to understand if these serological tests are similar to those included in this review and therefore correctly order and interpret test results. Currently, PCR should not be used in clinical practice for chronic Chagas disease diagnosis and there is no PCR test commercially available for this purpose. Tests limitations and directions for future research are discussed.
C1 [Brasil, Pedro E. A. A.; De Castro, Liane; Hasslocher-Moreno, Alejandro M.; Sangenis, Luiz H. C.] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil.
   [Brasil, Pedro E. A. A.; Braga, Jose U.] Univ Estado Rio de Janeiro, Inst Social Med, BR-20550011 Rio De Janeiro, Brazil.
   [Braga, Jose U.] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Ctr Referencia Prof Helio Fraga, Rio De Janeiro, Brazil.
RP Brasil, PEAA (corresponding author), Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil.
EM pedro.brasil@ipec.fiocruz.br
RI Brasil, Pedro Emmanuel/AAG-2280-2019; Hasslocher-Moreno, Alejandro
   Marcel/F-3414-2011; Brasil, Pedro E A A/B-4357-2008
OI Brasil, Pedro Emmanuel/0000-0002-6700-2268; Brasil, Pedro E A
   A/0000-0002-6700-2268
FU Instituto de Pesquisa Clinica Evandro Chagas
FX Thanks to Dr Valdilea Veloso, director of Instituto de Pesquisa Clinica
   Evandro Chagas to financial support in accessing some full text; to Dr.
   Daria Kiselica, Leonardo de Castro Monteiro and Thais Pereira Monteiro
   for English review; to Mr Alejandro Schijman and Mr Richard Reithinger
   for valuable suggestions for draft improvement while in peer review.
   List of excluded papers and comments about reasons of exclusions is
   available (Additional file 8). Additional search strategies in
   electronic databases are available (Additional file 9).
CR Alberti Amador Esteban, 1998, Revista Cubana de Medicina Tropical, V50, P75
   ALMEIDA E, 1990, MEM I OSWALDO CRUZ, V85, P513, DOI 10.1590/S0074-02761990000400023
   Almeida IC, 1997, TRANSFUSION, V37, P850, DOI 10.1046/j.1537-2995.1997.37897424410.x
   [Anonymous], 2008, REV CHIL INFECTOL, V25, P379
   [Anonymous], 2007, BOOK NORM TECN PREV
   [Anonymous], RELIABILITY STAT
   [Anonymous], KINETOPLAST MINICIRC
   [Anonymous], NATURE, V465, pS8
   Arrieta R, 2004, SALUD PUBLICA MEXICO, V46, P430, DOI 10.1590/s0036-36342004000500009
   AVILA HA, 1993, J CLIN MICROBIOL, V31, P2421, DOI 10.1128/JCM.31.9.2421-2426.1993
   Avila JL, 1996, CLIN EXP IMMUNOL, V103, P40, DOI 10.1046/j.1365-2249.1996.877569.x
   Aznar C, 1997, FEMS IMMUNOL MED MIC, V18, P31, DOI 10.1111/j.1574-695X.1997.tb01024.x
   Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171
   Berrizbeitia M, 2006, J CLIN MICROBIOL, V44, P291, DOI 10.1128/JCM.44.2.291-296.2006
   Berrizbietia M, 2004, J CLIN MICROBIOL, V42, P1766, DOI 10.1128/JCM.42.4.1766-1769.2004
   Betonico GN, 1999, T ROY SOC TROP MED H, V93, P603, DOI 10.1016/S0035-9203(99)90064-0
   Borges-Pereira J, 1994, REV BRAS PATOL CLIN, P133
   Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41
   Breniere SF, 1997, MEM I OSWALDO CRUZ, V92, P503, DOI 10.1590/S0074-02761997000400011
   BRITTO C, 1995, PARASITOLOGY, V110, P241, DOI 10.1017/S0031182000080823
   Britto C, 1999, MEDICINA-BUENOS AIRE, V59, P176
   Bucio MI, 1999, IMMUNOL INVEST, V28, P257, DOI 10.3109/08820139909060860
   Caballero ZC, 2007, CLIN VACCINE IMMUNOL, V14, P1045, DOI 10.1128/CVI.00127-07
   Cannova D, 2002, SALUS, V3, P4
   Carbonetto C H, 1989, Rev Argent Microbiol, V21, P79
   Carriazo CS, 1998, DIAGN MICR INFEC DIS, V30, P183, DOI 10.1016/S0732-8893(97)00238-1
   CARVALHO MR, 1993, TRANSFUSION, V33, P830, DOI 10.1046/j.1537-2995.1993.331094054620.x
   CASTILLA MM, 1988, J PARASITOL, V74, P805, DOI 10.2307/3282258
   Castro AM, 2002, PARASITOL RES, V88, P894, DOI 10.1007/s00436-002-0679-3
   Castro C, 1999, REV SOC BRASILEIRA M, V32
   Castro C, 2000, REV SOC BRASILEIRA M, V33
   Castro E, 2009, TRANSFUSION MED, V19, P16, DOI 10.1111/j.1365-3148.2009.00915.x
   CETRON MS, 1992, ACTA TROP, V50, P259, DOI 10.1016/0001-706X(92)90082-9
   Chang CD, 2006, TRANSFUSION, V46, P1737, DOI 10.1111/j.1537-2995.2006.00965.x
   Chappell FM, 2009, STAT MED, V28, P2653, DOI 10.1002/sim.3631
   Chiaramonte MG, 1996, MEDICINA-BUENOS AIRE, V56, P259
   Chiaramonte MG, 1999, ACTA TROP, V72, P295, DOI 10.1016/S0001-706X(99)00005-4
   Contreras M C, 1992, Bol Chil Parasitol, V47, P76
   Coronado Ximena, 2005, Mol Diagn, V9, P35, DOI 10.2165/00066982-200509010-00005
   Corral RS, 1996, J CLIN MICROBIOL, V34, P1957, DOI 10.1128/JCM.34.8.1957-1962.1996
   Corredor Arjona Augusto, 1999, Revista do Instituto de Medicina Tropical de Sao Paulo, V41, P229, DOI 10.1590/S0036-46651999000400005
   da Silveira JF, 2001, TRENDS PARASITOL, V17, P286, DOI 10.1016/S1471-4922(01)01897-9
   De Hubsch R M, 1988, Mem Inst Oswaldo Cruz, V83, P277, DOI 10.1590/S0074-02761988000300003
   Dorn PL, 1997, MEM I OSWALDO CRUZ, V92, P253, DOI 10.1590/S0074-02761997000200020
   DOSSANTOS CND, 1992, BIO-TECHNOL, V10, P1474, DOI 10.1038/nbt1192-1474
   Duffy T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000419
   Enciso Clara, 2004, Biomédica, V24, P104
   Enemark H, 2000, Ugeskr Laeger, V162, P2567
   Espinoza AG, 1996, J CLIN MICROBIOL, V34, P485
   Ferreira AW, 2001, J CLIN MICROBIOL, V39, P4390, DOI 10.1128/JCM.39.12.4390-4395.2001
   FIGUEREDOSILVA J, 1991, REV I MED TROP, V33, P193, DOI 10.1590/S0036-46651991000300005
   Fitzwater S, 2008, AM J TROP MED HYG, V79, P768, DOI 10.4269/ajtmh.2008.79.768
   Florian Sanz F, 2005, ANALES MED INTERNA, V11, P538
   Frank M, 1997, INFECTION, V25, P355, DOI 10.1007/BF01740817
   FUCHS A P, 1980, Revista do Instituto de Medicina Tropical de Sao Paulo, V22, P242
   Gadelha AAM, 2003, VOX SANG, V85, P165, DOI 10.1046/j.1423-0410.2003.00340.x
   Gascon J, 2005, MED CLIN-BARCELONA, V125, P230, DOI 10.1157/13077386
   Gil J, 2007, BIOMEDICA, V27, P83, DOI 10.7705/biomedica.v27i1.251
   Gomes ML, 1999, AM J TROP MED HYG, V60, P205, DOI 10.4269/ajtmh.1999.60.205
   Gomes YM, 2001, MEM I OSWALDO CRUZ, V96, P497, DOI 10.1590/S0074-02762001000400009
   Gonzalez J., 1986, Boletin Chileno de Parasitologia, V41, P21
   Gorlin J, 2008, TRANSFUSION, V48, P531, DOI 10.1111/j.1537-2995.2007.01566.x
   Gutierrez R, 2004, PARASITOLOGY, V129, P439, DOI 10.1017/S0031182004005785
   Hamerschlak N, 1997, Rev Soc Bras Med Trop, V30, P205, DOI 10.1590/S0037-86821997000300006
   Haynes RB, 2009, EVIDENCE BASED CLIN
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Houghton RL, 1999, J INFECT DIS, V179, P1226, DOI 10.1086/314723
   Irwig LM, EVIDENCE BASED CLIN
   Jackson Yves, 2008, Rev Med Suisse, V4, P1212
   Junqueira ACV, 1996, T ROY SOC TROP MED H, V90, P129, DOI 10.1016/S0035-9203(96)90111-X
   KAHN T, 1983, IRCS MED SCI-BIOCHEM, V11, P670
   Kirchhoff LV, 2006, TRANSFUSION, V46, P298, DOI 10.1111/j.1537-2995.2006.00715.x
   KNECHER LM, 1994, INT J PARASITOL, V24, P207, DOI 10.1016/0020-7519(94)90027-2
   Krautz GM, 1998, AM J TROP MED HYG, V58, P137, DOI 10.4269/ajtmh.1998.58.137
   Lane DJ, 2000, BLOOD, V96, p60A
   Le Loup G, 2009, PRESSE MED, V38, P1654, DOI 10.1016/j.lpm.2009.01.015
   Leeflang M, 2007, CLIN CHEM, V53, P164, DOI 10.1373/clinchem.2006.076398
   Leiby DA, 2000, J CLIN MICROBIOL, V38, P639, DOI 10.1128/JCM.38.2.639-642.2000
   Lissaldo Ana Maria, 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P163, DOI 10.1590/S0036-46651994000200012
   LORCA M, 1992, REV MED CHILE, V120, P420
   LORCA M, 1994, REV MED CHILE, V122, P925
   MACHADOCOELHO GLL, 1995, MEM I OSWALDO CRUZ, V90, P59, DOI 10.1590/S0074-02761995000100013
   MAGNAVAL JF, 1985, REV FR TRANSFUS IMMU, V28, P201, DOI 10.1016/S0338-4535(85)80112-4
   Malan AK, 2006, J MED MICROBIOL, V55, P171, DOI 10.1099/jmm.0.46149-0
   Marcipar IS, 2005, J CLIN MICROBIOL, V43, P5498, DOI 10.1128/JCM.43.11.5498-5503.2005
   Marcipar IS, 2004, PROTEIN EXPRES PURIF, V34, P1, DOI 10.1016/j.pep.2003.11.022
   Marcipar IS, 2003, FEMS MICROBIOL LETT, V220, P149, DOI 10.1016/S0378-1097(03)00090-9
   Marin MH, 2006, BIOCHEM BIOPH RES CO, V339, P89, DOI 10.1016/j.bbrc.2005.11.001
   Meira WSF, 2002, J CLIN MICROBIOL, V40, P3735, DOI 10.1128/JCM.40.10.3735-3740.2002
   Ministerio da Saude. Secretaria de Vigilancia em Saude, 2005, Rev Soc Bras Med Trop, V38 Suppl 3, P7
   Moncayo A, 2009, MEM I OSWALDO CRUZ, V104, P17, DOI 10.1590/S0074-02762009000900005
   Monteon VM, 1997, J CLIN MICROBIOL, V35, P3316
   MONTEON VM, 1995, SALUD PUBLICA MEXICO, V37, P232
   MONTEON-M V, 1989, Revista Latinoamericana de Microbiologia, V31, P35
   Moretti E, 2004, ACTA BIOQUIM CLIN L, V38, P159
   Nabity MB, 2006, VET PARASITOL, V140, P356, DOI 10.1016/j.vetpar.2006.03.034
   Nakazawa M, 2001, CLIN DIAGN LAB IMMUN, V8, P1024, DOI 10.1128/CDLI.8.5.1024-1027.2001
   Ochs DE, 1996, AM J TROP MED HYG, V54, P526, DOI 10.4269/ajtmh.1996.54.526
   Oelemann WMR, 1998, J CLIN MICROBIOL, V36, P2423, DOI 10.1128/JCM.36.9.2423-2427.1998
   Palacios X, 2000, Rev Panam Salud Publica, V8, P411, DOI 10.1590/S1020-49892000001100006
   PAN AA, 1992, J INFECT DIS, V165, P585, DOI 10.1093/infdis/165.3.585
   Partel CD, 1998, IMMUNOL INVEST, V27, P89, DOI 10.3109/08820139809070892
   PASTINI AC, 1994, CLIN CHEM, V40, P1893
   PERALTA JM, 1994, J CLIN MICROBIOL, V32, P971, DOI 10.1128/JCM.32.4.971-974.1994
   Pereira Valeria R.A., 2000, Revista da Sociedade Brasileira de Medicina Tropical, V33, P367, DOI 10.1590/S0037-86822000000400006
   PETRAY P, 1992, REV INST MED TROP SP, V34, P141, DOI 10.1590/S0036-46651992000200010
   Pinho RT, 1999, ACTA TROP, V72, P31, DOI 10.1016/S0001-706X(98)00075-8
   Pirard M, 2005, TRANSFUSION, V45, P554, DOI 10.1111/j.0041-1132.2005.04214.x
   Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019
   Portela-Lindoso AAB, 2003, REV SAUDE PUBL, V37, P107, DOI 10.1590/S0034-89102003000100016
   R Development Core Team, 2009, BOOK R LANG ENV STAT
   RAMOSECHEVARRIA AA, 1993, SALUD PUBLICA MEXICO, V35, P56
   REQUEJO HIZ, 1991, BRAZ J MED BIOL RES, V24, P471
   REQUENA JM, 1992, MOL BIOCHEM PARASIT, V51, P271, DOI 10.1016/0166-6851(92)90077-W
   Ribeiro-Dos-Santos G, 1999, ANN TROP MED PARASIT, V93, P689, DOI 10.1080/00034989957934
   Riera C, 2006, AM J TROP MED HYG, V75, P1078, DOI 10.4269/ajtmh.2006.75.1078
   Sanchez B, 2001, ARCH MED RES, V32, P382, DOI 10.1016/S0188-4409(01)00303-4
   SCHATTSCHNEIDER W, 1992, TROP GEOGR MED, V44, P210
   SCHECHTER M, 1985, T ROY SOC TROP MED H, V79, P637, DOI 10.1016/0035-9203(85)90176-2
   Schwarzer G, 2009, BOOK META META ANAL
   SOLANA ME, 1995, J CLIN MICROBIOL, V33, P1456, DOI 10.1128/JCM.33.6.1456-1460.1995
   SPENCER HC, 1980, AM J TROP MED HYG, V29, P179, DOI 10.4269/ajtmh.1980.29.179
   Steele L S, 2007, J Immigr Minor Health, V9, P43
   Stramer S. L., 2007, Morbidity and Mortality Weekly Report, V56, P141
   STURM NR, 1989, MOL BIOCHEM PARASIT, V33, P205, DOI 10.1016/0166-6851(89)90082-0
   TAMBOURGI DV, 1995, AM J TROP MED HYG, V52, P516, DOI 10.4269/ajtmh.1995.52.516
   Tobler LH, 2007, TRANSFUSION, V47, P90, DOI 10.1111/j.1537-2995.2007.01068.x
   Umezawa ES, 2004, J CLIN MICROBIOL, V42, P449, DOI 10.1128/JCM.42.1.449-452.2004
   Umezawa ES, 2003, TRANSFUSION, V43, P91, DOI 10.1046/j.1537-2995.2003.00279.x
   Umezawa ES, 1999, J CLIN MICROBIOL, V37, P1554, DOI 10.1128/JCM.37.5.1554-1560.1999
   Umezawa ES, 2001, DIAGN MICR INFEC DIS, V39, P169, DOI 10.1016/S0732-8893(01)00216-4
   Verani JR, 2009, AM J TROP MED HYG, V80, P410
   Duarte AMV, 2006, REV SOC BRAS MED TRO, V39, P385, DOI 10.1590/S0037-86822006000400014
   WENDEL S, 1993, VOX SANG, V64, P1, DOI 10.1111/j.1423-0410.1993.tb02507.x
   Westwood ME, 2005, BMC MED RES METHODOL, V5, DOI 10.1186/1471-2288-5-20
   WHITING P, 2005, BMC MED RES METHODOL, V5
   Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25
   Whiting PF, 2006, BMC MED RES METHODOL, V6
   *WHO, 2002, 2 WHO
   WINCKER P, 1994, AM J TROP MED HYG, V51, P771, DOI 10.4269/ajtmh.1994.51.771
   Wincker P, 1997, PARASITOLOGY, V114, P367, DOI 10.1017/S0031182096008554
   WINKLER MA, 1995, TRANSFUSION, V35, P219, DOI 10.1046/j.1537-2995.1995.35395184278.x
   Young C, 2007, TRANSFUSION, V47, P540, DOI 10.1111/j.1537-2995.2006.01147.x
   ZICKER F, 1990, B WORLD HEALTH ORGAN, V68, P465
NR 144
TC 67
Z9 76
U1 0
U2 31
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 25
PY 2010
VL 10
AR 337
DI 10.1186/1471-2334-10-337
PG 17
WC Infectious Diseases
SC Infectious Diseases
GA 697KZ
UT WOS:000285513800001
PM 21108793
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Selig, L
   Guedes, R
   Kritski, A
   Spector, N
   Silva, JRLE
   Braga, JU
   Trajman, A
AF Selig, L.
   Guedes, R.
   Kritski, A.
   Spector, N.
   Lapa e Silva, J. R.
   Braga, J. U.
   Trajman, A.
TI Uses of tuberculosis mortality surveillance to identify programme errors
   and improve database reporting
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE tuberculosis; death certificate; surveillance; hospital mortality;
   programme evaluation
ID RIO-DE-JANEIRO; MYCOBACTERIUM-TUBERCULOSIS; HEALTH; DEATHS; CARE;
   PREVALENCE; IMPACT
AB BACKGROUND: In 2006, 848 persons died from tuberculosis (TB) in Rio de Janeiro, Brazil, corresponding to a mortality rate of 5.4 per 100 000 population. No specific TB death surveillance actions are currently in place in Brazil.
   SETTING: Two public general hospitals with large open emergency rooms in Rio de Janeiro City.
   OBJECTIVE: To evaluate the contribution of TB death surveillance in detecting gaps in TB control. METHODS: We conducted a survey of TB deaths from September 2005 to August 2006. Records of TB-related deaths and deaths due to undefined causes were investigated. Complementary data were gathered from the mortality and TB notification databases.
   RESULTS: Seventy-three TB-related deaths were investigated. Transmission hazards were identified among fire-fighters, health care workers and in-patients. Management errors included failure to isolate suspected cases, to confirm TB, to correct drug doses in underweight patients and to trace contacts. Following the survey, 36 cases that had not previously been notified were included in the national TB notification database and the outcome of 29 notified cases was corrected.
   CONCLUSION: TB mortality surveillance can contribute to TB monitoring and evaluation by detecting correctable and specific programme- and hospital-based care errors, and by improving the accuracy of TB database reporting. Specific local and programmatic interventions can be proposed as a result.
C1 [Selig, L.] Serra dos Orgaos Univ, Rio De Janeiro, Brazil.
   [Selig, L.; Guedes, R.] Rio de Janeiro State Hlth Dept, Rio De Janeiro, Brazil.
   [Kritski, A.; Spector, N.; Lapa e Silva, J. R.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Braga, J. U.] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil.
   [Trajman, A.] Univ Gama Filho, Rio De Janeiro, Brazil.
RP Selig, L (corresponding author), Rua Anibal Mendonca 72-202 CEP, BR-22410050 Rio De Janeiro, Brazil.
EM lia.selig@gmail.com
RI Lapa e Silva, Jose R./AAS-4793-2020; Kritski, Afranio/I-6760-2016;
   Trajman, Anete/C-7679-2016; Guedes, Roberto MC/A-2665-2008; Guedes,
   Roberto M. C./P-2389-2018
OI Lapa e Silva, Jose R./0000-0003-3116-0253; Trajman,
   Anete/0000-0002-4000-4984; Guedes, Roberto MC/0000-0002-6464-1566;
   Guedes, Roberto M. C./0000-0002-6464-1566; kritski,
   afranio/0000-0002-5900-6007
FU International Clinical, Operational and Health Services Research
   Training Award; FIC/NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [5U2 R TV006883-03]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico-Institutos do MilenioNational
   Council for Scientific and Technological Development (CNPq)
   [480269/2003-3]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883] Funding Source: NIH RePORTER
FX This work was supported by International Clinical, Operational and
   Health Services Research Training Award for AIDS/TB grant, FIC/NIH # 5U2
   R TV006883-03 and Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico-Institutos do Milenio 480269/2003-3. The authors wish to
   thank the surveillance hospitals' teams for their kind collaboration
   with this
CR Bastos LGV, 2007, INT J TUBERC LUNG D, V11, P156
   Braga JU, 2007, REV SAUDE PUBL S1, V41, P77, DOI DOI 10.1590/S0034-89102007000800011
   Camargo K R Jr, 2000, Cad Saude Publica, V16, P439
   Chiang CY, 2007, INT J TUBERC LUNG D, V11, P739
   da Costa PA, 2009, J HOSP INFECT, V72, P57, DOI 10.1016/j.jhin.2009.01.016
   Dye C, 2008, LANCET INFECT DIS, V8, P233, DOI 10.1016/S1473-3099(07)70291-8
   Edginton ME, 2006, INT J TUBERC LUNG D, V10, P1018
   Façanha Mônica Cardoso, 2005, Rev. bras. epidemiol., V8, P25
   GRIFFITH DE, 1995, AM J RESP CRIT CARE, V152, P808, DOI 10.1164/ajrccm.152.2.7633747
   Jenssen HK, 2005, INDIANA U MATH J, V54, P1, DOI 10.1512/iumj.2005.54.2685
   Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494
   Khan K, 2006, CAN MED ASSOC J, V175, P749, DOI 10.1503/cmaj.060124
   Korenromp EL, 2009, INT J TUBERC LUNG D, V13, P283
   LAGUARDIA J, 2004, EPIDEMIOL SERV SAUDE, V13, P135
   LEYSER ME, 2007, GLOB FUND WORKSH TB
   Maher D, 2005, INT J TUBERC LUNG D, V9, P123
   Malta Deborah Carvalho, 2007, Ciênc. saúde coletiva, V12, P765, DOI 10.1590/S1413-81232007000300027
   Malta DC, 2007, EPIDEMIOL SERV SAUDE, V16, P233
   *MIN SAUD, INF SAUD EST VIT
   *MIN SAUD SECR VIG, 2007, PROGR NAC CONTR TUB
   Ministerio da Saude/Secretaria de Vigilancia em Saude, 2005, GUIA VIG EP
   NUNES M, 2007, GLOB FUND WORKSH TB
   PEARSON ML, 1992, ANN INTERN MED, V117, P191, DOI 10.7326/0003-4819-117-3-191
   Pelaquin Monica Hid Haddad, 2007, J. bras. pneumol., V33, P311, DOI 10.1590/S1806-37132007000300013
   PORTELA AAB, 2008, REV SAUDE PUBL, V42, P805
   Resende Mariângela Ribeiro, 2005, J. bras. pneumol., V31, P225, DOI 10.1590/S1806-37132005000300008
   RIEDER HL, 1991, CHEST, V100, P678, DOI 10.1378/chest.100.3.678
   RUTSTEIN DD, 1976, NEW ENGL J MED, V294, P582, DOI 10.1056/NEJM197603112941104
   RUTSTEIN DD, 1983, AM J PUBLIC HEALTH, V73, P1054, DOI 10.2105/AJPH.73.9.1054
   Sanchez AR, 2007, CAD SAUDE PUBLICA, V23, P545, DOI 10.1590/S0102-311X2007000300013
   Santo Augusto Hasiak, 2006, J. bras. pneumol., V32, P544, DOI 10.1590/S1806-37132006000600012
   Selig L, 2003, INT J TUBERC LUNG D, V7, P855
   Selig L., 2004, Jornal Brasileiro de Pneumologia, V30, P327, DOI 10.1590/S1806-37132004000400006
   *WHO, 2006, MEAS PROGR TB CONTR
   Wisnivesky JP, 2000, ARCH INTERN MED, V160, P2471, DOI 10.1001/archinte.160.16.2471
   Wisnivesky JP, 2005, ARCH INTERN MED, V165, P453, DOI 10.1001/archinte.165.4.453
   World Health Organization, 2008, WHOHTMTB2008393
   World Health Organization, 2007, INT STAT CLASS DIS R
   Zachariah R, 2004, INT J TUBERC LUNG D, V8, P1058
   ZALUAR A, 2007, GLOBAL REPORT HUMAN
NR 40
TC 9
Z9 10
U1 0
U2 0
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD AUG
PY 2009
VL 13
IS 8
BP 982
EP 988
PG 7
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA 477JW
UT WOS:000268516300010
PM 19723378
DA 2020-12-01
ER

PT J
AU Horst, NL
   Marques, RG
   Diestel, CF
   Matzke, BD
   Caetano, CER
   Simoes, FC
   Andrade, AFB
   Lobao, WI
   Vaz, LCA
   Portela, MC
   Braga, JU
   Melo, PA
AF Horst, Nara L.
   Marques, Ruy Garcia
   Diestel, Cristina F.
   Matzke, Bianca D.
   Caetano, Carlos Eduardo R.
   Simoes, Fernanda Correia
   Andrade, Arnaldo F. B.
   Lobao, Wagner I.
   Vaz, Luiz Carlos A.
   Portela, Margareth C.
   Braga, Jose Ueleres
   Melo, Paulo A.
TI Effects of Probiotic Supplementation on Markers of Acute Pancreatitis in
   Rats
SO CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
LA English
DT Article
DE probiotics; acute pancreatitis; bacterial translocation; infection
ID RANDOMIZED CLINICAL-TRIAL; ACUTE INFECTIOUS DIARRHEA; BACTERIAL
   TRANSLOCATION; ANTIBIOTIC USE; DOUBLE-BLIND; LACTOBACILLUS BACTEREMIA;
   INTESTINAL-MUCOSA; TIME-COURSE; COMPLICATIONS; NECROSIS
AB BACKGROUND: Intestinal barrier disruption followed by bacterial translocation seems to play a role in secondary pancreatic infection in acute pancreatitis. The use of probiotics as a possible adjuvant strategy in the treatment of acute pancreatitis needs to be investigated.
   OBJECTIVE: The aim of this Study was to determine the effects of dietary supplementation with a prophylactically administered multispecies probiotic mixture on the markers of acute pancreatitis and on the occurrence of bacterial translocation.
   METHODS: Thirty adult male Wistar rats were randomly assigned to I of 3 groups of 10 rats each: (1) the PS group, in which the rats were given probiotic supplementation prior to induction of acute pancreatitis; (2) the WP group, in which the rats underwent surgery to induce acute pancreatitis without prior probiotic supplementation; and (3) the control group, in which the rats underwent sham surgery. For 14 days before surgery, animals in the PS group received a single daily dose containing similar to 1.2 x 10(9) colony-forming units of a probiotic mixture administered intragastrically as a bolus. On day 15, the animals underwent surgery to induce acute pancreatitis (PS and WP groups) or simulated surgery (control group). Blood samples were collected to determine leukocyte Count, amylase and lipase activities, and glucose and calcium concentrations immediately before and 6 and 12 hours after the beginning of the procedure. Samples of pancreas, spleen, liver, and mesenteric lymph nodes were harvested for microbiologic and histopathologic analysis after the last blood sample collection. The pathologist examining the histopathology was blinded to treatment assignment.
   RESULTS: The mean leukocyte Count was significantly increased in the PS group compared with the WP group (P = 0.018), whereas the serum amylase and lipase activities and the serum glucose and calcium concentrations were not significantly different between the 2 groups. Comparing the risk for tissue colonization in the PS group with that of the WP group, the odds ratio (OR) for pancreas was 2.91 (95% CI, 0.13-67.10); liver, 66.55 (95% CI, 1.89-2282.66); spleen, 88.58 (95% CI, 3.04-2583.08); and mesenteric lymph nodes, 1.23 (95% CI, 0.06-25.48). When the risks for histopathologic changes were compared between the 2 groups, the OR for acinar necrosis was 1.73 (95% CI, 0.21-12.17); steatonecrosis, 12.08 (95% CI, 1.26-115.54); hemorrhage, 1.38 (95% CI, 0.21-9.53); and leukocyte infiltration, 5.91 (95% CI, 0.64-54.89).
   CONCLUSION: Probiotic supplementation before the induction of acute pancreatitis was associated with a greater degree of bacterial translocation and pancreatic tissue damage in this animal model. (Curr Ther Res Clin Exp. 2009;70:136-148) (C) 2009 Excerpta Medica Inc.
C1 [Horst, Nara L.; Marques, Ruy Garcia; Diestel, Cristina F.; Matzke, Bianca D.; Caetano, Carlos Eduardo R.; Simoes, Fernanda Correia; Braga, Jose Ueleres] Univ Estado Rio De Janeiro, Expt Surg Lab, Rio De Janeiro, Brazil.
   [Andrade, Arnaldo F. B.] Univ Estado Rio De Janeiro, Dept Microbiol Immunol & Parasitol, Rio De Janeiro, Brazil.
   [Lobao, Wagner I.] Univ Estado Rio De Janeiro, Univ Hosp Pedro Ernesto, Cent Lab, Rio De Janeiro, Brazil.
   [Vaz, Luiz Carlos A.] Univ Estado Rio De Janeiro, Dept Pathol & Labs, Rio De Janeiro, Brazil.
   [Portela, Margareth C.] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Dept Hlth Planning & Adm, Rio De Janeiro, Brazil.
   [Melo, Paulo A.] Univ Fed Rio de Janeiro, Dept Pharmacol, Rio De Janeiro, Brazil.
RP Marques, RG (corresponding author), Rua Clovis Salgado 255-204, BR-22795230 Recreio Rio De Janeiro, RJ, Brazil.
EM Rmarques@uerj.br
RI Portela, Margareth C/G-6699-2012
OI Portela, Margareth C/0000-0002-9858-9276
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro, Rio de Janeiro, Brazil
FX This work was partially supported by a grant from Fundacao Carlos Chagas
   Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, Rio de Janeiro,
   Brazil.
CR AHO HJ, 1980, SCAND J GASTROENTERO, V15, P411, DOI 10.3109/00365528009181493
   Ammori BJ, 2003, PANCREAS, V26, P122, DOI 10.1097/00006676-200303000-00006
   Anderson ADG, 2004, GUT, V53, P241, DOI 10.1136/gut.2003.024620
   Bauer TM, 2002, J HEPATOL, V36, P501, DOI 10.1016/S0168-8278(02)00003-X
   BEGER HG, 1986, GASTROENTEROLOGY, V91, P433, DOI 10.1016/0016-5085(86)90579-2
   Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X
   Besselink MGH, 2005, DIGEST SURG, V22, P234, DOI 10.1159/000088053
   Brown Amy C, 2004, Nutr Clin Care, V7, P56
   Butturini G, 2001, J HOSP INFECT, V49, P4, DOI 10.1053/jhin.2001.1001
   Chermesh I, 2007, DIGEST DIS SCI, V52, P385, DOI 10.1007/s10620-006-9549-7
   Clancy TE, 2005, J GASTROINTEST SURG, V9, P440, DOI 10.1016/j.gassur.2004.09.027
   COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2
   Dambrauskas Z, 2007, MEDICINA-LITHUANIA, V43, P291, DOI 10.3390/medicina43040036
   FAO/WHO, 2001, EV HLTH NUTR PROP PR
   FOITZIK T, 1994, ANN SURG, V220, P193, DOI 10.1097/00000658-199408000-00011
   Gismondo MR, 1999, INT J ANTIMICROB AG, V12, P287, DOI 10.1016/S0924-8579(99)00050-3
   Heinrich S, 2006, ANN SURG, V243, P154, DOI 10.1097/01.sla.0000197334.58374.70
   Isaji Shuji, 2003, J Hepatobiliary Pancreat Surg, V10, P419, DOI 10.1007/s00534-002-0811-x
   JOHANSSON ML, 1993, APPL ENVIRON MICROB, V59, P15, DOI 10.1128/AEM.59.1.15-20.1993
   Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026
   Levy J, 2000, AM J GASTROENTEROL, V95, pS8, DOI 10.1016/S0002-9270(99)00808-4
   Mallery JS, 2003, GASTROINTEST ENDOSC, V57, P633, DOI 10.1053/ge.2003.v57.amge030576633
   Manes G, 2006, DIGEST LIVER DIS, V38, P423, DOI 10.1016/j.dld.2006.02.019
   Mangiante G, 1999, Chir Ital, V51, P221
   Mangiante G, 2001, DIGEST SURG, V18, P47, DOI 10.1159/000050096
   Marques RG, 2009, ACTA CIR BRAS, V24, P69, DOI 10.1590/S0102-86502009000100015
   Marteau P, 2003, BEST PRACT RES CL GA, V17, P725, DOI 10.1016/S1521-6918(03)00055-6
   Mazaki T, 2006, BRIT J SURG, V93, P674, DOI 10.1002/bjs.5389
   McNaught CE, 2002, GUT, V51, P827, DOI 10.1136/gut.51.6.827
   MEDICH DS, 1993, AM J SURG, V165, P46, DOI 10.1016/S0002-9610(05)80403-9
   Mifkovic A, 2006, Bratisl Lek Listy, V107, P296
   Mitchell RMS, 2003, LANCET, V361, P1447, DOI 10.1016/S0140-6736(03)13139-X
   Moyshenyat Issac, 2006, Curr Gastroenterol Rep, V8, P121, DOI 10.1007/s11894-006-0007-7
   Muftuoglu MAT, 2006, EUR J CLIN NUTR, V60, P464, DOI 10.1038/sj.ejcn.1602338
   Nazli A, 2004, AM J PATHOL, V164, P947, DOI 10.1016/S0002-9440(10)63182-3
   O'Boyle CJ, 1998, GUT, V42, P29, DOI 10.1136/gut.42.1.29
   Olah A, 2002, BRIT J SURG, V89, P1103, DOI 10.1046/j.1365-2168.2002.02189.x
   Olah A, 2007, HEPATO-GASTROENTEROL, V54, P590
   PERDIGON G, 1995, J DAIRY SCI, V78, P1597, DOI 10.3168/jds.S0022-0302(95)76784-4
   PETROIANU A, 1996, ACTA CIR BRAS, V11, P157, DOI DOI 10.1590/S0102-86502000000400001
   Raty S, 1998, INT J PANCREATOL, V24, P187
   RUNKEL NSF, 1991, J SURG RES, V51, P18, DOI 10.1016/0022-4804(91)90064-S
   Salminen MK, 2004, CLIN INFECT DIS, V38, P62, DOI 10.1086/380455
   Salminen MK, 2002, CLIN INFECT DIS, V35, P1155, DOI 10.1086/342912
   Schiffrin EJ, 2002, EUR J CLIN NUTR, V56, pS60, DOI 10.1038/sj.ejcn.1601489
   Schmid SW, 1999, GUT, V45, P311, DOI 10.1136/gut.45.2.311
   Schwarz M, 2000, SURGERY, V127, P427, DOI 10.1067/msy.2000.104116
   Sekimoto M, 2006, J HEPATO-BILIARY-PAN, V13, P10, DOI 10.1007/s00534-005-1047-3
   Servin AL, 2003, BEST PRACT RES CL GA, V17, P741, DOI 10.1016/S1521-6918(03)00052-0
   SHERMAN S, 1991, PANCREAS, V6, P350, DOI 10.1097/00006676-199105000-00013
   SUASSUNA I, 1978, REV BRAS PATOL CLIN, V14, P201
   Szajewska H, 2001, J PEDIATR GASTR NUTR, V33, pS17, DOI 10.1097/00005176-200110002-00004
   Taranto MP, 2006, RES MICROBIOL, V157, P720, DOI 10.1016/j.resmic.2006.04.002
   TARPILA E, 1993, EUR J SURG, V159, P109
   Teitelbaum JE, 2002, ANNU REV NUTR, V22, P107, DOI 10.1146/annurev.nutr.22.110901.145412
   Tejada-Simon MV, 1999, J DAIRY SCI, V82, P649, DOI 10.3168/jds.S0022-0302(99)75281-1
   Tenner S, 1997, GASTROENTEROLOGY, V113, P899, DOI 10.1016/S0016-5085(97)70185-9
   Timmerman HM, 2007, CLIN NUTR, V26, P450, DOI 10.1016/j.clnu.2007.04.008
   Timmerman HM, 2004, INT J FOOD MICROBIOL, V96, P219, DOI 10.1016/j.ijfoodmicro.2004.05.012
   Toouli J, 2002, J GASTROEN HEPATOL, V17, pS15, DOI 10.1046/j.1440-1746.17.s1.2.x
   Van Felius ID, 2003, NEUROGASTROENT MOTIL, V15, P267, DOI 10.1046/j.1365-2982.2003.00410.x
   van Minnen LP, 2007, SURGERY, V141, P470, DOI 10.1016/j.surg.2006.10.007
   Van Niel CW, 2002, PEDIATRICS, V109, P678, DOI 10.1542/peds.109.4.678
   Walker WA, 2006, EUR J NUTR, V45, P1, DOI 10.1007/s00394-006-1101-1
   Woodcock NP, 2004, CLIN NUTR, V23, P1069, DOI 10.1016/j.clnu.2004.01.010
   Yasui H, 1999, ANTON LEEUW INT J G, V76, P383, DOI 10.1023/A:1002041616085
NR 66
TC 8
Z9 8
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0011-393X
EI 1879-0313
J9 CURR THER RES CLIN E
JI Curr. Ther. Res.-Clin. Exp.
PD APR
PY 2009
VL 70
IS 2
BP 136
EP 148
DI 10.1016/j.curtheres.2009.04.004
PG 13
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 447TS
UT WOS:000266215300006
PM 24683225
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Bernardes-Engemann, AR
   Penha, CVLY
   Benvenuto, F
   Braga, JU
   Barros, ML
   Orofino-Costa, R
   Lopes-Bezerra, LM
AF Bernardes-Engemann, Andrea R.
   Loureiro y Penha, Carla V.
   Benvenuto, Fabiana
   Braga, Jose Ueleres
   Barros, Monica L.
   Orofino-Costa, Rosane
   Lopes-Bezerra, Leila M.
TI A comparative serological study of the SsCBF antigenic fraction isolated
   from three Sporothrix schenckii strains
SO MEDICAL MYCOLOGY
LA English
DT Article
DE Sporotrichosis; serology; Sporothrix schenckii; SsCBF antigen; ROC
   analysis
ID LINKED-IMMUNOSORBENT-ASSAY; SPOROTRICHOSIS; DIAGNOSIS
AB A previous work showed that an antigenic fraction of Sporothrix schenckii, SsCBF, was specifically recognized by IgG antibodies present in patients' clinical specimens. The objective of this investigation was to compare the reactivity of this antigen recovered from three S. schenckii strains. ROC curve analysis revealed a variation in the sensitivity and specificity of the antigen derived from each of the strains, with a higher AUC for strain 1099-18. Moreover, the presence of the main O-glycosidically-linked epitopes described in the SsCBF fraction was ascertained. A significant reduction in SsCBF reactivity of all the strains was observed after beta-elimination confirming the presence of O-glycan epitopes. The antigen isolated from strain 1099-18 proved to be a more accurate diagnostic tool for serodiagnosis of sporotrichosis.
C1 [Lopes-Bezerra, Leila M.] Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Dept Biol Celular, Lab Micol Celular & Prote, BR-20550011 Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Programa Posgraducao Fisiopatol Clin & Expt, BR-20550011 Rio De Janeiro, Brazil.
   [Orofino-Costa, Rosane] Univ Estado Rio de Janeiro, Hosp Univ Pedro Ernesto, Lab Micol, BR-20550011 Rio De Janeiro, Brazil.
   [Barros, Monica L.] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil.
RP Lopes-Bezerra, LM (corresponding author), Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Dept Biol Celular, Lab Micol Celular & Prote, Rua Sao Francisco Xavier 524,PHLC Sala 205, BR-20550011 Rio De Janeiro, Brazil.
EM leila.lopes_bezerra@pq.cnpq.br
RI Orofino-Costa, Rosane/AAF-6844-2020; Lopes Bezerra, Leila/K-8405-2015
OI Orofino-Costa, Rosane/0000-0002-1603-418X; Lopes Bezerra,
   Leila/0000-0003-2397-7597
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Brazilian Health Ministry [E-26/170.794/2005]
FX A.R.B.E. and L.M.L.B. were granted fellowships by the Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq). This work was
   supported by Brazilian Health Ministry (E-26/170.794/2005).
CR Albuquerque CF, 2005, J CLIN MICROBIOL, V43, P1944, DOI 10.1128/JCM.43.4.1944-1946.2005
   Almeida-Paes R, 2007, CLIN VACCINE IMMUNOL, V14, P244, DOI 10.1128/CVI.00430-06
   Barrera PB, 2007, J TRACE ELEM MED BIO, V21, P1, DOI 10.1016/j.jtemb.2007.09.005
   Bernardes-Engemann AR, 2005, MED MYCOL, V43, P487, DOI 10.1080/13693780400019909
   CASSERONE S, 1983, SABOURAUDIA, V21, P317
   Celik U, 2007, TUBERK TORAK, V55, P108
   Chan CPY, 2008, ADV BIOCHEM ENG BIOT, V109, P123, DOI 10.1007/10_2007_075
   da Rosa ACM, 2005, J AM ACAD DERMATOL, V52, P451, DOI 10.1016/j.jaad.2004.11.046
   DIXON DM, 1991, J CLIN MICROBIOL, V29, P1106, DOI 10.1128/JCM.29.6.1106-1113.1991
   Feeney KT, 2007, EMERG INFECT DIS, V13, P1228, DOI 10.3201/eid1308.061462
   Kauffman CA, 1999, CLIN INFECT DIS, V29, P231, DOI 10.1086/520190
   Lopes Alves Leila, 1994, Glycobiology, V4, P281
   Lopes-Bezerra LM, 2006, AN ACAD BRAS CIENC, V78, P293, DOI 10.1590/S0001-37652006000200009
   LOPESALVES LM, 1992, GLYCOCONJUGATE J, V9, P75, DOI 10.1007/BF00731702
   Penha CVLY, 2000, MED MYCOL, V38, P1
   SINGER JI, 1952, NEW YORK STATE J MED, V52, P2147
   TAKATA M, 1983, MYCOPATHOLOGIA, V84, P31, DOI 10.1007/BF00436994
NR 17
TC 8
Z9 8
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1369-3786
EI 1460-2709
J9 MED MYCOL
JI Med. Mycol.
PY 2009
VL 47
IS 8
BP 874
EP 878
DI 10.3109/13693780802695520
PG 5
WC Infectious Diseases; Mycology; Veterinary Sciences
SC Infectious Diseases; Mycology; Veterinary Sciences
GA 535WW
UT WOS:000273003600013
PM 19194817
OA Bronze
DA 2020-12-01
ER

PT J
AU Braga, JU
AF Braga, Jose Ueleres
TI Tuberculosis surveillance and health information system in Brazil,
   2001-2003
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE tuberculosis, epidemiology; morbidity; diseases registries; registries;
   data source; Brazil
AB OBJECTIVE: To assess the quality of tuberculosis surveillance in Brazil.
   METHODS: Local data from 2001 to 2003 were assessed according to the quality of detection and follow-up of the cases in the region, the quality of the information produced by the notification system, and the load of morbidity of tuberculosis. Cities were classified into four groups, according to tuberculosis epidemiologic stage and the quality of tuberculosis surveillance.
   RESULTS: In the study period, about 8% of the Brazilian cities presented over 10% of the cases of tuberculosis notified by the health care services of another city. In about 950 cities, the frequency of patients with pulmonary tuberculosis undergoing sputum examination was lower than 90%. In the North region, Amazonas, Para and Amapa presented more cities classified in the groups of poor tuberculosis surveillance. In the Northeast, Pernambuco, Ceara and Bahia presented the poorest surveillance. The South and Midwest regions presented greater number of cities with better tuberculosis surveillance.
   CONCLUSIONS: One third of the Brazilian cities present poor tuberculosis surveillance. This picture is not homogeneous in Brazil, and the regions with highest tuberculosis incidence have a great number of cities with apparently insufficient control measures.
C1 [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Inst Social Med, Dept Epidemiol, Rio De Janeiro, RJ, Brazil.
RP Braga, JU (corresponding author), R Belisario Tavora 653,Apto 202 Laranjeiras, BR-22245070 Rio De Janeiro, RJ, Brazil.
EM ueleres@pq.cnpq.br
CR ASSUNCAO RM, 1998, CAD SAUDE PUBLICA, V14, P712
   Bailey T.C., 1995, INTERACTIVE SPATIAL
   RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220
   RUFFINONETTO A, 1999, INFORME EPIDEMIOLOGI, V8, P35
NR 4
TC 5
Z9 5
U1 0
U2 0
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD SEP
PY 2007
VL 41
SU 1
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 265RL
UT WOS:000253378500011
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Santos, M
   Braga, JU
   Gomes, RV
   Werneck, GL
AF Santos, Marisa
   Braga, Jose Ueleres
   Gomes, Renato Vieira
   Werneck, Guilherme L.
TI Predictive factors for pneumonia onset after cardiac surgery in Rio de
   janeiro, Brazil
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article
ID VENTILATOR-ASSOCIATED PNEUMONIA; RISK-FACTORS; MECHANICAL VENTILATION;
   MENINGOCOCCAL DISEASE; NOSOCOMIAL PNEUMONIA; LOGISTIC-REGRESSION;
   BYPASS; PREVENTION; OPERATIONS; DECONTAMINATION
AB Objective. To develop a predictive system for the occurrence of nosocomial pneumonia in patients who had cardiac surgery performed.
   Design. Retrospective cohort study.
   Setting. Two cardiologic tertiary care hospitals in Rio de Janeiro, Brazil.
   Patients. Between June 2000 and August 2002, there were 1,158 consecutive patients who had complex heart surgery performed. Patients older than 18 years who survived the first 48 postoperative hours were included in the study. The occurrence of pneumonia was diagnosed through active surveillance by an infectious diseases specialist according to the following criteria: the presence of new infiltrate on a radiograph in association with purulent sputum and either fever or leukocytosis until day 10 after cardiac surgery. Predictive models were built on the basis of logistic regression analysis and classification and regression tree ( CART) analysis. The original data set was divided randomly into 2 parts, one used to construct the models ( ie, "test sample") and the other used for validation ( ie, "validation sample").
   Results. The area under the receiver-operating characteristic ( ROC) curve was 69% for the logistic regression model and 76% for the CART model. Considering a probability greater than 7% to be predictive of pneumonia for both models, sensitivity was higher for the logistic regression models, compared with the CART models ( 64% vs 56%). However, the CART models had a higher specificity ( 92% vs 70%) and global accuracy ( 90% vs 70%) than the logistic regression models. Both models showed good performance, based on the 2-graph ROC, considering that 84.6% and 84.3% of the predictions obtained by regression and CART analyses were regarded as valid.
   Conclusion. Although our findings are preliminary, the predictive models we created showed fairly good specificity and fair good specificity and fair sensitivity.
C1 Univ Estado Rio De Janeiro, Pro Cardiac Hosp, Inst Social Med, Natl Inst Cardiol & Pro Cardiac, Rio De Janeiro, Brazil.
   State Univ Rio de Jainero, Pro Cardiac Hosp, Inst Social Med, Dept Epidemiol, Rio De Janeiro, Brazil.
RP Werneck, GL (corresponding author), Univ Estado Rio De Janeiro, Pro Cardiac Hosp, Inst Social Med, Natl Inst Cardiol & Pro Cardiac, Rio De Janeiro, Brazil.
EM gwerneck@nesc.ufrj.br
RI Werneck, Guilherme/A-2841-2013; da Silva Santos, Marisa/ABA-3418-2020
OI Werneck, Guilherme/0000-0003-1169-1436; da Silva Santos,
   Marisa/0000-0002-2174-6800
CR Asensio A, 1996, Clin Perform Qual Health Care, V4, P67
   Barquet N, 1997, JAMA-J AM MED ASSOC, V278, P491, DOI 10.1001/jama.278.6.491
   Bergmans DCJJ, 2001, AM J RESP CRIT CARE, V164, P382, DOI 10.1164/ajrccm.164.3.2005003
   Branca P, 2001, CHEST, V119, P537, DOI 10.1378/chest.119.2.537
   Breiman L., 1984, CLASSIFICATION REGRE
   *CDCP, 2003, GUID PREV HLTH CAR A
   Collard HR, 2003, ANN INTERN MED, V138, P494, DOI 10.7326/0003-4819-138-6-200303180-00015
   Estrada CA, 2003, ANN THORAC SURG, V75, P1392, DOI 10.1016/S0003-4975(02)04997-4
   FLAHERTY J, 1990, J INFECT DIS, V162, P1393, DOI 10.1093/infdis/162.6.1393
   GAYNES R, 1991, ANN THORAC SURG, V51, P215, DOI 10.1016/0003-4975(91)90787-Q
   Greiner M, 1996, J IMMUNOL METHODS, V191, P93, DOI 10.1016/0022-1759(96)00013-0
   Leal-Noval SR, 2000, CRIT CARE MED, V28, P935, DOI 10.1097/00003246-200004000-00004
   MIHOLIC J, 1985, ANN THORAC SURG, V40, P224, DOI 10.1016/S0003-4975(10)60032-X
   NG CSH, 2002, CHEST, V122, P245
   Ranucci M, 1997, PERFUSION-UK, V12, P309, DOI 10.1177/026765919701200506
   Rebollo MH, 1996, J THORAC CARDIOV SUR, V112, P908, DOI 10.1016/S0022-5223(96)70090-9
   Rello J, 2001, CHEST, V120, P955, DOI 10.1378/chest.120.3.955
   Sabik JF, 2002, J THORAC CARDIOV SUR, V124, P698, DOI 10.1067/mtc.2002.121975
   Smulders K, 2002, CHEST, V121, P858, DOI 10.1378/chest.121.3.858
   Thwaites GE, 2002, LANCET, V360, P1287, DOI 10.1016/S0140-6736(02)11318-3
   Wan S, 1997, CHEST, V112, P676, DOI 10.1378/chest.112.3.676
   Werneck GL, 1999, J TROP PEDIATRICS, V45, P248, DOI 10.1093/tropej/45.4.248
NR 22
TC 7
Z9 7
U1 0
U2 1
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
SN 0899-823X
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD APR
PY 2007
VL 28
IS 4
BP 382
EP 388
DI 10.1086/513119
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 205NN
UT WOS:000249121000004
PM 17385142
DA 2020-12-01
ER

PT J
AU Duarte, SFP
   Francischetti, EA
   Genelhu-Abreu, V
   Barroso, SG
   Braga, JU
   Cabello, PH
   Pimentel, MMG
AF Pimentel Duarte, Stenio Fernando
   Francischetti, Emilio Antonio
   Genelhu-Abreu, Virginia
   Girao Barroso, Sergio
   Ueleres Braga, Jose
   Hernan Cabello, Pedro
   Goncalves Pimentel, Marcia Mattos
TI p.Q223R leptin receptor polymorphism associated with obesity in
   Brazilian multiethnic subjects
SO AMERICAN JOURNAL OF HUMAN BIOLOGY
LA English
DT Article
ID BODY-MASS INDEX; LEPR POLYMORPHISMS; GENE; WEIGHT; POPULATIONS;
   VARIANTS; CLONING; DNA
AB Several genes play a major role in obese phenotypes, and studies suggest that genetic variations among individuals, as well as their lifestyles, may bring about different body compositions. Among these genes, LEP, which codifies leptin, and the LEPR gene encoding its receptor were extensively studied for variants that could explain the obese phenotype. The LEPR p.Q223R gene polymorphism was analyzed in a sample of obese and nonobese individuals from Brazil to evaluate the role of this polymorphism in the obese phenotype in the population. Two hundred obese patients (60 males, 140 females, body mass index (BMI) > 30 kg/m(2)) were screened, together with 150 lean or normal healthy individuals (63 males, 87 females, BMI < 24 kg/m(2)). Genomic DNA was extracted and amplified by polymerase chain reaction (PCR). PCR products were digested with the restriction of endonuclease MspI, and separated by electrophoresis through an 8% polyacrilamide gel stained with silver nitrate. There was a significant difference in LEPR p.Q223R polymorphism frequency when comparing obese and lean subjects, with an odds ratio of 1.92 and a 95% confidence interval of 1.15-3.22 (P = 0.013). There is a strong association of the LEPR p.Q223R gene polymorphism with obesity in Brazil.
C1 Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Serv Genet Humana, Dept Biol Celular & Genet, BR-20550013 Rio De Janeiro, Brazil.
   Univ Estado Rio de Janeiro, Clin Hipertensao, Lab Fisiopatol Clin & Expt, BR-20551030 Rio De Janeiro, Brazil.
   Inst Oswaldo Cruz, Lab Genet Humana, BR-21045900 Rio De Janeiro, Brazil.
RP Francischetti, EA (corresponding author), Rua Paulo Cesar Andrade 106-602, BR-22221090 Rio De Janeiro, Brazil.
EM eafranc@uerj.br
RI Francischetti, Emilio/AAX-8544-2020
OI Pimentel, Marcia/0000-0002-8872-7073
CR Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrg862, 10.1038/nrn902]
   Bribiescas RG, 2001, AM J PHYS ANTHROPOL, V115, P297, DOI 10.1002/ajpa.1085
   Chagnon YC, 2000, J CLIN ENDOCR METAB, V85, P29, DOI 10.1210/jc.85.1.29
   Chagnon YC, 1999, INT J OBESITY, V23, P278, DOI 10.1038/sj.ijo.0800809
   Clement K, 1998, NATURE, V392, P398
   Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503
   Echwald SM, 1997, BIOCHEM BIOPH RES CO, V233, P248, DOI 10.1006/bbrc.1997.6430
   FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1
   Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376
   Gotoda T, 1997, HUM MOL GENET, V6, P869, DOI 10.1093/hmg/6.6.869
   Hebebrand J, 2001, INT J OBESITY, V25, pS10, DOI 10.1038/sj.ijo.0801689
   Heo M, 2002, INT J OBESITY, V26, P640, DOI 10.1038/sj.ijo.0801990
   Heo M, 2001, GENETICS, V159, P1163
   Lindeberg S, 2001, J INTERN MED, V249, P553, DOI 10.1046/j.1365-2796.2001.00845.x
   Lindgarde F, 2004, METABOLISM, V53, P1355, DOI 10.1016/j.metabol.2004.04.012
   LopezCamelo JS, 1996, BRAZ J GENET, V19, P659, DOI 10.1590/S0100-84551996000400024
   Mann DR, 2003, J CLIN ENDOCR METAB, V88, P3339, DOI 10.1210/jc.2002-022030
   Mantzoros CS, 1999, ANN INTERN MED, V130, P671, DOI 10.7326/0003-4819-130-8-199904200-00014
   Matsuoka N, 1997, DIABETOLOGIA, V40, P1204
   Mattevi VS, 2002, INT J OBESITY, V26, P1179, DOI 10.1038/sj.ijo.0802067
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185
   Paracchini V, 2005, AM J EPIDEMIOL, V162, P101, DOI 10.1093/aje/kwi174
   Perez-Bravo F, 1998, INT J OBESITY, V22, P943, DOI 10.1038/sj.ijo.0800667
   Quinton ND, 2001, HUM GENET, V108, P233, DOI 10.1007/s004390100468
   SANTOS FR, 1993, HUM GENET, V90, P655
   Santos JL, 2000, ANN HUM BIOL, V27, P271
   Silver K, 1997, DIABETES, V46, P1898, DOI 10.2337/diab.46.11.1898
   Skibola CF, 2004, CANCER EPIDEM BIOMAR, V13, P779
   Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5
   Thompson DB, 1997, HUM MOL GENET, V6, P675, DOI 10.1093/hmg/6.5.675
   van Rossum CTM, 2002, INT J OBESITY, V26, P517, DOI 10.1038/sj.ijo.0801964
   Yiannakouris N, 2001, J CLIN ENDOCR METAB, V86, P4434, DOI 10.1210/jc.86.9.4434
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
NR 34
TC 38
Z9 40
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1042-0533
EI 1520-6300
J9 AM J HUM BIOL
JI Am. J. Hum. Biol.
PD JUL-AUG
PY 2006
VL 18
IS 4
BP 448
EP 453
DI 10.1002/ajhb.20519
PG 6
WC Anthropology; Biology
SC Anthropology; Life Sciences & Biomedicine - Other Topics
GA 057VU
UT WOS:000238624100002
PM 16788891
DA 2020-12-01
ER

PT J
AU Duarte, SFP
   Barroso, SG
   Genelhu-Abreu, V
   Braga, JU
   Valenca, DCT
   Francischetti, EA
   Pimentel, MMG
AF Duarte, SFP
   Barroso, SG
   Genelhu-Abreu, V
   Braga, JU
   Valenca, DCT
   Francischetti, EA
   Pimentel, MMG
TI Genetic analysis of the LEP and LEPR gene polymorphisms in obese
   subjects from Brazil
SO JOURNAL OF HYPERTENSION
LA English
DT Meeting Abstract
CT 15th European Meeting on Hypertension
CY JUN 17-21, 2005
CL Milan, ITALY
SP European Soc Hypertens, AstraZeneca, Bristol-Myers Squibb Co, Boehringer Ingelheim, MSD, NOVARTIS, RECORDATI, SANKYO, Sanofi Aventis, Bayer Healthcare AG, Pfizer Inc, Solvay Pharmaceut GmbH
C1 UERJ, CLINEX, Hypertens Clin, Rio De Janeiro, Brazil.
RI Francischetti, Emilio/AAX-8544-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA
SN 0263-6352
J9 J HYPERTENS
JI J. Hypertens.
PD JUN
PY 2005
VL 23
SU 2
BP S371
EP S371
PG 1
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 947JO
UT WOS:000230639802340
DA 2020-12-01
ER

PT J
AU Rodrigues, MLG
   Araujo, AC
   Gomes, KBB
   Martins, RCV
   Valenca, DCT
   Braga, JU
   Abreu, V
   Francischetti, EA
AF Rodrigues, MLG
   Araujo, AC
   Gomes, KBB
   Martins, RCV
   Valenca, DCT
   Braga, JU
   Abreu, V
   Francischetti, EA
TI Effects of a hypocaloric diet on the oxidative stress, evaluated by the
   comet assay
SO JOURNAL OF HYPERTENSION
LA English
DT Meeting Abstract
CT 15th European Meeting on Hypertension
CY JUN 17-21, 2005
CL Milan, ITALY
SP European Soc Hypertens, AstraZeneca, Bristol-Myers Squibb Co, Boehringer Ingelheim, MSD, NOVARTIS, RECORDATI, SANKYO, Sanofi Aventis, Bayer Healthcare AG, Pfizer Inc, Solvay Pharmaceut GmbH
C1 UERJ, Hypertens Clin, Rio De Janeiro, Brazil.
   UERJ, Dept Biophys & Biometry, Rio De Janeiro, Brazil.
RI Francischetti, Emilio/AAX-8544-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA
SN 0263-6352
J9 J HYPERTENS
JI J. Hypertens.
PD JUN
PY 2005
VL 23
SU 2
BP S338
EP S338
PG 1
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 947JO
UT WOS:000230639802218
DA 2020-12-01
ER

PT J
AU Braga, JU
   Genelhu-Abreu, V
   Vaitsman, GP
   Oliveira, AB
   Maluly, VG
   Francischetti, EA
AF Braga, JU
   Genelhu-Abreu, V
   Vaitsman, GP
   Oliveira, AB
   Maluly, VG
   Francischetti, EA
TI Determinants of uncontrolled hypertension in Brazilian ambulatory
   patients of a university hypertension service
SO JOURNAL OF HYPERTENSION
LA English
DT Meeting Abstract
CT 14th European Meeting on Hypertension
CY JUN 13-17, 2004
CL Paris, FRANCE
C1 Univ Estado Rio De Janeiro, CLINEX, Hypertens Clin, Rio De Janeiro, Brazil.
RI Francischetti, Emilio/AAX-8544-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0263-6352
J9 J HYPERTENS
JI J. Hypertens.
PD JUN
PY 2004
VL 22
SU 2
BP S393
EP S393
DI 10.1097/00004872-200406002-01382
PG 1
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 843QN
UT WOS:000223099401380
DA 2020-12-01
ER

PT J
AU Rocha-Castelli, R
   Genelhu-Abreu, V
   Braga, JU
   Kaiser, SE
   Barroso, SG
   Rodrigues, MLG
   Francischetti, EA
AF Rocha-Castelli, R
   Genelhu-Abreu, V
   Braga, JU
   Kaiser, SE
   Barroso, SG
   Rodrigues, MLG
   Francischetti, EA
TI Obesity, hypertension and cardiovascular profile in Brazilian children
   and adolescents
SO JOURNAL OF HYPERTENSION
LA English
DT Meeting Abstract
CT 14th European Meeting on Hypertension
CY JUN 13-17, 2004
CL Paris, FRANCE
C1 Univ Estado Rio De Janeiro, Hypertens Clin, CLINEX, Rio De Janeiro, Brazil.
   Totalcare Amill, Amill, RJ, Brazil.
RI Francischetti, Emilio/AAX-8544-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0263-6352
J9 J HYPERTENS
JI J. Hypertens.
PD JUN
PY 2004
VL 22
SU 2
BP S229
EP S229
DI 10.1097/00004872-200406002-00800
PG 1
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 843QN
UT WOS:000223099400798
DA 2020-12-01
ER

PT J
AU Rocha-Castelli, R
   Genelhu-Fagundes, V
   Kaiser, SE
   Rodrigues, MLG
   Barroso, SG
   Braga, JU
   Fellows, IB
   Romero, TS
   Francischetti, EA
AF Rocha-Castelli, R
   Genelhu-Fagundes, V
   Kaiser, SE
   Rodrigues, MLG
   Barroso, SG
   Braga, JU
   Fellows, IB
   Romero, TS
   Francischetti, EA
TI In obese male Brazilian adolescents the intraerythrocyte sodium content
   participates in the non-modulation of the renin-angiotensin system
SO JOURNAL OF HYPERTENSION
LA English
DT Meeting Abstract
CT 13th European Meeting on Hypertension
CY JUN 13-17, 2003
CL MILAN, ITALY
SP European Soc Hypertens
C1 Clinex Rio de Janeiro State Univ, Rio De Janeiro, Brazil.
   TotalCare, Amil, RJ, Brazil.
RI Francischetti, Emilio/AAX-8544-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0263-6352
J9 J HYPERTENS
JI J. Hypertens.
PD JUN
PY 2003
VL 21
SU 4
BP S298
EP S298
PG 1
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 705QT
UT WOS:000184406701055
DA 2020-12-01
ER

PT J
AU DeRiemer, K
   Moreira, FM
   Barreto, AMW
   Braga, JU
AF DeRiemer, K
   Moreira, FM
   Barreto, AMW
   Braga, JU
TI Survey of mycobacteriology laboratory practices in an urban area with
   hyperendemic pulmonary tuberculosis
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE tuberculosis; laboratory training; biosafety; smear microscopy; Brazil
ID SPUTUM SMEAR MICROSCOPY; ACID-FAST BACILLI; RESISTANT TUBERCULOSIS;
   COUNTRIES; INFECTION
AB SETTING: Rio de Janeiro, Brazil, where 10 210 cases of tuberculosis (TB) were reported in 1997, 86.2% of them with pulmonary TB,
   OBJECTIVE: To assess laboratory resources, practices, biosafety measures and training needs relative to the volume of work required for the TB control program and implementation of directly observed therapy, short course (DOTS).
   DESIGN: A cross-sectional survey of laboratories that receive funds from the public sector and work with mycobacteria, using a structured questionnaire and onsite visits to collect data. The main outcome measure of interest was processing greater than or equal to 20 specimens per week.
   RESULTS: More than half (56.5%) of the laboratories reported performing <20 specimens per week, a level at which it is difficult to maintain proficiency in mycobacteriologic techniques. The demand for sputum smear microscopy was not met. Working conditions such as shared laboratory and air space, inadequate ventilation, accidents with biological specimens, and inadequate disposal of biological waste present risks of TB transmission to laboratory workers and other staff.
   CONCLUSION: Training and supervising laboratory workers in good technique and biosafety practices and providing the necessary organization, resources and working conditions will strengthen TB control and facilitate implementation of DOTS. Several simple interventions are proposed.
C1 Minist Saude, Ctr Referencia Prof Helio Fraga, Fdn Nacl Saude, BR-22710550 Rio De Janeiro, Brazil.
   Univ Calif Berkeley, Sch Publ Hlth, Div Publ Hlth Biol & Epidemiol, Berkeley, CA 94720 USA.
RP Barreto, AMW (corresponding author), Minist Saude, Ctr Referencia Prof Helio Fraga, Fdn Nacl Saude, Estrada Curicica 2000, BR-22710550 Rio De Janeiro, Brazil.
EM werneck@openlink.com.br
OI DeRiemer, Kathryn/0000-0002-8375-7505
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [K01TW000001, D43TW000003, D43TW000003,
   D43TW000003, D43TW000003, K01TW000001, D43TW000003, D43TW000003,
   D43TW000003, D43TW000003, D43TW000003, D43TW000003, D43TW000003,
   D43TW000003, K01TW000001, D43TW000003, D43TW000003, D43TW000003,
   K01TW000001, D43TW000003, D43TW000003, D43TW000003, D43TW000003,
   D43TW000003, D43TW000003, K01TW000001, D43TW000003, D43TW000003,
   D43TW000003, D43TW000003, D43TW000003, D43TW000003, D43TW000003,
   D43TW000003, D43TW000003, D43TW000003, K01TW000001, D43TW000003,
   D43TW000003, K01TW000001, K01TW000001, D43TW000003, D43TW000003,
   K01TW000001, D43TW000003, D43TW000003, D43TW000003, D43TW000003,
   D43TW000003, D43TW000003, K01TW000001, D43TW000003, D43TW000003,
   D43TW000003, D43TW000003, D43TW000003, D43TW000003, D43TW000003,
   D43TW000003, D43TW000003, D43TW000003, D43TW000003, D43TW000003,
   D43TW000003, D43TW000003, D43TW000003, D43TW000003] Funding Source: NIH
   RePORTER; FIC NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [K01 TW000001, D43-TW00003, K01 TW000001-01]
   Funding Source: Medline
CR [Anonymous], 1998, ANT DRUG RES WORLD
   *ASS STAT TERR PUB, 1995, MYC TUB ASS YOUR LAB
   Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0
   Bradford WZ, 1998, INFECT DIS CLIN N AM, V12, P157, DOI 10.1016/S0891-5520(05)70415-3
   CAVALCANTE SC, 1998, B PNEUMOLOGIA SANITA, V6, P81
   COLLIER TK, 1993, ENV SCI, V2, P161
   COLLINS CH, 1999, LAB ACQUIRED INFECT
   DASILVA EAM, 1992, REV I A LUTZ, V52, P37
   Davis YM, 1997, CLIN CHEST MED, V18, P19, DOI 10.1016/S0272-5231(05)70353-1
   De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457
   Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677
   ENARSON DA, 1995, TUBERCLE LUNG DIS, V76, P95, DOI 10.1016/0962-8479(95)90548-0
   ENARSON DA, 1996, TUBERCULOSIS GUIDE L, P49
   Espinal MA, 1998, INT J TUBERC LUNG D, V2, P490
   FARMER P, 1999, GLOBAL IMPACT DRUG R
   Fujiwara PI, 1997, INT J TUBERC LUNG D, V1, P297
   *FUND I BRAS GEOGR, 1998, CONT POP 1996
   Harries AD, 1997, B WORLD HEALTH ORGAN, V75, P477
   HEINSOHN PA, 1995, BIOSAFETY REFERENCE
   *MIN SAUD, 1995, MAN NORM CONTR TUB A
   Nyirenda TE, 1998, INT J TUBERC LUNG D, V2, P690
   Pinto Walkyria P., 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P15, DOI 10.1590/S0036-46651996000100004
   Pio A, 1997, B WORLD HEALTH ORGAN, V75, P569
   Royston P, 1992, STAT COMPUT, V2, P117, DOI DOI 10.1007/BF01891203
   Selvin S, 1995, PRACTICAL BIOSTATIST
   *SUBG DAD VIT, 1997, GER INF EP SECR SAUD, P1
   TENOVER FC, 1993, J CLIN MICROBIOL, V31, P767, DOI 10.1128/JCM.31.4.767-770.1993
   Van Deun A, 1998, INT J TUBERC LUNG D, V2, P756
   *WHO, 1995, WHOTB95191
   *WHO, 1998, WHOTB98247
   1998, INFECT CONTROL HOSP, V19, P370
NR 31
TC 9
Z9 10
U1 0
U2 0
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD AUG
PY 2000
VL 4
IS 8
BP 776
EP 783
PG 8
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA 344HG
UT WOS:000088752700013
PM 10949331
DA 2020-12-01
ER

EF